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Abstract 
 
Cell polarity is a fundamental property of most living cells, and its disruption is 
associated with diseases such as cancer. Members of the N-terminal RASSF protein 
family have been proposed to function as tumour suppressors and oncogenes, but the 
underlying mechanisms are not well understood. Proteomic approaches have recently 
linked the human N-terminal RASSFs to PP1 phosphatases, as well as its regulatory 
subunit ASPP and two RASSFs - RASSF9 and RASSF10 - showed additional 
associations to both planar cell polarity (PCP) proteins and the apical-basal polarity 
determinant Par3/Bazooka.  
This thesis investigates the developmental function of RASSF9 and RASSF10 in 
Drosophila. The human interaction network of RASSF9 and RASSF10 is largely 
conserved in Drosophila and additional interactors are revealed. In vitro both RASSFs 
can associate with PCP proteins and the polarity protein Bazooka. In the case of 
RASSF10 this work suggests a role in establishing cell polarity in the context of 
asymmetric cell divisions of sensory organ precursors (SOP), the progenitor cells that 
will give rise to the sensory bristles. Cell biological and genetic approaches provide 
evidence that RASSF10 functions, together with its interaction partners Dishevelled, 
Frizzled and Bazooka, in the initial polarisation of SOPs prior to their asymmetric 
division.  
The second part of my thesis investigates the function of the ubiquitin system at the 
kinetochore in relation to Spc25, which was previously characterised as a novel 
ubiquitin-binding protein. My data suggest that the ubiquitin-binding properties of 
Spc25 might be important for the stability of the KMN (Knl1/Mis12/Ndc80) network 
within the kinetochore complex, also supported by the findings that members of the 
KMN network, namely Dsn1, Nsl1 and Spc105 are ubiquitylated, giving them the 
potential to interact with the ubiquitin-binding domain of Spc25. Furthermore, my 
findings suggest that the ubiquitin system centred on the ubiquitin-binding activity of 
Spc25 and the KMN network is independent from ubiquitin-mediated degradation. 
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Chapter 1 Introduction 
 
In this thesis, I pursued two very different projects and therefore the introduction will 
cover these separately.  
The first project is centred on the developmental function of RASSF9/10 in 
Drosophila. Therefore I will briefly introduce Drosophila melanogaster as a model 
organism. I will then give an overview on the RASSF protein family with the main 
focus on N-terminal RASSFs. Next, PP1 phosphatases and their connection to N-
terminal RASSFs will be explored. I will then provide background to the molecular and 
functional settings for three potential interactors of RASSF9/10: Wg/Fz canonical 
signalling and planar cell polarity for Fz/Dsh and the role of Baz in polarity 
establishment. And lastly, asymmetric cell divisions of sensory organ precursors of the 
peripheral nervous system will be outlined, in which both planar cell polarity and 
apical-basal polarity are implicated. 
The second project is based on the function of the ubiquitin system associated with 
Spc25 at the kinetochore in Saccharomyces cerevisiae. Firstly, I will briefly introduce S. 
cerevisiae as a model organism and then cover three main topics: the ubiquitin system, 
the yeast kinetochore, with the main focus on Spc25 and lastly I will introduce Spc25 as 
a novel ubiquitin-binding protein.  
 
1.1 Drosophila melanogaster as a model organism 
1.1.1 Advantages and development 
Drosophila melanogaster, commonly referred to as the fruit fly, has been studied for 
over 100 years. Sequencing of the fly genome in the year 2000 (Adams et al., 2000) and 
genomic comparative analysis revealed that about 70% of human disease genes have 
homologous sequences in the Drosophila genome (Reiter et al., 2001). Consequently, 
Drosophila represents an ideal model organism to study functions of genes in disease as 
well as developmental processes. Moreover, Drosophila has only four chromosomes 
(one sex chromosome and 3 autosomes), making genetic manipulations relatively 
straightforward. The genetic toolkit for Drosophila has vastly expanded over the years 
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and there are multiple strategies to generate transgenic flies, harbouring for example 
gene deletions or genomic insertions (see Material and Methods) (del Valle Rodriguez 
et al., 2012, St Johnston, 2013). There are many different resources available, such as 
RNAi collections for knock-down of genes of interest or tagged transgenes. Besides the 
genetic advantages, the maintenance of flies is cheap and simple. Another major benefit 
is the short life cycle: it takes just 10 days for the development of a fertilised egg to the 
adult fly when kept at 25 °C.  
The life cycle comprises four stages, namely the embryo, larva, pupa and adult. The 
embryo develops within one day after fertilisation and hatches as a first instar larva, 
which then grows over the next four to five days, increasing its weight about 200 times 
(from first to second to third larval instar) (Stocker and Gallant, 2008). The third instar 
larva pupariates and after four to five days the adult fly emerges. During metamorphosis 
in the pupal stage, adult tissues are formed and most larval tissues are removed. The 
adult structures such as eyes, wing, legs and thorax develop from larval epithelial 
structures - the so-called imaginal discs. The different stages and tissues provide a 
variety of model systems to choose from to analyse different processes such as 
proliferation, cell death and differentiation. 
 
1.1.2 The development of the wing imaginal disc 
In this thesis I have primarily worked with wing imaginal discs, as well as pupal or 
adult wing and notum. Therefore I will briefly introduce their development. Imaginal 
discs are epithelial structures, which derive from the embryonic epithelium (Bate and 
Arias, 1991). During larval development they grow exponentially - the wing imaginal 
disc starts from 30 cells and consist of approximately 50.000 cells when reaching the 
pupal stage (Milán et al., 1996). With the onset of metamorphosis the wing imaginal 
disc undergoes morphological changes and gives rise to the wing (hinge and blade) as 
well as part of the notum (the other part is contributed by the leg disc (Zeitlinger and 
Bohmann, 1999)) (Figure 1.1) (Stocker and Gallant, 2008). The differential expression 
of several organisers, such as Hedgehog, Engrailed, Wingless and Dpp 
(Decapentaplegic), defines the growth and patterning of the distinct compartments 
(Gomez-Skarmeta et al., 2003).  
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Figure 1.1 - The wing imaginal disc and corresponding adult structures. 
The adult wing (hinge and blade) and part of the adult notum are formed from the wing 
imaginal disc (on the left). Dpp (red) is expressed along the anterior-posterior boundary and Wg 
(green) along the dorsal-ventral boundary.  
 
 
1.2 N-terminal RASSFs 
1.2.1 The Ras association domain family 
The Ras association domain family (RASSF) comprises a group of proteins that share a 
conserved domain - the Ras association (RA) domain. According to the position of RA 
domain, RASSFs are classified into classical RASSFs (RA domain at C-terminus) and 
N-terminal RASSFs (RA-domain at N-terminus) (Sherwood et al., 2010). In humans 
there are 6 different classical RASSFs (RASSF1-6) and 4 N-terminal RASSFs 
(RASSF7-10) (Figure 1.2). None of these contain any known enzymatic domains and 
they therefore appear to be scaffold proteins. Besides their RA domain, classical 
RASSFs have a Salvador/RASSF/Hippo (SARAH) domain at their C-terminus, which 
gives them the potential to homo-dimerise or hetero-dimerise with other SARAH 
domain proteins, such as Mst1/2 (Mammalian Sterile 20-like, Drosophila Hippo) (Chan 
et al., 2013, Scheel and Hofmann, 2003). N-terminal RASSFs lack the SARAH domain, 
but have predicted coiled-coil regions towards their C-termini. The name of the RA 
domain implies that RASSFs interact with Ras GTPases. Many of them can indeed bind 
to Ras or other small GTPases in vitro (Rodriguez-Viciana et al., 2004), but for example 
RASSF8 and RASSF10 lack this ability, and the RA domain of these proteins are likely 
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to bind other ligands (Chan et al., 2013). Indeed, the functional relevance of binding to 
small GTPases still needs to be established in most RASSF family members (Sherwood 
et al., 2010). Strikingly, RASSFs are misregulated in various forms of cancer, making 
them of high interest for research (Sherwood et al., 2010, Volodko et al., 2014, Richter 
et al., 2009).  
 
 
 
 
Figure 1.2 - Domain structure of the human RASSF family.  
The human RASSF family consists of classical RASSFs (RASSF1-6) and N-terminal RASSFs 
(RASSF7-10) (figure adapted from (Sherwood et al., 2010)). N-terminal RASSFs contain an N-
terminal RA domain (purple) and predicted coiled-coil regions (green). Besides their RA 
domains, classical RASSFs also have SARAH domain (blue) at the C-terminus, which enables 
them to form homo- and heterodimers. RASSF1 and RASSF5 also contain cysteine rich C1 
domains (orange). 
  
 
1.2.2 Human N-terminal RASSFs are associated with various cancers 
In the following sections, I will present what is known about the human N-terminal 
RASSFs and then introduce the Drosophila homologues in the next subchapters. 
RASSF7 is a candidate oncogene, as RASSF7 expression is found to be upregulated 
in various cancers (Sherwood et al., 2010). Consistent with this, its expression can be 
induced by hypoxia (Recino et al., 2010), which often occurs in tumours. Studies in 
Xenopus embryos and human cell culture demonstrated that it is required for normal 
mitosis, as knockdown of RASSF7 prevents spindle formation and induces growth 
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arrest (Recino et al., 2010, Sherwood et al., 2008). Indeed, RASSF7 localises to the 
centrosomes (Recino et al., 2010, Sherwood et al., 2008) and is thought to promote 
tubulin growth (Recino et al., 2010). Another study suggested that RASSF7 has an 
additional function in negatively regulating the pro-apoptotic function of JNK signalling 
by interacting with the small GTPase N-Ras and the Map kinase MKK7, thus 
preventing MKK from activating JNK (Takahashi et al., 2011).  
In contrast to RASSF7, RASSF8 seems to act as a tumour suppressor. RASSF8 
mRNA expression is downregulated in lung cancer tissue and ectopic expression can 
inhibit colony formation of lung cancer cell lines (Falvella et al., 2006). These findings 
were further supported by a more recent study, which showed that RASSF8 depletion 
increases colony formation and tumour growth in mouse xenograft experiments (Lock 
et al., 2010). Importantly, this study showed that RASSF8 localises to the cell junctions, 
and upon reduction of RASSF8 levels, junction formation is inhibited, as indicated by 
mislocalisation of the junctional components β-catenin and E-cadherin. As a mechanism 
for the tumour formation upon RASSF8 depletion, it has been proposed that the 
destabilisation of junctions firstly increases cytoplasmic β-catenin levels, thus 
promoting Wnt/β-catenin signalling (Wg/Fz signalling, see 1.4.1) and secondly 
increases anti-apoptotic NF-κB signalling (Lock et al., 2010).  
RASSF9, formerly known as P-CIP1 (PAM C-terminal interactor protein-1), was 
suggested to function in the endosomal trafficking of peptidylglycine α-amidating 
monooxygenase (PAM) (Chen et al., 1998). However, this hypothesis is based on the in 
vitro interaction between PAM and RASSF9, as well as the subcellular localisation of 
ectopically expressed RASSF9 (which was found enriched in endosomes), thus further 
research would be necessary to validate this proposed function. More recently, the 
function of RASSF9 was revisited. In mice and rats RASSF9 mRNA is widely 
expressed with strong expression in heart, lung, kidney and skin (Lee et al., 2011, Chen 
et al., 1998). In the skin, RASSF9 is specifically expressed in the epidermal 
keratinocytes and is important for normal epidermal homeostasis, as loss of RASSF9 
leads to hyperproliferation and impaired differentiation of keratinocytes in mice (Lee et 
al., 2011). Interestingly, mice mutant for RASSF9 are also reduced in size and life span 
(Lee et al., 2011). The underlying mechanisms of the function of RASSF9 still need to 
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be resolved. Moreover, there are contradicting reports about whether or not RASSF9 is 
able to bind to Ras GTPases in vitro (Rodriguez-Viciana et al., 2004, Chan et al., 2013).  
RASSF10 is considered to be a potential tumour suppressor based on the finding that 
it is epigenetically silenced by promoter methylation in a variety of cancers, such as 
gastric cancer, prostate cancer, glioblastomas, pancreatic cancer, childhood leukaemia 
and thyroid cancer (Dansranjavin et al., 2012, Hill et al., 2011, Schagdarsurengin et al., 
2009, Wei et al., 2013, Hesson et al., 2009, Richter et al., 2012). In addition, RASSF10 
overexpression inhibits colony formation of cancer cell lines (Wei et al., 2013, Hill et 
al., 2011) and reduces tumour growth in mouse xenograft experiments (Wei et al., 2013, 
Guo et al., 2015), while reduction of RASSF10 levels induces colony formation (Hill et 
al., 2011). So far two different models have been suggested how RASSF10 acts as a 
tumour suppressor based on changes in expression profiles. Firstly, it has been proposed 
that RASSF10 activates p53 by inhibition of the p53 inhibitor Mdm2 and thus promotes 
the expression of pro-apoptotic genes (Guo et al., 2015). Secondly, RASSF10 was 
suggested to inhibit growth by supressing Wnt/β-catenin signalling (Wei et al., 2013). 
However, the mechanism(s) of how RASSF10 functions in either pathway still needs to 
be resolved. Interestingly, RASSF10 was found to be cytoplasmic and localises to the 
spindle poles during mitosis in cell lines (Hill et al., 2011), similar to RASSF7, 
suggesting a potential additional mitotic role.  
 
1.2.3 N-terminal RASSFs in Drosophila 
In Drosophila, the RASSF family contains four members: one classical RASSF (see 
1.3.2) and three N-terminal RASSFs (RASSF8-10). RASSF8 is the homologue of 
human RASSF7 and RASSF8 and the Drosophila genes CG13875 and CG32150 are 
believed to encode the homologues of mammalian RASSF9 and RASSF10 (Sherwood 
et al., 2010). I will subsequently refer to CG13875 as RASSF9 and to CG32150 as 
RASSF10, as this nomenclature has already been introduced (Sherwood et al., 2010).  
The function of RASSF8 has been extensively studied in our lab and it was shown 
that RASSF8 is an important factor for junctional integrity (similar to human RASSF8), 
together with its binding partner ASPP (see following subchapter).  
In contrast, the function of RASSF9 and RASSF10 in Drosophila has not been 
analysed in detail. There have been no reports about RASSF9. Although the function of 
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RASSF10 has so far not directly been addressed, it has been recovered in different high-
throughput approaches. Firstly, in a genome-wide RNAi screen, RASSF10 was found to 
negatively regulate Hedgehog signalling (Nybakken et al., 2005). Strikingly, in 
microarray screens, RASSF10 mRNA was shown to be highly and specifically 
expressed in sensory organ precursors of the peripheral nervous system in wing 
imaginal discs and the pupal notum (Reeves and Posakony, 2005, Buffin and Gho, 
2010). Furthermore, the mRNA expression seems to be regulated by the proneural 
Achaete-Scute complex (Reeves and Posakony, 2005). Interestingly, in Xenopus 
tadpoles RASSF10 mRNA is prominently expressed in the brain, suggesting a potential 
role for RASSF10 in neurogenesis (Hill et al., 2011).  
 
1.2.4 RASSF8 and ASPP 
Drosophila RASSF8, similar to human RASSF8, is important for the junctional 
remodelling in the developing retina, which undergoes drastic morphological changes. 
During the development of the retina, excess cells are removed by apoptosis and new 
junctions are formed to give rise to the perfectly patterned compound eye. Our lab has 
shown that RASSF8 acts together in this process with another scaffold protein - ASPP 
(apoptosis stimulating protein of p53, or Ankyrin-repeat, SH3-domain and proline-rich-
region containing protein). RASSF8 can directly bind to ASPP and both proteins 
require each other for their specific localisation at the adherens junctions (Langton et al., 
2009). Loss of either of the proteins leads to gaps in the adherens junction belts as well 
as mis-arrangements of the cells, causing a rough eye phenotype (Langton et al., 2009, 
Langton et al., 2007). How do RASSF8 and ASPP regulate the junctional remodelling? 
Our lab found that ASPP is required for the activity of the C-terminal Src kinase (Csk) 
at the junctions, where it normally inhibits the activity of Src kinase and thus prevents 
Src from disassembling the junctions (Langton et al., 2009, Langton et al., 2007). 
Recently it has been shown that the localisation of the ASPP-RASSF8 complex in 
interommatidial cells is dependent on the scaffold protein Magi, which seems to 
position them at the adherens junctions, most likely by direct binding to RASSF8 
(Zaessinger et al., 2015). Furthermore this study proposed an additional mechanism: 
Magi together with the ASPP-RASSF8 complex recruits the polarity determinant 
Bazooka (Baz, vertebrate Par3) to the developing junctions (Zaessinger et al., 2015), 
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which in turn could promote the deposition of new junctional material (see 1.5). Further 
investigations are necessary to test whether and how the Csk/Src and Baz-mediated 
mechanisms are connected.    
Flies mutant for either ASPP or RASSF8 are overgrown, suggesting that they both act 
as tumour suppressors (Langton et al., 2009, Langton et al., 2007). However, the 
phenotypes of ASPP or RASSF8 mutants are not completely identical, suggesting that 
they also have independent functions. For instance, loss of RASSF8 induces a wing 
rounding phenotype that is not observed in ASPP mutants (Langton et al., 2009), 
probably due to a defect in proximal-distal axis elongation.   
While Drosophila has a single ASPP protein, there are three different mammalian 
ASPP isoforms - ASPP1, ASPP2 and iASPP (inhibitor of ASPP). ASPP proteins are 
dysregulated in many cancers and can act as tumour suppressors (ASPP1/2) and 
oncogenes (iASPP) (Sullivan and Lu, 2007). As the name suggests mammalian ASPPs 
can bind to p53 (Bergamaschi et al., 2004, Bergamaschi et al., 2003). While ASPP1/2 
promote the activity of p53 in activating the transcription of pro-apoptotic genes (e.g. 
Bax, Pig3) (Samuels-Lev et al., 2001, Bergamaschi et al., 2004), iASPP inhibits p53 
(Bergamaschi et al., 2003). Drosophila ASPP is considered the homologue of ASPP1/2, 
but in contrast does not appear to regulate the activity of p53, as ASPP mutants do not 
phenocopy Drosophila p53 mutant (failure of radiation-induced cell death) and the 
ASPP1/2 contact residues on p53 are not conserved in flies (Langton et al., 2007).  
In addition to its nuclear function in promoting p53 activity, ASPP2, like Drosophila 
ASPP, localises to the tight junctions (in Drosophila to the adherens junctions) in 
mammalian epithelial cells and is required for junctional integrity (Cong et al., 2010). 
ASPP2 associates with Par3 and recruits it to the junctions, thus promoting their 
formation as well as polarity establishment (Sottocornola et al., 2010, Cong et al., 2010). 
Considering that in Drosophila ASPP acts together with RASSF8 (and Magi) to recruit 
Baz (Zaessinger et al., 2015) it would be interesting to see whether RASSF8 is also 
implicated in Par3 recruitment in mammalian systems, especially since human RASSF8 
is also required for the integrity of cell junctions (Lock et al., 2010) and can bind to 
ASPP1/2 (Langton et al., 2009).  
In addition to the described characteristics and potential functions of the mammalian 
N-terminal RASSFs (1.2.2) and ASPP isoforms, they all interact with the catalytic 
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subunits of PP1 serine/threonine phosphatases and especially ASPP is a well-described 
regulatory subunit with identified ASPP/PP1 substrates (see following subchapter). 
 
1.3 Serine/threonine phosphatases - connections to RASSF 
and ASPP protein families 
Protein phosphorylation is an important post-translational modification. Kinases 
catalyse the transfer of the γ phosphate from ATP to certain amino acid residues, mostly 
serine, threonine or tyrosine residues. Protein phosphorylation is crucial for a variety of 
cellular functions, for instance allowing specific interactions between proteins, defining 
their subcellular localisation, targeting proteins for degradation or changing the activity 
of enzymes. Importantly, protein phosphorylation is reversible, since phosphates can be 
removed by phosphatases. The regulation of proteins by the opposing interplay of 
kinases and phosphatases allows modulating different cellular functions and signalling 
events.  
 
1.3.1 PP1, a protein serine/threonine phosphatase 
Phosphoprotein phosphatases (PPP) form one of the four described phosphatase 
superfamilies, and specifically dephosphorylate serine and threonine residues (Boens et 
al., 2013). Members of the PPP superfamily - namely PP1, PP2A, PP2B (PP3 or 
Calcineurin), PP4, PP5, PP6 and PP7 - have highly similar catalytic domains, which 
require binding of metal ions (Mg2+ or Mn2+) (Shi, 2009). Catalytic subunits exhibit 
little intrinsic substrate specificity - therefore they associate with regulatory subunits, 
which allow specific binding of substrates, often define the subcellular localisation of 
the catalytic subunit, and sometimes restrict access to the catalytic site.  
PP2A holoenzymes are heterotrimeric complexes and consist of a catalytic subunit C, 
a scaffold subunit A (C and A exist as a heterodimer) and a regulatory subunit B, which 
specifies the substrate. PP1 holoenzymes are composed of a catalytic subunit, and one 
of a large array of regulatory subunits (around 200 candidates have been identified so 
far) (Boens et al., 2013). In humans there are four different catalytic subunits: PP1α, 
PP1β/δ, and the two splice variants, PP1γ1 and PP1γ2 (Peti et al., 2013). Drosophila also 
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has four different catalytic subunits, but these are encoded by separate loci. PP1α96A, 
PP1α87B and PP1α13C, which represent homologues of human PP1α and PP1γ, and 
PP1β9C, which is related to human PP1β/δ (Kirchner et al., 2007). PP1 catalytic 
subunits share a high level of sequence identity, thus it is not surprising that most 
regulatory subunits can bind to all subunits, however, some regulatory subunits can 
discriminate between catalytic subunits. For example, Drosophila MYPT-75D (myosin 
phosphatase targeting subunit, homologue of human MYPT1) associates solely with the 
PP1β9C subunit (Kirchner et al., 2007). Most, but not all, of the regulatory subunits 
interact with the PP1 catalytic subunits through conserved motifs. So far 10 different 
motifs were described (Boens et al., 2013), such as the highly common RVxF motif, the 
SILK motif, the MyPhoNE (myosin phosphatase N-terminal element) motif and the 
RARL motif to name a few (Hendrickx et al., 2009, Wakula et al., 2003).  
Besides the substrate-specifying regulatory subunits, catalytic subunits can bind to 
inhibitory subunits (e.g. Inhibitor-1, Inhibitor-2, CPI-17), which suppress the activity of 
the catalytic subunit by sterically obstructing the catalytic domain (Boens et al., 2013), 
as seen for example in the crystal structure of Inhibitor-2 and PP1 (Hurley et al., 2007). 
Interestingly, in some instances, the regulatory and inhibitory subunits form trimeric 
complexes with the catalytic domain, e.g. the Spinophilin/Inhibitor-2/PP1 complex. 
Structural analysis showed that, in the trimeric complex, Inhibitor-2 binds to PP1 
through its SILK motif instead of the RVxF motif, leaving the RVxF binding surface 
free for the regulatory subunit Spinophilin (Dancheck et al., 2011). Although there are 
no reports for the simultaneous binding of two regulatory subunits, it is possible that 
trimeric complexes could also exist through differential binding to the PP1 surface. 
Importantly, structural data obtained so far suggest that neither binding of regulatory 
nor inhibitory subunits changes the confirmation of the catalytic subunit (Peti et al., 
2013).    
In the following section I will give an overview of the connections between PPP and 
classical RASSFs, the ASPP protein family and N-terminal RASSFs.   
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1.3.2 Drosophila RASSF functions with PP2A as a negative regulator of 
Hippo signalling 
In Drosophila there is solely one classical RASSF, which has been shown to bind to the 
serine/threonine kinase Hippo to suppress the Hippo signalling pathway, a major growth 
control pathway (Polesello et al., 2006). The conserved Hippo pathway promotes 
inhibition of cell proliferation as well as induction of apoptosis (Yu and Guan, 2013). 
Briefly, activation of Hippo (mammalian Mst1/2) results in the phosphorylation by the 
downstream kinase Warts (mammalian LATS) of the transcriptional co-activator Yorkie 
(mammalian YAP and TAZ), which is thereby retained in the cytoplasm and cannot 
activate its pro-growth transcriptional programme in concert with transcription factors 
such as Scalloped (Yu and Guan, 2013).  
Another study provided the underlying mechanism by which RASSF regulates Hippo 
signalling: RASSF is part of the STRIPAK (Striatin-interacting phosphatase and kinase) 
PP2A phosphatase complex, which inhibits Hippo by dephosphorylating sites required 
for its activity (Ribeiro et al., 2010). Although all human classical RASSFs can bind to 
Mst1/2, RASSF3 is the only one interacting with the STRIPAK complex (Hauri et al., 
2013), suggesting that not all classical RASSFs inhibit Mst1/2 similarly to Drosophila 
RASSF. This is also consistent with previous findings that some of the human classical 
RASSFs promote Mst1/2 activity, for example RASSF1A prevents PP2A from 
dephosphorylating and thus inhibiting Mst1/2 (Guo et al., 2011). It will be interesting to 
test whether RASSF3, like Drosophila RASSF, acts together with PP2A to inhibit 
Hippo signalling. 
 
1.3.3 ASPP is a PP1 substrate specificity subunit 
The three mammalian ASPP isoforms can all bind to PP1 catalytic subunits (Llanos et 
al., 2011, Skene-Arnold et al., 2013). Moreover, ASPP1 and ASPP2 interact with PP1 
catalytic subunits via the RVxF motif, while iASPP, which lacks the RVxF motif binds 
to PP1 through a RARL motif (Llanos et al., 2011, Skene-Arnold et al., 2013). ASPP 
family proteins may therefore act as specificity subunits for PP1 complexes. Indeed, 
different studies provided evidence for functional ASPP/PP1 complexes.  
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Phosphorylation of the mammalian Hippo pathway transcriptional co-activators YAP 
and TAZ (the mammalian Yorkie homologues) prevents their nuclear localisation 
therefore shutting down their transcriptional activity (Yu and Guan, 2013). Both YAP 
and TAZ have been shown to be dephosphorylated by PP1 in vitro (Wang et al., 2011, 
Liu et al., 2011) and also that they can bind to ASPP2 (Hauri et al., 2013, Liu et al., 
2011). Furthermore, expression of ASPP2 decreases phospho-YAP (Royer et al., 2014) 
or TAZ (Liu et al., 2011) levels in HEK293 cells, while PP1-binding mutants of ASPP2 
(affecting the RVxF motif) have no such effect. In agreement with this, ASPP1/2 
expression increases YAP/TAZ transcriptional activity, while its depletion has the 
opposite effect (Royer et al., 2014, Liu et al., 2011, Hauri et al., 2013). Interestingly, in 
the case of YAP, ASPP2 functions at junctions to recruit PP1 and to specifically 
dephosphorylate junctional YAP (Royer et al., 2014). Thus, the ASPP2/PP1 complex 
promotes the nuclear localisation of YAP/TAZ. It is interesting to note that this pro-
growth function contrasts with ASPP1/2 tumour-suppressive role in promoting p53 
activity (see 1.2.4), suggesting that ASPP’s role in in different types of cancer may be 
determined by its sub-cellular localisation. 
Recently another substrate was identified for the ASPP/PP1 complex - the 
centrosome linker protein C-Nap1, which promotes the assembly of centrosomes 
(Zhang et al., 2015). Phosphorylation of C-Nap1 by the kinase NEK2A prior to mitosis 
is thought to promote centrosome linker disassembly, thus facilitating centrosome 
duplication and formation of a bipolar spindle, while PP1 counteracts C-Nap1 
phosphorylation (Meraldi and Nigg, 2001). C-Nap1 interacts with both ASPP1 and 
ASPP2, which bridge its interaction with PP1 (Zhang et al., 2015), and PP1 can 
dephosphorylate the NEK2A phosphorylation sites in vitro (Helps et al., 2000). 
Importantly, overexpression of either ASPP1 or ASPP2, but not of PP1-binding mutants 
reduces the phosphorylation levels of C-Nap1 (Zhang et al., 2015). Lastly, simultaneous 
knockdown of ASPP1 and ASPP2 causes defects in centrosome assembly in late 
telophase, suggesting that they act redundantly (Zhang et al., 2015). In conclusion these 
studies provide evidence that mammalian ASPP1/2 act as regulatory subunits of PP1 
providing specificity for several substrates and directing the localisation of PP1.   
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1.3.4 N-terminal RASSFs in the PP1 network 
A recent study revealed potential novel functions for human N-terminal RASSFs. Hauri 
et al. established an interaction network for N-terminal RASSFs by performing mass 
spectrometry on affinity purifications of different bait proteins (Hauri et al., 2013). 
Strikingly, all of the N-terminal RASSFs interacted with PP1 catalytic subunits (PP1α, 
PP1β/δ and PP1γ) as well as ASPP family proteins, ASPP1 and ASPP2 (see Figure 1.3).  
 
 
 
Figure 1.3 - Interaction network of N-terminal RASSFs, ASPP and PP1. 
Affinity purification of bait proteins (hexagons) was followed by mass spectrometry to allow 
identification of interactors (prey proteins, circles). Arrows indicate the direction of the affinity 
purification. Interaction network between PP1 catalytic subunits (blue), known PP1 regulatory 
subunits (grey), ASPP family proteins (green), N-terminal RASSFs (orange), Ccdc85 family 
proteins (yellow) and potential substrates (purple) (adapted from (Hauri et al., 2013)). Dashed 
lines indicate that there is just an interaction with one of the subunits/isoforms.  
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These results suggested that N-terminal RASSFs could be part of the previously 
described ASPP/PP1 complexes and thus be additional substrate-specifying regulatory 
subunits. 
In addition, this study revealed novel and specific interactors for human RASSF9 
and RASSF10, as they were found to co-purify several core planar cell polarity proteins 
- Dishevelled, Prickle and Vang - as well as the polarity determinant Par3, which could 
be potential substrates of N-terminal RASSF/ASPP/PP1 complexes (see Figure 1.3) 
(Hauri et al., 2013). Importantly, PP1 was previously shown to dephosphorylate Par3 at 
several residues important for its subcellular localisation in vitro (Traweger et al., 2008), 
however the regulatory subunit(s) involved are unknown. In the case of ASPP and 
RASSF8 this could explain how they might influence the junctional integrity via Par3, 
which has been reported to promote the recruitment of E-cadherin clusters to 
remodelling junctions (McGill et al., 2009, McKinley et al., 2012). Thus, the data 
presented by Hauri et al., opens the possibility that the N-terminal RASSFs function in 
the context of cell polarity as part of PP1 phosphatase complexes. In the following 
subchapters I will therefore introduce the functions and regulation of core planar cell 
polarity proteins and the polarity determinant Baz/Par3 in Drosophila. 
 
1.4 Canonical Wg/Fz signalling and planar cell polarity 
The canonical Wg/Fz signalling pathway and the planar cell polarity (PCP) pathway 
share two common components: the seven-pass transmembrane receptor Frizzled (Fz) 
and its effector Dishevelled (Dsh in flies, Dvl in mammals). Both pathways were first 
described in Drosophila, however mammalian homologues have been identified and 
were demonstrated to be conserved and essential in vertebrates. Though both pathways 
function through Fz and Dsh, their mechanisms and outputs are very different. While 
canonical Wg/Fz signalling results in activation of transcriptional expression of target 
genes via Armadillo (Arm, β-catenin in vertebrates), the PCP pathway establishes the 
polarisation of cells along a tissue axis visible by the asymmetric distribution of its core 
components and subsequently of its effectors (Strutt, 2003). 
Wg (Wingless) was the first of the seven Wnt genes to be identified in Drosophila 
and is the ligand/signal that activates the canonical cascade. 
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mutant alleles of wg and other pathway members demonstrated the importance of 
Wg/Fz signalling in Drosophila development. Loss of canonical Wg/Fz signalling at the 
embryonic stage is lethal and leads to segmentation and multiple patterning defects in 
embryos (Patel et al., 1989, Lawrence et al., 1995, Immergluck et al., 1990). During 
larval stages Wg/Fz signalling is required for a number of processes, such as wing 
growth and patterning (Sharma and Chopra, 1976, Johnston and Sanders, 2003, 
Giraldez and Cohen, 2003, Neumann and Cohen, 1996, Martinez Arias, 2003) and 
patterning for the development of the peripheral nervous system (Phillips and Whittle, 
1993, Couso et al., 1994). Dsh was early on demonstrated to be essential for Wg/Fz 
signalling, as complete loss of Dsh function resulted in wg-like phenotypes (Perrimon 
and Mahowald, 1987). Strikingly, Frizzled was not discovered as the Wg/Wnt receptor 
until almost 10 years later (Bhanot et al., 1996), due to the redundancy between the two 
frizzled genes fz and fz2. Loss of function of neither fz nor fz2 caused wg-like 
phenotypes on their own, however Wg/Fz signalling was disrupted upon loss of both 
(Chen and Struhl, 1999), finally demonstrating the absolute requirement for Fz 
receptors in transducing the Wg signal. In vertebrates, canonical signalling is essential 
for normal development and its disruption causes diverse diseases including cancer 
(reviewed in (Clevers and Nusse, 2012, Clevers, 2006)), making the canonical Wg/Fz 
signalling pathway a field of great therapeutic interest. 
The Arm/β-catenin-independent functions of Fz and Dsh were discovered early on, 
since viable mutant alleles caused defects in the planar polarisation of trichomes and 
sensory bristles on the adult fly (Theisen et al., 1994, Adler et al., 1987), distinct to Wg 
or Arm loss of function. Mutational analysis, followed by genetic interaction studies in 
Drosophila revealed other genes that were required for establishing the polarity within 
the plane of the tissue/epithelium leading to the definition of the PCP pathway. In the 
following sections, I will firstly introduce the canonical Wg/Fz signalling pathway and 
the PCP pathway. I will then highlight the different requirements for Fz and Dsh in both 
pathways and lastly look at post-translational modifications of Fz/Dsh. 
 
1.4.1 The canonical Wg/Fz signalling pathway 
Over 30 years of research in multiple model systems including Drosophila, Xenopus 
and mammals has led to the following model of the signalling cascade. In the canonical 
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Wg/Fz pathway, Frizzled functions as the receptor for Wg/Wnt ligands and the 
signalling cascade ultimately leads to Armadillo (Arm, β-catenin in vertebrates) 
dependent activation of the expression of multiple target genes, leading to a variety of 
cellular responses. In the absence of Wg/Wnt, cytoplasmic Arm/β-catenin is associated 
with GSK3 (glycogen synthase kinase 3, Shaggy in flies), Axin and APC (adenomatous 
polyposis coli) (Hamada et al., 1999, Yu et al., 1999, Itoh et al., 1998), which promotes 
phosphorylation of Arm/β-catenin by GSK3 and Casein Kinase I (CKI) (Yanagawa et 
al., 2002, Pai et al., 1997). Phosphorylated Arm/β-catenin is targeted for ubiquitylation 
and subsequent proteasomal degradation via the SCFβ-TrCP complex (Jiang and Struhl, 
1998, Aberle et al., 1997, Winston et al., 1999), thus limiting its cytoplasmic 
accumulation. In the nucleus, the Wg/Wnt signalling responsive transcription factor 
TCF (T cell factor) is bound to the co-repressor Groucho, and supresses the expression 
of Wg/Wnt target genes in the absence of a ligand (Cavallo et al., 1998, Lawrence et al., 
2000).  
The pathway is activated by the presence of Wg/Wnt ligands. Secreted Wg/Wnt 
binds to the extracellular cysteine-rich region of the N-terminus of Frizzled receptors, 
which then associate with their co-receptor Arrow (mammalian LPR5/6) (Tolwinski et 
al., 2003, Wehrli et al., 2000, Tamai et al., 2000). The signal is transmitted via Dsh 
binding to the intracellular domains of Fz (Wong et al., 2003) and “activated” Dsh 
protects Arm/β-catenin from degradation (see below). The cytoplasmic stabilised 
Arm/β-catenin translocates to the nucleus where it associates with TCF (van de 
Wetering et al., 1997) and together with the other co-activators Pygopus and Legless 
(mammalian BCL9) (Thompson et al., 2002, Kramps et al., 2002), activates the 
expression of various Wg/Wnt target genes.  
The role of Dsh and how exactly Arm/β-catenin is stabilised are still not clear. Upon 
activation of the signalling cascade Axin was shown to be recruited and to interact with 
LPR5 at the membrane (Mao et al., 2001), subsequently disassembling the GSK3-Axin-
APC destruction complex. One suggested role for Dsh is the recruitment of Axin to the 
membrane (Cliffe et al., 2003, Kishida et al., 1999), and both proteins were shown to 
directly bind to each other (Fiedler et al., 2011). Interestingly, the phosphorylation state 
of Axin appears to be important for the maintenance of the destruction complex. 
Phosphorylation of Axin by CKI promotes its binding to GSK3, whereas 
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dephosphorylation by PP1 destabilises the destruction complex in cell culture 
experiments (Luo et al., 2007, Kim et al., 2013). Moreover, cell culture overexpression 
experiments suggest that the association of Axin and LPR5/6 depends on GSK3 and 
CKI-mediated phosphorylation of the co-receptor itself (Zeng et al., 2005), which 
requires both Fz and Dsh (Zeng et al., 2008).  
The published work suggested a model in which Arm/β-catenin stabilisation is 
achieved via inactivation/disassembly of the destruction complex. However, a 
contrasting model was recently proposed (Li et al., 2012). In this study the authors 
found by looking at endogenous protein levels in HEK293 cells that activation of the 
signalling cascade does not interfere with the assembly of the destruction complex, but 
instead appears to block ubiquitylation of phosphorylated β-catenin, which then stays 
associated with the destruction complex (which is still recruited to Dsh-LPR5/6) and 
unbound, unphosphorylated β-catenin is then free transfer to the nucleus. In another 
recent study an additional mechanism of Arm/β-catenin stabilisation via endocytosis 
was proposed, since inhibition of endocytosis decreased Arm/β-catenin levels 
independently of the GSK3-Axin-APC destruction complex in Drosophila (Gagliardi et 
al., 2014). Further research will be necessary to elucidate the mechanism(s) by which 
Arm/β-catenin is stabilised upon activation by Wg/Wnt and especially how Dsh, which 
is essential for this process, contributes to the signalling cascade.  
 
1.4.2 Planar cell polarity 
There are two types of polarity in most epithelial cells: apical-basal polarity (see 1.5) 
and PCP. PCP is required for correct tissue morphogenesis and disruption of the 
pathway elicits visible phenotypes on all cuticular epithelial structures of the adult fly - 
making Drosophila an ideal model to study PCP. In Drosophila the components of the 
core PCP pathway are: Fz, Dsh, the cytoplasmic proteins Diego (Dgo) and Prickle (Pk), 
the four-pass transmembrane protein Strabismus (Stbm, or Van Gogh, Vang) and the 
seven-pass transmembrane protocadherin Flamingo (Fmi, or Starry night/Stan). Loss of 
any of the core components leads to typical PCP defects, such as swirly trichomes 
(hairs) on the wing and body, random orientation of sensory bristles (except for Dgo 
(Feiguin et al., 2001)) and of ommatidia in the eye (Adler et al., 1987, Theisen et al., 
1994, Usui et al., 1999, Feiguin et al., 2001, Wolff and Rubin, 1998, Taylor et al., 1998, 
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Gubb and Garcia-Bellido, 1982). All components are conserved in vertebrates, and PCP 
has been shown to be involved in many different processes (in epithelia as well as non-
epithelial tissues), such as hair orientation, neural tube closure and gastrulation in mice 
(Singh and Mlodzik, 2012). However, the analysis of PCP in vertebrates is more 
complex compared to Drosophila due to redundancy between the homologues of the 
core components. Hence, Drosophila remains the preferred model system for 
elucidating the mechanisms involved in establishing PCP. 
The core PCP pathway operates in parallel to a second molecular system - the 
Fat/Dachsous/Four-jointed (Ft/Ds/Fj) system, which is composed of the atypical 
cadherins Ft and Ds and the Golgi-localised kinase Fj (which modulates Ft and Ds by 
phosphorylation) (see 1.4.5 and (Goodrich and Strutt, 2011)). Like the core PCP 
pathway, the Ft/Ds/Fj group is required to establish the polarity along tissue axes. Loss 
of Ft or Ds activity results in classical PCP defects (Casal et al., 2002, Adler et al., 1998, 
Yang et al., 2002). In addition the Ft/Ds/Fj system is required for proximo-distal (P-D) 
axis elongation, for instance in the wing by promoting oriented cell divisions along the 
P-D axis and orienting cell flows during pupal development (Mao et al., 2011, Aigouy 
et al., 2010, Baena-Lopez et al., 2005). 
The epithelial cuticular structures of the adult fly display the outcome of PCP: the 
epithelial cells of the wing have one trichome localised on the distal side of each cell, 
the trichomes of the thorax and abdomen are on the posterior side, and all hairs/bristles 
and external sensory bristles are aligned along the tissue axis. Thousands of cells of the 
various epithelial tissues need to be polarised along the appropriate axis. Thus it is 
thought that planar polarisation requires firstly a directional input, which initiates the 
direction of polarisation, secondly interpretation of the cue leading to intracellular 
polarisation and lastly intercellular cell-cell communication to propagate the asymmetry 
locally.  
 
1.4.3 Asymmetric localisation of PCP components 
During pupal wing development, just before prehair formation, Fz, Dsh and Dgo 
become highly enriched at the distal apical cell cortex (Axelrod, 2001, Strutt, 2001, 
Feiguin et al., 2001), whereas Stbm and Pk are at the posterior apical cell cortex of wing 
epithelial cells (Figure 1.4) (Bastock et al., 2003, Tree et al., 2002). Fmi is planar 
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polarised on the distal and proximal side and homophilically interacts with Fmi on 
adjacent cells (Figure 1.4) (Usui et al., 1999). In sensory organ precursors (SOPs), that 
will eventually give rise to the sensory bristles, Fz/Dsh are found on the posterior cell 
cortex and Stbm/Pk on the anterior cell cortex (pupal notum SOPs) (Segalen et al., 2010, 
Bellaiche et al., 2004) while Flamingo is uniformly localised (Lu et al., 1999). 
Asymmetric localisation of Fz/Dsh/Dgo and Stbm/Pk is also observed at specific stages 
in the R3/R4 photoreceptor precursors in the developing eye imaginal disc (Das et al., 
2004, Strutt et al., 2002). 
The asymmetry of the core components is important for their downstream effectors, 
which interpret the PCP signal. Effectors differ for each PCP tissue: In the wing the 
formation of a single trichome on the distal side of each cell is dependent on the 
interplay of the downstream effectors Fuzzy, Fritz and Inturned, which localise to the 
proximal side (reading the Stbm/Pk signal) and promote the distal localisation of 
Multiple Wing Hairs, thus restricting hair formation to the distal side (Strutt and 
Warrington, 2008). In SOP cells, the asymmetric localisation of the core components is 
required for spindle orientation (see 1.7.2). In the R3 photoreceptor, Fz and Dsh 
positively regulate the transcription of the Notch ligand Delta (Dl), thus allowing 
Notch-mediated cell fate specification of the R3 and R4 photoreceptors (Fanto and 
Mlodzik, 1999, Strutt et al., 2002). These examples demonstrate the importance of the 
asymmetric localisation of the core components and moreover the diverse outputs of 
PCP.  
Over the last decades several studies have addressed how the asymmetric localisation 
is maintained within the cell and how neighbouring cells communicate the polarity, by 
performing genetic interactions, subcellular localisation, clonal analysis and co-
immunoprecipitation experiments. Firstly, loss-of-function experiments revealed that 
the asymmetric distribution is dependent on the presence of all of the core components 
(Strutt, 2002). Moreover, Fmi is absolutely required for initiating the apical localisation 
of the other components since for all, the membrane localisation is abolished in loss-of-
function clones of fmi (Tree et al., 2002, Bastock et al., 2003, Shimada et al., 2001, 
Feiguin et al., 2001, Strutt, 2001). Based on similar loss-of-function experiments, the 
next molecules in this apparent hierarchy are Fz and Stbm, which are required to re-
localise the cytoplasmic components to the membrane. Fz recruits Dsh (Axelrod et al., 
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1998) and Dgo binds to Dsh (Jenny et al., 2005), whereas Stbm recruits Pk to the 
opposite side (Jenny et al., 2003, Bastock et al., 2003). Loss or overexpression of Dsh, 
Pk and Dgo does not affect the membrane localisation of the receptors, but their 
asymmetric distribution (Shimada et al., 2001, Strutt, 2001, Feiguin et al., 2001, Tree et 
al., 2002, Bastock et al., 2003). Thus, the cytoplasmic components are required to 
maintain, but not to establish the initial asymmetry and moreover their levels need to be 
regulated. 
 
 
 
Figure 1.4 - Asymmetric distribution of core PCP components. 
(A) Outline of a planar polarised cell showing the asymmetric distribution and interactions of 
core polarity components. Stbm/Fmi complexes localise apically to the proximal side opposite 
Fz/Fmi complexes at the distal side. Fz recruits Dsh and Dgo, whereas Stbm recruits Pk. Mutual 
antagonism between Pk and Dgo contribute to the asymmetry, as well as intercellular 
interactions between neighbouring Fz/Fmi and Stbm/Fmi complexes based on homophilic Fmi 
interactions and preferential clustering of Fz/Fmi and Stbm/Fmi. (B) PCP components show 
initially no planar polarisation in epithelial cells of the pupal wing and are uniformly spread 
around the cell cortex. During development they become planar polarised along the proximal-
distal axis, due to an unknown polarity cue. Fz/Dsh/Dgo (green) localise distally, whereas 
Stbm/Pk (blue) localise to the proximal side.  
 
 
Positive feedback loops and mutual antagonism involving the core components are 
thought to promote the asymmetry. Dgo promotes Dsh binding to Fz, whereas Pk can 
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compete with Dgo for Dsh binding and thus inhibits Dsh/Fz activity (Figure 1.4) (Tree 
et al., 2002, Jenny et al., 2005). In addition, clustering of Fz/Fmi complexes into 
concentrated puncta (promoted by Dsh) at the distal side and Stbm/Fmi complexes 
(promoted by Pk) on the adjacent membrane of the neighbouring cell results in highly 
stable complexes and thus provides positive feedback (Figure 1.4) (Strutt et al., 2011, 
Aigouy et al., 2010). 
Besides the feedback regulation of the main components, other mechanisms 
contribute to maintain the asymmetry. Fz and Dsh are transported in vesicles along non-
centrosomal microtubules to the distal side of the cell (Shimada et al., 2006). Moreover 
the ubiquitin system regulates the levels of the cytoplasmic components, as 
ubiquitylation contributes to keep Pk (via the Cullin1/SkpA/Supernumerary limbs 
ubiquitin ligase complex) and Dsh (via the Cullin-3/Diablo/Kelch ubiquitin ligase 
complex) at the right level at the apical junctions (Strutt et al., 2013a, Strutt et al., 
2013b, Cho et al., 2015). Regulation of the core components via ubiquitin-mediated 
degradation seems to be a general mechanism as in mice, levels of the Pk homologue 
Prickle1 are regulated by Smurf ubiquitin ligases (Narimatsu et al., 2009). 
 
1.4.4 Intercellular communication 
Between two neighbouring cells, distal Fz/Fmi complexes of one cell interact with 
proximal Stbm/Fmi complexes of the adjacent cell. The intercellular association seems 
to be facilitated by homophilic Fmi interactions (Usui et al., 1999) and interactions 
between the extracellular domains of Fz and Stbm (Wu and Mlodzik, 2008, Chen et al., 
2008). The communication of polarity information between cells became first obvious 
in the non-autonomous effects seen for fz loss-of-function clones in the developing 
pupal wing. Neighbouring wild type cells re-orient their polarity (hair) towards the 
mutant tissue (Adler et al., 1997). Loss-of-function clones of stbm cause the opposite 
phenotype, with the hair pointing away from the clonal area (Taylor et al., 1998). In fz 
mutant clones, solely Stbm/Fmi complexes are present, which then recruit the Fz/Fmi 
complexes of the neighbouring wild type cell to the adjacent membrane, thus altering 
the polarity of the surrounding cells. Conversely, Fz/Fmi complexes of stbm mutant 
cells associate with Stbm/Fmi complexes of wild type cells. Although loss of fmi does 
not cause non-autonomous effects on its own, double mutant clones for either fz/fmi or 
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stbm/fmi do not alter the polarity of adjacent wild type tissue, demonstrating that Fmi is 
required for intercellular communication (Strutt and Strutt, 2007). Taken together, the 
intercellular connection between Fz/Fmi and Stbm/Fmi complexes allows the 
communication of polarity from cell to cell. Interestingly, the Drosophila Selectin 
Furrowed has recently been shown to promote and stabilise the intercellular interactions 
between Fz and Stbm together with Fmi (Chin and Mlodzik, 2013). 
The intercellular communication does not require the cytoplasmic components Dsh, 
Pk and Dgo, as none of them cause non-autonomous defects when clonally inactivated. 
Moreover, unlike fmi, they do not supress the non-autonomous fz or stbm phenotypes 
(Strutt and Strutt, 2007). However, Dsh and Pk participate in concentrating the clusters 
of the intercellular Fz-Fmi and Stbm-Fmi complexes into stable puncta (Strutt et al., 
2011).  
Importantly mutant clones of fz or stbm only affect the polarity of surrounding wild 
type cells in close proximity, but not the overall polarity of the wing, suggesting that 
most of the cells orient towards the stronger upstream cue. Intra- and intercellular 
interactions explain how asymmetry is maintained and communicated between cells. 
But what is the directional input that initially defines the polarity axis? 
 
1.4.5 Directional inputs for PCP 
The Ft/Ds/Fj system is proposed to provide directional inputs for the asymmetry of the 
core components (Ma et al., 2003, Yang et al., 2002). The ligand of Ft, Ds, and Ft form 
heterophilic complexes in trans across neighbouring cells (Matakatsu and Blair, 2006) 
and are planar polarised (Ambegaonkar et al., 2012, Bosveld et al., 2012, Brittle et al., 
2012), with Ft localising proximally and Ds distally in the developing wing (Brittle et 
al., 2012, Sagner et al., 2012). The planar polarisation is the result of, firstly, opposing 
expression gradients of Ds and Fj (Ds is high proximally and Fj is high distally) (Yang 
et al., 2002). Secondly, Fj modulates the affinity of the Ft-Ds interaction by 
phosphorylation, such that phosphorylation of Ft enhances the interaction whereas 
phosphorylation of Ds decreases it (Simon et al., 2010, Ishikawa et al., 2008, Brittle et 
al., 2010). The opposing expression gradients of Ds and Fj and the modulation of the Ft-
Ds affinity by Fj thus provide an axis for polarity direction, which leads to asymmetric 
distribution of Ft and Ds within the cell (Hale et al., 2015).  
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The global polarity axis created by the Ft/Ds/Fj system is therefore an attractive 
candidate to provide directional input for the polarity of the core PCP system. Indeed, it 
was recently demonstrated that the Ft/Ds/Fj group orients apical non-centrosomal 
microtubules along the P-D axis (plus ends are enriched distally), thereby facilitating 
the directed vesicular transport of Fz and Dsh to the distal cortex of the wing and thus 
orienting the polarity of the core components at least in the proximal and central wing 
regions (Matis et al., 2014, Olofsson et al., 2014, Shimada et al., 2006, Harumoto et al., 
2010). In the study from Matis et al., the authors point out that the P-D orientation of 
the microtubules in the distal wing margin is independent of the Ft/Ds/Fj system and 
suggest that a different signal must operate to polarise them in distal regions. It is worth 
pointing out that, after many years of controversy relating to how core PCP and 
Ft/Ds/Fj PCP are functionally connected, three recent studies showed that they are 
indeed linked via one of the two Pk isoforms (Spiny-legs), although these studies 
suggest different mechanisms (Ayukawa et al., 2014, Merkel et al., 2014, Olofsson et al., 
2014). 
In canonical Wg/Fz signalling, Wg/Wnts are the ligands for Frizzled receptors (see 
1.4.1). Several studies have suggested that Wnts might be the directional input for PCP 
in different vertebrate systems (Gao et al., 2011, Gros et al., 2009). In Drosophila a 
study from the Mlodzik lab suggests that Wg and Wnt4, which are both expressed at the 
wing margin, act redundantly (explaining why this function was not previously 
identified) as polarity cues in the wing (Wu et al., 2013). This study shows that mis-
expression and loss-of-function of Wg/Wnt4 affects polarity similarly to the effects of 
core components and independently of canonical Wg/Fz signalling. Furthermore, the 
authors suggest a mechanism in which the Wg/Wnt4 gradient emanating from the wing 
margin modulates the affinity of the Fz/Stbm intercellular interactions, thus providing 
directional input (Wu et al., 2013). Interestingly, the previously mentioned study from 
the Axelrod lab suggests an alternative role for Wnt4 in the orientation of non-
centrosomal microtubules, as mis-expression of Wnt4 (but not Wg) disturbs their 
alignment along the P-D axis (Matis et al., 2014).  
Moreover, morphogenetic movements during development from the wing imaginal 
disc to the pupal wing are also thought to provide directional input (Sagner et al., 2012, 
Aigouy et al., 2010). Taken together, the examples detailed above demonstrate that 
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there is likely more than one directional input for the PCP system. It is therefore 
possible that these inputs act redundantly, providing robustness to PCP establishment. 
 
1.4.6 Different requirements for Fz and Dsh in the canonical and PCP 
pathways 
The canonical Wg/Fz and the PCP pathway both signal through Fz and Dsh, however 
the downstream effectors are distinct and specific for each pathway. Specificity seems 
to be achieved by different engagements and requirements for Fz and Dsh. Frizzled 
receptors belong to the superfamily of G-protein-coupled receptors (GPCRs) and 
comprise an N-terminal extracellular domain (containing the CRD domain for Wg/Wnt 
binding), a seven-pass transmembrane domain and a C-terminal intracellular domain 
(Wang et al., 2006). In Drosophila the two different Frizzled receptors Fz and Fz2 act 
redundantly in Wg/Fz signalling (Chen and Struhl, 1999). Fz2 seems to be the main 
receptor and was shown to have the higher affinity for Wg/Wnt binding (Strapps and 
Tomlinson, 2001, Rulifson et al., 2000). Conversely, the PCP pathway seems to 
function solely through Fz, as firstly expression of Fz2 does not rescue the PCP 
phenotype in fz and fz2 double mutants (Chen and Struhl, 1999) and secondly 
overexpression of Fz2 results in Wg-specific defects (and no PCP defects) (Rulifson et 
al., 2000). A further difference is that the apical localisation of Fz is not essential for 
canonical Wg/Fz signalling, as endogenous and ectopically expressed Fz2 localise 
along the entire apical-basal membrane (Wu et al., 2004). The intracellular C-terminal 
tail is critical for the subcellular localisation, as transgenic Fz2 chimeras containing the 
Fz C-terminus are able to localise apically (Wu et al., 2004). 
The cytoplasmic protein Dsh/Dvl contains three conserved domains: an N-terminal 
DIX (Dishevelled and Axin) domain, a PDZ (PSD95, Dlg, ZO-1) domain and a C-
terminal DEP (Dishevelled, Egl-10, Pleckstrin) domain (Boutros et al., 1998). Several 
studies in Drosophila and Xenopus used Dsh/Dvl truncation approaches combined with 
rescue experiments and binding studies with Fz receptors to decipher the different 
requirements for the Wg/Fz and core PCP pathway. PCP signalling requires the PDZ 
domain and the DEP domain, while canonical Wg/Fz engages the DIX domain, the 
PDZ domain and to a lesser degree the DEP domain (Axelrod et al., 1998, Boutros et al., 
1998, Penton et al., 2002). Dsh/Dvl supposedly binds through the DEP domain 
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(Axelrod, 2001) to the intracellular C-terminal tail and the three intracellular loop 
(ICL1-3) of Frizzled receptors (Tauriello et al., 2012). Moreover, a conserved motif 
within the C-terminal tail of Fz - the KTxxxW motif (Drosophila Fz: aa 557–561) - is 
critical for Dsh/Dvl binding (Strutt et al., 2012, Wu et al., 2008), which was shown to 
also weakly interact with the PDZ domain of Dsh/Dvl (Wong et al., 2003). Interestingly, 
the stable localisation of Dsh at the membrane, which is essential for PCP, is apparently 
not required for canonical Wg/Fz signaling (Axelrod, 2001, Wu et al., 2004). 
A recent study tried to dissect the different requirements of Fz in more detail by 
large-scale mutagenesis (Strutt et al., 2012). While several residues were found to be 
essential for both pathways, the analysis also revealed mutations (in the ICL and the 
KTxxxW motif) that caused PCP-specific defects. The authors propose a model in 
which Fz receptors might undergo conformational changes upon PCP activation, thus 
allowing specific Dsh interactions (Strutt et al., 2012). However, it is as yet unclear for 
either pathway exactly how Fz gets activated. Activation of Dsh is believed to depend 
on the phosphorylation state of Dsh, which will be explored in the next subchapter.  
 
1.4.7 Regulation of Dsh and Fz by post-translational modifications 
Dsh/Dvl is a known phosphoprotein (Yanagawa et al., 1995) and contains about 14% of 
serine and threonine residues, as well as several tyrosine residues. Endogenous Dsh is 
hyperphosphorylated (in fly embryos, larvae and pupae) and phosphorylation of Dsh 
can be induced in cell culture upon co-expression of Wg, Fz, Fz2 and Dgo (Yanfeng et 
al., 2011, Yanagawa et al., 1995, Jenny et al., 2005). This strongly suggests that Dsh is 
activated by phosphorylation for both the Wg/Fz and PCP pathway. Several kinases, 
such as CKI, CKII and Par1, were shown to bind to and phosphorylate Dsh (Sun et al., 
2001, Willert et al., 1997, Song et al., 2000, Klein et al., 2006, Strutt et al., 2006). 
However, the functional relevance of the phosphorylation is not well understood. In 
Drosophila, CKIε (Dco, Discs overgrown) promotes Dsh asymmetric distribution in 
pupal wings (Strutt et al., 2006). Loss of CKIε reduces the phosphorylation level of 
endogenous Dsh and causes mild PCP defects, although no specific phosphorylation 
sites were identified (Strutt et al., 2006). Similarly, loss of the non-receptor tyrosine 
kinase Abelson (Abl) elicits PCP defects, and Abl phosphorylates Dsh on a conserved 
residue (Tyr473) within the DEP domain in Drosophila (Singh et al., 2010). 
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Furthermore, dsh (Y473F) mutant flies show strong PCP defects (but no canonical 
Fz/Wg defects) and the mutant protein fails to localise at the membrane, thus 
demonstrating the importance of phosphorylation in vivo (Singh et al., 2010).  
The two examples above highlight the positive effects of Dsh phosphorylation. 
However, phosphorylation of Dsh/Dvl can also target it for degradation. Phosphorylated 
Dvl was shown to be ubiquitylated by the E3 ubiquitin ligase Itch and subsequently 
degraded in HEK293 cells (Wei et al., 2012). Strikingly, Dvl can be partially 
dephosphorylated by PP1c in vitro upon association with the kinase Hipk2, which 
protects Dvl from Itch-mediated degradation (Shimizu et al., 2014). As mentioned 
above, Drosophila Dsh is ubiquitylated by the Cullin-3/Diablo/Kelch ubiquitin ligase 
complex, which appears to specifically target the hyperphosphorylated form of Dsh 
(Strutt et al., 2013a). Phosphorylation-dependent degradation of Dsh/Dvl could 
therefore be a conserved mechanism to maintain the appropriate levels of Dsh. 
Interestingly, although several conserved serine and threonine residues are found 
phosphorylated in endogenous Dsh, mutation of these residues does not cause canonical 
Wg/Fz or PCP defects (Yanfeng et al., 2011). This could mean that Dsh activity might 
require phosphorylation of multiple residues. Thus, phosphorylation and 
dephosphorylation of Dsh can regulate its activity in both canonical Wg/Fz and PCP 
signalling. The underlying mechanisms, especially how activation of the pathways 
promotes or activates the kinases and phosphatases, remain elusive.    
As well as Dsh/Dvl activity, phosphorylation has also been reported to regulate Fz 
activity. Fz receptors have predicted protein kinase A (PKA), protein kinase C (PKC) 
and casein kinase II (CKII) phosphorylation sites (Wang et al., 2006). Indeed, two 
serine residues (Ser554 and Ser560, just before and within the KTxxxW motif) in the C-
terminal tail of Drosophila Fz can be phosphorylated in vitro by aPKC (Djiane et al., 
2005). This study further showed that phosphorylation by aPKC inhibits Fz PCP 
activity in the developing eye through an unknown mechanism independent of Dsh 
recruitment (Djiane et al., 2005). Similarly, inhibitory effects in connection with 
phosphorylation were reported for the Xenopus Fz3 receptor (Yanfeng et al., 2006). 
Ectopically expressed Fz3 in Xenopus embryos was found to be phosphorylated on 
Ser576 (70 aa after the KTxxxW motif) and other C-terminal residues, which was 
dependent on the presence of co-expressed Dvl. Expression of Ser576 non-
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phosphorylatable mutants increased the induction of neural crest markers, indicating 
that phosphorylation might have an inhibitory effect on Fz signalling activity (Yanfeng 
et al., 2006). Phosphorylation of Fz could lead to its destabilisation or 
internalisation/degradation (Djiane et al., 2005). Indeed, Fz receptors have recently been 
reported to be regulated by ubiquitylation. Drosophila Fz2 and mammalian Fz4 are 
stabilised by the deubiquitylation enzyme UBPY (USP8), which therefore promotes 
canonical Wg/Fz signalling (Mukai et al., 2010). Conversely, two related 
transmembrane E3 ubiquitin ligases, RNF43 and ZNRF3, have been shown to inhibit Fz 
activity by targeting it to the lysosome in different vertebrate systems (Hao et al., 2012, 
Koo et al., 2012). 
 
1.5 The polarity determinant Bazooka 
Polarity of cells as described for PCP is achieved by asymmetric distribution of polarity 
determinants. Epithelial cells are not only polarised along the tissue axis (as described 
above), but also along the apical-basal axis. Polarisation of cells along a certain axis is 
essential for many different cellular functions, such as determination of cell fate of 
daughter cells, migration, cell shape or orientation of cell divisions. 
The PDZ domain-containing scaffold protein Bazooka (Baz, Par3 in vertebrates) is a 
crucial polarity determinant for many different cell types. Together with other polarity 
determinants Baz/Par3 is, for example, essential for establishing the anterior-posterior 
axis in Drosophila oocytes and C. elegans embryos, apical-basal polarity in epithelial 
cells and the asymmetry of cell fate determinants in the developing nervous system of 
Drosophila (Goldstein and Macara, 2007). In the following section, I will outline the 
functions of Baz as a polarity determinant, its interactors and its regulation in epithelial 
cells and non-epithelial cells in Drosophila.  
In Drosophila oocytes, neuroblasts (neuronal stem cells) and SOPs (the precursors of 
the external sensory organs, see 1.7), Baz localises asymmetrically on one side of the 
cell, together with the serine/threonine kinase aPKC and its binding partner Par6 
(Segalen and Bellaiche, 2009, St Johnston and Ahringer, 2010). Baz can bind to both 
aPKC (Wodarz et al., 2000) and Par6 (Petronczki and Knoblich, 2001), which also 
associate independently of Baz (Hutterer et al., 2004). In oocytes, the serine/threonine 
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kinase Par1 and Lethal giant larvae (Lgl) localise posteriorly, opposite the Baz-aPKC-
Par6 complex and this asymmetry defines the A-P axis (St Johnston and Ahringer, 
2010). The asymmetric localisation is maintained by mutual antagonism and positive 
feedback between the two complexes. Par1 can phosphorylate Baz on and Ser151 and 
Ser1085, which induces 14-3-3 binding to Baz, thereby excluding it from the posterior 
cortex (Benton and St Johnston, 2003b). On the other hand, aPKC can phosphorylate 
Par1 and Lgl, and non-phosphorylatable mutants of which are no longer restricted to the 
posterior domain of the oocyte cortex (Doerflinger et al., 2010, Tian and Deng, 2008). 
Thus, phosphorylation of Par1 and Lgl by aPKC removes the former from 
anterior/lateral regions. In dividing neuroblasts, the Baz-aPKC-Par6 complex localises 
together with the other polarity determinants Inscuteable and Partner of Inscuteable 
(Pins) at the apical cortex to establish the basal asymmetric enrichment of cell fate 
determinants required for producing daughter cells of distinct fates through asymmetric 
cell division (ACD) (Knoblich, 2008). The apical-basal asymmetry is, as in oocytes, 
maintained by mutual inhibition of apical and basal polarity determinants: Baz is 
excluded from the basal cortex by Par1 phosphorylation and aPKC-mediated 
phosphorylation of Lgl removes it apically (Betschinger et al., 2003, Wirtz-Peitz et al., 
2008). 
In epithelial cells, the interactions and regulation of Baz are more complex, due to 
the presence of different domains along the apical-basal axis defined by distinct polarity 
determinants. Epithelial cells can be divided into the apical domain (containing the tight 
junctions in mammals), the adherens junction, the lateral domain (containing the septate 
junctions in Drosophila) and the basal domain (Figure 1.5) (St Johnston and Ahringer, 
2010). Apical-basal polarity is crucial to epithelial cell function, as it is required to form 
stable cell-cell junctions and hence act as a barrier that allows directed transport of 
different ions and molecules (Tepass, 2012). In this section, I will focus on Drosophila 
apical-basal polarity.  
Besides Baz, aPKC and Par6, two other conserved groups of proteins are involved in 
polarity determination - the Crumbs (Crb) complex and the Scribble group (St Johnston 
and Ahringer, 2010). The Crb complex is composed of the transmembrane protein Crb 
with the cytoplasmic proteins Stardust (Sdt) and PatJ. Like the Baz-aPKC-Par6 complex, 
the Crb complex localises apically (Figure 1.5). The Scribble group is composed of 
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Scribble, Lgl and Dlg and defines the basolateral region (Figure 1.5), where Par1 also 
localises (Benton and St Johnston, 2003b). aPKC/Par6 and Baz are also localised 
apically, however, unlike in oocytes and neuroblasts, the localisation of Baz and 
aPKC/Par6 only partially overlaps (Figure 1.5). For instance, in the epithelial cells of 
the Drosophila embryonic epidermis and in the photoreceptors, aPKC and Par6 co-
localise with the Crb complex, whereas Baz is found more basally at the adherens 
junctions (Walther and Pichaud, 2010, Morais-de-Sa et al., 2010, Harris and Peifer, 
2005).  
 
 
 
Figure 1.5 - Apical-basal polarity determinants in Drosophila epithelial cells.  
Outline of a Drosophila epithelial cell showing the localisation of important polarity 
components along the apical-basal axis. Apical polarity determinants (Crb complex, Par 
complex) define the apical and subapical region (green). The adherens junctions (AJ, purple) 
contain the junctional components E-cadherin, Arm and also the polarity determinant Baz. The 
Scribble group proteins are found at the basal and basolateral region (blue), which contain the 
septate junctions. 
 
 
The apical and basal polarity determinants prevent each other from spreading into the 
opposite domains, thus maintaining the apical-basal polarity (Bilder et al., 2003, 
Johnson and Wodarz, 2003, Tanentzapf and Tepass, 2003), though the exact 
mechanisms are still not fully understood and several factors appear to be involved 
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(Tepass, 2012). As in oocytes and neuroblasts, the different inhibitory phosphorylations 
contribute to the polarisation: phosphorylation of Baz by Par1 and 14-3-3 binding 
removes it from the basolateral domain and phosphorylation of Par1 and Lgl by aPKC 
removes them apically (Benton and St Johnston, 2003b, Betschinger et al., 2003). In 
addition, Crb self-recruitment through its extracellular domain is thought to reinforce 
the apical domain (Fletcher et al., 2012).  
Baz has several functions in the establishment of the apical domain. Firstly, Baz is 
required for the recruitment of aPKC/Par6 to the apical cortex, which is also dependent 
on Cdc42 (Harris and Peifer, 2005, Hutterer et al., 2004). It was recently shown that 
Baz also recruits Sdt, thus promoting the formation of the Crb complex apically (Krahn 
et al., 2010a). Taken together this promotes interactions between aPKC/Par6 and the 
Crb complex (Sotillos et al., 2004, Kempkens et al., 2006), which are required to define 
the apical domain. Another important function of Baz is its role in the positioning and 
assembly of the adherens junctions (Harris and Peifer, 2005, McGill et al., 2009), which 
is independent of aPKC/Par6. All these functions require the apical cortical localisation 
of Baz, which is facilitated by the following characteristics: Baz can bind directly 
through a polybasic C-terminal region to phosphoinositides of the cortical membrane, 
which can be disrupted by Rho-kinase mediated phosphorylation (Krahn et al., 2010b, 
Simoes Sde et al., 2010). Additionally, Baz interacts via its PDZ domains with the 
adherens junction components Arm and Echinoid (Wei et al., 2005b). Moreover 
oligomerisation of Baz via its N-terminus promotes its cortical localisation (Benton and 
St Johnston, 2003a).  
The apical exclusion of Baz and its restriction to adherens junctions, which requires 
the dissociation of Baz from aPKC/Par6 is important for the apical polarity in epithelial 
cells (Laprise and Tepass, 2011). This is achieved by two different means: firstly, aPKC 
phosphorylates Baz on Ser980, which weakens the interaction between Baz and aPKC 
and secondly, Crb competes with Baz for Par6 binding (Morais-de-Sa et al., 2010, 
Walther and Pichaud, 2010). The importance of the competition between Crb and Baz 
for Baz apical exclusion is further strengthened by the finding that phosphorylated Baz 
is still part of the aPKC/Par6 complex in oocytes and neuroblasts - both of which lack 
the Crb complex (Morais-de-Sa et al., 2010, Hong et al., 2001). Thus phosphorylation 
of Baz on Ser890 is not sufficient to disrupt the Baz-aPKC-Par6 complex and is not 
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essential for polarity in oocytes or neuroblasts. As mentioned above, phosphorylation 
by Par1 removes Baz from the basolateral cortex, thus further restricting its localisation 
to the adherens junctions. 
Lastly, phosphorylation of Baz can be reversed by dephosphorylation. In Drosophila 
neuroblasts the Par1 site Ser1085 of Baz can be dephosphorylated by PP2A phosphatase 
complexes (Krahn et al., 2009). Inhibition of PP2A reverses apical-basal polarity in the 
neuroblasts, thus suggesting that it is important to maintain certain levels of 
phosphorylated and dephosphorylated Baz (Krahn et al., 2009). Interestingly, PP1 can 
dephosphorylate mammalian Par3 in vitro (corresponding sites in Baz: the Par1 site 
Ser151 and the aPKC site Ser980), and inhibition of PP1 delays the formation of tight 
junctions (adherens junctions in Drosophila) in cell culture experiments (Traweger et al., 
2008). In conclusion, the interplay between kinases and phosphatases gives rise to 
dynamic regulation of apical-basal polarity, which is important when cells are 
remodelled during development.  
 
1.6 Cross talk between PCP and polarity determinants 
Several studies link core PCP components to apical-basal polarity determinants. 
Mammalian Dishevelled can bind aPKC in vitro and regulate its activity in the context 
of axonal differentiation (Zhang et al., 2007). In addition, Dishevelled was reported to 
regulate the basal localisation of Lgl in Xenopus ectoderm and Drosophila follicular 
cells (Dollar et al., 2005). In developing Drosophila photoreceptors, it was proposed 
that Fz activity in non-PCP dependent photoreceptors is inhibited through 
phosphorylation by aPKC, most likely mediated by PatJ binding to Fz, whereas Baz 
binding to aPKC suppresses the inhibitory function in planar-polarised photoreceptors 
(Djiane et al., 2005). Moreover, Scribble functions in PCP in Drosophila and 
vertebrates (Montcouquiol et al., 2003, Courbard et al., 2009). Loss-of-function of 
Scribble in Drosophila causes PCP defects in eye and wing and Scribble might function 
as an effector of Stbm, supported by the finding that they can bind to each other across 
species (Courbard et al., 2009, Kallay et al., 2006). Lastly, Baz can bind to one of the 
two Fmi splice variants and Baz overexpression can cause mild PCP defects in the wing, 
however, the physiological relevance of this finding could not be established 
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(Wasserscheid et al., 2007). Most relevant to this thesis, apical-basal polarity 
determinants and PCP components are functionally linked in the asymmetric cell 
divisions of sensory organ precursors (SOP), which will be introduced in following 
section.  
 
1.7 Asymmetric cell divisions of sensory organ precursors  
Sensory organ precursor (SOP) cells are the progenitors of the external sensory organs 
in Drosophila. External sensory organs (often referred to as bristles) are part of the 
peripheral nervous system and allow sensing of mechanical (via mechanoreceptors) and 
chemical (via chemoreceptors) stimuli (Jarman, 2002, Stocker, 1994). 
Mechanoreceptors, such as microchaetes and macrochaetes on the notum or abdomen, 
or the margin bristles of the wing are composed of an external hair, socket, sheath and 
neuron and appear in regularly spaced stereotypical positions (Huang et al., 1991, 
Hartenstein and Posakony, 1989). They are the result of asymmetric cell divisions 
starting from a single SOP cell.   
 
1.7.1 Development of external sensory organs 
With onset of the metamorphosis, one epithelial cell within the single-layered epithelial 
tissue is selected to become the SOP. The selection requires the expression of proneural 
genes in a group of cells (the proneural cluster). Proneural genes, such as the Achaete-
Scute complex, encode basic helix-loop-helix (bHLH) transcription factors (Calleja et 
al., 2002). Their expression in imaginal disks is in turn regulated by different patterning 
genes, such as Iroquois, Pannier and Wg, which define the localisation of the proneural 
cluster (Simpson, 2007). One cell of the proneural cluster will express the highest level 
of proneural genes and will subsequently become the SOP. The selection is based on 
Notch-mediated lateral inhibition (Simpson, 1990). Proneural proteins together with 
other bHLH transcription factors (e.g. Daughterless (Murre et al., 1989)) activate 
specific genetic programmes required for SOP fate (Reeves and Posakony, 2005). 
Once the SOP cell is selected, it will divide asymmetrically in the plane of the 
epithelium and along the tissue axis into two daughter cells of different fate: pIIa and 
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pIIb (Figure 1.6C) (Roegiers et al., 2001b, Hartenstein and Posakony, 1989). The pIIa 
cell will undergo another asymmetric division in the plane of the epithelium, giving rise 
to the hair and socket cells (Figure 1.6). The pIIb cell is of neural fate and will 
asymmetrically divide along the apical-basal axis (like neuroblasts) to give rise to the 
glial cell (with undergoes apoptosis) and the pIIIb cell which itself divides 
asymmetrically into the neuron and the sheath cell (Figure 1.6A, B) (Hartenstein and 
Posakony, 1989, Gho et al., 1999). The different cell fates in the SOP lineage are 
dependent on the presence of the cell fate determinants Numb and Neuralized, which 
are asymmetrically localised during each of the divisions and hence unequally 
distributed into the two daughter cells (Figure 1.6A, C) (Le Borgne and Schweisguth, 
2003, Rhyu et al., 1994). The different cell fates of the daughter cells are achieved and 
maintained via Notch-mediated lateral inhibition, and the presence of Numb and 
Neuralized inhibits Notch signalling in the pIIb cell, whereas Notch signalling is active 
in the pIIa sibling (Le Borgne and Schweisguth, 2003, Rhyu et al., 1994, Schweisguth, 
2015). The asymmetry of cell fate determinants within the SOP is dependent on 
different apical-basal polarity determinants, while PCP is required to orient the division. 
 
 
 
Figure 1.6 - Cell lineage of the SOP divisions and composition of mechanosensory bristles. 
(A) Cell fate lineage of the SOP cell. The SOP cell divides asymmetrically into pIIa and pIIb 
cell, by unequal distribution of cell fate determinants (red). Asymmetric division of pIIa gives 
rise to socket (blue) and hair cell (purple). The pIIb lineage consists of two follow up 
asymmetric divisions producing sheath cell (orange) and neuron (green). (B) Composition of an 
adult mechanosensory bristle (colours correspond to A). (C) The first asymmetric division of 
the SOP is within the plane of the epithelium and along the tissue axis (here anterior-posterior). 
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1.7.2 PCP and apical-basal polarity determinants are required to 
establish asymmetry in SOPs  
The SOPs of the pupal notum divide along the anterior-posterior (A-P) axis and cell fate 
determinants localise to the anterior cortex, thus giving rise to an anterior pIIb and a 
posterior pIIa cell (Roegiers et al., 2001b, Le Borgne and Schweisguth, 2003). The core 
PCP proteins, the apical-basal polarity determinants Baz, aPKC, Par6, Dlg, as well as 
Pins (Partner of Inscuteable) and the G-protein subunit Gαi establish SOP asymmetry 
(Segalen and Bellaiche, 2009).  
In epithelial cells, the Baz-aPKC-Par6 complex is found at the apical cell cortex, 
whereas Dlg localises basolaterally around the cortex (St Johnston and Ahringer, 2010). 
However, in premitotic SOP cells, the polarity determinants are found asymmetrically 
localised with the Baz-aPKC-Par6 complex at the posterior apical cortex, while Pins, 
Dlg and Gαi form a complex (Pins can bind to both Dlg and Gαi) at the anterior lateral 
cortex (Schaefer et al., 2001, Bellaiche et al., 2001b). Consequently, in SOPs the 
localisation of the apical-basal polarity determinants needs to be remodelled and PCP 
provides the initial polarity cue, as epithelial cells and SOPs are planar polarised along 
the A-P axis with Fz/Dsh on the posterior side and Stbm/Pk on the anterior side 
(Bellaiche et al., 2004, Segalen et al., 2010). Fz/Dsh recruits the Baz-aPKC-Par6 
complex to the posterior apical cortex (though it is unclear how), while Stbm/Pk 
promotes the anterior localisation of the Dlg-Pins-Gαi complex, probably by direct 
binding between Stbm and Dlg, at least at the apical-most part of the cortex (Figure 1.7) 
(Bellaiche et al., 2004).  
The asymmetric localisation of the polarity determinants then directs the cell fate 
determinants to the anterior cortex upon entry of mitosis (Figure 1.7). As mentioned 
above, Neuralized localises asymmetrically, however the mechanism for its anterior 
positioning is unknown (Schweisguth, 2015). Numb is excluded from the posterior 
cortex through an inhibitory phosphorylation by aPKC (Wirtz-Peitz et al., 2008). In this 
study it was suggested that, in interphase, aPKC/Par6 is bound to Lgl, which inhibits the 
activity of aPKC. Upon entry into mitosis, the mitotic kinase Aurora A activates aPKC 
by phosphorylation of Par6, leading to Lgl phosphorylation by aPKC, removing Lgl 
from the complex. Lgl displacement allows binding of Baz, which then recruits Numb 
to aPKC/Par6. However, the inhibitory role of Lgl does not appear to be essential for 
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SOP ACD, because lgl mutants show a normal, albeit delayed, asymmetry of Baz and 
cell fate determinants (Langevin et al., 2005a, Wirtz-Peitz et al., 2008, Justice et al., 
2003).  
 
 
 
 
Figure 1.7 - Asymmetry in dividing SOP cells and spindle orientation. 
The PCP components are planar polarised along the anterior-posterior axis and promote the 
planar localisation of polarity determinants (side view). Fz/Dsh position the Baz-aPKC-Par6 
complex at the anterior cell cortex, whereas Stbm/Pk promote the localisation of the Dlg-Pins-
Gαi complex at the posterior side. Both polarity determinant complexes direct the localisation of 
cell fate determinants to the posterior cell cortex. Fz/Dsh align the spindle along the anterior-
posterior axis due to direct interactions of Dsh with Mud/NuMA (top view) and Pins with 
Mud/NuMA (side view), ensuring in-plane divisions. 
 
 
None of the core PCP proteins are essential for the asymmetric localisation of the 
polarity determinants in mitosis and therefore for the asymmetric localisation of cell 
fate determinants. In PCP mutants, the polarity complexes still localise opposite each 
other (albeit uncoupled from the A-P axis), due to the so-called mitotic rescue, most 
likely mediated by Pins (Bellaiche et al., 2004, Bellaiche et al., 2001b). Interestingly, in 
contrast, at interphase the PCP components are essential for the asymmetric localisation 
of the Baz-aPKC-Par6 complex. Moreover, the polarity seems independent of the Dlg-
Pins-Gαi complex, thus suggesting that the initial polarity is indeed provided by PCP 
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(Besson et al., 2015). It is unclear how Fz/Dsh promote the posterior apical enrichment 
of Baz-aPKC-Par6, though mammalian Dvl has been shown to associate with aPKC 
(Zhang et al., 2007). In epithelial cells, Baz and aPKC/Par6 localisation only partially 
overlaps, due to phosphorylation of Baz by aPKC and competition between Baz and 
Crb for aPKC/Par6 binding. In SOP cells, which remain connected to the neighbouring 
epithelial cells, a special mechanism must operate which allows the strong Fz/Dsh 
dependent apical enrichment of Baz-aPKC-Par6 complexes at interphase. It is not 
known whether the differential phosphorylations of Baz (by aPKC or Par1) are 
important for its localisation in SOPs.   
 
1.7.3 Spindle orientation in ACD 
As mentioned before, SOPs in the pupal notum divide along the A-P axis and in the 
plane of the epithelium (Figure 1.6C and Figure 1.7). Strikingly, unlike in symmetric 
divisions of epithelial cells, Fz and Dsh are required to localise the spindle along the A-
P axis. In fz or dsh mutants ACD of SOPs exhibit a randomised division angle (Gomes 
et al., 2009, Bellaiche et al., 2001a, Bellaiche et al., 2004), whereas SOPs mutant for 
baz or pins divide along the A-P axis (Bellaiche et al., 2001b). Indeed, Dsh binds via its 
DEP domain to the C-terminus of Mushroom body defective (Mud, the homologue of 
mammalian Nuclear Mitotic Apparatus, NuMA), which in turn orients the spindle along 
the A-P axis via binding to the dynein complex (Segalen et al., 2010). As Fz and Dsh 
localise to the apical posterior cortex, this would result in an out-of-plane spindle 
orientation along the apical-basal axis. The anterior localised Pins, which can also bind 
to Mud-Dynein (Bowman et al., 2006), is thought to oppose this effect by positioning 
the spindle more towards the plane of the epithelium (Figure 1.7) (Segalen et al., 2010).  
Interestingly, PCP proteins are neither required for spindle orientation nor cell fate 
determinant asymmetry in the subsequent ACDs of the pIIa and pIIb cells, whereas Baz 
is essential (Roegiers et al., 2001a, Roegiers et al., 2001b). Moreover, the pIIb and pIIIb 
divisions resemble neuroblast asymmetric divisions along the apical-basal axis, where 
the Baz-aPKC-Par6 complex localises together with Inscuteable (not expressed in SOPs 
or pIIa) apically and positions cell fate determinants basally (e.g. Miranda, Prospero, 
Numb) (Roegiers et al., 2001a, Roegiers et al., 2001b). In neuroblasts Inscuteable 
recruits Pins and Gαi to the apical cortex, which, together with Mud-NuMA, align the 
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spindle along the apical-basal axis (Bowman et al., 2006, Mapelli and Gonzalez, 2012). 
It is not clear which factors (except for Baz) are required for the pIIa ACD, but it seems 
neither Fz/PCP nor Inscuteable are involved, suggesting a different, as yet unknown 
mechanism (Roegiers et al., 2001a, Roegiers et al., 2001b).     
  
1.8 An introduction to Saccharomyces cerevisiae  
The second part of my thesis uses Saccharomyces cerevisiae, also known as budding 
yeast, as a model organism. The yeast genome was the first eukaryotic genome to be 
fully sequenced in 1996 and although yeast is a fungus, about 31% of the proteins have 
clearly identifiable human homologues (Botstein et al., 1997). Yeast cells can either be 
haploid or diploid. Haploid cells undergo mitosis in asymmetric cell divisions (budding) 
and two haploid cells of different mating type (MATa and MATα) can form diploid cells. 
Diploid cells can either mitotically divide, or under nitrogen limiting conditions 
undergo meiosis to form four haploid spores. Genetic manipulation in yeast is very 
effective, due to its high homologous recombination efficiency and the fact that cells 
can be easily transformed. This allows besides ectopic expression of plasmids, also the 
stable and exact integration of foreign DNA sequences into the genome. Moreover, 
genes can therefore easily be deleted or tagged using PCR-based methods and site-
specific mutations introduced (see Material and Methods). The tool-kits to manipulate 
the yeast genome are well established and collections of tagged genes are available, 
making yeast an ideal organism to work with.  
 
1.9 Ubiquitin and ubiquitin-binding domains 
1.9.1 Ubiquitylation of proteins 
Ubiquitylation is an important post-translational modification, within which the minute 
8 kDa ubiquitin is conjugated to a lysine residue on the modified protein. Three 
different enzymes are involved in this process - namely, an ubiquitin-activating enzyme 
(E1), an ubiquitin-conjugating enzyme (E2) and an ubiquitin ligase (E3) (Figure 1.1A) 
(Finley et al., 2012). Firstly, the E1 activates ubiquitin by forming a thioester bond with 
the glycine residue of ubiquitin, under ATP consumption. Activated ubiquitin is then 
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transferred onto the E2, forming another thioester bond. Lastly, the E3s help in the final 
step of covalently binding the C-terminus of ubiquitin to the ε-amino group of a lysine 
residue on the target protein. This leads to the monoubiquitylation of a protein. 
However, there are a number of different ubiquitin signals, as one protein can be 
monoubiquitylated several times and repeated conjugation of another ubiquitin 
molecule to a lysine residue on an already-bound ubiquitin results in the formation of 
polyubiquitin chains (Figure 1.1B) (reviewed in (Ikeda and Dikic, 2008, Behrends and 
Harper, 2011). Ubiquitin has seven lysine residues and, for all of them polyubiquitin 
chains have been described (lysine 6, 11, 27, 29, 33, 48, or 63), as well as linear 
ubiquitin chains via linkage of the N-terminal methionine. Furthermore, ubiquitylation 
is a reversible modification as deubiquitylation enzymes (DUBs) have the capacity to 
remove ubiquitin signals, by catalysing the hydrolysis of the isopeptide bond between 
ubiquitin and the target (Finley et al., 2012).  
The different ubiquitin signals are then specifically recognised by ubiquitin receptor 
proteins, which can be ubiquitin-binding adaptors for targeting to the proteasome or 
other effector proteins unrelated to proteolysis. Consequently, ubiquitin signalling can 
be found in a vastly wide-ranging number of different cellular processes for example, 
endocytosis, DNA repair, cell cycle control, apoptosis, stress response, transcription 
regulation and of course ubiquitin-mediated proteolysis to name but a few (reviewed in 
(Grabbe et al., 2011, Hammond-Martel et al., 2012, Chen and Sun, 2009, Broemer and 
Meier, 2009, Hochstrasser, 1996)). The degradation of proteins via the 26S proteasome 
requires the action of multiple ubiquitin receptors, as well as DUBs (Finley et al., 2012). 
The proteasome consists of two components, the 20S core particle (CR) and the 19S 
regulatory particle (RP). The CR provides the proteolytic activity, whereas the RP 
contains the ubiquitin receptors Rpn10 and Rpn13 to recognise ubiquitylated substrates 
and DUBs to recycle ubiquitin. Ubiquitylated proteins are transported to the RP by 
shuttling ubiquitin receptors Rad23, Ddi1 and Dsk1 (Finley et al., 2012).  
Mass spectrometry analysis of the human and yeast proteome has revealed over 
10,000 potential ubiquitylation sites for 4,273 human proteins and 870 sites for 438 
yeast proteins (Wagner et al., 2011, Starita et al., 2012). This presents us with the 
possibility of revealing yet unknown functions of ubiquitin signalling.  
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Figure 1.8 - Model of the ubiquitylation cascade and downstream processes, as well as 
different ubiquitin signals. 
(A) The ubiquitylation cascade involves the three different enzymes E1, E2 and E3, which 
conjugate ubiquitin to the lysine residue of a target protein. Ubiquitin can be removed by 
deubiquitylation mediated by DUBs. (B) Examples for the different ubiquitylation signals. The 
cascade can lead to monoubiquitylation, multiple monoubiquitylation or polyubiquitylation of 
target proteins. Linear, lysine 48 and lysine 63 linked chains are shown as examples for 
polyubiquitylation.  
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1.9.2 Ubiquitin conjugating factors 
In yeast there is just one ubiquitin-activating enzyme E1 - Uba1, which is consequently 
absolutely essential (McGrath et al., 1991). Conversely, there are 11 different ubiquitin-
conjugating enzymes E2 and strikingly over 50 different E3 ubiquitin ligases (Hicke et 
al., 2005). E2s can cooperate with several different E3s, which recognise the substrate 
and thus provide the substrate specificity. For example, the E2 Rad6 (Ubc2) can 
function together with the E3 Ubr2 to ubiquitylate Rpn4 (transcription factor of 
proteasomal genes), which leads to its degradation (Wang et al., 2004) or with the E3 
Rad18 to ubiquitylate PCNA, important for the DNA damage tolerance pathway (Hoege 
et al., 2002). Moreover, Rad6 works together with the E3 Ubr1 in the N-end rule 
pathway, in which substrates with destabilised N-terminal residues are specifically 
recognised by Ubr1 and subsequent ubiquitylation targets them for proteasomal 
degradation (Sriram et al., 2011).  
Ubiquitin ligases are classified according to their domain into HECT (homologous to 
the E6-AP carboxyl terminus) domain and RING (really interesting new gene) domain 
E3s. While HECT domain E3s form a thioester with ubiquitin before transferring it to 
the target protein, RING domain E3s do not and instead facilitate the ubiquitylation by 
positioning target and E2 in close proximity (Figure 1.1A) (Finley et al., 2012). RING 
domain E3s can either bind to the target protein themselves (e.g. Rad18) or associate 
with subunits that specify the substrate specificity, as seen for example for SCF 
complexes or the multi-subunit APC/C (Anaphase promoting complex/cyclosome) 
complexes (Deshaies and Joazeiro, 2009).  
 
1.9.3 Ubiquitin-binding domains 
The various ubiquitin signals on modified proteins as well as free ubiquitin are 
recognised by ubiquitin-binding proteins (also known as ubiquitin receptors). These 
contain ubiquitin-binding domains (UBD) over which the interaction with ubiquitin 
takes place. Interaction with the target protein itself increases the specificity of 
recognition. To date, about 20 different UBDs have been described (see Figure 1.9 for 
examples, reviewed in (Husnjak and Dikic, 2012, Hurley et al., 2006, Dikic et al., 
2009)). They have been classified according to their structure, e.g. α-helical UBDs, zinc 
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finger (ZnF) and plekstrin homology domain. Besides their structural variation, 
ubiquitin-binding domains also differ, even within one group of UBDs, with regards to 
their affinity for ubiquitin, the interaction surface on ubiquitin and - perhaps most 
importantly - their specificity for certain ubiquitin linkages. Therefore, the following 
section aims to highlight the complexity of ubiquitin recognition by ubiquitin-binding 
domains using a series of examples.  
In order to determine the affinity of UBDs for ubiquitin (in form of the dissociation 
constant KD) several biophysical methods, such as isothermal titration calorimetry (ITC), 
surface plasmon resonance (SPR) experiments, NMR and also electrospray ionisation-
mass spectrometry (ESI-MS), can be used. The affinity for ubiquitin ranges between 1 
µM and 1 mM for different UBDs (Hicke et al., 2005). The α-helical UIM (ubiquitin-
interacting motif) domain, for example, of the human Eps15 protein binds to 
monoubiquitin relatively weakly with 900 µM, while the UIM-1 domain of Vps27 has 
been shown to have a higher affinity with 250 µM (Fisher et al., 2003). In addition to 
the interaction between the UBD and ubiquitin, ubiquitin receptors interact in most 
cases with the ubiquitylation target itself. The combination of two weak affinities 
facilitates the high specificity for the modified target, as too high affinities for ubiquitin 
binding would lead to unspecific interactions. The affinity variation among different 
UBDs can, in some cases, be explained by the fact that many ubiquitin receptors contain 
more than one UBD and sometimes even different kinds of UBDs. Many of the UBDs 
interact with ubiquitin via the hydrophobic patch (formed by isoleucine 44, valine 70, 
leucine 8) on ubiquitin. Some UBDs, however, bind to a completely different region on 
ubiquitin. The human protein Rabex-5 contains besides an α-helical MIU (motif 
interacting with ubiquitin), the structurally different zinc-finger domain (ZnF A20). 
Both of them have been shown to interact with ubiquitin (Lee et al., 2006, Penengo et 
al., 2006). The crystal structure of Rabex-5 and ubiquitin demonstrates that the MIU 
domain interacts with the isoleucine 44 hydrophobic patch on ubiquitin with a KD of ~ 
28 µM, while the ZnF A20 domain binds to a different region on ubiquitin centred 
around aspartate 58 and with a higher affinity (~ 12 µM) (Penengo et al., 2006) (Figure 
1.9B). The presence of both domains increases the affinity to about 6 µM. 
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Figure 1.9 - Modes of ubiquitin binding by different ubiquitin-binding domains. 
(A) Crystal structure of the UIM domain of Vps27 and monoubiquitin (PDB access code: 
1Q0W). The UIM domain contacts ubiquitin via its hydrophobic patch, centred around Ile44 
(red). (B) Crystal structure of the MIU and ZnF A20 domain of Rabex-5 and ubiquitin (PDB 
access code: 2FIF). While the MIU domain binds to the hydrophobic patch of ubiquitin, the 
ZnF20 A20 domain contacts a different region (around aspartate 58, in blue) of ubiquitin. (C) 
Crystal structure of the UBA domain of human RAD23A and lysine 48-linked diubiquitin (PDB 
access code: 1ZO6). The UBA domain binds specifically to lysine 48-linked ubiquitin chains. 
(D) Crystal structure of the NZF domain of Tab2 and lysine 63-linked diubiquitin (PDB access 
code: 2WWZ). The UBA domain binds specifically to lysine 63-linked ubiquitin chains. 
  
 
Remarkably, ubiquitin receptors can distinguish between different ubiquitin signals 
and possess, in some cases, a high affinity for a certain ubiquitin signal. In a recent 
study the affinities of different UBDs to various ubiquitin linkages were compared 
using ESI-MS (Sokratous et al., 2012). While the previously described MIU domain of 
Rabex-5 had no certain linkage specificity (interacts with monoubiquitin), the three-α-
helical UBA (ubiquitin-associated) domain of human RAD23A (Figure 1.9C) was 
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highly specific for lysine 48-linked polyubiquitin chains, when compared to the other 
linkages (lysine 11, 27 or 63) or monoubiquitin. Crystal structures of the UBD with 
ubiquitin help us understand how high affinities for certain linkages can be explained. 
For instance, the zinc finger containing NZF (Npl4 associated zinc finger) domain of 
the human protein Tab2 has a preference for binding to lysine 63-linked polyubiquitin 
chains. Crystallisation of Tab2 with lysine 63-linked diubiquitin revealed that there are 
two interaction sites within the NZF domain (Figure 1.9D) (Kulathu et al., 2009). In this 
context, the two ubiquitins contact one interface each, while monoubiquitin and linear 
chains are sterically not able to bind both interfaces.  
Recognition of ubiquitin signals by UBDs is, as seen in the examples above, a very 
complex procedure that can be achieved in various ways. Crystal structures of 
ubiquitin-binding proteins and ubiquitin, as well as the characterisation of the 
interaction between them help in understanding how individual UBDs of certain 
proteins function. The kinetochore protein Spc25 has previously been revealed as a 
novel ubiquitin-binding protein in S. cerevisiae (Shengkai Zhao, unpublished result). 
The ubiquitin-binding domain was so far not identified and sequence comparison with 
known UBDs showed no similarity, indicating that Spc25 has an as yet unknown 
strategy of binding ubiquitin.  
 
1.10 The yeast kinetochore 
The kinetochore is a multi-protein complex that connects the plus-ends of microtubules 
to the centromeres and governs chromosome segregation in both meiosis and mitosis. In 
yeast, solely one kinetochore binds to each point centromere of 125 bp (comprised of 
DNA-elements CDI, CDII, CDIII), however, in vertebrates it is rather more 
complicated as one kinetochore complex attaches up to 20 microtubules to regional 
centromeres, which can be several mega bp long (Westermann et al., 2007). The many 
proteins, more than 60 in yeast (over 100 in mammalians), that build the kinetochore are 
mainly organised in subcomplexes - Cbf3, Ctf19, Ndc80, Mtw1, Spc105, Ipl1 and 
Dam1 complex (Figure 1.10A). According to their position within the kinetochore, they 
have been classified as inner (centromere binding), central (linking the inner to the outer 
kinetochore) or outer kinetochore (binding to the plus-ends of the microtubule) proteins 
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(reviewed in (Cheeseman et al., 2002, Westermann et al., 2007)). A variety of different 
approaches, such as loss-of-function studies, interaction studies, co-purifications, 
subcellular localisation and structural analysis, have contributed in dissecting the 
organisation of the kinetochore. 
Inner kinetochore components are the Cbf3 complex (Cep3, Ctf13, Ndc10 and Skp1), 
which binds directly to the CDIII element of the centromere (Espelin et al., 1997) and 
the H3 histone variant Cse4, which is part of the nucleosome exclusively at centromeres 
(Furuyama and Biggins, 2007). Mif2 is another inner kinetochore protein and requires 
both, Cbf3 and Cse4 for centromere attachment. In addition, Mif2 associates with the 
Mtw1 (Mtw1, Dsn1, Nsl1, Nnf1) complex, thus acting as a link between inner and 
central components (Westermann et al., 2003). Central components are besides the 
Mtw1 complex, the Spc105 complex (Spc105, YDR532), the Ndc80 complex (Ndc80, 
Nuf2, Spc24, Spc25) and the Ctf19 complex (COMA complex and several other 
proteins) (Joglekar et al., 2009, Westermann et al., 2007). The Mtw1, Spc105 and 
Ndc80 subcomplexes are closely interacting with each other and form the KMN (Knl1/ 
Mis12/Ndc80) network (see 1.10.1). Lastly, the Ipl1 complex and the S. cerevisiae 
specific Dam1 complex as well as Stu2 are positioned at the microtubules and are 
grouped as outer kinetochore components (Westermann et al., 2007). The kinase Ipl1 
(yeast homologue of Aurora B) of the Ipl1 complex regulates correct kinetochore-
microtubule attachment by phosphorylation (see 1.10.2) (Pinsky et al., 2006b). The 
Dam1 complex is crucial for the chromosome segregation, as it moves with the 
depolymerising microtubules towards the spindle poles and thus provides the necessary 
pulling force (Westermann et al., 2006).  
 
1.10.1  The Ndc80 complex and the KMN network 
The Ndc80 complex, which is crucial for the chromosome segregation, belongs to the 
central kinetochore and connects microtubules and inner kinetochore proteins. The 
conserved four-protein complex consists of the Ndc80-Nsl1 heterodimer and the Spc25-
Spc24 heterodimer and all four proteins are required for proper chromosome 
segregation (Janke et al., 2001, Wigge and Kilmartin, 2001, Wei et al., 2005a). Spc25 
and Spc24 have C-terminal globular domains, and N-terminal coiled-coil regions, while 
Ndc80 (yeast homologue of human Hec1) and Nuf2 have N-terminal globular domains 
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with the coiled-coil regions located at the C-terminus (Figure 1.10D) (reviewed in 
(Tooley and Stukenberg, 2011)). The two heterodimers bind to each other, via the 
coiled-coil regions, producing the dumbbell-shaped Ndc80 complex. Regarding the 
overall structural organisation, the Ndc80 complex consists of two globular domains 
(formed by the globular domains of either Spc24 and Spc25 or Ndc80 and Nuf2) 
separated by a long coiled-coil region. This was first revealed by rotary shadowing 
electron microscopy (EM) (Wei et al., 2005a). The structure of Ndc80 complex was 
later confirmed in another study with the crystal structure of a “bonsai” version of the 
human Ndc80 complex, in which large proportions of the coiled-coil regions of all four 
proteins were removed (as they might have been too flexible) and Spc25 was fused to 
Ndc80 and Spc24 to Nuf2 (see Figure 1.10D) (Ciferri et al., 2008). The comparison of 
the human complex to the crystal structure of the globular domains of yeast Spc25 and 
Spc24 show how highly conserved the structures are from yeast to humans (Figure 
1.10C) (Wei et al., 2006).  
Figure 1.10B illustrates the interactions of the Ndc80 complex. The Ndc80 complex 
binds to the microtubule interface directly via the Ndc80-Nuf2 heterodimer (Wei et al., 
2005a). Dam1, of the 10-protein Dam1 complex, interacts with the Ndc80 complex and 
was shown to be required for the binding of Ndc80 to the microtubules in vitro 
(Lampert et al., 2010, Tien et al., 2010). Phosphorylation of the N-terminus of C. 
elegans Ndc80 by Aurora B kinase inhibits binding to the microtubules in vitro and in 
mammalian cell culture (Cheeseman et al., 2006, DeLuca et al., 2006). However, a 
more recent study has shown that phosphorylation of Ndc80 by Ipl1, is not essential for 
intact chromosome segregation in yeast in vivo (Akiyoshi et al., 2009). 
The Ndc80 complex is a member of the KMN network, which includes, besides the 
Ndc80 complex, the Mtw1 complex (also MIND or MIS12 complex) and the Spc105 
complex (also Knl1 complex) (Nekrasov et al., 2003, Cheeseman et al., 2006, Petrovic 
et al., 2010). The Mtw1 complex consists of the four proteins Mtw1, Nnf1, Dsn1 and 
Nsl1, in which Mtw1 and Nnf1, as well as Dsn1 and Nsl1 form stable heterodimers 
(Maskell et al., 2010). Thus far, the following interactions were reported for the KMN 
network: Ndc80 interacts, via the globular domain of the Spc25-Spc24 dimer, with the 
Mtw1 complex, as seen in Figure 1.10B (Maskell et al., 2010, Hornung et al., 2010).  
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Figure 1.10 - Organisation of the yeast kinetochore and of the Ndc80 complex. 
(A) Model of the architecture of the yeast kinetochore. The main complexes of the kinetochore 
are highlighted in different colours (figure adapted from (Westermann et al., 2007)). (B) Model 
of the interactions of the Ndc80 complex. The Ndc80 complex interacts via the Ndc80-Nuf2 
heterodimer with the microtubules directly and binds to the Mtw1 complex via the Spc25-Spc24 
heterodimer. (C) Structure of the globular domains of yeast Spc25 and Spc24 (PDB access 
code: 2FV4)(Wei et al., 2006). (D) Structure of the bonsai version of the human Ndc80 complex 
(PDB access code: 2VE7). In this “bonsai” version a large proportion of the coiled-coil region 
of the human Ndc80 complex was removed, Spc25 (118-224) was fused to Ndc80 (80-286) and 
Spc24 (122-197) to Nuf2 (1-169) in order to gain the crystal structure (Ciferri et al., 2008). 
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Most interestingly, in vitro interaction studies have shown that the interaction of the full 
Ndc80 complex with the Mtw1 complex was stronger than interaction with the Spc25-
Spc24 dimer, indicating that the entire Ndc80 complex is required for increased binding 
and also that the Dsn1-Nsl1 heterodimer alone is not sufficient for binding to the Ndc80 
complex (Hornung et al., 2010). A further study with human proteins has revealed that 
the interaction takes place between Spc24 and the C-terminus of Nsl1 and that Knl1 
(yeast Spc105) also binds to the Mtw1 complex via Nsl1 (Petrovic et al., 2010). In 
addition, Spc105 (human Knl1) binds the Mtw1 complex in yeast and humans via its C-
terminus, while the N-terminus interacts with the microtubules (Cheeseman et al., 2006, 
Kiyomitsu et al., 2007, Maskell et al., 2010). Nonetheless a more detailed insight into 
the interactions within the KMN network is still to be discovered. 
The Mtw1 complex has the important role of connecting the Ndc80 complex to the 
inner kinetochore (via binding to Mif2). In addition, the Ndc80 complex is attached to 
the inner kinetochore by direct binding to the recently identified centromere associated 
Cnn1 complex (Cnn1 and Wip1) (Schleiffer et al., 2012, Malvezzi et al., 2013). The 
association of Spc24/Spc25 with Cnn1 (CENP-T) is dependent on its phosphorylation 
status and Cnn1 competes with the Mtw1 complex for binding to Spc24/Spc25 
(Malvezzi et al., 2013).  
 
1.10.2  Post-translational modifications of kinetochore components 
Post-translational modifications of kinetochore components play a crucial role to 
control the correct chromosome segregation. I will use a few examples to illustrate the 
importance. Ipl1 (Aurora B) phosphorylates several of the kinetochore components, for 
example Dam1, Ndc80 and Dsn1. Ipl1-mediated phosphorylation of Ndc80 and Dam1 
has supposedly inhibitory functions for their microtubule attachment (Cheeseman et al., 
2006, DeLuca et al., 2006, Gestaut et al., 2008), while Dsn1 phosphorylation is 
important for proper assembly of the kinetochore (Akiyoshi et al., 2013a). As a 
counterbalance PP1 phosphatases can oppose the activity of Ipl1 (Pinsky et al., 2006a, 
Francisco et al., 1994). Ipl1 activates (most likely by causing microtubule-kinetochore 
detachment) the spindle checkpoint, which stalls the cell cycle until kinetochores are 
properly attached to the microtubules (Pinsky et al., 2006b, Biggins, 2013). In addition, 
the spindle checkpoint can be activated by phosphorylation of Spc105 by Mps1 (while 
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PP1 counteracts), which leads to the recruitment of spindle checkpoint proteins to the 
kinetochore (Biggins, 2013, London et al., 2012). Besides regulation of kinetochore 
components by phosphorylation/dephosphorylation, several kinetochore components 
have been shown to be modified by SUMOylation and ubiquitylation. For example, the 
modification of Ndc10 with small ubiquitin-like modifier (SUMO) is required for its 
localisation at the spindle (Montpetit et al., 2006). Conversely, SUMOylation of the 
mammalian inner kinetochore component CENP-I leads to its degradation 
(Mukhopadhyay et al., 2010).  
 
1.10.3  The ubiquitin system at the kinetochore  
To date, there have been a few reports about ubiquitin signalling at the kinetochore, 
with most of them being associated with ubiquitin-mediated degradation. One instance 
is the ubiquitin-mediated degradation of Cse4. Cse4 is a histone variant of H3, which 
can is only found at centromeric nucleosomes (see Figure 1.10A). The exclusive 
location of Cse4 at the centromere was demonstrated to be achieved by ubiquitin-
mediated degradation of Cse4, with Psh1 as the E3 ubiquitin ligase in yeast 
(Hewawasam et al., 2010, Ranjitkar et al., 2010). The proposed mechanism behind this 
is that the Scm3-bound Cse4 is incorporated into the centromeric nucleosome and 
protected from ubiquitylation and degradation, while free Cse4 is degraded, which 
consequently prevents the mislocation into euchromatin (Hewawasam and Gerton, 
2011). Furthermore, CID, the Cse4 homolog in Drosophila melanogaster was also 
shown to be regulated via proteolysis, indicating a conserved mechanism for the 
localisation of Cse4 (Moreno-Moreno et al., 2006). Another case where ubiquitin-
mediated degradation plays a role within the kinetochore comes within the regulation of 
the spindle-checkpoint by means of controlling the Aurora B kinase (Aurora2) in 
humans (Biggins et al., 1999, Honda et al., 2000). In addition, a recent study revealed 
that Dsn1 levels were regulated by ubiquitin-mediated degradation through the E3 
ubiquitin ligase Ubr2 (Akiyoshi et al., 2013b). Ubr2 binding to Dsn1 requires the Ubr2 
adaptor Mub1. Interestingly, Ubr2/Mub1 targeted prominently a mutated version of 
Dsn1, which cannot be phosphorylated by Ipl1 (Aurora B), suggesting that the function 
of Ubr2/Mub1 might be to ensure the correct integrity of the kinetochore (Akiyoshi et 
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al., 2013b). These few chosen examples illustrate, that ubiquitin-mediated degradation 
of kinetochore components plays an important role for kinetochore function.  
However, the first report of ubiquitin signalling independent from ubiquitin-mediated 
proteolysis was the regulation of Dam1 methylation (by Set1) via ubiquitylation of the 
histone H2BK123, as missing ubiquitylation prevented the methylation of Dam1 
(Latham et al., 2011). However, it is not clear how the regulation between these two 
post-translational modifications is carried out. 
 
1.10.4  Yeast Spc25 is a novel ubiquitin-binding protein  
In his PhD thesis Shengkai Zhao introduced Spc25 as a novel ubiquitin-binding protein 
(Zhao, 2010). Zhao characterised the ubiquitin-binding properties of Spc25 using 
different biochemical, as well as physical, approaches and furthermore, tried to reveal 
the function of the ubiquitin binding of Spc25 within the kinetochore. The following 
section will focus on his main findings.  
Spc25 was discovered as a novel ubiquitin-binding protein in a yeast two-hybrid 
screen. The 221 amino acid long Spc25 consists of a N-terminal coiled-coil region (1-
106), a flexible linker (107-132) and a C-terminal globular domain (133-221), as 
illustrated in Figure 1.11. Bioinformatical analysis showed that the protein sequence of 
Spc25 shares no similarity to any previously described ubiquitin-binding domains. 
Hence, Spc25 binds to ubiquitin via an unknown UBD. In order to reveal the minimum 
region of Spc25 required for the interaction with ubiquitin, yeast two-hybrid 
experiments with different truncations of Spc25 were performed. This elucidated that 
Spc25 binds to ubiquitin via its flexible linker region as well as the C-terminal globular 
domain. Furthermore, mutation of a number of moderately conserved hydrophobic 
residues within Spc25 showed that the leucine 109 residue within the linker region is 
critical to the ubiquitin binding, as the interaction with ubiquitin was abolished in the 
two-hybrid system. As with many ubiquitin-binding proteins, Spc25 interacts with the 
hydrophobic patch on ubiquitin (formed by leucine 8, isoleucine 44 and valine 70), 
which was shown by in vitro pull-down experiments. The dissociation constant, KD, for 
the interaction between monoubiquitin and a truncated version of the Spc25-Spc24 
complex was determined with the surface plasmon resonance based BIACORE system. 
The result showed that ubiquitin binds to the Spc25-Spc24 complex with a high affinity 
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(14.2 µM). As previously mentioned, Spc25 forms a heterodimer with Spc24 within the 
Ndc80 complex and crystallisation has revealed that the globular domains of both 
Spc25 and Spc24 are combined in a single globular domain within the Ndc80 complex 
in both yeast (Figure 1.10C) and humans (Figure 1.10D) (Wei et al., 2006, Ciferri et al., 
2008). Although Spc24 was negative for interaction with ubiquitin in the yeast two-
hybrid system, it cannot be ruled out that Spc24 contributes to the ubiquitin binding.  
 
 
 
C 
1 107 133 221 
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Globular domain 
N 
Region required for interaction with ubiquitin   
 
Figure 1.11 - Model of the organization of yeast Spc25.  
Spc25 contains a N-terminal coiled-coil region, a flexible linker and a C-terminal globular 
domain. Interaction with ubiquitin requires the flexible region as well as the globular domain. 
 
 
Several approaches were then taken to uncover the biological function of the 
ubiquitin binding of Spc25. First of all, cells harbouring the ubiquitin-binding deficient 
L109A mutation of SPC25 were analysed regarding their phenotype. However, no 
obvious defects were found, as spc25 (L109A) mutants were viable and possessed 
normal growth compared to wild type cells. As it is known that Spc25 is required for 
chromosome segregation and a normal spindle checkpoint (Janke et al., 2001), it was 
then tested whether ubiquitin binding was involved in these functions. Treatment with 
the microtubule toxin benomyl did not affect the spindle checkpoint in spc25 (L109A) 
mutants. Furthermore, the mutation did not result in an increased plasmid loss in a 
plasmid loss assay, indicating that chromosome segregation is not grossly disturbed. In 
conclusion, the L109A mutation of Spc25 did not interfere with chromosome 
segregation, or with the spindle checkpoint. However, it is possible that the L109A 
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mutation of Spc25 does not completely suppress its binding to ubiquitin and therefore 
did not bring about an obvious phenotype.  
Despite the fact that the ubiquitin-binding deficiency of Spc25 did not noticeably 
affect cells in vivo, this study did reveal useful synthetic interactions of the spc25 
(L109A) mutant. Firstly, it was discovered that spc25 (L109A) cells exhibited a growth 
defect when combined with GFP-tagged Mcm21 of the Ctf19 complex. Furthermore, 
spc25 (L109A) increased the temperature sensitivities for mutant alleles of DSN1 (dsn1-
7 and dsn1-8 respectively). These synthetic interactions have given rise to the theory 
that the ubiquitin binding of Spc25 might be required for maintaining the stability of the 
kinetochore complex.  
Ubiquitin signalling is based on specific interactions of the ubiquitin-binding protein 
with both ubiquitin and the ubiquitylated target itself. In order to find the ubiquitylated 
target that interacts with the ubiquitin-binding domain of Spc25, 16 kinetochore 
proteins were screened for in vivo ubiquitylation. Tested candidates were kinetochore 
proteins in close proximity to Spc25 as well as spindle checkpoint proteins (MAD 
proteins). A large proportion of the proteins were found to be modified. Most strikingly, 
from the synthetic interaction experiments, Dsn1 and Mcm21 were both ubiquitylated. 
 
1.11 Aims of this thesis 
Members of the N-terminal RASSF family are associated with several cancers and are 
considered to be tumour suppressors and oncogenes (1.2.2). Little is known about the 
function of two of its members - RASSF9 and RASSF10 - which have homologues in 
Drosophila. This thesis aims to characterise the developmental function of RASSF9 and 
RASSF10 using Drosophila as a model organism. A recent study from our collaborator 
Matthias Gstaiger revealed, that all members of the human N-terminal RASSFs are 
found in an interaction network with PP1 catalytic subunits and ASPP family members 
(Figure 1.3) (Hauri et al., 2013). In humans ASPP can act as a regulatory subunit of PP1 
(1.3.3) and Drosophila RASSF8 and ASPP function together (Langton et al., 2009). 
Taken together, this led us to speculate that N-terminal RASSFs in general might act as 
specificity subunits for ASPP/PP1 phosphatase complexes. RASSF9 and RASSF10 
were also found to interact with several members of the planar cell polarity pathway, as 
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well as the apical-basal polarity determinant Par3/Baz, suggesting a connection to cell 
polarity (Hauri et al., 2013). This thesis aims to establish whether Drosophila RASSF9 
and RASSF10 could potentially act as specificity subunits for ASPP/PP1 phosphatase 
complexes, and especially whether and how these two N-terminal RASSFs are 
connected to planar cell polarity.    
In Chapter 3 of this thesis, I will describe the interaction network for Drosophila 
RASSF9 and RASSF10 and the in vivo approaches taken to address their developmental 
function. Based on these findings Chapter 4 investigates the specific role of RASSF10 
in the polarity establishment of SOPs of the peripheral nervous system. 
In Chapter 5, I will present the separate project I worked on in Helle Ulrich’s lab 
(London Research Institute, Clare Hall laboratories). The kinetochore component Spc25 
was previously characterised as a ubiquitin-binding protein, raising the possibility that 
this ubiquitin-binding property might be important for the stability of the kinetochore 
(1.10.4). Therefore this project aimed at further elucidating the function of the ubiquitin 
system around Spc25 at the kinetochore.  
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Chapter 2 Materials and Methods 
 
2.1 General bacterial methods  
2.1.1 Transformation of chemically competent cells  
For bacterial transformations, chemically competent E. coli were first thawed on ice. 
The plasmid was added and the cells carefully mixed. This was followed by incubation 
on ice for 30 minutes and heat shock for 50 seconds at 42 °C. Cells transformed with 
plasmids possessing an ampicillin resistance could be plated directly onto LB plates 
containing ampicillin. For plasmids encoding for a kanamycin or zeocin resistance, LB 
medium without antibiotics was added to the cells first. Cells were then recovered for 
one hour at 37 °C before being plated on LB plates with the appropriate antibiotic. 
Double transformations, with both ampicillin and kanamycin resistance, were treated 
the same as those with kanamycin alone and grown on LB plates containing both 
antibiotics. For a full list of bacterial strains used in this thesis, please refer to the 
Appendix, Table 7.2. 
 
2.1.2 Isolation of plasmid DNA 
To isolate plasmids from transformed bacterial cells, single colonies were picked with 
the tip of a pipette and inoculated in 3 mL fresh LB medium containing the appropriate 
antibiotic(s). Cultures were grown overnight at 37 °C and plasmids were purified with 
the QIAprep Spin Miniprep Kit (Qiagen, Tapon lab) or the GeneJET Plasmid Miniprep 
Kit (Thermo scientific, Ulrich lab) according to the manufacturer’s instructions. 
Alternatively, for larger quantities of plasmid DNA, midipreps were performed using 
the GenElute HP plasmid midi kit (Sigma-Aldrich). The concentration of plasmids was 
then determined by measuring the absorbance at 260 nm with a NanoDrop ND-1000 
Spectrophotometer (Thermo Scientific), using 1.5 µL of plasmid solution.  
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2.2 General molecular biology methods 
2.2.1 PCR - Polymerase chain reaction 
Standard PCRs were performed with the Taq PCR Master Mix (Qiagen) in 20 µL 
reactions, containing 0.8 µL of both sense and antisense primer (10 µM) and 1 µL DNA. 
The standard PCR programme was: 
1. 94 °C, 3 minutes 
2. 94 °C, 30 seconds 
3. X °C, 30 seconds (X= specific annealing temperature for primer pair) 
4. 72 °C, 1 min/1000 bp Repeat steps 2-4, 34 times 
5. 72 °C, 10 minutes 
 
Inserts for cloning (restriction and Gateway) were amplified with the PWO Master Mix 
(Roche) in 20 µL reactions containing 0.8 µL of both sense and antisense primer (10 
µM) and 1 µL DNA, using the following programme: 
1. 94 °C, 2 minutes 
2. 94 °C, 30 seconds 
3. X °C, 30 seconds 
4. 72 °C, 1 min/1000 bp Repeat steps 2-4, 34 times 
5. 72 °C, 5 minutes 
 
Alternatively, the Phusion high fidelity DNA polymerase (Finnzymes) was used for 
insert amplification. A 50 µL reaction was set up with 10 µL 5x Phusion HF buffer, 0.4 
µL dNTPs (25 mM), 2.5 µL of both sense and antisense primer (10 µM), 0.5 µL 
Phusion polymerase and 1 µL DNA. Cycling conditions were as follows: 
1. 98 °C, 30 seconds 
2. 98 °C, 10 seconds 
3. X °C, 30 seconds  
4. 72 °C, 30 seconds/1000 bp Repeat steps 2-4, 29 times 
5. 72 °C, 10 minutes 
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In Helle Ulrich’s lab, standard PCRs were performed using the Simple Red Taq DNA 
polymerase (Thermo Scientific). A 25 µL reaction contained 2.5 µL 10x buffer with 15 
mM MgCl2, 0.8 µL dNTPs (25 mM), 1.25 µL of both sense and antisense primer (10 
µM), 0.25 µL Simple Red polymerase and 1 µL DNA. The standard PCR programme 
was: 
1. 94 °C, 2 minutes 
2. 94 °C, 20 seconds 
3. X °C, 30 seconds  
4. 72 °C, 1 min/1000 bp Repeat steps 2-4, 34 times 
5. 72 °C, 5 minutes 
 
For all PCRs a Peltier Thermal Cycler (MJ Research) was used. After the amplification, 
the PCR products were checked for their sizes by gel electrophoresis. 
 
2.2.2 Agarose gel electrophoresis 
Agarose gels generally contained 1% agarose (Life Technologies), which was dissolved 
in 0.5x TAE buffer (1x TAE in Helle Ulrich’s lab). To visualize the DNA, ethidium 
bromide (Sigma-Aldrich) or SYBR® Safe (1:10000, Life Technologies) was mixed into 
the melted agarose. Ready gels were placed in a TAE (0.5x or 1x) buffer-filled, 
horizontal gel electrophoresis unit (Advance Scientific or Jencons). DNA samples were 
mixed with 6x or 10x DNA loading buffer and loaded onto the gel. As a sizing standard, 
the 1 kbp plus ladder (Life Technologies), was run with the samples. Electrophoresis 
was carried out at 100-135 V for 20 to 45 minutes (depending on the size of the 
product). The DNA was visualised with the UV transilluminator BioDoc-ItTM system 
(UVP) and gel pictures were printed using a video graphic printer (SONY). To cut out 
bands of gels, DNA was visualised with a transilluminator (Syngene). 
 
2.2.3 Restriction enzyme based cloning  
For cloning, plasmids and PCR products were digested with the appropriate restriction 
enzymes (New England Biolabs) according to the manufacturer’s recommendations. A 
typical 50 µL digestion contained 1 µg of DNA, 5 µL 10x buffer (supplied with the 
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restriction enzymes), 10-20 units of enzyme and, if required, 100 µg/mL BSA. It was 
then incubated for 1-2 hours at 37 °C. Before the ligation, vector and insert were 
purified using either the QIAEX II Gel Extraction Kit (Qiagen) or the GeneJET Gel 
Extraction Kit (Thermo Scientific, Ulrich lab) following the manufacturer’s instructions. 
For the ligation of the digested, purified insert and vector, the Quick-Stick ligase from 
BIOLINE was used. Vector and insert were mixed in a 1:3 ratio, and 0.5 µL Quick-
Stick ligase and 2.5 µL 4x QS buffer were added (final volume of 10 µL). The reaction 
was mixed thoroughly by pipetting and incubated for 10 minutes at room temperature to 
allow ligation. The ligation was either used directly in the transformation of E. coli 
(2.1.1) or stored at −20 °C until further usage.  
 
2.2.4 Gateway system 
Expression plasmids for S2 cells, and plasmids for injection of fly embryos, were all 
made with the Gateway system (Life Technologies), which does not require restriction 
enzymes and is based on the site-specific recombination system of bacteriophage λ. The 
BP clonase mix facilitates the site-specific recombination between attB and attP 
sequences, creating attL and attR sites. The LR clonase mix promotes the recombination 
of attL and attR sites (creating attB and attP sites). Inserts flanked by attB sites are, in 
the first step, recombined into a pDONR vector (BP clonase reaction). Inserts in the 
pDONR vectors are flanked by attL sequences and can then be recombined into a 
destination vector with attR sites (LR clonase reaction). 
Inserts were amplified from existing plasmids, or cDNA from DGRC with 
appropriate primers to allow recombination into pDONR Zeo vectors. Forward primers 
were designed the following way: They contained the attB1 sequence, the Kozak 
sequence, the start codon and the insert-specific sequence. The reverse primers were 
comprised of the insert specific sequence, in case of N-terminal tags, followed by a stop 
codon and the attB2 sequence. Inserts were PCR amplified, analysed by agarose gel 
electrophoresis and purified with the QIAEX II Gel Extraction Kit (Qiagen). For the 5 
µL BP-reaction, 100 ng of insert and 100 ng of pDONR Zeo were incubated with 1 µL 
BP clonase mix for approximately 2-3 hours, at room temperature. The BP-reaction was 
then transformed in E. coli (2.1.1) (Zeocin selection) and plasmids checked by PCR and 
sequencing. Inserts from pDONR vectors were then transferred into destination vectors 
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in the LR reaction. The 5 µL reaction contained 1 µL of the destination vector, 0.5 µL 
of pDONR and 1 µL LR clonase mix. After 2-3 hours incubation at room temperature, 
bacteria were transformed with the reaction and plasmids were then checked by PCR 
and sequencing. Destination vectors for expression of tagged proteins in S2 cells all 
derived from the Drosophila Gateway™ Vector Collection. 
 
2.2.5 Sequencing  
Sequencing was carried out in order check the correctness of plasmids and the presence 
of mutations. 150 ng of plasmid DNA or x ng of PCR products (x = length of PCR 
product times 0.02, purified beforehand by Gel Extraction) were used for the 
sequencing reaction. Furthermore, the 20 µL reaction contained 7.5 µL Big Dye 
sequencing buffer (Applied Biosystems), 0.5 µL Big Dye terminator v3.1 ready mix and 
3.2 pmol primer. The reaction took place in a Peltier Thermal Cycler (MJ Research) 
with a PCR programme approved by Applied Biosystems. Sequence products were 
cleaned with the DyeEx 2.0 Spin Kit (Qiagen). The Sequencing was then carried out by 
the CRUK sequence facility. Sequences were analysed using the SeqMan programme 
(DNAStar Inc.). 
 
2.3 General protein methods 
2.3.1 SDS-PAGE 
For the SDS-PAGE, ready-made NuPAGE 4-12% Bis-Tris gradient gels (Life 
Technologies) were used. These were run with the manufacturer’s NuPAGE MOPS 
SDS Running Buffer in the XCell SureLock® mini-cell (Life Technologies). Samples 
were mixed using the NuPAGE sample buffer with reducing agent as recommended by 
Life Technologies and heated for 10 minutes at 75 °C. As a sizing standard, the 
Amersham Rainbow Marker (GE Healthcare) was loaded next to the protein samples 
and all gels were run at 150 to 200 V for between 1 and 2 hours, depending on the 
molecular weight of the proteins. After SDS-PAGE, gels were analysed by Coomassie 
staining or western blot.  
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In Helle Ulrich’s lab, besides the ready-made gels, Tris-glycine gels were prepared 
according to Lämmli (Laemmli, 1970) using the Mini-PROTEAN system (Bio-Rad). 
The stacking gel had an acrylamide concentration of 5%, while the acrylamide 
concentration for the separating gel ranged from 7.5% to 15%, according to the size of 
the protein of interest. Samples were mixed with 5x Lämmli loading buffer (5 minutes 
at 95 °C) or HU buffer for yeast protein extracts (10 minutes at 65 °C) and PageRulerTM 
pre-stained protein ladder (Fermentas) was used as a sizing standard. 
 
2.3.2 Coomassie staining  
To detect proteins directly on the gel, protein gels were stained with the Coomassie-
based solution, Simple Blue Safe Stain (Life Technologies) or InstantBlue (Expedeon). 
Gels were incubated in the solution, with gentle agitation for up to an hour, then washed 
extensively with water to remove excess dye. For documentation, gels with visualised 
proteins were scanned.  
 
2.3.3 Western Blots  
Western blot analysis was performed to detect proteins using specific antibodies after 
SDS-PAGE. Proteins were transferred from the polyacrylamide gels onto a PVDF 
membrane (Amersham Hybond from GE Healthcare) using the Mini-PROTEAN Tetra 
cell system (Bio-Rad). Firstly, the membrane was activated with methanol and then 
rinsed with water. Western blotting filter paper (Thermo Scientific) and sponges were 
soaked in cold transfer buffer. The set-up in the cassette from the positive anode to the 
negative cathode was as follows: 1 sponge, 1 filter paper, the activated membrane, the 
gel, 1 filter paper and 1 sponge. The transfer took place at 4 °C for 1.5 hours at 100 V. 
Afterwards, the membrane was blocked in PBS with 5% milk for 1 hour, at room 
temperature. Incubation - with the appropriate dilution of the primary antibody in PBS 
with 5% milk - was either carried out overnight at 4 °C, or for 2 hours at room 
temperature. To remove any unbound antibody, the membranes were washed three 
times for 10 minutes in TBS-T and then incubated with the appropriate dilution of 
secondary antibody in PBS with 5% milk for 1 hour at room temperature. As before, 
three 10-minute wash steps in TBS-T removed the excess antibody. Antibodies, and 
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their dilutions used for western blot analysis, can be found in Table 2.3. The HRP-
labelled proteins were detected with the Pierce ECL 2 Western Blotting Substrate 
(Thermo Scientific). The membrane was then exposed for different time periods to 
films (Amersham Hyperfilm ECL from GE Healthcare), which were developed in an 
automatic X-ray film processor JP-33 (Jungwon Precision Industry).  
If the membrane was to be used for detection with another antibody, it was first 
washed for 20 minutes in TBS-T and then stripped by incubation for 10 minutes in 0.5 
M NaOH. The membrane was subsequently washed for 20 minutes in TBS-T and could 
then be used for antibody detection, as before. 
In Helle Ulrich’s lab, a semi-dry blotting apparatus (Roth) with a three-buffer system 
was used for transfers. The set-up in the semi-dry blotting apparatus from the positive 
anode to the negative cathode was as follows: 1 layer of filter paper (Whatman® gel 
blotting paper from Fisher Scientific) soaked in western blot buffer I, 1 layer of filter 
paper in western blot buffer II, the activated membrane (Immobilon®-P transfer 
membrane from Millipore), the gel and finally two layers of filter paper in western blot 
buffer III. The transfer was carried out at 60 mA for 1 hour (1.5 hours for proteins over 
70 kDa). Blocking (PBS-T with 5% milk), antibody incubations (in PBS-T with 5% 
milk) and washing (in PBS-T) steps were carried out as previously described. The 
different antibodies and working dilutions are listed in Table 2.5. In the Ulrich lab, the 
HRP-catalysed Western Lightning Plus system (PerkinElmer) and CL-XPosureTM films 
(Thermo Scientific) were used for developing.  
 
2.3.4 Determining protein concentrations 
In order to determine the protein concentration, the Bio-Rad protein assay was used. 
This colorimetric assay is based on Bradford. The Bio-Rad protein assay dye reagent 
was diluted 1:5 in water and 1 mL was added to a cuvette, mixed with 1 µL protein 
sample and the absorbance at 595 nm was measured in a Biophotometer (Eppendorf). 
Protein concentrations in mg/mL were calculated by comparing the measured 
absorbance at 595 nm to a BSA standard curve, which was created beforehand with 
defined concentrations of BSA.  
In some cases, the concentration of purified proteins was determined with the 
absorbance at 280 nm, using the NanoDrop ND-1000 Spectrophotometer (Thermo 
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scientific). The molar extinction coefficient (ε) of proteins was estimated with the 
following formula: 
ε = (no. of tyrosines) x 1490 + (no. of tryptophans) x 5500 + (no. of cysteines) x 125 
 
Concentrations of the proteins could then be calculated with Lambert-Beer’s law (with a 
path length of 1): 
Concentration = Absorbance at 280 nm / (ε x path length) 
 
2.4 Methods for Drosophila melanogaster experiments 
2.4.1 Fly husbandry and stock maintenance  
Flies were kept in plastic vials, or bottles, with fly food and at 25 °C. 
Balancer chromosomes have two characteristics - recessive lethal or sterile mutations 
and multiple inversion breakpoints - which allow the maintenance of genetic loci, e.g. 
mutations or inserted transgenes. This keeps the occurrence of meiotic recombination 
between the balancer and the genetic locus of interest to a minimum. Therefore, stable 
stocks of mutants or transgenes can be kept (and are not lost over generations), as viable 
progeny and will either be heterozygous for the balancer and the mutation/transgene, or 
homozygous for the mutation/transgene if viable. Additionally, balancer chromosomes 
have visible markers allowing them to be recognised and making them essential for 
cross schemes. Balancer chromosomes used for the X (homozygous sterile) 
chromosome were FM6 and FM7c (B1 as visible marker), for the second chromosome, 
CyO (Cy1 as visible marker) and, for the third chromosome, TM6b (AntpHu and Tb1 as 
visible marker), TM3 Sb (Sb1 as visible marker) and TM3 Ser (Ser1 as visible marker).  
 
2.4.2 Gene disruption by imprecise P-element excision 
Mutant flies for RASSF9 were generated by imprecise P-element excision. The 
following cross scheme was used:  
F0: ♂♂ Δ2-3; Dr/TM3        ✕  ♀♀ P(EP)G18523/TM6b 
F1: ♂♂ Δ2-3/+; P(EP)G18523/TM3   ✕  ♀♀ TM3/TM6b 
F2: single ♂ P(EP)G18523/TM3 or TM6b ✕  ♀♀ TM3/TM6b 
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Flies harbouring the P-element P(EP)G18523 in the first intron of the RASSF9 locus 
were crossed to a Δ2-3 transposase-expressing stock (F0). As P-elements are 
transposons, they can be mobilised by their cognate transposase. Both the P-element 
and the transposase carried the mini-white gene as a visible marker, causing red eyes. 
Males heterozygous for the P-element and the transposase were crossed to a balancer 
stock (F1). In these males (and their germline) the transposase was active, mobilising 
the P-element. Therefore, males of the next generation (F2) with white eyes had the P-
element excised and were negative for the transposase, as the mini-white marker was 
absent. Single white-eyed males were crossed to a balancer stock and, after 3 days, 
genotyped by PCR for the presence of an imprecise excision, where part of the 
neighbouring sequences are deleted along with the transposon. DNA was extracted from 
single males with the DNeasy Blood and Tissue kit (Qiagen) (see 2.4.9). As part of the 
P-element could still be present, a long-range DNA polymerase, the LA Taq (Takara), 
was used for the screening. A 20 µL reaction contained 0.2 µL LA Taq, 2 µL 10X LA 
PCR Buffer II, 3.2 µL of dNTP (2.5 mM), 0.2 µL DMSO, 0.4 µL of each primer (10 
µM) and the following programme was used: 
1. 94 °C, 1 minute 
2. 94 °C, 30 seconds 
3. 54 °C, 30 seconds  
4. 72 °C, 12 minutes Repeat steps 2-4, 34 times 
5. 72 °C, 10 minutes 
 
The progeny of males positive for a deletion in RASSF9 were used to establish the stock. 
 
2.4.3 Gene disruption using CRISPR/Cas9 
RASSF10 mutant flies were made with the CRISPR/Cas9 system. This system is based 
on the bacterial CRISPR associated nuclease (Cas) that causes double strand breaks in 
specific genomic sites, which are complementary to a CRISPR RNA. CRISPR 
(clustered regularly interspaced short palindromic repeats) and Cas nucleases form an 
immune system in bacteria to protect the bacterial genome from the exogenous DNA of 
viruses or plasmids. The CRISPR/Cas9 system has been successfully modified for site-
specific genome engineering (e.g. deletions or tagging of genes) in flies (Gratz et al., 
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2013, Port et al., 2014). The CRISPR RNA was shortened to the minimum-required 
region for the direction and binding of Cas9 and is referred to as guide RNA (gRNA). 
gRNAs contain a 20-nucleotide region complementary (spacer) to the chosen cleavage 
site in the fly genome and a transactivating RNA for binding to Cas9 (already present in 
the expression plasmids). The only requirement for a potential target site of Cas9 is the 
presence of the 3 bp protospacer adjacent motif (PAM, NGG) at the 3’ end of the 
cleavage site. Expression plasmids for the gRNA just have to be injected into transgenic 
flies expressing the Cas9 nuclease (various different lines are available) and the progeny 
can then be screened for desired modifications.  
To generate deletion mutants of RASSF10, gRNA pairs - causing two double strand 
breaks and, therefore, potentially leading to deletions excising part of RASSF10 - were 
used. Maxine Holder in the Tapon lab designed the oligonucleotides (see Table 2.8) for 
the gRNAs using the Perrimon lab's website (http://www.flyrnai.org/crispr/). The two 
gRNA pairs used for the injection, the sequence of the respective genomic target site 
and the respective oligonucleotides, are listed in Table 2.1. gRNA pair B should target 
Cas9 to cut in the intron before exon 2 (gRNA B1) and 260 bp into exon 4 (gRNA B2), 
potentially creating a deletion of 1546 bp. Cas9 directed by gRNA pair C should cut 
before exon 1 and 335 bp into exon 1, potentially causing a 822 bp deletion.  
 
 
Table 2.1 - RASSF10 gRNA pairs for injection in flies with genomic target site  
 gRNA Target site 5’ to 3’ (PAM and cut site▼) Oligonucleotides 
gRNA 
pair B 
gRNA B1 CCTCTT▼AATCGATCTACATACTC gRNA B1 fw and rv 
gRNA B2 CCAACT▼GTATAGGGGTACCGAAA gRNA B2 fw and rv 
gRNA 
pair C 
gRNA C1 GGCCCACAGGGGCCGTG▼AAATGG 
Intron before exon 1  
gRNA C1 fw and rv 
gRNA C2 CCTCTA▼TGGCGTTAATAGCACTG gRNA C2 fw and rv 
 
 
My colleague, Maxine Holder cloned the gRNA expression plasmids for the 
injection in flies, as follows: For the phosphorylation and annealing of the ordered 
oligonucleotides following reaction was set up: 6.5 µL water, 1 µL of both sense and 
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antisense oligo (100 µM) and 0.5 µL T4 PNK (New England Biolabs). The following 
programme was used for the thermo cycler: 
37 °C, 30 minutes 
95 °C, 5 minutes 
Ramp down to 25 °C at 0.1 °C per second 
 
The pCFD3-dU6:3gRNA plasmid (Simon Bullock) was digested with BbsI 
restriction enzyme (New England Biolabs) and the insert ligated. For the ligation, a 15 
µL reaction contained: 50 ng of linearised plasmid, 1 µL annealed and phosphorylated 
oligonucleotides (diluted 1/200, 1.5 µL of 10X T4 DNA ligase buffer and 1 µL of T4 
DNA ligase (New England Biolabs). After incubation for 30 minutes at room 
temperature, 3 µL of the ligation was used for the transformation of competent bacteria. 
Plasmids were confirmed for correctness by sequencing and sent, for embryo injections, 
to the Fly Facility (Department of Genetics) at the University of Cambridge. The gRNA 
expression plasmid pairs (250 ng/µL of each plasmid for pair B and pair C) were 
injected into embryos of a germ-line restricted nos-Cas9 line (y1, M(nos-Cas9.P)ZH-2A, 
w). Surviving founders were crossed to a balancer stock (y;;Dr/TM3).  
As the activity of Cas9 is not uniform within the germ line, one founder produces 
progeny of which only a proportion will be positive for deletions (or cuts). Additionally, 
the cut sites (and therefore deletions) can differ between individuals. Hence, the 
following screening strategy was used to identify positive founders: a pool of the female 
progeny of the founders was genotyped for the presence of deletions. In parallel, the 
male progeny was crossed to a RASSF10 deficiency line (Df(3L)BSC575/TM6b) to 
identify mutants by phenotype. Five of the female progeny of each founder were pooled 
and total DNA was extracted with fly DNA buffer (see 2.4.9). For the genotyping PCR 
2 µL of DNA and the Taq PCR Master Mix (Qiagen) was used (see Table 2.8 for 
genotyping primers). 10 white-eyed (negative for Cas9) males of the progeny (2nd 
founder) from each positive founder were individually crossed to females of the 
deficiency line and, after 3 days, genotyped for deletions in RASSF10. Progeny 
heterozygous for the deficiency and the deletion mutant could then be checked for 
phenotypic changes. A single male of the progeny of several 2nd founders, heterozygous 
for a RASSF10 deletion and the balancer TM6b, was then crossed to females of a 
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balancer stock (w;;TM3/TM6b) to establish stable lines balanced over TM6b. From 
these lines, DNA was extracted and the RASSF10 locus sequenced to characterise the 
deletion.  
To obtain a control stock with an identical genetic background, exactly the same 
crosses were made, starting with a non-injected male of the nos-Cas9 line. 
 
2.4.4 Recombination of genetic loci 
The combination of genetic loci located on the same chromosome was achieved by 
meiotic recombination in females. Flies harbouring one or other of the two loci of 
interest were crossed. Virgin females of the next generation heterozygous for both loci, 
allowing meiotic crossover, were collected. The females (F1) were then crossed with 
males of a suitable balancer stock and the progeny (F2) screened for positive 
recombinants. The method of screening was dependent on the loci. 
Screening for combinations of mutant alleles was done by genotyping. Single males 
were first crossed to females of a balancer stock. The DNA of males was extracted with 
fly DNA buffer after 3 days (see 2.4.9) and 2 µL of DNA were used for the genotyping 
PCRs with PWO Master Mix (Roche) or Taq PCR Master Mix (Qiagen). Genotyping 
primers are listed in Table 2.8. Progeny of males positive for both mutations were used 
to establish a stable stock. Recombination of three mutant alleles was achieved in two 
steps. First, double mutants were generated and then double mutants were combined to 
generate triple mutants and genotyped.  
The recombination of an FRT chromosome with a mutant allele (see 2.4.7) was 
monitored depending on the FRT chromosome used. In the case of FRT chromosomes 
(FRT82B) with neomycin resistance, G418 food allowed pre-selection solely of 
progeny harbouring the FRT. G418- resistant males were crossed with a balancer stock 
and then genotyped for the presence of the mutation. For FRT chromosomes without 
neomycin resistance, males had to be screened by genotyping PCRs for the presence of 
both the mutant allele and the FRT.  
Recombinants of GAL4 drivers and UAS fluorophore-tagged transgenes were 
identified by the presence of fluorophore signal with the pE-300white illumination system 
(CoolLED). The recombination of GAL4 drivers with UAS transgenes whose 
expression caused an obvious defect was detected by phenotype. 
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2.4.5 PhiC31 integrase-mediated transgenesis 
To express GFP-tagged transgenes in flies, the PhiC31 integrase-mediated system was 
used. The bacteriophage-derived PhiC31 integrase facilitates the site specific and stable 
recombination between two sequences, the bacterial attachment site, attB, and phage 
attachment site, attP. Plasmids containing attB sites can therefore be integrated site 
specifically into attP sites inserted in the fly genome. Fly lines with different attP sites 
were made by P-element insertion, and injection of plasmids with attB site and 
transgene allows the insertion of the transgenes into the genome. The expression vectors 
used in this thesis - pKC26w_GW and pKC26_UAS_GW - also contain the mini-white 
gene as a visible marker, which allows the identification of positive transformants by 
the orange-red eye colour. pKC26w_GW (Yanxiang Zhou) contains the ubiquitin 
promoter, that allows ubiquitous expression of transgenes with an N-terminal GFP-tag. 
In this study, the pKC26_UAS_GW vector was made by replacing the ubiquitin 
promoter with UAS sequences. Hence, UAS-transgenes with an N-terminal GFP-tag 
can be inserted into the genome and their expression can then be controlled with Gal4 
drivers (see 2.4.6). Plasmids were sent to BestGene Inc for injection in embryos and 
selection of positive transformants. Table 2.2 lists all the plasmids, genomic insertion 
sites and the genotype of the fly line used to make transgenic flies.  
 
Table 2.2 - Plasmids, insertion sites and fly lines used for injections  
Plasmid name  Plasmid backbone Insertion site Genotype 
UAS-GFP-RASSF10 pKC26w_UAS_GW 2L 28E7 PBac(yellow[+]-
attP-3B)VK00002 UAS-GFP-RASSF9 
Ubi-GFP-RASSF10 pKC26w_GW 2L 28E7 PBac(yellow[+]-
attP-3B)VK00002 Ubi-GFP-RASSF9 
Ubi-GFP-RASSF8 
Ubi-GFP 
UAS-GFP-RASSF10 pKC26w_UAS_GW 3R 89E11 PBac(yellow[+]-
attP-9A)VK00027 UAS-GFP-RASSF9 
 
 
2.4.6 Gal4/UAS system 
The Gal4/UAS system allows pattern-specific expression of transgenes in flies. It is 
based on a bipartite expression system in which the S. cerevisiae transcription factor 
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Gal4 binds to upstream activating sequences (UAS) from where it then activates gene 
expression. In flies, Gal4 driver lines enable Gal4 expression in the distinct pattern of a 
driver gene where a transposon encoding the Gal4 gene is inserted. The UAS sequence 
can be fused to transgenes of interest (tagged or native genes and RNAi constructs) and 
inserted into the fly genome. Crossing a Gal4 driver line to one that harbours the UAS-
transgene will lead to transgene expression in the pattern of the Gal4-driver expression. 
In this study, the ubiquitously-driving tubulin-Gal4 and actin-Gal4, the wing pouch 
driving nubbin-Gal4 and MS1096-Gal4, the dorsal wing compartment driving apterous-
Gal4 and the sensory organ precursor specific Neuralized-Gal4 lines were used for 
targeted expression of either transgenes (tagged or untagged) or RNAi lines for gene 
silencing. 
 
2.4.7 The FRT/FLP system 
Mutant clones in fly tissues were made with the FRT/FLP system. This system is based 
on the yeast FLP recombinase (FLPase) that mediates site-specific recombination 
between two FLPase recombination target (FRT) sites on homologous chromosomes. 
Transgenic flies were generated with FRT sites located close to the centromere for each 
chromosome arm. To generate mutant clones, the respective FRT chromosomes were 
recombined with the mutant allele of interest (2.4.4). These flies were then crossed to a 
stock harbouring the FLPase and the same FRT chromosome recombined with a 
constitutively expressed marker (e.g. GFP, RFP or lacZ). In larval tissue of the progeny 
where the FLPase was active, mitotic recombination between the two FRT sites 
occurred, giving rise to daughter cells homozygous for the mutant allele (negative for 
the marker), homozygous for the marker (twin spot) or heterozygous for mutant allele 
and marker. The activity of the FLPase is thereby restricted by its promoter. In this 
thesis, two different FLPases were used to generate mutant clones. Firstly, UbxFLP was 
used, in which the FLPase activity is limited to the wing imaginal disc (also leg and 
haltere) in early larval stages. Clones were also made with hsFLP, in which a heat-
shock inducible promoter drives the FLPase activity. To induce the expression of 
FLPase, larvae were heat-shocked twice - 48 and 72 hours after egg laying - for 1 hour 
at 37 °C. 
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2.4.8 The FLPout system 
The FLPout system is a combination of the FLP/FRT and the Gal4/UAS systems. It 
allows the clonal Gal4 driven expression of transgenes. A line harbouring both hsFLP 
and the UAS-GFP-transgene was crossed with a line with a FLPout construct. The 
progeny was heat-shocked for 8 minutes at 37 °C, 96 hours after egg laying. The 
FLPout construct contained the ubiquitously active actin promoter separated from the 
Gal4 transcription factor by two FRT sequences flanking a transcriptional termination 
signal. In this state, actin driven Gal4 expression is repressed. When heat-shocked, the 
FRT sites are recombined out in a small number of cells, removing the termination 
signal. In this way, Gal4 activity is restricted to the mitotic clones, facilitating the 
expression of the UAS-transgenes.  
 
2.4.9 Isolation of genomic DNA from fly tissue 
Fly DNA was usually extracted from a single fly using the DNeasy Blood and Tissue 
kit (Qiagen). Flies were homogenised in 180 µL PBS with a pipette tip and DNA 
extraction carried out according to the manufacturer's protocol. DNA was eluted in 100 
µL of the supplied elution buffer. The DNA was stored at 4 °C and, for PCRs, 1 µL of 
extracted DNA was used. Alternatively, for the genotyping (except for RASSF9 P-
element excision) a single fly was homogenised in 50 µL fly DNA buffer (with 
Proteinase K). The mixture was incubated for 30 minutes at 37 °C to allow digestion 
with Proteinase K, which was inactivated by a 2-minute incubation at 95 °C. 2 µL of 
this solution containing DNA was used for PCRs. 
 
2.4.10 Isolation of RNA from fly tissue and RT-PCR 
RNA from adult flies, embryos or pupae was extracted with the RNeasy Kit (Qiagen). 
Between 10 and 30 adult flies or embryos (collected from one apple juice plate and 
washed twice in PBS) were homogenised in 600 µL of RLT buffer, supplemented with 
β-mercaptoethanol (1 in 100) with a pellet pestle mixer (Sigma-Aldrich). RNA was 
extracted according to the manufacturer’s protocol. RNA concentrations were 
determined by measuring the absorbance at 260 nm with the NanoDrop ND-1000 
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Spectrophotometer (Thermo Scientific). Before the RNA could be used for reverse 
transcription PCR (RT-PCR), DNA was removed from the preparation by DNase 
treatment. For the 10 µL reaction, 1 µL of 10x DNase buffer (Promega) and 1 µL of 
DNase (Promega) were incubated with 1 µg of RNA for 30 minutes at 37 °C. The 
digestion was stopped by adding 1 µL of DNase Stop Solution (Promega) and 10 
minutes heat inactivation at 65 °C. DNase treated and untreated RNA was stored at 
−80 °C.  
RT-PCR was carried out with the First Strand cDNA Synthesis Kit (Roche) 
according to the manufacturer’s protocol, using 8.2 µL of the DNase-treated RNA and 
random primers. 2 µL of synthesised cDNA was used for PCR reactions with PWO (see 
2.2.1). 
 
2.5 Immunofluorescence and imaging 
2.5.1 Dissection and staining protocols for different fly tissues 
For dissection and staining of imaginal discs, L3 larvae or white prepupae were 
collected and dissected in cold PBS with sharp forceps (#5, Dumont). Larvae were 
halved and the anterior part turned inside out. The carcasses were fixed in 4% 
paraformaldehyde (PFA, Taab) in PBS for 20 minutes at room temperature. All 
incubation steps were carried out with mild agitation in a light protected chamber at 
room temperature (except primary antibody incubation). Samples were washed four 
times for 5 minutes in cold PBT and then permeabilised with PBT-0.3 for half an hour. 
After another 5-minute wash in PBT, blocking was performed in 10% normal goat 
serum (NGS, MP Biomedicals) for 1 hour. Primary antibody incubation in 10% NGS in 
PBT took place overnight at 4 °C and excess antibody was removed in five wash steps 
for 5 minutes in PBT. Secondary antibody incubation was for 1 hour in 10% NGS in 
PBT, followed by five 5-minute wash steps in PBT. Imaginal discs were dissected in 
PBS and mounted in Vectashield anti-fade mounting medium (with or without DAPI, 
Vector laboratories) on glass slides (Thermo Scientific) for imaging.  
For pupal wing stainings, white prepupae were aged for 30 hours (30 hours APF). 
Pupae were then pulled out (from the anterior side) of the opened pupal cases and 
punctured to allow the fixative to enter. Fixation was carried out in 4% PFA in PBS at 
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4 °C overnight and protected from light. The next day pupal carcasses were rinsed with 
PBS. In PBT-0.3, pupal wings were carefully pulled out of the cuticle pocket. The 
following steps were then carried out at room temperature, slightly shaking in a light 
protected chamber: Wings were permeabilised for 40 minutes in PBT-0.3 and blocked 
with 0.15% BSA in PBT-0.3. Antibody incubations were in 0.15% BSA in PBT-0.3 
(overnight at 4 °C for primary and 1 hour at room temperature for secondary antibodies). 
Wings were then washed with PBT-0.3, for 4x10 minutes after primary antibody 
incubation and for 3x20 minutes after secondary antibody. Pupal wings were mounted 
in Vectashield.  
For pupal nota stainings, white prepupae were collected and aged for 15 hours (15 
hours APF). Pupae were attached with the posterior side to a rubber pad with fine 
needles, covered in PBS and the pupal case removed. Pupal nota were carefully cut out 
with micro scissors and fixed for 20 minutes in 4% PFA in PBS. After rinsing the tissue 
three times with PBT, nota were permeabilised for one hour in PBT and then blocked 
for 1 hour in 10% NGS in PBT. Primary antibodies were added for 2 hours and nota 
were washed for 3x10 minutes with PBT. Secondary antibody incubation was for 1 hour 
in 10% NGS in PBT and nota were washed three times in PBT. All staining steps were 
performed, without shaking, at room temperature under exclusion of light. To allow 
straightening of the tissue, nota were incubated in PBS 50% glycerol overnight at 4 °C. 
Finally, nota were mounted in Vectashield with the apical side facing up. 
All primary antibodies, fluorophore-labelled secondary antibodies, and their working 
dilutions used for immunofluorescence, are listed in Table 2.4. 
 
2.5.2 Mounting of adult wings 
For analysis of wing roundness and wing size, adult female flies were transferred into 
70% ethanol. In isopropanol, wings were removed from the flies with forceps and 
placed onto a glass slide. Wings were mounted in Euparal (ALS) with a cover slip 
placed upon them. Samples were then dried at 65 °C overnight in an SM30 incubator 
from Grant Boekel. 
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2.5.3 Microscopy and imaging  
Fluorophore-labelled samples prepared, as specified in 2.5.1, were imaged on an SP5 
laser scanning confocal (Leica) with 20x or 40x objectives. Generally, Z-stacks were 
acquired in order to cover the entire apical signal with a Z-stack size of 0.5 µm. Images 
were then processed with ImageJ 1.46r and Photoshop CS5.1. 
Images of adult wings (preparation see 2.5.2) were taken with an Axioplan2 
microscope from Zeiss and a Leica camera.  
Images of the notum and abdomen of adult flies (in 70% ethanol) were acquired with 
a Leica MZ7.5 dissection microscope and a Leica camera. 
 
2.5.4 Preparation and live imaging of pupal nota 
To image asymmetric cell divisions of sensory organ precursors in the pupal notum, 
pupae expressing fluorophore-tagged proteins were dissected at 15 hours APF. A single 
pupa was stuck (apical side facing up) onto a glass slide with double-sided tape. The 
pupal case was carefully removed from head and notum with forceps. Two stacks of 
18x18 mm cover slides (each stack contained 4 slides glued together with nail polish) 
were positioned in front and behind the pupa, forming a chamber. A thin layer of 
Voltalef Oil 10S (VWR) was spread evenly onto a 20x50 cover slide. The cover slide 
was placed carefully - with the oil side facing the pupa - onto the stacks and pupa, and 
sealed with nail polish. 
Live imaging was performed with an SP5 laser scanning confocal (Leica) with a 40x 
objective. Images (apical Z-stack, Z-stack size of 0.5 µm) were acquired for about 2 
hours. For the Pon-GFP analysis, apical Z-projections contained 10 stacks and images 
were acquired every 51.62 seconds. Movies were processed and analysed with ImageJ 
1.46r. 
 
2.6 Analysis and quantifications 
2.6.1 Quantification of wing size and roundness 
To quantify wing roundness, mounted wings (see 2.5.2) were analysed as follows: The 
length of the wing was measured by drawing a line along the L3 vein from the proximal 
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to the distal and the width by drawing a line from the anterior to the posterior passing 
through the posterior cross-vein (Figure 3.17). Wing roundness was then calculated as 
the ratio of length to width. 
As wing size is very sensitive to the supply of food (which, in turn, is dependent on 
the amount of larvae in one vial), flies of different genotypes had to develop under the 
same food conditions in density-controlled crosses. For density-controlled crosses, flies 
were kept for egg-laying on apple juice plates in cages overnight. The next day, 50 first 
instar larvae were carefully picked and transferred into a normal food vial. Wings of 
density-controlled adult flies were mounted and imaged, and the wing size determined 
with ImageJ 1.46r. Therefore an outline around the entire wing was drawn and the area 
measured. 
 
2.6.2 Quantification of mechanoreceptor defects 
Duplications of stout bristles of adult wings were quantified for 100 wings (the left and 
right wing for each of 50 flies, see Figure 4.2) of each genotype on a Leica dissection 
microscope. The same flies were also analysed for missing or additional thoracic 
macrochaetes (see Figure 4.3). 
 
2.6.3 Analysis and quantification of SOP divisions 
The Pon-GFP distribution from the mother SOP cell into daughter cells was measured 
in ImageJ 1.46r as follows: the Pon-GFP signal's Grey value was measured for both 
daughter cells (pIImin and pIImax) after the cells had fully divided (five time points after 
elongation onset). The Pon segregation was then calculated by dividing the smaller 
Grey value (intensity pIImin) by the bigger Grey value (intensity pIImax). In case of a Pon 
mis-segregation, pIImin and pIImax intensities will have similar values and the ratio will 
therefore be approaching 1.  
The division angle relative to the anterior-posterior body axis (A-P-axis: 0°) was also 
measured for each division (4 time points after elongation onset) in ImageJ 1.46r and as 
illustrated in Figure 4.18. Clockwise divisions were given positive values (0 to 180 °), 
and counter clockwise divisions ascribed negative values (0 to -180 °). 
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The analysis for the polarity of the Pon crescent was carried out with ImageJ 1.46r. 
First, a freehand tool was used to draw a perfect outline of each SOP cell (line width 3 
pixels) just before the start of division. This line was then straightened and a Plot Profile 
for the Pon-GFP signal was created (distance in microns over Grey value). The Grey 
values were then used to determine the polarity of the Pon crescent. We used a fast 
Fourier transformation to calculate the polarisation coefficient, using the following 
equation: 
P = a2 + b2  
a and b being defined as: 
a = 1N Ik=1
N
∑ k cos k2πN
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#
$
%
&
'  
b = 1N Ikk=1
N
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&
'  
N: Number of observations 
Ik = Grey value kMean of Grey values  
 
The normalisation to mean intensity was in order to control for different baseline signal 
intensities across the different video-micrographs. We are grateful to Xavier Tapon for 
providing a Python programme to help with the analysis.  
 
2.6.4 Statistical analysis 
Statistical analysis was performed with the Prism 6 software, using either an unpaired 
nonparametric t-test (Mann-Whitney test) or in case of multiple comparisons a one-way 
ANOVA (Bonferroni's correction multiple comparisons test) to test whether mean 
values differed significantly. In case of the bristle (margin and thoracic) analysis the 
distributions of bristle defect categories between different genotypes were tested for 
significant differences using the Fisher’s exact test (Freeman-Halton extension) 
(Freeman and Halton, 1951) with the SPSS 21 software. The extended Fisher’s exact 
test was used to calculate the P-values as the Chi square test was invalid for most of the 
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calculations, due to small numbers and the presence of 0 counts. In all figures error bars 
represent the mean ± the standard deviation. 
 
2.7 S2 cell culture and protein methods  
Drosophila S2 cells were maintained at 25 °C in 75 cm2 flasks (Corning) containing 12 
ml of S2 medium (Gibco). Once a week, cells were transferred into a flask (ratio 1:10) 
with fresh medium. To avoid contaminations, the handling of S2 cells took place in a 
safety cabinet (BioMAT2). 
 
2.7.1 Transient transfection of S2 cells 
To express tagged proteins in S2 cells, the cells were transiently transfected using the 
Effectene Transfection Reagent (Qiagen). First, 3x106 cells (in 1.5 mL medium) were 
seeded in the well of a 6-well plate (Corning) and left to settle for approximately 30 
minutes. In the meantime, plasmids (50-500 µg, depending on the expression level) 
were prepared for the transfection, according to the manufacturer’s instructions. 180 µL 
EC buffer, 8 µL enhancer and 25 mL Effectene Transfection Reagent were used per 
transfection. Cells were then incubated for 48 hours before being lysed. All plasmids 
used for transfections are listed in Table 2.6 of section 2.14.1. 
 
2.7.2 Isolation of total protein extracts from S2 cells 
Transfected cells from 2.7.1 were collected from each well of the 6-well plates 48 hours 
after transfection. Cells were then harvested by centrifugation at 10000 rpm for 1 
minute at 4 °C and washed in 1 mL ice-cold PBS. For the cell lysis, cell pellets were 
resuspended in 200 µL of freshly-prepared NP40 lysis buffer and then incubated for 10 
minutes on ice. This was followed by centrifugation at 13200 rpm for 20 minutes at 
4 °C. The protein extract with soluble proteins in the supernatant was then used either 
directly for western blot analysis, for co-IP experiments, or stored at −80 °C. 
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2.7.3 Co-immunoprecipitation  
For co-immunoprecipitation (co-IP) experiments 80 µL of the cell lysates (prepared as 
described in 2.7.2) was added to 220 µL of NP40 lysis buffer containing 10 µL of Anti-
FLAG M2 Affinity Gel (Sigma-Aldrich, in NP40 lysis buffer pre-equilibrated). The 
lysate-gel mix was then incubated under rotation for 1.5 hours at 4 °C to allow binding 
of FLAG-tagged proteins (and their binding partners) to the affinity gel. Beads were 
washed with NP40 lysis buffer for 4x5 minutes to remove unspecific binding. After the 
last wash, 10 µL of 4xNuPAGE sample buffer, 6 µL of Np40 lysis buffer and 4 µL 
10xNuPAGE reducing agent were added to the dried beads, and samples were then 
denatured for 10 minutes at 75 °C. Input samples for co-IPs contained 5 µL of total 
lysate, 5 µL of 4xNuPAGE sample buffer, 2 µL of 10xNuPAGE reducing agent and 8 
µL of NP40 lysis buffer. 20 µL of co-IP and input samples were then analysed via SDS-
PAGE and western blot. 
 
2.8 RASSF10 antibody generation 
To generate an antibody against RASSF10, the following expression and purification 
strategy was used. A short fragment of GSTRASSF10 (375-468) with an N-terminal 
GST-tag was expressed from pGEX-4-T1 (GE Healthcare) in the E. coli strain BL21 
Codon2+. A pre-culture was grown overnight at 37 °C in an LB medium containing 
ampicillin (100 µg/mL). The following day, the overnight culture was used to set up the 
main culture with a starting OD600 of 0.1 to 0.2 in LB with the respective antibiotics. 
The main culture was grown at 37 °C until an OD600 of 0.5 to 0.8 was reached. At this 
point, protein expression was induced by adding 0.5 mM IPTG and the culture then kept 
at 18 °C overnight. The cells were pelleted the next morning by centrifugation at 
4000xg for 20 minutes. For the cell lysis, cells were resuspended in ice-cold GST lysis 
buffer and opened by sonication (SANYO sonifier) on ice using 4 one-minute bursts 
with a one-minute interval in between each burst. From this point on, all subsequent 
steps were carried out on either on ice, or at 4 °C. Cell debris was removed by 
centrifugation at 30000xg for 30 minutes (Beckman). Purification of the GST-tagged 
protein was carried out as follows. The soluble lysate was incubated with Glutathione 
Sepharose 4B (GE Healthcare) (pre-equilibrated in GST wash buffer) under rotation for 
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one hour at 4 °C to allow the binding of GST-tagged proteins. The medium was 
collected by centrifugation at 500xg for one minute and the supernatant was removed. 
Next, the medium was washed six times with GST wash buffer (followed each time by 
medium sedimentation at 500xg). The GST-tagged RASSF10 fragment was eluted from 
the Glutathione Sepharose 4B by adding GST elution buffer. The medium was 
sedimentated by centrifugation at 500xg, and the GST-RASSF10 containing supernatant 
could be collected. Fractions from wash and elution steps were then analysed by SDS-
PAGE and Coomassie staining as well as by anti-GST western blot. To remove the 
glutathione from the purified protein, the eluate was dialysed against PBS with 10% 
glycerol at 4 °C overnight.  
The purified RASSF10 (375-468) fragment (4.2 mg) was then sent to Eurogentec for 
antibody production (3-month immunisation programme in rabbits) and antibody 
purification.  
 
2.9 Methods for yeast experiments 
2.9.1 Yeast cultivation and strains  
Yeast cells were grown under standard conditions in YPD medium at 30 °C. 
Temperature-sensitive mutants were instead grown at their permissive temperature of 
25 °C and normally shifted to higher temperatures for the experiments. Strains that 
carried episomal plasmids, integrated cassettes or integrative plasmids were grown on 
SC (synthetic complete) medium lacking the amino acid of the respective marker. All 
media contained 2% glucose as the carbon source.  
All the yeast strains used in this thesis are listed in Table 7.1 in the Appendix. Strains 
created by myself were made either by crossings, PCR-based epitope tagging or 
disruption of genes, or by integration of plasmids. YIp128 vectors were linearised by 
EcoRV digestion and integrated into the LEU2 locus. In order to introduce the L109A 
mutation of Spc25 in the wild type allele, the YIp211-P-SPC25-T (L109A) vector was 
digested with PstI and integrated in the URA3 locus. Growth on 5-FOA (5-fluoroorotic 
acid) plates allowed for the selection of clones that had lost the integrated plasmid and 
colonies that were positive for the L109A mutation in the SPC25 allele (due to 
recombination) were identified via sequencing. 
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2.9.2 Yeast mating and tetrad dissection  
In order to create mutant strains, haploid cells of different genotypes were first mated. 
The haploid strains were grown overnight in 3 mL YPD at 30 °C and, for temperature-
sensitive mutants, at 25 °C. The next day, 5 µL of each culture was directly pipetted on 
top of each other onto a YPD plate and incubated for 4 to 6 hours at 25/30 °C (until 
zygotes were detected under the microscope). Zygotes were then picked and separated 
on the plate using a MSM micromanipulator (Singer) and grown for 2 to 3 days in the 
incubator. Diploids were scraped off the plate and mixed into 1 mL of 1% KOAc to 
allow sporulation. After 2 to 3 days 5 µL of the spores were mixed with 5 µL Z0.5 
solution and incubated for 15 minutes at room temperature in order to digest the ascus 
wall. 5 µL of the solution was then dropped and distributed in a line on an YPD plate 
and the tetrads were dissected with the micromanipulator. After growth for 3 to 5 days 
at 25/30 °C, tetrads were replica-plated and analysed by growth on restrictive media or 
temperature shift to 37 °C for temperature-sensitive alleles or PCR/sequencing.  
 
2.9.3 Spot assay for temperature sensitivity  
Yeast cultures were grown in YPD overnight at the permissive temperature of 25 °C. 
The next day a dilution series was set up with the culture starting from an OD600 of 0.2 
and then further diluted by the factor 1/10 to an OD600 of 2x10−4. For every culture 3.3 
µL of the four dilutions were spotted on YPD plates (one for every temperature). Plates 
were incubated for 3 days at the different temperatures (25-35 °C) and scanned at day 2 
and day 3.  
 
2.9.4 Yeast transformation  
In order to tag alleles, delete genes, integrate plasmids in the yeast genome or for 
expression from episomal plasmids, yeast cells were transformed with the respective 
DNA in the following way. First, the relevant strain was grown overnight at 30 °C (or at 
25 °C for temperature-sensitive mutants), diluted with fresh medium in the morning and 
grown until an OD600 of 1 to 2 was reached. Cells were then harvested by centrifugation 
for 3 minutes at 800xg and the pellet resuspended in 100 µL LIT. Following this, DNA 
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was mixed with 10 µL herring sperm DNA and then added to the cells. For 
transformations, 5 µL PCR product was used for PCR-based epitope tagging or gene 
disruption, whereas for linearised or circular plasmids 0.5 to 1 µg and for episomal 
plasmids 100 ng were used respectively. 500 µL PEG/LIT was mixed into the cell-DNA 
suspension by vortexing. The cells were then incubated for 15 to 30 minutes under 
rotation. 50 µL of DMSO were added just before the heat shock at 42 °C for 15 minutes 
or 10 minutes for temperature-sensitive strains. Cells were harvested at 800xg for 30 
seconds and resuspended in 100 µL sterile water. Cells were plated on selective medium 
according to the selection marker used. In the case of the KanMX auxotrophic marker, 
cells were not plated directly but recovered for 4 hours in YPD medium before plating 
them on G418 plates. Colonies were analysed after 3 days incubation at 25 or 30 °C by 
colony PCR and where applicable by SDS-PAGE/western blot. 
 
2.9.5 Isolation of genomic DNA  
In order to extract genomic DNA from yeast cells, the MasterPureTM yeast DNA 
purification kit from Epicentre was used. Therefore, 1 mL cells of an overnight culture 
(OD600 of 8 to 10) were harvested and DNA was isolated according to the 
manufacturer’s instructions.  
 
2.9.6 Colony PCR for yeast  
For the yeast colony PCR a small fraction of the colony was picked with the tip of a 
pipette and resuspended in 50 µL zymolyase mix. After 10 minutes incubation 
spherobalsted cells were pelleted for 5 minutes at 4500xg and the supernatant was 
sucked off. After the pellet was dried for 5 minutes at 95 °C, 25 µL PCR mix (Simple 
Red polymerase from Thermo Scientific) was added directly. Following PCR 
programme was applied: 
1. 94 °C for 3 minutes 
2. 94 °C for 45 seconds 
3. 54 °C for 30 seconds 
4. 72 °C for 1 minute Repeat step 2-4 for 34 times 
5. 72 °C for 7 minutes 
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2.9.7 PCR-based gene disruption and epitope tagging 
In order to epitope tag the C-terminus of alleles (Knop et al., 1999) or delete them 
(Longtine et al., 1998), a PCR-based technique was applied. Therefore, special plasmids 
containing tagging cassettes (6HA-, 9myc etc.) for selection with different auxotrophic 
markers (Knop et al., 1999, Funakoshi and Hochstrasser, 2009), or plasmids with 
knockout cassettes (Wach et al., 1994) were used. In both cases specific primer pairs 
had to be designed according to (Longtine et al., 1998, Knop et al., 1999, Funakoshi and 
Hochstrasser, 2009). For epitope tagging, sense primers contained the last 50 bp 
upstream of the stop codon from the respective gene, while reverse primers contained 
50 bp after the stop codon. Both of them ended in 3’ with specific sequences flanking 
the tagging cassette. The gene disruption primers also consisted in 3’ of sequences 
complementary to the knockout cassette, but the gene specific 5’ region contained 50 bp 
upstream of the start codon for forward primers and 50 bp upstream of the stop codon 
for reverse primers.  
Tagging or disruption cassettes were then amplified with the relevant primers from 
the plasmids in a 100 µL Simple Red polymerase reaction (see 2.2.1). PCR products 
were ethanol precipitated, resuspended in 15 µL sterile water and analysed by agarose 
gel electrophoresis. The strains of interest were transformed with 5 µL of the PCR 
product as described in 2.9.4 and grown on SC− plates for 3 days. Following this, 
colonies were analysed via PCR for the presence of the tag and, in case of deletions for 
the absence of the gene, using primers within the open reading frame. Furthermore, the 
expression of the tagged proteins was tested by SDS-PAGE and western blot with 
antibodies according to the tagging.  
 
2.9.8 Site-directed mutagenesis 
In order to create single amino acid substitutions in proteins (Spc25 (L109A), Rabex-5 
(A58G)), mutations were introduced in the integrative yeast plasmids by site-directed 
mutagenesis. Site-directed mutagenesis was carried out as specified by the 
QuickChange® Site-Directed Mutagenesis Kit manual from Stratagene, using the 
PfuTurbo DNA polymerase.  
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2.9.9 Isolation of total protein extract from yeast  
To test the expression of proteins, total protein extract from yeast cells was obtained in 
the following way. Cells were grown overnight in YPD at 30 °C (or 25 °C for 
temperature-sensitive strains) and diluted 1:10 for the main culture. At an OD600 of 2 the 
cells were harvested and kept on dry ice. Pellets were resuspended in 500 µL sterile 
water and mixed with 75 µL of 1.85 M NaOH and 7.5% β-mercaptoethanol. After 
incubation for 15 minutes on ice 75 µL of 55% (w/v) TCA was added, followed by 
another 10 minutes incubation on ice to allow the precipitation of proteins. After 
centrifugation for 10 minutes at 16000xg, the supernatant was carefully removed so that 
no liquid remained. The protein-containing pellets were then resuspended in 40 µL HU 
buffer, denatured for 10 minutes at 65 °C and samples were then ready to be analysed 
via SDS-PAGE and western blot.  
 
2.9.10 Pull-downs to test in vivo ubiquitylation 
To test the in vivo ubiquitylation of kinetochore components, Ni-NTA pull-downs under 
denaturing conditions were performed (Ulrich and Davies, 2009). For this purpose, 
strains harbouring TAP-, 6xHA-, or 9xmyc-tagged alleles of different kinetochore 
proteins were first transformed with an episomal vector for the copper inducible 
expression of 6xHis-tagged ubiquitin. Cultures were then grown overnight in 3 mL 
YPD at 30 °C in the presence of 0.1 mM CuSO4 to allow His-ubiquitin expression. The 
next day, the overnight cultures were used to set up 50 mL main cultures in YPD and 
0.1 mM CuSO4, which were grown at 30 °C until an OD600 between 1 and 2 was 
reached. For the pull-downs, 50 OD600 cells were used. Cells were harvested by 
centrifugation for 5 minutes at 800xg and pellets were kept on dry ice. They were then 
resuspended in 5 mL of cooled water and, at this point, 50 µL of the suspension was 
used to prepare the input samples as described in section 2.9.9. To open the cells, 0.8 
mL of 1.85 M NaOH and 7.5% β mercaptoethanol were added to the remaining cell 
solution, strongly vortexed and incubated for 20 minutes on ice. Next, 0.8 mL of 55% 
(w/v) TCA were mixed in and after another 20 minutes on ice, proteins were pelleted by 
centrifugation with 16000xg at 4 °C for 20 minutes. The supernatant was then carefully 
removed and the protein-pellet dissolved for approximately 1 hour in 1.5 mL buffer A 
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at room temperature. The insoluble fraction was removed by centrifugation at 10000xg 
for 15 minutes. Total ubiquitin conjugates were isolated by adding 20 µL of in buffer A 
pre-equilibrated Ni-NTA resin (Qiagen). Imidazole and Tween 20 were also added, so 
that the binding buffer contained 15 mM imidazole and 0.15% Tween 20. Binding of 
His-tagged ubiquitin conjugates was carried out overnight under rotation at room 
temperature. Unspecific binding to the resin was then removed by extensive washing of 
the beads - twice with buffer A and three times with buffer C. After the final wash step, 
all the liquid was removed from the beads and they were boiled in 40 µL NuPAGE 
sample buffer (Life Technologies, prepared according to the manufacturer) for 3 
minutes at 100 °C. Pull-down and input samples (1:8 dilution) were loaded directly on 
NuPAGE 4-12% Bis-Tris gels (Life Technologies) and analysed by western blot with 
an antibody against the respective tag.  
To test the effect of inhibition of the proteasome on the ubiquitylation of proteins, 
the respective alleles were tagged in a PDR5 deletion strain to enable the efficient 
uptake of the inhibitor MG132 (Calbiochem). Strains were then transformed with the 
episomal plasmid for copper inducible His-ubiquitin expression. Cell cultures were 
grown as described above, with the difference that 50 µM MG132 was added to the 
main culture at an OD600 of 1 and then grown for a further 2 hours before the cells were 
harvested. Pull-downs were performed as before and analysed by SDS-PAGE/western 
blot. 
 
2.9.11 Cycloheximide chase assay 
In order to test the stability of tagged (TAP, 9xmyc, 6xHA) proteins, a cycloheximide 
chase assay was carried out. Therefore, strains harbouring the tagged alleles were grown 
overnight in 3 mL YPD at 30 °C. The next day, the cultures were diluted in 30 mL YPD 
and further grown until an OD600 of approximately 1 was reached. Protein de novo 
synthesis was then inhibited by adding cycloheximide to a final concentration of 100 
µg/mL and the cells’ protein amount was monitored by taking 1 mL aliquots at several 
time points. The cells were harvested and pellets were kept on dry ice. Total protein 
extracts were prepared as described in section 2.9.9 and analysed by SDS-PAGE and 
western blot using the appropriate antibodies. 
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2.10 Protein purification and protein interaction studies 
2.10.1 Purification of the Spc25 (107-221)-Spc24 (154-213) complex and 
ubiquitin for crystallisation trials 
For the crystallisation of the Spc25 (107-221)-Spc24 (154-213) complex with ubiquitin, 
the following expression systems and purification strategies were applied. Spc25 (107-
221) was expressed from pET15b (Novagen) and HisSpc24 (154-213) from pEHisTeva 
(derived from pET30a) with a N-terminal TEV protease cleavable His-tag. Spc25 (107-
221) and HisSpc24 (154-213) were co-expressed in the E. coli strain BL21 Codon2+. A 
pre-culture was grown overnight at 37 °C in LB medium containing ampicillin (100 
µg/mL) and kanamycin (50 µg/mL). The following day the overnight culture was used 
to set up the main culture with a starting OD600 from 0.1 to 0.2 in LB with the respective 
antibiotics. The main culture was grown at 37 °C until an OD600 of 0.5 to 0.8 was 
reached. At this point protein expression was induced by adding 0.2 mM IPTG and the 
culture was kept at 37 °C for a further 5 hours. The cells were then pelleted by 
centrifugation at 7700xg for 20 minutes. Cell pellets were either stored at −80 °C or put 
on ice for further processing. Cell pellets were resuspended in ice-cold Ni-NTA 
lysis/wash buffer and the cells were opened by sonication (BRANSON sonifier) on ice 
using 5 bursts for 1 minute (40% input) with a one-minute interval in between. From 
this point on, all subsequent steps were carried out on either ice or at 4 °C. Cell debris 
was removed by two centrifugation steps, first at 10000xg for 30 minutes followed by 
ultracentrifugation of the soluble fraction (Beckmann Ultracentrifuge) at 100000xg for 
30 minutes. The soluble lysate was then incubated with in Ni-NTA lysis/wash buffer 
pre-equilibrated Ni-NTA resin (Qiagen) under rotation for 1 hour at 4 °C to allow the 
binding of His-tagged proteins and then loaded onto a column. The flow through was 
collected and the resin was extensively washed with Ni-NTA lysis/wash buffer (at least 
6 times). This was done to minimize unspecific binding before the Spc25 (107-221)-
HisSpc24 (154-213) complex was eluted from the Ni-NTA resin with imidazole 
containing Ni-NTA elution buffer. At this stage, the His-tag of Spc24 was removed 
using TEV protease. Therefore, TEV protease was added in an OD280 ratio of 1:20 to 
the sample. Cleavage was carried out overnight at 4 °C and under dialysis in Ni-NTA 
dialysis buffer to remove the imidazole of the sample. In order to expunge the His-
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tagged TEV protease from the sample another Ni-NTA affinity chromatography was 
carried out the next day. The procedure was as described above, but differed in that the 
Ni-NTA wash buffer II, which contains a lower concentration of imidazole, was used 
for washing. The Spc25-Spc24 complex with the cleaved His-tagged was collected from 
the flow-through and wash fractions. Cleavage with TEV protease and reverse Ni-NTA 
affinity chromatography was repeated because there was still His-tagged Spc24 present 
(tested via anti-His western blot and Coomassie staining of the gel).  
After the initial Ni-NTA purification there were still various other proteins present, 
so three more purification steps with different columns on an ÄKTA protein 
purification system (GE Healthcare) were performed. After testing different purification 
strategies the following one turned out to be the most efficient in obtaining a very pure 
Spc25 (107-221)-Spc24 (154-213) complex: First of all, the probe was run over a 
HiTrap Q HP anion exchange column (GE Healthcare), taking advantage of the very 
poor binding ability of the Spc25-Spc24 complex to a strong anion exchanger. 
Therefore, the protein sample was dialysed against HiTrap Q buffer I overnight and 
loaded onto the in HiTrap Q buffer I pre-equilibrated anion exchange column. This 
buffer contained 100 mM salt and, under those conditions, the Spc25-Spc24 complex 
did not bind to the column but most of the contamination proteins did. These were 
eluted in a salt gradient from 100 mM to 1 M NaCl (10 to 100% HiTrap Q elution 
buffer I) and discarded. In the next step, the wash fractions with the Spc25-Spc24 were 
pooled and dialysed against HiTrap Q buffer II and loaded onto an in HiTrap Q buffer II 
pre-equilibrated HiTrap Q column. With no salt present in the buffer the Spc25-Spc24 
complex bound to the column and was eluted by using a 0 to 200 mM salt gradient (0 to 
20% HiTrap Q elution buffer II). The remaining proteins on the column were eluted via 
a 200 mM to 1 M salt gradient. The already very pure Spc25-Spc24 protein sample was 
then concentrated in the centrifuge (5000 MCWO, Vivaspin) and loaded on a Superdex 
75 16/60GL gel filtration column (GE Healthcare) (pre-equilibrated with gel filtration 
buffer for crystallisation). The fractions were analysed by SDS-PAGE followed by 
Coomassie staining. 
Ubiquitin (bovine, Sigma-Aldrich) was dissolved in PBS with 10% glycerol and also 
loaded on the Superdex 75 16/60 column under the same conditions as described above. 
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2.10.2 Crystallisation trials 
The purified Spc25-Spc24 complex and ubiquitin (see 2.10.1) were sent to our 
collaborator, Martin Singleton, for crystallisation trials. Silva Zakian, a postdoc in 
Martin Singleton’s lab, set up crystallisation screens. Ubiquitin and the Spc25-Spc24 
complex were concentrated to 8 mg/mL and 14 mg/mL, respectively, and then mixed at 
a ratio of 1.2 to 1 (ubiquitin to complex). The sitting drop vapor diffusion technique was 
used. Different standard screens were set up and approximately 1000 different 
conditions were tested. 
 
2.10.3 Co-elution of Spc25-Spc24 and ubiquitin in a sizing column 
The interaction between the Spc25-Spc24 complex and ubiquitin was also tested for co-
elution in a sizing column. Proteins that bind to each other shift the elution profile when 
loaded together to a higher molecular weight. Spc25 (107-221) was expressed from 
pET15b (Novagen) and HisSpc24 (154-213) from pEHisTeva (derived from pET30a). 
Expression of the Spc25-HisSpc24 complex, cell lysis, Ni-NTA affinity chromatography 
(without His-tag cleavage) was carried out as described in 2.10.1. Samples were then 
dialysed overnight (using gel filtration buffer for the sizing column) and concentrated, 
before being loaded onto a Superdex 75 16/60 gel filtration column (GE Healthcare). 
Ubiquitin (bovine, Sigma-Aldrich) in PBS with 10% glycerol was loaded onto the 
Superdex 75 16/60 column under the same conditions.  
To test whether Spc25-24 and ubiquitin co-elute, the purified Spc25-HisSpc24 complex 
(0.39 mg) was first loaded alone onto the Superdex 75 16/60 column and the elution 
profile acquired. Next, ubiquitin (0.29 mg) and the complex (0.39 mg) were mixed in a 
molar ratio of 2:1 and loaded onto the sizing column to generate the second elution 
profile. An overlay of both elution profiles allowed for a direct comparison. 
 
2.10.4 Purification of His-tagged Spc25 and Spc24 for BIACORE 
HisSpc25 (107-221) and HisSpc25 (L109A)(107-221) were expressed from pET28a 
(Novagen) and HisSpc24 (154-213) from pET15b (Novagen). HisSpc25 (107-221) and 
HisSpc25 (L109A)(107-221) were both co-expressed with HisSpc24 (154-213) in BL21 
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Codon2+ under the same conditions as described in 2.10.1. Cell lysis and the Ni-NTA 
affinity chromatography were also done as in 2.10.1 expect that the His-tag was not 
cleaved afterwards. The concentrated samples (5000 MCWO, Vivaspin) were loaded 
directly on a Superdex 75 16/60 gel filtration column (GE Healthcare) (pre-equilibrated 
with gel filtration buffer for BIACORE). Fractions were analysed by SDS-PAGE and 
Coomassie staining as well as anti-His western blot. 
 
2.10.5 BIACORE analysis 
The interaction studies between the Spc25-Spc24 complex and ubiquitin using surface 
plasmon resonance technology were performed on a BIACORE X instrument (GE 
Healthcare). All steps were carried out with a flow rate of 5 µL/min at 25 °C and all the 
buffers and reagents were from GE Healthcare. Before the CM5 sensor chip was used, it 
was left at room temperature for half an hour to avoid condensation. The BIACORE 
instrument was prepared with HBS buffer and the chip was then inserted and docked. 
For activation of the sensor chip surface 30 µL of a NHS/EDC mix (1:1 ratio) was 
injected. 35 µL of diluted anti-GST antibody (30 µg/mL) was captured on the surface 
(9000 RU) and the chip was deactivated with 35 µL ethanolamine. Next, equimolar 
amounts of GST (662 RU) and GST-tagged ubiquitin (895 RU) were captured on two 
separate flow cells. Increasing concentrations of HisSpc25(107-221)-HisSpc24(154-213) 
(1-40 µM) or HisSpc25(L109A)(107-221)-HisSpc24(154-213) (10-400 µM) were injected 
and SPR signals (in RU) of both cells were measured for 300 seconds. The GST 
background SPR signal was subtracted from the GST-ubiquitin signal and, for the 
calculation of the dissociation constants, the BIAevaluation (version 3) software was 
used. Finally, SPR signals at the equilibrium state were plotted against the sample 
concentration in order to obtain the steady state KD.  
 
2.10.6 Yeast two-hybrid  
The interaction between human Spc25 and different ubiquitin constructs was monitored 
with the yeast two-hybrid system. Human Spc25 and ubiquitin constructs were already 
available fused to either the Gal4 activation domain (pGAD vector) or the Gal4 DNA 
binding domain (pGBT vector). Hence it was possible to test the interaction from both 
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sides, once for the fusion of Spc25 to the activation domain and the fusion of ubiquitin 
to the binding domain and vice versa. The yeast two-hybrid strain PJ69-4A was 
transformed (see 2.9.4) with the individual pGAD constructs and, at the same time, with 
the corresponding pGBT constructs, using 1.5 µL of each plasmid. Empty pGAD and 
pGBT vectors served as negative controls. Human Spc24 was co-expressed for the two-
hybrid analysis. Therefore, it was cloned in the YEplac195-ADH/T vector (pHU 2167) 
for episomal expression and then transformed into the different strains already 
harboring the pGAD and pGBT constructs (the empty expression vector was also 
transformed as a control). Transformants containing all three vectors were selected on 
plates lacking the respective markers. For the two-hybrid experiment 5 colonies were 
picked and resuspended in 500 µL of sterile water for each transformation. 3.3 µL of the 
cells were then spotted onto three different selective plates. Selective plates for the 
expression of the three plasmids served as a positive control. Plates additionally lacking 
histidine were used to monitor weak interactions, while plates without histidine and 
adenine were used to reveal stronger interactions. The plates were incubated at 30 °C 
for 3 days and scanned after 2 and 3 days. 
 
2.11 Media 
2.11.1 E. coli 
Luria Broth (LB) medium, LB agar and LB plates with 100 µg/mL ampicillin, 50 
µg/mL kanamycin and 50 µg/mL Zeocin were provided by the media production team 
of CRUK. Bacteria cultures were grown in LB medium containing 100 µg/mL 
ampicillin, 50 µg/mL kanamycin or both. LB medium with added antibiotics was stored 
at 4 °C. 
 
Ampicillin: 100 mg/mL in sterile water, filter sterilised (22 µm) 
 
Kanamycin: 50 mg/mL in sterile water, filter sterilised (22 µm)  
 
Zeocin: 50 mg/mL in sterile water, filter sterilised (22 µm) 
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2.11.2 Drosophila melanogaster 
Fly food: 360 g agar, 3600 g maize, 3600 g malt, 1200 mL molasses, 440 g soya, 732 g 
yeast extract, 280 mL of acid mix (500 mL propionic and 32 mL orthophosphoric acid) 
and water to make 50 L total (provided by the fly facility) 
 
Fly food with G418: 300 µL of 25 mg/mL Geneticin solution (Gibco) were added to 
one vial of pre-perforated food. 
 
Apple juice plates: 36 g agar, 1600 mL distilled water, 500 mL apple juice, 25 g sucrose, 
4 g nipagin, 20 mL ethanol (provided by the fly facility) 
 
S2 medium: Schneider’s Drosophila Medium (Gibco) with 10% Fetal Bovine Serum 
(Sigma-Aldrich) and 100 unit/mL penicillin and 100 mg/mL streptomycin (Gibco). 
 
2.11.3 Yeast  
Yeast peptone glucose (YPD) medium, YPD agar, 4% w/v bacto agar, 20% glucose was 
provided by CRUK’s media production team.  
 
Dropout powder stock: 2 g of p-aminobenzoic acid and 20 g each of alanine, arginine, 
asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, inositol, 
isoleucine, lysine, methionine, phenylalanine, proline, serine, threonine, tyrosine and 
valine were weighed out and mixed overnight under rotation. 
 
SC (synthetic complete) powder: 36.7 g dropout powder was mixed with the following 
components 2 g histidine, 4 g leucine, 2 g uracil, 2 g tryptophan, 0.5 g adenine, leaving 
any of these amino acids out as required.  
 
2.5x SC medium: 5 g SC powder (specific), 4.25 g of yeast nitrogen base (without 
amino acids and ammonium sulfate) and 12.5g ammonium sulfate were dissolved in 1 l 
water and stirred for at least half an hour. Aliquots of 200 mL were autoclaved. 
 
SC medium: 200 mL 2.5x SC medium, 50 mL 20% w/v glucose, 250 mL water 
 
SC plates: 200 mL 2.5x SC medium and 50 mL 20% w/v glucose were mixed with 250 
mL melted 4% w/v Bacto agar. 
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G418 plates: Geneticin 50 mg/mL (Gibco), 1:10 diluted in melted YPD agar (cooled 
down to 50 °C) 
 
5-FOA plates: 500 mg of 5-fluoroorotic acid was dissolved in 200 mL 2.5x SC medium, 
8 mL uracil (2mg/mL) and 8 mL adenine (2mg/mL), 50 mL 20% w/v glucose and then 
mixed with 250 mL melted 4% w/v Bacto agar. 
 
2.12 Buffers and solutions 
2.12.1 General 
CRUK’s media production facility provided following standard solutions: 0.5 M EDTA 
pH 8.0, 1 M MgCl2, 5 M NaCl, 1x and 10x PBS, 50x TAE buffer, TE buffer pH 8, 1 M 
Tris-HCl pH 7.5 and pH 8, 10x TBS. 
 
2.12.2  Tapon lab 
PBT: PBS with 0.1% (v/v) Triton X-100 (Fisher Scientific) 
 
PBT-0.3: PBS with 0.3% (v/v) Triton X-100 (Fisher Scientific) 
 
TBST: TBS with 0.1% (v/v) Tween 20 (Fisher Scientific) 
 
Transfer buffer: 25 mM Tris base, 192 mM glycine, 20% (v/v) methanol 
 
NP40 lysis buffer: 50 mM Tris HCl pH 8, 150 mM NaCl, 1% (v/v) IGEPAL (CA-630) 
(Sigma-Aldrich), 1 mM EGTA, 100 µL/ml NaF, 10 µL/ml phosphatase inhibitor 
cocktail 2 (Sigma-Aldrich), 10 µL/ml phosphatase inhibitor cocktail 3 (Sigma-Aldrich), 
protease inhibitor cocktail (Roche) 
 
Fly DNA buffer: 10 mM Tris-HCl pH8, 1mM EDTA, 25 mM NaCl, 1 µL Proteinase K 
(Roche) per 50 µL buffer 
 
10x DNA loading buffer: 25 mL 10x TAE, 25 mL glycerol and 0.175 g Orange G 
(Sigma-Aldrich) 
 
GST lysis buffer: PBS, 0.1% (v/v) IGEPAL (CA-630) (Sigma-Aldrich), protease 
inhibitor cocktail (Roche) 
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GST wash buffer: PBS, 0.1% (v/v) IGEPAL (CA-630) (Sigma-Aldrich) 
 
GST elution buffer: 50 mM Tris-HCl, 10 mM reduced glutathione, pH 8  
 
 
2.12.3 Ulrich lab 
1% KOAc: potassium acetate in sterile water, filter sterilised (22 µm)  
 
Z0.5 solution: 37 µL STE buffer, 2 µL 1 M DTT, 1 µL zymolyase 20T (20 mg/mL) 
 
STE buffer: 1.2 M sorbitol, 25 mM Tris HCl pH 8, 25 mM EDTA pH 8 
 
Zymolyase 20T: 20 mg/mL in sterile water from (Seikagaku Biobusiness) 
 
DTT 1M: dithiothreitol 154.2 mg/mL in sterile water (Melford) 
 
LIT: 100 mM lithium acetate, 10 mM Tris pH 7.4, autoclaved 
 
PEG/LIT: 100 g PEG 3350 dissolved in 100 mL LIT, autoclaved 
 
Herring sperm DNA: 10 mg/mL in TE buffer, sonicated and boiled for 5 minutes at 
95 °C (Sigma-Aldrich) 
 
HU buffer: 8 M urea, 5% SDS, 200 mM Tris-HCl pH 6.8, 1 mM EDTA, 0.1% 
bromophenol blue, before usage 1.5% DTT  
 
Zymolyase mix: 1 mg/mL Z20 zymolyase and 50 mM DTT in sterile water  
 
6x DNA loading buffer: 50% w/v sucrose, 0.1% w/v bromophenol blue, 0.1% w/v 
xylene cyanol F, dissolved in TE buffer 
 
TAE buffer: 40 mM Tris base, 40 mM glacial acetic acid, 1 mM EDTA pH 8 
 
5x Lämmli loading buffer: 250 mM Tris-HCl pH 6.8, 500 mM, 10% w/v SDS, 0.1% 
w/v bromophenol blue, 10% v/v glycerol 
 
5x Lämmli running buffer: 125 mM Tris base, 1.25 M glycine, 0.5% v/v SDS 
 
PBS-T: 1x PBS with 0.05% Tween 20  
 
Western blot buffer I: 300 mM Tris-HCl pH 10.4, 15% v/v methanol 
Chapter 2 Materials and Methods 
 
 106 
 
Western blot buffer II: 30 mM Tris-HCl pH 10.4, 15% v/v methanol 
 
Western blot buffer III: 25 mM Tris-HCl pH 9.4, 40 mM ε-aminocaproic acid, 15% v/v 
methanol 
 
Buffer A: 6 M guanidine hydrochloride, 100 mM phosphate buffer pH 8, 10 mM Tris-
HCl pH 8 
 
Buffer C: 8 M urea, 100 mM phosphate buffer pH 6.3, 10 mM Tris-HCl pH 6.3 
 
Phosphate buffer 0.1 M: mix 0.1 M Na2HPO4 and 0.1 M NaH2PO4 to the required pH 
 
Ni-NTA lysis/wash buffer: 30 mM imidazole, 100 mM NaCl, 50 mM NaH2PO4, pH 8 
 
Ni-NTA elution buffer: 250 mM imidazole, 100 mM NaCl, 50 mM NaH2PO4, pH 8 
 
Ni-NTA dialysis buffer: 100 mM NaCl, 50 mM NaH2PO4, 10% Glycerol, pH 8 
 
Ni-NTA wash buffer II: 20 mM imidazole, 100 mM NaCl, 50 mM NaH2PO4, pH 8 
 
HiTrap Q buffer I: 10% glycerol, 1 mM EDTA, 1 mM DTT, 50 mM Tris-HCl pH 8, 
100 mM NaCl 
 
HiTrap Q elution buffer I: 10% glycerol, 1 mM EDTA, 1 mM DTT, 50 mM Tris-HCl 
pH 8, 1 M NaCl 
 
HiTrap Q buffer II: 5% glycerol, 1 mM EDTA, 1 mM DTT, 10 mM Tris-HCl pH 7.8 
 
HiTrap Q elution buffer II: 5% glycerol, 1 mM EDTA, 1 mM DTT, 10 mM Tris-HCl 
pH 7.8, 1 M NaCl 
 
Gel filtration buffer for crystallisation: 10 mM DTT, 100 mM NaCl, 50 mM Tris-HCl 
pH 7.5 
 
Gel filtration buffer for sizing column: 100 mM NaCl, 50 mM Tris-HCl pH 7.5, 10% 
glycerol 
 
Gel filtration buffer for BIACORE: 10 mM Hepes pH 7.4, 150 mM NaCl, 3 mM EDTA 
 
HBS buffer: 10 mM Hepes pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% (v/v) 
surfactant P20 
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2.13 Antibodies 
2.13.1 Tapon lab 
Table 2.3 - List of antibodies used for western blotting in Nicolas Tapon’s lab 
Primary antibody Source Species Dilution 
FLAG (M2) Sigma-Aldrich Mouse 1:1000 
FLAG Sigma-Aldrich  Rabbit 1:5000 
GST (sc-138) Santa Cruz  Mouse 1:5000 
HA (3F10) Roche  Rat 1:1000 
HA (12CA5) CRUK Mouse 1:5000 
Myc (sc-40) Santa Cruz Mouse 1:1000 
Myc (sc-798) Santa Cruz Rabbit 1:1000 
Tubulin (E7) DSHB Mouse 1:2000 
Secondary antibody  Source Species Dilution 
HRP anti-mouse  GE Healthcare Sheep  1:5000 
HRP anti-rabbit  GE Healthcare Donkey 1:5000 
HRP anti-rat GE Healthcare Goat 1:5000 
 
 
Table 2.4 - List of antibodies used for immunofluorescence in Nicolas Tapon's lab 
Primary antibody Source Species Dilution 
Arm (N2 7A1) DSHB Mouse 1:10 
ASPP Nicolas Tapon/Eurogentec Rat 1:500 
Baz Franck Pichaud Rabbit 1:500 
Baz Andreas Wodarz Rat 1:500 
β-gal Promega Mouse 1:500 
β-gal MP Biomedicals Rabbit 1:500 
Ci (2A1) DSHB Rat 1:100 
Dsh (CA) Tadashi Uemura Rat 1:1000 
Ecad (DCAD2) DSHB Rat 1:20 
Fmi (74) DSHB Mouse 1:10 
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Hnt (1G9) DSHB  Mouse 1:20 
Rab11 Akira Nakamura Rabbit 1:8000 
RASSF10 This study/Eurogentec Rabbit 1:500 
Stbm David Strutt Rat 1:1000 
Secondary antibody  Source Species Dilution 
Alexa Fluor 488 anti-mouse Life Technologies Goat 1:500 
Alexa Fluor 633 anti-mouse Life Technologies Goat 1:500 
Rhodamine Red X anti-mouse Jackson ImmunoResearch Donkey 1:500 
Alexa Fluor 488 anti-rabbit Life Technologies Goat 1:500 
Alexa Fluor 546 anti-rabbit Life Technologies Goat 1:500 
Alexa Fluor 633 anti-rabbit Life Technologies Goat 1:500 
Cyanine Cy5 anti-rabbit Jackson ImmunoResearch Donkey 1:500 
Cyanine Cy5 anti-rat  Jackson ImmunoResearch  Donkey 1:500 
Rhodamine Red X anti-rat  Jackson ImmunoResearch Donkey  1:500 
 
2.13.2 Ulrich lab 
Table 2.5 - List of antibodies used in Helle Ulrich’s lab  
Primary antibody  Source Species Dilution 
FLAG (M2) Sigma-Aldrich Mouse 1:3000 
GST (sc-138) Santa Cruz Mouse 1:5000 
HA (12CA5) CRUK Mouse 1:5000 
His (H1029) Sigma-Aldrich Mouse 1:5000 
Myc (9E19) CRUK Mouse 1:5000 
PGK (A6457) Life Technologies Mouse 1:5000 
TAP (CAB1001) Cambio Rabbit  1:5000 
Ubiquitin (P4D1) Cell Signaling Technology Mouse  1:5000 
Secondary antibody  Source Species Dilution 
HRP anti-mouse (P0447) Dako Goat  1:5000 
HRP anti-rabbit (P0399) Dako Swine 1:5000 
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2.14 Plasmids 
2.14.1 Tapon lab 
Table 2.6 lists all the plasmids used in Nicolas Tapon’s lab. For plasmids made in this 
study the construction is described, for plasmids derived from other people the source is 
stated. 
 
Table 2.6 - List of plasmids used in Nicolas Tapon’s lab 
Name Construction or source 
Entry vector for Gateway cloning 
RASSF9 pDONR stop PCR amplify RASSF9 from plasmid with primers 47/48, BP 
reaction into pDONR Zeo 
RASSF10 pDONR stop PCR amplify RASSF10 from plasmid with primers 49/50, BP 
reaction into pDONR Zeo  
Pk pDONR  PCR amplify Pk from plasmid with primers 44/46, BP reaction 
into pDONR Zeo  
Sple pDONR  PCR amplify Sple from plasmid with primers 45/46, BP reaction 
into pDONR Zeo 
Stbm pDONR  PCR amplify Stbm from RE54419 (DGRC) with primers 1/2, BP 
reaction into pDONR Zeo 
Fz pDONR PCR amplify Fz from plasmid LD32066 (DGRC) with primers 
72/73, BP reaction into pDONR Zeo  
3stop-HA pDONR PCR amplify 3stop-HA from plasmid GFP pAHW with primers 
135/136, BP reaction into pDONR Zeo 
RASSF8 stop dTOPO Nicolas Tapon/Yanxiang Zhou 
Site specific integration and expression via the UAS or Ubi promoter in flies 
pKC26_UAS_GW PCR amplify UAS from plasmid pTGW with primers 39/40, 
MIuI/NotI digestion and clone into pKC26w_GW vector. 
UAS-GFP-RASSSF9 LR reaction of RASSF9 pDONR stop with pKC26w_UAS_GW 
UAS-GFP-RASSSF10 LR reaction of RASSF10 pDONR stop with pKC26w_UAS_GW 
pKC26w_GW Pedro Gaspar/Yanxiang Zhou 
Ubi-GFP-RASSF9 LR reaction of RASSF9 pDONR stop with pKC26w_GW  
Ubi-GFP-RASSF10 LR reaction of RASSF10 pDONR stop with pKC26w_GW 
Ubi-GFP LR reaction of 3stop-HA pDONR with pKC26w_GW 
Ubi-GFP-RASSF8 LR reaction of RASSF8 stop dTOPO with pKC26w_GW 
Expression in flies, CRISPR  
pCFD3-dU6:3gRNA Simon Bullock 
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Expression of RASSF10 (375-468) in E. coli for antibody generation 
pGEX-RASSF10 (375-
468) 
PCR amplify dRASSF10 fragment from plasmid with primers 
90/91, EcoRI/XhoI digestion and clone into pGEX-4T-1 
Expression in S2 cells 
ASPP pAMW Nicolas Tapon/ Paul Langton 
Baz pAFW Andreas Wodarz 
CKIα pAWF Nicolas Tapon/ Paulo Ribeiro 
CKIIα pAWF Nicolas Tapon 
Dco pAFW Nicolas Tapon/ Paulo Ribeiro 
Dsh pAWM Nicolas Tapon/ Lennart Kester 
Fz pAWM LR reaction of Fz pDONR with pAWM  
Gish I pAFW Nicolas Tapon/ Paulo Ribeiro 
Gish F pAFW Nicolas Tapon/ Paulo Ribeiro 
GFP pAFW Nicolas Tapon 
GFP pAHW Nicolas Tapon 
GFP pAMW Nicolas Tapon 
PP1α13C pAFW Nicolas Tapon/ Yanxiang Zhou 
PP1α87B pAFW Nicolas Tapon/ Yanxiang Zhou 
PP1α96A pAFW Nicolas Tapon/ Yanxiang Zhou 
PP1β9C pAFW Nicolas Tapon/ Yanxiang Zhou 
Prickle Pk pAWM LR reaction of Pk pDONR with pAWM 
Prickle Sple pAWM LR reaction of Sple pDONR with pAWM 
RASSF8 pAWF Nicolas Tapon/ Eunice Chan 
RASSF8 pAWH  Nicolas Tapon/ Eunice Chan 
RASSF9 pAWF Nicolas Tapon/ Lennart Kester 
RASSF9 pAWH Nicolas Tapon/ Lennart Kester 
RASSF10 pAWF  Nicolas Tapon/ Lennart Kester 
RASSF10 pAWH Nicolas Tapon/ Lennart Kester 
Sec15 pAFW Nicolas Tapon/ Eunice Chan 
Stbm pAWM LR reaction of Stbm pDONR with pAWM  
WAVE pAWF Nicolas Tapon/ Eunice Chan 
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2.14.2 Ulrich lab 
Table 2.7 lists all the plasmids used in Helle Ulrich’s lab. For plasmids made in this 
study the construction is described, for plasmids derived from other people the source is 
stated. 
 
Table 2.7 - List of plasmids used in Helle Ulrich’s lab 
pHU Name  Construction or source 
Yeast episomal expression vector 
73 YEplac195-G/T Helle Ulrich  
308 YEplac181 (Gietz and Sugino, 1988) 
386 YEplac112 (Gietz and Sugino, 1988) 
654 YEp181-ADH/T Helle Ulrich 
2167 YEplac195-ADH/T Cloning of ADH-promoter (pHU 654) as EcoRI/HindIII 
fragment in pHU73 YEplac195-G/T 
2187 YEplac195-ADH-
hSPC24 
PCR amplify hSpc24 from human cDNA with primers 
oHU1478/1479, BamHI digestion and clone into 
YEplac195-ADH/T vector 
818 YEp-His-UBI Helle Ulrich  
821 YEp181-CUP1-His-Ubi Helle Ulrich  
Yeast expression 
147 YIplac128-G/T Helle Ulrich 
2246 Ylplac204-Pdsn1-
Dsn1_a  
GENEART 
2247 Ylplac204-Pdsn1-
Dsn1_b  
GENEART  
2248 Ylplac204-Pdsn1-
Dsn1_c  
GENEART 
2249 Ylplac204-Pdsn1-
Dsn1_d  
GENEART  
2283 Ylplac128-Pdsn1-
Dsn1_a 
pHU2246 cut with EcoRI and SalI and fragment cloned 
into pHU147 
2284 Ylplac128-Pdsn1-
Dsn1_b 
pHU2247 cut with EcoRI and SalI and fragment cloned 
into pHU147 
2285 Ylplac128-Pdsn1-
Dsn1_c 
pHU2248 cut with EcoRI and SalI and fragment cloned 
into pHU147 
2286 Ylplac128-Pdsn1-
Dsn1_d 
pHU2249 cut with EcoRI and SalI and fragment cloned 
into pHU147 
2287 Ylplac128-Pdsn1-
Dsn1_wt 
pHU2286 cut with EcoRV and NsiI and fragment cloned 
into pHU2283 
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Yeast two hybrid   
82 pGBT9 Clontech 
145 pGAD424 Clontech 
1035 pGAD-Ubi3RΔGG Helle Ulrich  
1036 pGBT-Ubi3RΔGG Helle Ulrich  
1529 pGAD-Ubi4(3R,HT) Helle Ulrich  
1530 pGBT-Ubi4(3R,HT) Helle Ulrich  
1531 pGBT-Ubi4(3R,linker) Helle Ulrich  
1532 pGAD-Ubi4(3R,linker) Helle Ulrich  
1684 pGBT-SPC25 Helle Ulrich  
1700 pGAD-SPC25  Helle Ulrich  
1721 pGBT-hSPC25 Helle Ulrich  
1722 pGAD-hSPC25 Helle Ulrich  
Tagging or gene disruption 
233 pFA-HIS3 (Wach et al., 1994) 
245 pGEX-Ubi Helle Ulrich 
228 pYM3 (Knop et al., 1999) 
229 pYM6 (Knop et al., 1999) 
1724 YIp211-P-SPC25-T 
(L109A) 
Helle Ulrich  
2152 pFA6a-6xGLY-
3xFLAG-HIS3MX6 
(Funakoshi and Hochstrasser, 2009) 
2258 pFA6a-6xlinker-Vps27 
UIM-1 (256-278)-
6xGLY-3xFLAG 
PCR amplify Vps27 (256-278) from yeast gDNA with 
primers oHU2212/2213, PacI and BamHI digestion and 
clone into pHU2152  
2259 pFA6a-6xlinker-Rabex 
5 MIU-1 (48-74)-
6xGLY-3xFLAG 
PCR amplify Rabex-5 (48-74) from human cDNA with 
primers oHU2214/2215, PacI and BamHI digestion and 
clone into pHU2152 
2233 pFA6a-6xlinker-Rabex 
5 MIU-1 (A58G)-
6xGLY-3xFLAG 
Site directed mutagenesis of plasmid pHU 2259 with 
primers oHU2232/2233 
Expression in E. coli 
839 pet15b Merck 
1717 pET28a-Spc25 (107-
221) 
Helle Ulrich  
1720 pET15b-SPC24 (154-
213) 
Helle Ulrich  
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1985 pEHisTeva (Liu and Naismith, 2009) 
2120 pET15b-Spc25 (107-
221) 
PCR amplify Spc25 (107-221) from plasmid pHU1717 
with primers oHU1848/1164, NcoI/BamHI digestion and 
clone into pET15b vector 
2121 pEHisTeva-Spc24 (154-
213) 
PCR amplify Spc24 (154-213) from plasmid pHU1720 
with primers oHU1847/1228, NcoI/BamHI digestion and 
clone into pEHisTeva vector 
2122 pET28a-Spc25 L109A 
(107-221) 
Site directed mutagenesis of plasmid pHU1717 with 
primers oHU1700/1881 
 
 
2.15 DNA Oligonucleotides 
DNA Oligonucleotides were ordered from Sigma-Aldrich. 
 
2.15.1 Tapon lab  
Table 2.8 - List of oligonucleotides used in Nicolas Tapon’s lab 
# Name Sequence 
Gateway  
1 Stbm attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGGAAAACGAATCCGTCAAGTCGGAACAC 
2 Stbm attB2 ns GGGGACCACTTTGTACAAGAAAGCTGGGTGTACG
GATGTTTCGGAGTTCAACTTAAGAACAAATTTGTT
GC 
44 Prickle Pk attB1  GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGGATACCCCAAATCAAATGCCTGTTGAGC 
45 Prickle Sple attB1  GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGAGCAGCCTGTCAACCGGTGG 
46 Prickle attB2 ns GGGGACCACTTTGTACAAGAAAGCTGGGTGCGAG
ATGATGCAGTTCTTGTCCTTGTCGC 
47 dF9 attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGCAGAGCCTACCACTACCAGGAGAT 
48 dF9 attB2 stop GGGGACCACTTTGTACAAGAAAGCTGGGTGTTAAA
CAAGGGTGCCGAGGTGTTGAATATCC 
49 dF10 attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGGCGCCCCAACAACAGAACTC 
50 dF10 attB2 stop GGGGACCACTTTGTACAAGAAAGCTGGGTGTTACA
CCAGCATACTGGCATTATTATCGCAAAACTC 
72 Fz attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGTGGCGTCAAATCCTGTTTATTTTACCCACC 
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73 Fz attB2 ns GGGGACCACTTTGTACAAGAAAGCTGGGTGGACG
TACGCCTGCGCCCGG 
123 F10 attB1 252-end GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGTACAAGTGGCTCAAGAAGCTATTGCATCTGAA 
126 F10 attB1 405-end GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACC
ATGTCGGAAATGTGCCGACTGTACCG 
135 stop-HA attB1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCT
GACGTAAGCTAGATGGATCTCCACCGC 
136 HA attB2 GGGGACCACTTTGTACAAGAAAGCTGGGTGTCATC
CGCCATGAGCAGCGTAATCTG 
Cloning 
39 UASt fw CGACGCGTGCATGCCTGCAGGTCGGA 
40 UASt rv  TAATGCGGCCGCCATAGTGACTGGAT 
90 dF10 375-468 fw CGAATTCTTGCGAAATAGTGTACGATATAAGTTG 
91 dF10 375-468 rv CGCTCGAGCAGACGCTTTAAGT 
Reverse transcriptase PCR  
 
RpL32 fw TGTCCTTCCAGCTTCAAGATGACCATC 
 
RpL32 rv CTTGGGCTTGCGCCATTTGTG 
 
F10 5' UTR fw TGCAGTGTGAACCAGTGAAGA 
 
F10 ex1 rv TTCATCCACCAAACGCTCCT 
 
F10 ex2 fw CGGAGTGACGAACAAGACGA 
 
F10 ex4 rv ACATCGAAAATCCCGTGGCT 
Genotyping  
  RASSF8 fw AGGAGAAGCAGAAGCAGAAGAGGAG 
 
RASSF8 rv GTTGTGGCTGCTATGCTGATCGTAGTC 
 
RASSF9 fw ATAATATGGCAATGCTCGCA 
 
RASSF9 rv  GTGGGTTTTAGTTACTAATCCAC 
 
RASSF10 (B) fw GCCCCAACAACAGAACTCCAC 
 
RASSF10 (B) rv  CCTTTCGCCTCCTTATGCAG 
 
RASSF10 (C) fw GTTCCTTCGCTGCATTTTCC 
 
RASSF10 (C) rv  TTCAGTGGAAATGCTGGCG 
 
Neo2 f AGAGGCGCTTCGTCTACGGAGCGACA 
 
hsp70_FRT r CGGCAAGCAGGCATCGCCATGGGTC 
 
FRT(hs) fw  AGGTGAGGTTCTCGGCTAGT 
 
FRT(hs) rv AACTCTGAATAGGTCGATAGCGT 
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CRISPR oligonucleotides for gRNA 
 gRNA B1 fw GTCGAGTATGTAGATCGATTAAG 
 gRNA B1 rv AAACCTTAATCGATCTACATACT 
 gRNA B2 fw GTCGTTTCGGTACCCCTATACAGT 
 gRNA B2 rv AAACACTGTATAGGGGTACCGAAA 
 gRNA C1 fw GTCGGCCCACAGGGGCCGTGAAA 
 gRNA C1 rv AAACTTTCACGGCCCCTGTGGGC 
 gRNA C2 fw GTCGCAGTGCTATTAACGCCATAG 
 gRNA C2 rv AAACCTATGGCGTTAATAGCACTG 
 
2.15.2 Ulrich lab 
Table 2.9 - List of oligonucleotides used in Helle Ulrich’s lab 
oHU Name Sequence 
Deletion of genes and test for deletion  
108 UBR2 tag up GCTAATTTCGTAGCAATTTTGAATGACTAGACAT
TTGTTGGATAAATCGATGAATTCGAGCTCG 
109 UBR2 ko down AGGTAAGATTCGTTAACTAAATTAATAGCTACTT
AACAAGCACGCCGTACGCTGCAGGTCGAC 
1149 PDR5 ko test GTGCCACAACATTTTCAGATT 
1984 Ubr2 UTR test down ATAATCAACGCATTCATACTT 
1985 Ubr2 ORF test down CTATAACCAATATAAGAGAT 
1986 Ubr2 ORF test up CACTTTAGCAACATAAGAATG 
C-terminal tagging of genes and test for tagging 
1570 Dsn1 C terminal tagging 
down 
AACAGCTGTTGAAGGGATTAAGTTTATCTTTCAG
TAAAAAACTGGATTTACGTACGCTGCAGGTCGAC 
1571 Dsn1 C terminal tagging 
up 
ATGTTACATATGCAGAAGTATCCGATTTTTTTTTG
ATTTTTTCTTTTATTATCGATGAATTCGAGCTCG 
1572 Dsn1 test GCAGATGTTGAGACAAAG 
1976 Spc105 C terminal 
tagging down 
TGGAGTTCTTCCTTCATTTACGAAAAGTAGAATA
CATTTAGAGTTTACGCGTACGCTGCAGGTCGAC 
1977 Spc105 C terminal 
tagging up 
AAAAAAAGTGATGAGATATTACTAGTCATCGTTG
TCCTATTATAAACACTATCGATGAATTCGAGCTC
G  
1978 Spc105 test GAAGCGCTTTTGCAGTTCAA 
1980 Tag test AGATCTATATTACCCTGTTATCCCTAGCGG 
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2206 Spc25 tag down  ACCTCGCGGCATTTTTAGTCGTGGCCCGCGATAT
GCTTCTGGCATCTTTAGGGGGAGGCGGGGGTGGA 
2207 Spc25 tag up TCATCTAAATCATAGGCCCAGAATAAACTGAACA
GATGCGTATAAAGGCGATCGATGAATTCGAGCTC
G 
2208 Spc24 tag down ACCTCAGCGATTTCTATAAGACCAAATACATCTG
GGAAAGATTAGGAAAGGGGGGAGGCGGGGGTGG
A 
2209 Spc24 tag up GCTCATTGAATATGTATGCCACTGTAGTATTTTAT
TAATGATCTCAATTTATCGATGAATTCGAGCTCG 
2210 Spc25 UBD tag down ACCTCGCGGCATTTTTAGTCGTGGCCCGCGATAT
GCTTCTGGCATCTTTAGCTTCAGGATCTGGAGCA 
2211 Spc24 UBD tag down  ACCTCAGCGATTTCTATAAGACCAAATACATCTG
GGAAAGATTAGGAAAGGCTTCAGGATCTGGAGC
A 
Sequencing	   	  
1163 Spc25 down CGCGGATCCGAATGGCCAGCATAGACGCATT 
1267 ADH seq down CGTCATTGTTCTCGTTCCC 
Cloning	   	  
1164 Spc25 up CGCGGATCCTTATAAAGATGCCAGAAGCATA 
1227 Spc24 154 down CCGCTCGAGGAAGCAAACGAAAATATTCT 
1228 Spc24 up CGGGATCCTCACTTTCCTAATCTTTCCC 
1321 SPC25 117 down CGGAATTCGGTAAAGAGTGTGTCCAA 
1478 hSPC24 down CGCGGATCCCGATGGCCGCCTTCCGCG 
1479 hSPC24 up CGCGGATCCCTACCACTCGGTGTCCA 
1847 Spc24 (154) n down CCGCCATGGAAGCAAACGAAAATATTCT 
1848 Spc25 (107) n down CGCCATGGCGCGCGAGCTGGACTCGCTGCT 
1849 Spc25 (107) x up GCGCTCGAGTTATAAAGATGCCAGAAGCATATCG
C  
2059 DSN1 promoter down CGGAATTCAAGAGCGCAGAACCAAACCAAA 
2060 DSN1 promoter up CCGGGATCCCCTCTACCTAAATAAAGAAAA 
2212	   Vps27 UIM-1 (256-274) 
down	  
CGCGGATCCGCTTCAGGATCTGGAGCACCTGAGG
ATGAAGAAGAGCTGATAAGGAAA	  
2213	   Vps27 UIM-1 (256-278) 
up	  
GCGTTAATTAAAGCGCTATTTCTAGATTCTTT	  
2214 Rabex-5 MIU (48-74) 
down  
CGCGGATCCGCTTCAGGATCTGGAGCACAGAAGC
AGATTCAGGAGGACTGGGAGCTG 
2215 Rabex-5 MIU (48-74) 
up 
GCGTTAATTAAGCTCTGACTGCTGGCAAAGGC 
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Chapter 3 Interaction network and characterisation of 
Drosophila RASSF9 and RASSF10 
 
When I started working on this project, the mammalian affinity purification-mass 
spectrometry (AP-MS) results from our collaborator, Matthias Gstaiger, had shown that 
human N-terminal RASSFs are found in an interaction network with different PP1 
catalytic subunits and ASPP1/2 (Hauri et al., 2013). The substrate specificity of 
serine/threonine protein phosphatase 1 (PP1) catalytic subunits is achieved through 
association with different regulatory subunits, which not only allow substrate selection, 
but also define PP1 localisation within the cell. Human ASPP1/2 and iASPP were 
shown to bind to all of the PP1 catalytic subunits and are considered to be regulatory 
subunits for PP1s (Llanos et al., 2011, Skene-Arnold et al., 2013). At the time of my 
arrival in the Tapon lab, Yanxiang Zhou, a graduate student, was investigating the 
ASPP/PP1 complex in Drosophila. In his thesis, he was able to show that the ASPP/PP1 
holoenzyme associates with RASSF8, which in turn allows the recruitment of potential 
substrates, such as the polarity protein Baz (Zhou, 2014). Thus, RASSF8 functions as a 
specificity subunit of the ASPP/PP1 complex. Taken together, the mammalian AP-MS 
results and Yanxiang Zhou’s findings allow us to hypothesise that Drosophila RASSF9 
and RASSF10 could also be substrate-specifying subunits of alternative ASPP/PP1 
complexes (see Figure 3.1). Most interestingly, the Gstaiger lab discovered that human 
RASSF9 and RASSF10 also interact with a different set of proteins compared with 
RASSF7/8 - components of the PCP signalling pathway (Hauri et al., 2013).  
This chapter aims to characterise RASSF9 and RASSF10, two members of the N-
terminal RASSF family in Drosophila by looking at their interaction network, 
subcellular localisation and the gain- and loss-of-function phenotypes. In the following 
subchapters, I will first explore whether RASSF9 and RASSF10 are part of the 
ASPP/PP1 complex, share interaction partners with RASSF8 and test whether they 
function in planar cell polarity. Finally, I will present deletion mutants of RASSF9 and 
RASSF10 in flies, and lastly address a potential redundancy between N-terminal 
RASSFs. 
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Figure 3.1 - N-terminal RASSFs as potential specificity subunits of ASPP/PP1 complexes. 
RASSF8 is part of ASPP/PP1 phosphatase complexes and recruits their substrates. RASSF9 and 
RASSF10 could also act as specificity subunits for ASPP/PP1 complexes.  
 
 
 
3.1 Drosophila RASSF9 and RASSF10 
RASSF9/CG13875 encodes for a 486 aa protein and RASSF10/CG32150 for a 524 aa 
(CG32150-RA/RC) protein. An alternatively spliced variant of RASSF10 (CG32150-
RD) translates into a shorter 118 aa version, containing the N-terminus (see 3.5.2 for 
transcripts). Analysis of the protein sequences with InterProScan (Jones et al., 2014) 
revealed that RASSF9 (CG13875-PA/PB) and RASSF10 (CG32150-PA/PC) both 
contain an RA-like domain at the N-terminus, and have, like other RASSFs, predicted 
coiled-coil domains at the C-terminus (Figure 3.2). With either Drosophila sequence, 
NCBI BLAST searches return homologues of RASSF9 and RASSF10 across species. 
However, the alignment of RASSF9 and RASSF10 with their potential human 
homologues shows that they share relatively little sequence identity (23-31%) with the 
highest similarity displayed between their RA domains (Figure 3.2). In conclusion, 
although RASSF9 and RASSF10 are thought to represent the homologues of human 
RASSF9 and RASSF10, the human and fly proteins share limited sequence homology, 
begging the question whether their interaction partners are conserved across species.  
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Figure 3.2 - Predicted domain structure of N-terminal RASSFs in Drosophila. 
Protein domains were predicted using InterProScan and sequence identities with human 
RASSF9/10 were acquired using NCBI BLAST. RASSF9 and RASSF10 both contain a N-
terminal RA-like domain (highlighted in purple) and coiled-coil regions (highlighted in green). 
Coverage of the alignment with human RASSF9/10 is indicated by a dashed line and percentage 
sequence identities given below.  
 
 
3.2 N-terminal RASSFs as potential PP1 regulatory subunits 
3.2.1 Drosophila RASSF9 and RASSF10 bind to ASPP 
In Drosophila, ASPP and RASSF8 are well-established binding partners (Langton et al., 
2009). The mammalian AP-MS results from the Gstaiger laboratory showed that human 
RASSF9 and RASSF10 bind to the human ASPP isoforms, ASPP1 and ASPP2, as does 
human RASSF8. To test whether the interaction with ASPP was conserved in 
Drosophila, I performed co-immunoprecipitation (co-IP) experiments from lysates of 
transfected S2 cells (Figure 3.3). This revealed that ASPP co-immunoprecipitated with 
RASSF8, RASSF9 and - to a lesser degree - with RASSF10.  
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Figure 3.3 - ASPP binds to each of the N-terminal RASSFs. 
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed with cell lysates using anti-FLAG affinity gel. Immunoprecipitates (IP) and input 
samples were analysed by western blotting using the appropriate antibodies. Tubulin was used 
as a loading control. Cross-reacting, non-specific bands are labelled with an asterisk. ASPP co-
immunoprecipitates with each of the N-terminal RASSFs. Representative western blot of two 
independent co-IP experiments. 
 
 
3.2.2 Drosophila N-terminal RASSFs form a trimeric complex with 
ASPP-PP1α96A 
After confirming that the interaction of RASSF9 and RASSF10 with ASPP was indeed 
conserved in Drosophila, I performed co-IP experiments to test whether RASSF9/10 
can form a trimeric complex with ASPP/PP1. Yanxiang Zhou had already shown that 
ASPP bridges the association between RASSF8 and PP1 (Zhou, 2014). Drosophila has 
four different PP1 catalytic subunits, namely PP1α96A, PP1α87B, PP1α13C, and 
PP1β9C. I decided to use PP1α96A for this experiment, as this subunit had previously 
shown the strongest interaction with ASPP in co-IP experiments (Zhou, 2014). I pulled 
down FLAG-tagged PP1α96A and tested whether myc-tagged ASPP and HA-tagged 
RASSFs were present (Figure 3.4). In parallel, RASSFs were analysed for their ability 
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to bind to PP1α96A in the absence of transfected ASPP. As expected, 
immunoprecipitation of RASSF8 with PP1α96A only occurred in the presence of ASPP 
(Figure 3.4). RASSF9 and RASSF10 were also able to bind to ASPP/PP1 but, 
interestingly, they also immunoprecipitated with PP1α96A in the absence of ASPP. In 
contrast, N-terminal RASSFs were not recovered in control (FLAG-GFP) 
immunoprecipitates. Thus, Drosophila RASSF9 and RASSF10 associate with PP1α96A, 
but, unlike RASSF8, this interaction is not dependent on ASPP. RASSF9 appears to be 
stabilised in the presence of ASPP in the input samples (Figure 3.3 and Figure 3.4). 
However, in order to ascertain whether the stabilisation observed in transfected S2 cells 
has a biological relevance, this should be tested in vivo, for example ASPP loss-of-
function clones.  
 
 
 
Figure 3.4 - N-terminal RASSFs can form a trimeric complex with ASPP and PP1α96A. 
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blotting using the appropriate antibodies. Tubulin was used as a loading control. 
Cross-reacting, unspecific bands are labelled with an asterisk. ASPP and RASSF8 co-
immunoprecipitate with PP1α96A (96A). RASSF9 and RASSF10 co-immunoprecipitate with 
PP1α96A in, the presence or absence of ASPP. Representative western blot of two different co-
IP experiments. 
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3.2.3 RASSF9 and RASSF10 bind to all PP1 catalytic subunits 
Next, I investigated the binding of RASSF9 and RASSF10 to the four different PP1 
catalytic subunits, PP1α96A, PP1α87B, PP1α13C, and PP1β9C. In co-IP experiments 
with lysates of transfected S2 cells, pulling down the different FLAG-tagged PP1 
subunits, RASSF9-HA (Figure 3.5A) and RASSF10-HA (Figure 3.5B) were detectable 
for all four, but not in the FLAG-GFP controls.  
As RASSF9 and RASSF10 were found to bind to each of the PP1 catalytic subunits, 
I proceeded to analyse their protein sequence using ScanProsite (de Castro et al., 2006) 
for the presence of known PP1-binding elements, namely the RVXF, SILK, MyPhoNE 
and RARL motif (Hendrickx et al., 2009, Wakula et al., 2003). However, neither 
protein contained any of the motifs. This suggests that RASSF9 and RASSF10 contain 
an as yet unknown PP1-binding motif.  
In his PhD thesis, Yanxiang Zhou demonstrated that the preferential binding of 
Drosophila ASPP to PP1α96A and PP1β9C is facilitated by their extended C-terminus, 
which is not present in PP1α87B and PP1α13C (Zhou, 2014). However, RASSF9 and 
RASSF10 exhibited no preference for PP1α96A and PP1β9C over PP1α87B and 
PP1α13C (Figure 3.5), suggesting that the extended C-termini of PP1α96A and PP1β9C 
do not contribute to the interaction. This is in agreement with the fact that, unlike 
RASSF8, RASSF9 and RASSF10 do not require ASPP to associate with PP1 catalytic 
subunits. 
In conclusion, the presence of ASPP is not required for the interaction of PP1 with 
RASSF9/10, allowing us to consider two different scenarios: either RASSF9 and 
RASSF10 could function as regulatory subunits themselves, or a different regulatory 
subunit - one which is endogenously expressed in S2 cells - mediates the binding to 
PP1s. 
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Figure 3.5 - RASSF9 and RASSF10 can bind to all PP1 catalytic subunits in Drosophila. 
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blotting using the appropriate antibodies. Tubulin was used as a loading control. 
Cross-reacting, unspecific bands are labelled with an asterisk. RASSF9-HA (A) and RASSF10-
HA (B) co-immunoprecipitate with each of the PP1 catalytic subunits (96A: PP1α96A, 87B: 
PP1α87B, 13C: PP1α13C, 9C: PP1β9C). Representative western blot of two different co-IP 
experiments. 
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3.3 RASSF9 and RASSF10 bind to several RASSF8 
interactors  
In this section, I will explore the association of RASSF9 and RASSF10 with validated 
RASSF8 binding partners (Baz, Sec15 and SCAR/WAVE), which we identified using a 
yeast two-hybrid approach (Eunice Chan, unpublished results). Like RASSF8, these 
proteins are involved in cell-cell junction remodelling (Langevin et al., 2005b, McGill 
et al., 2009, McKinley et al., 2012, Walther and Pichaud, 2010), and we consider them 
as putative targets of the ASPP/PP1 complex.  
First, I tested whether RASSF9 and RASSF10 could associate with the polarity 
determinant Baz - the Drosophila homologue of human Par3. The binding to Baz was 
of particular interest, as Yanxiang Zhou showed in his thesis that Baz can bind, via 
RASSF8, to the ASPP/PP1 complex and, like Par3 (Traweger et al., 2008) can be 
dephosphorylated by PP1 in vitro, making it a likely in vivo substrate of the ASPP/PP1 
complex. Furthermore, Par3 was recovered in human RASSF9 and RASSF10 AP-MS 
experiments by the Gstaiger lab (Hauri et al., 2013). Indeed HA-RASSF9 and HA-
RASSF10 were recovered in FLAG-Baz immunoprecipitates (Figure 3.6). Note that 
expression of Flag-tagged Baz in S2 cells did not yield in a single band, but a ladder of 
bands, which represent degradation products of Baz, as has been previously reported 
(Krahn et al., 2009). Nonetheless, degraded Baz fragments were still able to co-
immunoprecipitate the N-terminal RASSFs.  
Next, I tested whether RASSF9 and RASSF10 could bind to Sec15, a member of the 
exocyst complex, and SCAR, an activator of actin filament polymerisation via the 
Arp2/3 complex (Zallen et al., 2002). I found that RASSF9 and RASSF10, but not the 
FLAG-GFP controls, both also bind to Sec15 (Figure 3.7A) and SCAR (Figure 3.7B).  
Interestingly, the input levels of all N-terminal RASSFs seem higher when 
coexpressed with Baz compared to the GFP control (Figure 3.6). Similarly, RASSF8 
(but not RASSF9/10) input levels increase upon coexpression of Sec15 (Figure 3.7A) or 
SCAR (Figure 3.7B). As mentioned before the biological relevance of these 
observations would have to be addressed in in vivo experiments. 
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Figure 3.6 - RASSF8, RASSF9 and RASSF10 associate with Baz.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. Cross-
reacting, unspecific bands are labelled with an asterisk. Representative western blot of two 
different co-IP experiments. 
 
 
In conclusion, despite the limited sequence homology between these proteins 
Drosophila RASSF9 and RASSF10 have the potential to physically interact with 
several known RASSF8 interactors. This could indicate that N-terminal RASSFs share 
certain functions and might therefore be at least partially redundant. The potential 
redundancy will be addressed in section 3.6. In the following section I will focus on the 
specific interactors of RASSF9 and RASSF10.  
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Figure 3.7 - RASSF8, RASSF9 and RASSF10 associate with Sec15 and SCAR.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. Cross-
reacting, unspecific bands are labelled with an asterisk. (A) N-terminal RASSFs co-
immunoprecipitate with the exocyst subunit Sec15. (B) N-terminal RASSFs co-
immunoprecipitate with Arp2/3 activator SCAR. Representative western blot of two different 
co-IP experiments. 
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3.4 Interactions with PCP components 
The results of the mammalian AP-MS analysis from our collaborator Matthias Gstaiger 
showed that human RASSF9 and RASSF10 bind to several proteins of the core planar 
cell polarity (PCP) pathway. Different isoforms of the human homologues of 
Drosophila Dishevelled, Strabismus, Prickle and Casein kinase subunits CKIIα and 
CKIIβ were found to interact with RASSF9 and RASSF10, but not with RASSF7 and 
RASSF8 (Hauri et al., 2013). Thus suggesting that these might be RASSF9 and 
RASSF10-specific interactors.  
Planar cell polarity is required for the polarity within the plane of an epithelium and 
is established by the asymmetric distribution of its core components: the seven-pass 
transmembrane receptor Fz, Dsh and Dgo localise on one side of the cell 
(distal/posterior) whereas the four-pass transmembrane protein Stbm and Pk are found 
on the other side (proximal/ anterior), while Fmi localises on both sides, as described in 
the introduction (see 1.4.3). Besides their function in PCP, Fz and Dsh are also key 
players in canonical Wg/Fz signalling, where Fz functions as the receptor for Wg/Wnt 
family ligands and transduces the signal via its effector Dsh (see 1.4.1). In order to 
explore whether RASSF9 and RASSF10 are involved in PCP and/or canonical Wg/Fz 
signalling, I tested whether the mammalian interactions were conserved in Drosophila. 
 
3.4.1 Interaction with Dishevelled  
Firstly, I checked the interaction of N-terminal RASSFs with the phosphoprotein Dsh 
(mammalian Dvl). Drosophila RASSF10 has previously been reported to interact with 
Dsh in a genome-wide yeast-two hybrid screen (Formstecher et al., 2005). Dsh robustly 
co-immunoprecipitated with RASSF9 and RASSF10, while no binding was observed to 
RASSF8 or the GFP controls (Figure 3.8). Interestingly, in input samples in which Dsh 
was co-expressed with the N-terminal RASSFs, Dsh was present as a double band, with 
a faint higher molecular weight band. A mobility shift representing phosphorylated Dsh, 
can be induced by co-expression of Dgo in HEK293 cells (Jenny et al., 2005) or Fz in 
S2 cells and HEK293 cells (Yanfeng et al., 2011). The form of Dsh co-
immunoprecipitated with RASSF9 and RASSF10 appears to run at a higher molecular 
weight (at 102 kDa) compared to the lower molecular weight band in the input samples 
Chapter 3 Results 
 
 128 
(below 102 kDa), indicating that RASSF9 and RASSF10 both preferentially bind to a 
post-translational modified - most likely phosphorylated - form of Dsh. This should be 
verified in the future with phosphatase treatment. 
 
 
Figure 3.8 - RASSF9/10, but not RASSF8 bind to Dsh.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blotting using the appropriate antibodies. Tubulin was used as a loading control. 
Cross-reacting, unspecific bands are labelled with an asterisk. Dsh interacts with RASSF9 and 
with RASSF10. Representative western blot of two different co-IP experiments. 
 
3.4.2 Interaction with Prickle and Strabismus  
Next, I explored the interaction between the N-terminal RASSFs and Pk (Prickle). In 
Drosophila, two of the three Pk isoforms are known to be involved in PCP, and cause 
distinct phenotypes (Gubb et al., 1999, Lin and Gubb, 2009). PkPk (Prickle) and PkSple 
(Spiny-legs) derive from alternative splicing and only differ in the length of their N-
terminal extensions: 13 aa in the case of PkPk, 346 aa for PkSple (Gubb et al., 1999, Lin 
and Gubb, 2009). Both PkPk (Figure 3.9A) and PkSple (Figure 3.9B) weakly associated 
with RASSF9, and not at all to RASSF10. However, the binding between RASSF9 and 
Pk isoforms was not consistent in different IP-experiments - sometimes a faint band was 
present and at other times no interaction was detectable.  
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Figure 3.9 - RASSF9, but not RASSF10 can bind weakly to both Prickle isoforms.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. Both 
Prickle isoforms (Pk: Prickle; Sple: Spiny-legs) weakly co-immunoprecipitate with RASSF9 
(not observed in two other co-IP experiments) and cannot be detected in RASSF8 or RASSF10 
precipitates. The co-IP between Dsh and RASSF10 was used as a positive control.  
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It is probable that the weak binding between RASSF9 and Pk isoforms is indirect and 
could be mediated by the endogenously expressed Dsh in S2 cells, as Pk and Dsh have 
been shown to bind to each other (Tree et al., 2002, Jenny et al., 2005). A similar 
scenario was observed for the four-pass transmembrane protein Stbm (Strabismus, also 
known as Van Gogh or Vang), which weakly and inconsistently interacted with 
RASSF9 (Figure 3.10). As for Pk, it is likely that the interaction with Stbm is indirect 
and could be bridged by endogenous Dsh, which can physically interact with Stbm 
(Bastock et al., 2003). 
 
 
Figure 3.10 - RASSF9 binds weakly to Strabismus.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. Stbm 
weakly co-immunoprecipitates with RASSF9 (not observed in two other co-IP experiments) and 
cannot be detected in RASSF8 or RASSF10 precipitates. The co-IP between Dsh and RASSF10 
was used as a positive control. 
 
3.4.3 Interaction with Frizzled  
In addition to the hits from the mammalian AP-MS results, I also checked whether any 
of the N-terminal RASSFs in Drosophila could bind to the seven-pass transmembrane 
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receptor Fz, which is essential for both canonical Wg/Fz-signalling and PCP and whose 
cytoplasmic tail binds Dsh (Strutt, 2003, Singh and Mlodzik, 2012). Fz co-
immunoprecipitated with RASSF10 and was not detectable for RASSF8, RASSF9 or 
the FLAG-GFP control (Figure 3.11). I repeated the pull-downs in both directions but 
could never detect any binding between Fz and RASSF9, whereas the interaction with 
RASSF10 was robust. The interaction of Fz and RASSF10 might not be conserved in 
humans, as Fz was not present in the AP-MS results for human RASSF9 and RASSF10 
(Hauri et al., 2013), and the HEK293 cells used in the analysis have been reported to 
express mRNA of several Fz receptors (Atwood et al., 2011). 
 
 
 
Figure 3.11 - RASSF10 binds to Frizzled.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. 
RASSF10, but not RASSF9 and RASSF8 can interact with Fz. Representative western blot of at 
least two independent co-IP experiments.  
 
3.4.4 Interaction with CKI and CKII family members 
Lastly, having examined interactions with core PCP components, I tested the interaction 
between casein kinases and N-terminal RASSFs. CKII and several CKI isoforms have 
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been associated with canonical Wg/Fz and PCP signalling. CKII, which comprises two 
catalytic α subunits and two regulatory β subunits, was shown to bind and 
phosphorylate Dsh in Drosophila (Willert et al., 1997, Song et al., 2000) and in 
mammary epithelial cells (Song et al., 2000). Moreover, several studies have shown the 
requirement of different CKI isoforms: CKIα (Strutt et al., 2006), CKIε (Dco, Discs 
Overgrown) (Strutt et al., 2006, Klein et al., 2006), CKIγ (Gish, Gilgamesh) (Zhang et 
al., 2006) for either canonical Wg/Fz or PCP, or both signalling pathways. 
Both RASSF9 and RASSF10 but not the GFP control or RASSF8 
immunoprecipitated with CKIIα (Figure 3.12A). I then tested the interactions with CKI 
isoforms α, ε and γ and found that RASSF9 and RASSF10 bound to all of them, while 
RASSF8 was only positive (and much weaker compared to RASSF9/10) for interaction 
with CKIα (see Figure 3.12B for summary of interactions). Overexpression of CKII or 
CKI isoforms did not cause a mobility shift in any of the RASSFs in the input samples, 
suggesting that they may not be substrates of these kinases. Thus, RASSF9 and 
RASSF10 can associate with not only PP1s, but also several protein kinases.  
 
 
Figure 3.12 - Description see following page. 
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Figure 3.12 - RASSF9 and RASSF10 bind to CKIIα and several CKI family members.  
S2 cells were transfected with the indicated tagged constructs and co-IP experiments were 
performed from cell lysates using anti-FLAG affinity gel. IP and input samples were analysed 
by western blot using the appropriate antibodies. Tubulin was used as a loading control. Cross-
reacting, unspecific bands are labelled with an asterisk. (A) RASSF9 and RASSF10, but not 
RASSF8 co-immunoprecipitate with CKIIα. Representative western blot of two independent co-
IP experiments. (B) Table of the tested interactions between N-terminal RASSFs and CKI 
family members. RASSF9/10 also interact with CKIα, CKIε and CKIγ, whereas RASSF8 is 
only able to bind to CKIα.  
 
3.4.5 Localisation of GFP-tagged RASSF9 and RASSF10  
A distinct feature of the core PCP proteins is their planar polarisation within the tissue. 
In epithelial cells of pupal wings, the seven-pass transmembrane cadherin Fmi localises 
asymmetrically to the distal and the proximal side of the cell (Usui et al., 1999). The 
seven-pass transmembrane receptor Fz and the cytoplasmic proteins Dsh and Dgo are 
found on the distal side (Axelrod, 2001, Strutt, 2001, Feiguin et al., 2001), whereas the 
four-pass transmembrane protein Stbm and the cytoplasmic protein Pk are located on 
the proximal side (Bastock et al., 2003, Tree et al., 2002). Since my interaction studies 
in S2 cells suggested a robust interaction between RASSF9/RASSF10 and Dsh, I 
examined their subcellular localisation in vivo.  
As no commercial antibodies were available against the endogenous proteins, I 
initially generated constructs to express GFP-tagged versions of RASSF9 or RASSF10 
under control of the ubiquitin 63E (ubi) promoter, as well as UAS constructs for 
expression under the UAS/Gal4 system. Transgenic flies were inserted on 2L 
(cytological location 28E7) (Ubi-lines and UAS-lines) or 3R (cytological location 
89E11) (UAS-lines) using the PhiC31 integrase system. 
I first looked at the localisation in wing imaginal discs of L3 larvae. Ubiquitously-
expressed N-terminal GFP-tagged RASSF9 and RASSF10 both localised in the same 
plane as E-cadherin at the adherens junctions in wing disc epithelial cells, as seen in 
planar (XY) and transverse (Z) confocal sections in Figure 3.13 (A-B’’ for RASSF9 and 
C-D’’ for RASSF10). Moreover, the localisation of RASSF10 appeared to be polarised 
proximo-distally in the wing disc (Figure 3.13C-C’’).  
Chapter 3 Results 
 
 134 
 
Figure 3.13 - Localisation of GFP-RASSF9 and GFP-RASSF10 in L3 wing imaginal discs 
and pupal wings.  
Planar (A-A’’, C-C’’) and transverse confocal sections (B-B’’, D-D’’) of wing imaginal discs 
stained for Ecad. GFP-RASSF9 and GFP-RASSF10 were expressed under the ubi promoter. 
GFP-RASSF9 (A-B’’) and GFP-RASSF10 (C-D’’) co-localise with E-cadherin at the adherens 
junctions. Posterior is to the left and anterior to the right. Scale bar = 20 µm. Planar confocal 
sections of pupal wings at 30 hours APF stained for Fmi (E-F’’). FLPout clones expressing 
GFP-RASSF9 or GFP-RASSF10 under control of actin-Gal4 were induced with hsFLP. GFP-
RASSF9 (E-E’’) and GFP-RASSF10 (F-F’’) are planar polarized and localize in the same plane 
as Fmi. Proximal is to the left, distal to the right (E-F’’). Scale bar = 5 µm. 
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Since RASSF10 appeared planar-polarised in L3 wing discs, I examined its 
localisation in pupal wings. Using the FLPout system, mitotic clones expressing GFP-
RASSF9 or GFP-RASSF10 under control of actin-Gal4 were induced with hsFLP. 
RASSF9 and RASSF10 were localised in the same plane as Fmi in pupal wings 30 
hours APF (after pupa formation) (Figure 3.13E-F’’). Moreover, at the clonal border of 
GFP-RASSF9 and GFP-RASSF10 expressing cells, both appeared to localise to the 
distal side of the cell. This indicates a similar localisation to Dsh and Fz, further 
supporting the connection between RASSF9/10 and the Fz/Dsh complex. 
 
3.4.6 Localisation of RASSF10, but not RASSF9 is dependent on 
Frizzled and Dishevelled  
Since distal PCP proteins are dependent on Fz for their cortical localisation, I tested 
whether RASSF9 and RASSF10 localisation is affected by loss of Fz or Dsh. Therefore, 
I combined the ubi-GFP-RASSF9/10 lines with fz and dsh mutants on FRT 
chromosomes. fzP21 is a planar polarity specific allele encoding for a truncated version 
of Fz (Jones et al., 1996). dsh3 is a lethal allele for Dsh, affecting both planar cell 
polarity and Wg-signalling (Yanagawa et al., 1995, Strutt et al., 2006). Mitotic clones 
mutant for either fz or dsh had no visible effect on the subcellular localisation of GFP-
RASSF9 in L3 wing imaginal discs (Figure 3.14A-A’’, C-C’’). Strikingly, GFP-
RASSF10 was barely detectable in both fz and dsh mutant clones, while E-cadherin was 
unaffected (Figure 3.14B-B’’, D-D’’).  
In late larval wing imaginal discs Dsh is mainly cytoplasmic, but also shows a weak 
symmetric membrane localisation, which has been shown to be independent of Fz 
whereas, from the pupal stages on, localisation of Dsh at the membrane requires Fz 
(Axelrod, 2001). Though Fz has been shown to lose its asymmetric localisation in dsh 
clones, it remains localised to the membrane, at least in pupal wings (Strutt, 2001). 
These findings suggest that, in the case of larval wing imaginal discs, Dsh will still be at 
the membrane in fz clones and Fz will be present in dsh clones. The loss of RASSF10 
localisation in dsh and in fz clones therefore implies that RASSF10 stability and its 
localisation at the membrane in wing imaginal discs most likely requires the presence of 
both Dsh and Fz simultaneously. Interestingly, GFP-RASSF10 localised in a clear 
border at the edge of fz mutant clones in wing imaginal discs (Figure 3.14B-B’’). This 
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observation resembles the effect seen for the localisation of, for example, Fz, Fmi and 
Pk in cells neighbouring fz mutant clones in pupal wings, where a loss of fz affects the 
polarity of bordering wild type cells due to its non-autonomous effect (Tree et al., 2002, 
Strutt, 2001, Usui et al., 1999). 
Additionally to the effect on RASSF10 levels in fz and dsh mutant clones described 
above, I observed that Fz and Dsh also affected RASSF10 levels in S2 cells (Figure 
3.15). Co-expression of Fz with RASSF10 caused an increase in RASSF10 levels, 
compared to the GFP-myc control, while expression of Dsh had no noticeable effect on 
RASSF10 levels. Co-expression of Dsh and Fz led to hyper-phosphorylation of Dsh, 
visible by the appearance of strong additional bands at higher molecular weight as 
previously described (Yanfeng et al., 2011). RASSF10 can also induce a mobility shift 
of Dsh (Figure 3.8), however this effect is much weaker compared to the one induced 
by Fz (Figure 3.15). Interestingly, co-expression of all three proteins not only greatly 
stabilised RASSF10, but also led to an increase in Fz and Dsh levels.  
In conclusion, I showed that RASSF9 stability and localisation is independent of Fz 
and Dsh in wing imaginal discs. This suggests that RASSF9 is associated with different 
proteins at the adherens junctions. Conversely, I found that the stability and localisation 
of RASSF10 required the presence of both Fz and Dsh. In S2 cells, Fz co-expression 
leads to Dsh phosphorylation and RASSF10 stabilisation and all three proteins are 
greatly stabilised when co-expressed. However, the molecular mechanism of this 
stabilisation remains unclear. 
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Figure 3.14 - Loss of Frizzled and Dishevelled affects RASSF10, but not RASSF9 
localisation in wing imaginal discs. 
Planar confocal sections of wing imaginal discs stained for E-cad (A-D’’). Mitotic clones were 
induced with UbxFlp for fzP21 and hsFlp for dsh3. Wild type tissue is lacZ (stained with β-gal) or 
RFP positive, mutant tissue lacZ/RFP negative. GFP-RASSF9 and GFP-RASSF10 were 
expressed under the ubi promoter. GFP-RASSF9 (A-A’’’, C-C’’’) and E-cad localisation are not 
affected, whereas GFP-RASSF10 (B-B’’’, D-D’’’) disappears in fzP21 and dsh3 clones. Posterior 
is to the left and anterior to the right. Scale bar = 20 µm. 
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Figure 3.15 - RASSF10 is stabilised by the presence of Dsh and Fz in S2 cell lysates. 
S2 cells were transfected with the indicated tagged constructs and cell lysates were analysed by 
western blot using the appropriate antibodies. Tubulin was used as a loading control. Co-
expression of Fz and Dsh leads to stabilisation of RASSF10. Representative western blot of two 
different transfections. 
 
 
3.4.7 Gain-of-function phenotypes of RASSF9 and RASSF10  
The association with planar cell polarity proteins in S2 cells, the localisation of GFP-
tagged RASSF9/10 and RASSF10's stability dependence upon the presence of Dsh and 
Fz all suggested a potential involvement in planar cell polarity. Ectopic expression of 
core PCP proteins causes loss of planar cell polarity, which is visible in adult flies in the 
form of, for example, eye roughness, random orientation of thoracic or abdominal 
bristles and trichome swirls on the wing. To test whether ectopic expression of RASSF9 
and RASSF10 would lead to similar phenotypes, I expressed UAS-GFP-RASSF9/10 
lines with a set of different drivers (actin-Gal4, apterous-Gal4, engrailed-Gal4, nubbin-
Gal4, MS1096-Gal4, patched-Gal4, scabrous-Gal4, tubulin-Gal4). For RASSF9 
misexpression, I could not see a PCP phenotype with any driver. Strong expression of 
GFP-RASSF10 with tubulin-Gal4 and apterous-Gal4 elicited a small swirly trichome 
patch on the wing around the L4 vein (Figure 3.16A, D, G), whereas UAS-GFP-
RASSF9 expression (Figure 3.16C, F) behaved like the UAS-CD8::GFP control (Figure 
3.16B, E).  
Chapter 3 Results 
 
 139 
 
Figure 3.16 - Ectopic expression of RASSF10 causes a small trichome swirl. 
(A) Adult wing outlining the position of the trichome swirl. (B-G) Close up of adult wings as 
outlined in (A). Ectopic expression of CD8::GFP (B, E) and GFP-RASSF9 (C, F) with tubulin-
Gal4 or apterous-Gal4 does not lead to trichome swirls, whereas expression of GFP-RASSF10 
(D, G) causes small swirls with both drivers.  
 
 
In conclusion, ectopic expression of RASSF10 only caused a very mild PCP defect 
with the strong drivers, tubulin and apterous-Gal4. However, the biological relevance 
of this gain-of-function phenotype is questionable as none of the other drivers tested 
caused an obvious defect.  
Tubulin-Gal4-driven expression of RASSF9 and RASSF10 also mildly affected wing 
shape in opposing ways (Figure 3.17A-C). While expression of GFP-RASSF10 caused 
significantly longer wings compared to expression of the GFP control, GFP-RASSF9 
expression caused rounder wings. Though there was a mild effect on wing shape for the 
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ectopic expression of RASSF9 and RASSF10, the results should be treated with caution 
as even expression of GFP elongated the wing compared with tubulin-Gal4/+ flies. 
 
 
 
Figure 3.17 - Ectopic expression of RASSF9 and RASSF10 mildly affects wing shape.  
Adult wings of flies expressing CD8::GFP (A), GFP-RASSF9 (B) or GFP-RASSF10 (C) with 
the tubulin-Gal4 driver. (D) Quantification of the wing roundness. The wing roundness was 
measured by dividing the length of the wing along the L3 vein by the width of the wing from 
the anterior to the posterior passing through the cross-vein as seen in (D’). 20 wings were 
measured for each genotype and error bars represent the mean ± standard deviation. Wing 
roundness differed significantly between the tubulin-Gal4/+ control and the tubulin-Gal4 driven 
CD8::GFP control. Expression of CD8::GFP or GFP-RASSF10 led to elongated wings, with 
GFP-RASSF10 being significantly longer than CD8::GFP expressing wings. Expression of 
GFP-RASSF9 caused significantly rounder wings compared to CD8::GFP. (One-way ANOVA 
with Bonferroni’s correction: ***P<0.001). 
 
 
3.5 RASSF9 and RASSF10 loss of function  
Thus far, I have shown that Drosophila RASSF9 and RASSF10 can bind to ASPP and 
PP1 subunits and therefore have the potential to be part of a phosphatase complex with 
or without ASPP. Interestingly, they are also able to bind to several known RASSF8 
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interactors, hinting at a potential redundancy between N-terminal RASSFs. Furthermore, 
I was able to demonstrate that the binding of RASSF9 and RASSF10 to Dsh is 
conserved in Drosophila and to discover the interaction of RASSF10 with Fz. The 
stability and localisation of ectopic expressed RASSF10, but not RASSF9, is dependent 
on the Fz receptor and its effector Dsh.  
In order to gain insight into RASSF9 and RASSF10 in vivo function, I examined 
their loss-of-function phenotypes. In the following section, I will describe the 
generation and characterisation of mutant alleles of RASSF9 and RASSF10. 
 
3.5.1 Generation and characterisation of a RASSF9 mutant  
At the beginning of this thesis, RASSF9/CG13875 was an uncharacterised gene with no 
available mutant alleles. In order to generate flies mutant for RASSF9, I performed 
imprecise P-element excisions using P(EP)G18523, which is inserted in the first intron 
before the 5’ UTR of the RA transcript, as illustrated in Figure 3.18A. The P-element 
was mobilised by crossing to a transposase source, as described in the Material and 
Methods section (2.4.2). Putative excision males were identified by the absence of the 
mini-white marker in the P-element and individually crossed to a balancer stock, then 
genotyped by PCR to identify imprecise excisions.  
In total, 176 males were screened for a genomic deletion. Out of those, only one 
male (number 128) was positive for an obvious genomic deletion of approximately 1.7 
kbp, and the allele was named RASSF9128 (Figure 3.18B). I also recovered one of the 
precise excisions to use as a control stock in subsequent experiments. 
To characterise the alleles, mutant and control RASSF9 loci were sequenced. This 
showed that the RASSF9128 allele has 1783 bp excised, removing the 5’ UTR of 
transcript RA, exon1-3 and 374 bp of exon 4. Furthermore, it contains an additional 30 
bp insertion (originating from the P-element) upstream of the remaining exon 4. The 
RASSF9 locus of the precise excision had no changes compared to the wild type, except 
for an additional 58 bp (remains of the P-element) upstream of the 5’ UTR (RA). 
 
Chapter 3 Results 
 
 142 
 
 
Figure 3.18 - Disruption of RASSF9/CG13875 by imprecise P-element excision.  
(A) Genomic map of the RASSF9 (CG13875) locus, showing the position of the P-element 
P(EP)G18523 and the two predicted RASSF9 transcripts (RA and RB). RASSF9 exons are 
highlighted in orange, untranslated regions in black. Neighbouring genes, Vdup1 and Mkp, are 
highlighted in grey. The generated imprecise excision RASSF9128 (marked in red) has the P-
element and most of RASSF9 deleted. (B) PCR with primers flanking the RASSF9 locus on 
DNA from RASSF9128 or control (precise P-element excision) flies confirming the 1783 bp 
excision.  
 
 
RASSF9128 mutants were homozygous viable and could be kept as a healthy and 
stable homozygous stock. I could not detect any visible phenotype, either in the 
homozygotes, or in trans with a deficiency line for RASSF9 (Df(3L)ED201). I was 
unable to detect RASSF9 transcript by reverse transcriptase PCR (RT-PCR) from fly 
tissues, presumably because of low expression level, therefore I could not confirm the 
absence of transcript in the mutant. Nevertheless, since RASSF9128 removes all RASSF9 
conserved regions, including the entire RA domain, this allele is likely to represent a 
null. 
Given the interaction partners and subcellular localisation of GFP-RASSF9, I 
examined the RASSF9 mutants for PCP-like phenotypes or phenotypes similar to loss 
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of ASPP or RASSF8. Mutants in genes involved in PCP usually display misorientation 
of sensory bristles (mechanoreceptors) and trichomes on the wings and body (see 1.4.2). 
I examined the RASSF9128 mutant flies carefully for bristle orientation, but could not 
detect any abnormalities. 
Flies mutant for ASPP or RASSF8 share two common phenotypes. Both have a rough 
eye phenotype as they are required for correct tissue morphogenesis in the developing 
retina, and also display a modest overgrowth (Langton et al., 2007, Langton et al., 2009). 
However, the eyes of flies lacking RASSF9 appeared completely normal. To address 
whether there was a growth defect, I measured the wing size for RASSF9 mutant and 
RASSF9 control flies in density-controlled conditions. The measurements showed that 
the wings of RASSF9128 flies were significantly smaller (about 6 %) than those of 
control flies (P<0.001, n=19) (Figure 3.19). This suggests that RASSF9, unlike ASPP 
and RASSF8, is a positive rather than negative regulator of tissue size. Besides wing 
overgrowth, loss of RASSF8 causes a wing rounding phenotype (Langton et al., 2009). 
This phenotype will be analysed in section 3.6. 
 
 
 
Figure 3.19 - RASSF9 mutant flies have a mildly reduced wing size. 
(A) The wing size (outline of the entire wing) was measured for RASSF9128 mutant and control 
flies (precise P-element excision) and normalised against the average wing size of the controls. 
19 wings were measured for each genotype and error bars represent the mean ± standard 
deviation. RASSF9128 mutant wings are significantly smaller than control wings (Mann-Whitney 
test: ***P<0.001). (B) Adult wing of RASSF9128 mutant compared to control fly (precise 
excision). 
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3.5.2 Generation and characterisation of RASSF10 loss-of-function 
alleles 
To generate deletion mutants for RASSF10/CG32150, the CRISPR/Cas9 system was 
used (Port et al., 2014). This was done with the help of Maxine Holder from our lab, 
who designed and cloned the gRNAs and set up the initial crosses. The system takes 
advantage of the bacterial CRISPR (clustered regularly interspaced short palindromic 
repeats) associated nuclease (Cas), which causes site-specific double strand breaks in 
genomic sites, directed by a complementary CRISPR RNA-containing guide RNA 
(gRNA). The detailed strategy and description of the CRISPR/Cas9 system can be 
found in the Material and Methods section in 2.4.3. For the design of the guide RNAs, a 
gene that lies within the first intron of RASSF10 had to be taken into account. It encodes 
for a micro RNA (mir-263b), which has been associated with loss of interommatidial 
bristles (Hilgers et al., 2010). So as not to interfere with the mir-263b expression, gRNA 
pair B was designed to target the Cas9 nuclease to cut just before exon 2 and within 
exon 4 and therefore theoretically excising 1546 bp, as seen in Figure 3.20A. As an 
alternative, gRNA pair C would induce cuts in the first intron and at the end of the first 
exon, removing 822 bp. Plasmid pairs (B and C) for the expression of the gRNAs were 
injected into embryos of a germ-line restricted nos-Cas9 line.  
The surviving potential founders were crossed to balancer stock and their progeny 
screened by PCR for the presence of deletions. For the screening it was important to 
consider, firstly, that not all of the progeny of one founder would be positive for 
deletions and, secondly, that deletions within the progeny could also differ. Therefore, I 
first identified positive founders by genotyping a pool of their female progeny by PCR 
for the presence of deletions (see Table 2.8 for primer sequences). This pre-screening 
revealed that gRNA pair B produced three positive founders (out of 35), while with 
gRNA pair C, one positive founder was obtained (out of 34). In the next step, several 
males of the progeny of the positive founders were crossed to a RASSF10 deficiency 
line (Df(3L)BSC575), which would allow immediate phenotypical examination of the 
next generation and were subsequently genotyped. Using this approach, nine potential 
alleles for gRNA pair B and three for gRNA pair C were obtained. Subsequent 
sequencing to characterise the exact cleavage sites revealed that all of the deletions 
clustered around the predicted Cas9 cutting sites and showed, as expected, variability 
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within the progeny of one founder (Gratz et al., 2013, Port et al., 2014). I then picked 
one allele derived from gRNA pair B (RASSF10B221) and one from gRNA pair C 
(RASSF10C321) to further characterise. In order to have a RASSF10 wild type control 
stock with the same genetic background, I followed the same cross scheme used for the 
RASSF10 mutants, beginning with an uninjected male of the original nos-Cas9 line. 
RASSF10B221 has 1585 bp excised with an insertion of 3 bp (a 1546 bp deletion was 
predicted) leaving the 5’ UTR and exon 1 unaffected and 635 bp of exon 4 remaining 
(Figure 3.20A, B). RASSF10C321 harbours a 839 bp deletion (822 bp were predicted), 
which excises the entire first exon (see Figure 3.20A, B). In order to test whether 
transcripts of the remaining exons were still detectable, I performed RT-PCRs. 
RASSF10B221 was positive for transcript expression of the 5’ UTR and exon 1, and 
RASSF10C321 still expressed the remaining exons 2 to 4 (Figure 3.20C). Moreover the 
transcript levels were not detectably reduced compared to those of the RASSF10 control.  
The results from the RT-PCRs and the sequencing data imply the following 
regarding translations: RASSF10B221 mutants most likely express a truncated protein 
containing the first 118 amino acids encoded by exon 1, which are - depending on 
precision of the splicing of the remaining intron between exon 1 and exon 4 - followed 
by a premature stop codon or several missense substitutions and a stop codon. Within 
exon 4, just after the cleavage site, lies another ATG (out of frame with the first start 
codon), which could theoretically allow the expression of the C-terminus (aa 390-524). 
In the case of RASSF10C321, a start codon right at the beginning of exon 2 could allow 
the expression of a N-terminally truncated protein containing 102 of the 107 amino 
acids of the RA domain and the complete rest of the sequence. 
Both RASSF10B221 and RASSF10C321 could be kept as a healthy homozygous stock. 
Mutant flies, either as homozygotes or in trans to a deficiency, did not display any PCP 
defects, but presented sensory bristle defects: missing or additional macrochaetes on the 
thorax, duplicated bristles at the wing margin and split bristles on the thorax or 
abdomen. This phenotype will be explored in detail in Chapter 4.  
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Figure 3.20 - Disruption of RASSF10/CG32150 using the CRISPR/Cas9 system.  
(A) Genomic map of the RASSF10 (CG32150) locus, showing the predicted cut sites of the two 
gRNA pairs (B and C) used for CRISPR and the three predicted RASSF10 transcripts (RA, RC 
and RD). RASSF10 exons are highlighted in orange, untranslated regions in black. The 
neighbouring gene, CG15715, and the micro RNA mir-263b within the first intron of RASSF10 
are highlighted in grey. Two different deletion mutants were generated with the CRISPR/Cas9 
system. RASSF10B221, derived from gRNA pair B (marked in red), has exon 2, exon 3 and part 
of exon 4 removed and RASSF10C321 derived from gRNA pair C (marked in blue) and has the 
first exon excised. (B) PCR with primers flanking the RASSF10 locus on DNA from RASSF10 
mutants or control flies confirming the deletions. (C) RT-PCR on mRNA from RASSF10 
mutants or control flies showing that truncated transcripts are still expressed for both deletions.  
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3.6 Redundancy between N-terminal RASSFs 
I have previously shown that RASSF9 and RASSF10 share several binding partners of 
RASSF8 (3.2.1 and 3.3). Moreover flies mutant for RASSF8, RASSF9 or RASSF10 are 
homozygous viable and do not display severe phenotypes. This raised the question 
whether N-terminal RASSFs could be redundant. To address this hypothesis, I 
recombined the mutant alleles (RASSF8 is located on 3R, RASSF9 and RASSF10 on 3L) 
to generate double mutants and a triple mutant. Double and triple mutants were then 
confirmed by genotyping PCR for the individual alleles. The RASSF86, RASSF9128 
double mutant flies were homozygous viable and could be kept as a homozygous stock, 
however, the adult flies seemed less active than their control counterparts. 
Recombination of RASSF86 and RASSF10B221 resulted also in homozygous viable flies, 
which were very weak and could not be maintained as a homozygous stock. Triple 
mutants of RASSF86, RASSF9128, RASSF10B221 were, as with the RASSF86, 
RASSF10B221 double mutants, homozygous viable but could not be kept as a 
homozygous stock. Double and triple mutants had, like the RASSF86 single mutant, an 
obvious eye roughness and round wings, which appeared even rounder than those of 
RASSF86.  
Eunice Chan from our lab had previously examined the round wing phenotype of the 
RASSF86 mutants. She found that RASSF8, together with its binding partner Sec15 of 
the exocyst complex, are needed for the docking of Rab11 recycling endosomes to the 
membrane in pupal wings and eyes, as Rab11 containing endosomes were accumulated 
in both RASSF86 and sec15 mutants (unpublished results). This led her to propose that 
RASSF8 is needed to facilitate polarised vesicle trafficking to the growing junctions 
thereby promoting cell-cell rearrangements leading to growth along the P-D axis. Since 
RASSF9 and RASSF10 were also able to bind Sec15 (see 3.3), I tested for redundancy 
between the N-terminal RASSFs in P-D wing elongation.  
Firstly, I measured the wing roundness for the three N-terminal single mutants and 
their individual controls (Figure 3.21A). RASSF86 single mutants had 15% rounder 
wings than control. RASSF9128 mutant wings were also slightly rounder, (2.5% when 
compared to the RASSF9 control), whereas RASSF10B221 mutants were modestly 
different from controls (1.3% rounder).  
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Next, I analysed the double and triple N-terminal RASSF mutants and compared 
them to the RASSF86 single mutant (Figure 3.21B). Combinatorial loss of RASSF9 and 
RASSF10 led to a stepwise increase in wing roundness compared with RASSF86 (2.5% 
for RASSF86, RASSF9128 double mutants; 5% for RASSF86, RASSF10B221 double 
mutants; 6.7% for, RASSF86, RASSF9128, RASSF10B221 triple mutants). I then tested 
whether the double and triple mutants could be rescued by expression of ubi-GFP-
RASSF9/10 constructs. To have controls with the same genetic background as the ubi-
GFP-RASSF9/10 lines, I generated an ubi-GFP line with the plasmid used for the ubi-
GFP-RASSF9/10 lines (see 3.4.5), which was inserted using the PhiC31 integrase-
mediated system into the same genomic locus (2L 28E7). I combined the three different 
lines accordingly with the RASSF86 single, the RASSF86, RASSF9128 and the RASSF86, 
RASSF10B221 double mutants as well as the triple mutant and measured their wing 
roundness (Figure 3.21A, B).  
 
 
 
Figure 3.21 - Wing roundness of RASSF86, RASSF9128 and RASSF10B221 single, double and 
triple mutants. 
The wing roundness was determined as described in Figure 3.17C. 20 wings were measured for 
each genotype and error bars represent the mean ± standard deviation. (A) Wings of N-terminal 
RASSF mutants are significantly rounder than wings of their controls (Mann-Whitney test: 
***P<0.001, **P=0.0051). (B) The wing roundness of RASSF86 mutants is significantly 
increased upon loss of RASSF9128 or/and RASSF10B221 (One-way ANOVA with Bonferroni’s 
correction: ***P<0.001). n = 20 for all genotypes. 
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This analysis led to several puzzling observations. First, ectopic expression of 
RASSF9 under the ubiquitin promoter enhanced rather than rescued the wing roundness 
of the double and triple mutant combinations (Figure 3.22A). This is consistent with the 
previous finding that RASSF9 expression under control of tubulin-Gal4 caused a slight 
round wing phenotype (Figure 3.17). Secondly, while it was clear that ectopic 
expression of RASSF10 under the ubiquitin promoter did not significantly rescue the 
double and triple mutant phenotypes, the enhancement of wing roundness in the triple 
mutant compared with the RASSF86, RASSF10B221 double mutants (see Figure 3.21B) 
was no longer observed when combined with the ubi-GFP control construct (Figure 
3.22B). Thus, it is likely that genetic background influences the wing roundness 
phenotypes elicited by N-terminal RASSF mutations. Although much care was taken in 
generating the correct control stocks for the wing roundness analysis of the mutant 
combinations in Figure 3.21, these results should be interpreted with caution in light of 
the rescue results. I therefore cannot conclude on the potential redundancy between N-
terminal RASSF proteins based on these experiments. 
The most robust cellular phenotype of the RASSF8 mutants is the accumulation of 
Rab11 endosomes in the cytoplasm, while other endosomal markers such as Rab5 or 
Rab7 are unaffected (Eunice Chan, unpublished observations). In order to test the 
redundancy between N-terminal RASSF proteins using Rab11 localisation as a readout, 
I generated a triple mutant stock on a double FRT82B, FRT2A chromosome. Hence, 
within one imaginal disc, mitotic clones mutant for RASSF8 or RASSF9, RASSF10 or 
RASSF8, RASSF9, RASSF10 (in overlapping areas) could be generated and compared to 
each other. Using this approach, I found that Rab11 strongly accumulated in RASSF86 
mutant clones of wing imaginal discs (outlined in red), whereas loss of RASSF9 and 
RASSF10 (outlined in green) did not affect Rab11 distribution (Figure 3.23A-A’’’). 
Moreover, the Rab11 enrichment did not seem to be enhanced in the triple mutant 
clones (outlined in yellow) when compared to the RASSF8 single mutant clones. I also 
tested whether E-cadherin, as a potential cargo of Rab11 endosomes (Figure 3.23B-
B’’’), or their common binding partner Baz (Figure 3.23C-C’’’) were affected in triple 
mutant clones in wing imaginal discs. However, I saw no evidence of redundancy in L3 
wing discs using these markers. 
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Figure 3.22 - Ectopic expression of RASSF9 or RASSF10 do not rescue the enhanced wing 
roundness of double and triple mutants.  
The wing roundness was determined as described in Figure 3.17C. 20 wings were measured for 
each genotype and error bars represent the mean ± standard deviation. (A) Ubiquitous 
expression of GFP-RASSF9 does not rescue the phenotype of double and triple mutants and 
even makes the wings rounder (Mann-Whitney test: ***P<0.001, **P=0.0035). (B) Ubiquitous 
expression of GFP-RASSF9 does not rescue the phenotype of double and triple mutants (Mann-
Whitney test: ***P<0.001, *P=0.0262). 
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Figure 3.23 - Staining of Rab11, Ecad and Bazooka in RASSF86 single, RASSF9128, 
RASSF10B221 double and RASSF86, RASSF9128, RASSF10B221 triple mutant clones.  
Planar confocal sections of wing imaginal discs with hsFLP induced mitotic clones stained for 
Rab11 (A-A’’’), Ecad (B-B’’’) or Baz (C-C’’’). RASSF8 wild type tissue is RFP positive and 
RASSF86 mutant tissue is RFP negative (outlined in red). Wild type tissue for RASSF9, 
RASSF10 is GFP positive and RASSF9128, RASSF10B221 double mutants are GFP negative 
(outlined in green). Mitotic clones mutant for RASSF86, RASSF9128, RASSF10B221 are outlined in 
yellow. Posterior is to the left and anterior to the right. Scale bar = 30 µm. 
 
 
3.7 Concluding remarks  
In this chapter, I have established an interaction network for Drosophila RASSF9 and 
RASSF10 performing co-IP experiments with S2 cells, based on the interactors of their 
potential human homologues. Even though RASSF9 and RASSF10 bear limited 
resemblance to their human counterparts, the interaction network is highly conserved. 
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They can form a trimeric complex with ASPP/PP1 and, moreover, associate 
independently of ASPP with all PP1 catalytic subunits. This gives RASSF9 and 
RASSF10 the potential to function both as regulatory subunits and as specificity 
subunits for PP1. However, whether they can function as such in vivo still needs to be 
established.  
I have shown that RASSF9 and RASSF10 share other known RASSF8 binding 
partners - namely, Baz, Sec15 and SCAR - suggesting that N-terminal RASSFs might 
function in similar ways. Whether there is an overlap, and hence a redundancy, in their 
function or whether it is time and tissue-specific needs to be further investigated. I 
demonstrated that in the case of the round wing phenotype of RASSF8 mutants, a 
redundancy between N-terminal RASSFs is unlikely to be biologically significant. First, 
despite the modest incremental increases in wing roundness in double and triple mutant 
combinations (Figure 3.21B), RASSF9 or RASSF10 ubiquitous expression did not 
rescue the triple mutant flies (Figure 3.22A, B). Furthermore, on a cellular basis, the 
Rab11 accumulation in RASSF8 clones was not modified by RASSF9/10 loss (Figure 
3.23A-A’’’), at least in the L3 wing disc. These experiments could be repeated in pupal 
wings and eyes, where the RASSF8 defects are most obvious (Langton et al., 2009). 
Thus, while it is doubtful that N-terminal RASSFs have redundant functions in the P-
D axis elongation of the pupal wing, a redundancy in other tissues or developmental 
stages cannot be ruled out. The observation that RASSF86, RASSF10B221 double mutants 
and RASSF86, RASSF9128, RASSF10B221 triple mutants were less healthy than the 
RASSF86 single mutant and that homozygous stocks could not be established, supports 
the possibility of redundant functions. However, this could also be due to a cumulative 
effect of losing the functions of several genes functioning in separate processes on fly 
viability. Therefore, the mechanistic basis for this viability would need to be established 
and studied in order to pursue the possible redundancy between N-terminal RASSF 
proteins.  
RASSF9 and RASSF10 also have specific interactors, which are not associated with 
RASSF8. They can both bind to Dsh (Figure 3.8) and RASSF10 can also bind to Fz 
(Figure 3.11), suggesting a potential function in canonical Wg/Fz or PCP signalling. 
This connection is further supported by the ability of GFP-tagged transgenes to planar 
polarise in pupal wings (Figure 3.13). In the case of RASSF10, however, the evidence is 
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more suggestive, as its stability is dependent on both Dsh and Fz (Figure 3.14) and 
strong misexpression of RASSF10 can cause mild PCP defects, whereas no such effects 
were observed for RASSF9 (Figure 3.16). The RASSF10 mutants, albeit not showing 
classical PCP defects, have a defect of their sensory bristles, which derive from a series 
of asymmetric cell divisions from a single SOP cell. The core PCP components and Baz, 
among others, are required to establish the polarity within the SOP cell prior to the first 
asymmetric division (Furman and Bukharina, 2011), thus suggesting that RASSF10 
might be linked to these proteins in this context. This theory is supported by previous 
findings, which have shown RASSF10 mRNAs to be highly enriched in the proneural 
clusters of the wing disc that give rise to the SOP cells (Reeves and Posakony, 2005) 
and SOP cells of the pupal notum (Buffin and Gho, 2010). Moreover, Baz, Dsh and Fz 
are all known to be phosphorylated on multiple residues and Baz can be 
dephosphorylated in vitro by PP1 (see 1.3.4 and 1.4.7). This led us to speculate these 
might be substrates of a RASSF10/PP1 complex in SOPs. RASSF9 mutants exhibit no 
obvious phenotype, except for slight undergrowth (Figure 3.19), which makes it 
extremely difficult to address its developmental function. Thus, I decided to make the 
function of RASSF10 the focus of my research, as described in the next chapter, and 
addressed the function of RASSF9 only in this context.  
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Chapter 4 The function of RASSF9/10 in the formation 
of external sensory organs 
 
The Drosophila external sensory organs (bristles), such as mechanoreceptors and 
chemoreceptors are part of the peripheral nervous system (PNS) and originate from a 
single cell - the sensory organ precursor (SOP). The selection of the SOP within the 
epithelial cell field is a complex process, which involves the action of different 
proneural proteins, their regulators and Notch-mediated lateral inhibition (see 1.7.1). 
Once the SOP cell is selected, it will divide asymmetrically into two cells of different 
fate and will, after subsequent asymmetric divisions, give rise to the four cells that form 
the sensory organ. In the case of mechanoreceptors, these are the neuron, the sheath, the 
socket and the shaft cell (see Figure 1.6). The key to the asymmetric division is the 
establishment of the asymmetric localisation of cell fate determinants. The three 
potential interactors of RASSF10 - Fz, Dsh and Baz- are all required to establish the 
asymmetry of the SOP cell. PCP facilitates the initial symmetry breaking within the 
SOP cell and also orients the division angle. Fz and Dsh promote the localisation of the 
Baz-aPKC-Par6 complex at the posterior cortex, whereas Stbm and Prickle promote the 
anterior localisation of the Dlg-Pins-Gαi complex (see 1.7.2). The asymmetric and 
opposite localisation of the Baz-aPKC-Par6 complex and Dlg-Pins-Gαi complex 
ultimately lead to the asymmetric localisation of the cell fate determinants, which, upon 
cell division, are unequally distributed into the daughter cells and ultimately induce 
them to adopt distinct identities - pIIa and pIIb (see 1.7). How Fz/Dsh link to the Baz-
aPKC-Par6 complex to localise it to the posterior cortex of the SOP remains unknown, 
but RASSF10 is a potential candidate.  
In this thesis chapter, I will address whether RASSF10 is linked to asymmetric cell 
divisions of SOPs. Therefore, I will first characterise the RASSF10 loss-of-function 
phenotype and explore the subcellular localisation of endogenous RASSF10. 
Furthermore, I will present genetic interactions between RASSF10 and different ACD 
machinery components. Finally, asymmetric divisions of SOPs in RASSF10 mutants 
will be analysed by live imaging. 
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4.1 Loss of function of RASSF10 causes an external sensory 
organ defect  
As described in section 3.5.2, the two different mutant RASSF10 alleles, RASSF10B221 
and RASSF10C321, display an external sensory bristle defect. The two most frequent 
defects were observed in the sensory bristles of the wing margin and in the thoracic 
macrochaetes. In the notal macrochaetes, two different defects were present: individual 
macrochaetes were either missing or occurred at random positions (Figure 4.1A). In a 
few cases, I observed duplications of individual thoracic microchaetes with a single 
socket (Figure 4.1B), which was most frequent in abdominal microchaetes (Figure 
4.1C). Individual bristles of the wing margin were duplicated (Figure 4.1D, E).  
 
 
Figure 4.1 - RASSF10 mutants have an external sensory organ defect.  
(A-E) Images of an adult RASSF10B221 mutant fly, bristle defects are indicated by white and 
black arrows. RASSF10B221 mutants have missing and extra thoracic macrochaetes (A), split 
microchaetes on thorax (B) and abdomen (C). Wing of an adult RASSF10B221 mutant fly (D, E) 
with duplicated stout bristles (E) and wild type control fly (F).  
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Overall the defect seemed stronger for the RASSF10B221 allele compared to 
RASSF10C321, suggesting that RASSF10C321, which encodes for a N-terminally truncated 
protein missing the first 134 aa, is a hypomorph. To address the question whether 
RASSF9 has redundant functions with RASSF10, I recombined the RASSF9128 allele 
with the RASSF10B221 allele using the same strategy as for the double and triple mutants 
(see 3.6). RASSF9128, RASSF10B221 double mutants were homozygous viable and 
showed the same external sensory organ defects as RASSF10B221. 
 
4.1.1 RASSF10 mutants have duplicated stout bristles  
In order to characterise the different RASSF10 mutants, I quantified the most frequent 
defects - the margin bristle defect and the thoracic missing/extra macrochaete defect.  
The anterior wing margin harbours three types of bristles: firstly, the singly 
innervated stout (mechanosensory) bristles that are found on the dorsal side of the 
anterior wing margin, secondly, the singly innervated slender (mechanosensory) bristles 
located on the ventral side of the anterior wing margin and on the dorsal and ventral 
side towards the distal wing margin and lastly the multiply innervated recurved 
(chemosensory) bristles (see Figure 4.2B and (Hartenstein and Posakony, 1989)). The 
bristles of the posterior wing margin resemble the slender bristles, but are not 
innervated. I decided to quantify the defect for the stout bristles of the anterior wing 
margin (see Figure 4.2A, B), as these are thicker compared to the other bristles types 
and therefore defects are easier to score. I counted the number of duplicated bristles for 
both wings from 50 flies for each genotype. At the same time the flies were analysed for 
the missing and extra macrochaete defect (see 4.1.2). 
Firstly, I analysed the defects for the different RASSF10 alleles - RASSF10B221 and 
RASSF10C321 - and also for the RASSF9128, RASSF10B221 double mutant. The 
quantification of the stout bristle defect in females revealed the following for the 
different alleles of RASSF10 (Figure 4.2C). 60% of the wings of RASSF10B221 mutants 
had duplicated stout bristles. Wings harbouring the defect had 1 to 3 duplicated bristles, 
with an average of 0.87 duplicated bristles per wing. On the contrary, the defect was 
much milder in RASSF10C321 mutants, as just 10% of the wings of were affected (0.1 
duplicated bristles per wing). RASSF9128, RASSF10B221 double mutants caused a defect 
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comparable to the RASSF10B221 mutant (63%, 0.9 duplicated bristles per wing) (n.s.) 
(Table 7.3). RASSF10 control flies did not show the defect (1%).  
The defect of RASSF10B221 (56%, 0.74 duplicated bristles per wing) and RASSF9128, 
RASSF10B221 double mutant (59%, 0.92 duplicated bristles per wing) was not enhanced 
over a deficiency (Df(3L)BSC575) (n.s.) (Table 7.3). This suggests that the 
RASSF10B221 allele is a null allele for RASSF10 and that the N-terminal 118 aa, encoded 
by the first exon, are not sufficient for RASSF10 function. In contrast, the defect of 
RASSF10C321 was doubled over the deficiency (22%), supporting the notion that the N-
terminally truncated protein might still retain some function and that the RASSF10C321 
allele is likely to be a hypomorph (P=0.0381) (Table 7.3). Therefore the RASSF10B221 
allele was exclusively used for all the following experiments. Moreover, only females 
were analysed, as the margin bristle defect was approximately half as strong in 
RASSF10B221 males compared to females (P<0.0001) (Table 7.3).  
In order to confirm whether the bristle defect was indeed due to RASSF10 loss of 
function, I tested whether expression of ubi-GFP-RASSF10 could rescue the defect of 
RASSF10B221 and RASSF9128, RASSF10B221. Moreover, I wished to test whether 
expression of ubi-GFP-RASSF9 could rescue loss of RASSF10, and therefore 
suggesting redundant functions for RASSF9 and RASSF10, even though loss of 
RASSF9 on its own did not cause any stout bristle duplication (Figure 4.2E). Indeed, as 
seen in Figure 4.2D, expression of ubi-GFP-RASSF10 almost completely abolished the 
stout bristle defect, for both RASSF10B221 (1%) and RASSF9128, RASSF10B221 (3%). 
Expression of ubi-GFP-RASSF9 could not rescue the defect of either mutant (n.s.) 
(Table 7.3) and on the contrary even seemed to slightly worsen the phenotype compared 
to the GFP control (P=0.0047) (Table 7.3). The defect of RASSF10B221 mutants 
significantly differed from ubi-GFP; RASSF10B221 flies (P=0.0031) (Figure 4.2 and 
Table 7.3), thus indicating that the RASSF10B221 stout bristle defect varies in different 
genetic backgrounds. Significances higher than this background noise P value should 
therefore be treated with caution, as such phenotypic differences might not be 
biologically relevant.  
To further address whether there is a redundancy between the N-terminal RASSFs, I 
also quantified the defect for RASSF86, RASSF10B221 double mutants and RASSF86, 
RASSF9128, RASSF10B221 triple mutants (Figure 4.2E).  
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Figure 4.2 - Stout bristle duplication defect of RASSF10 mutants. 
(A) Wing of an adult fly outlining the stout bristle region on the anterior wing margin. (B) 
Schematic of the wing margin showing the different bristle types (adapted from (Hartenstein 
and Posakony, 1989)). The dorsal side of the anterior wing margin harbours singly innervated 
stout bristles and multiply innervated recurved bristles, whereas the ventral row consists of 
slender bristles and recurved bristles. (Continued on next page) 
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Figure 4.2 (Continued from previous page) - (C-E) Quantification of duplicated stout bristles 
for 100 wings (left and right wing of females, males in (C)) for each of the indicated genotype. 
For each wing, the number of duplicated bristles was counted. The average stout bristle defect 
per wing is written above the chart. (C) Stout bristle defect in different RASSF10 mutants (Df: 
Df(3L)BSC575, deficiency line for RASSF10). (D) Expression of ubi-GFP-RASSF10 but not 
ubi-GFP-RASSF9 rescues the stout bristle defect of RASSF10B221 and RASSF9128, RASSF10B221. 
(E) Stout bristle defect in RASSF86 single, RASSF9128 single, RASSF86, RASSF10B221 double and 
RASSF86, RASSF9128, RASSF10B221 triple mutants. Statistics can be found in Table 7.3 in the 
Appendix.  
 
 
RASSF86, as with RASSF9128, did not exhibit a defect on its own. The RASSF86, 
RASSF10B221 double mutants (38%) and RASSF86, RASSF9128, RASSF10B221 triple 
mutants (53%) displayed duplicated stout bristles, however, the defect was slightly 
decreased and not increased compared to RASSF10B221 alone (P= 0.0045 for RASSF86, 
RASSF10B221 and n.s. for RASSF86, RASSF9128, RASSF10B221) (Table 7.3). Taken 
together, it seems very unlikely that N-terminal RASSFs share overlapping functions in 
the formation of the mechanoreceptors. 
 
4.1.2 RASSF10 mutants have a missing macrochaete defect 
The thorax of an adult fly harbours exactly 22 macrochaetes (excluding the 4 humeral 
bristles of the prethorax), which are located at fixed positions (illustrated in Figure 
4.3A). I counted for each thorax the number of missing macrochaetes and as well as the 
presence of extra macrochaetes.  
 The quantifications of the missing macrochaete defect (Figure 4.3C-E) overall mirror 
and thus support the results of the stout bristle defect. The missing macrochaete defect 
was stronger for RASSF10B221 flies (40%) and than for RASSF10C321 (12%) (Figure 
4.3C). However, unlike the stout bristle defect, the defect was more pronounced in 
RASSF9128, RASSF10B221 double mutants (with 68%) and enhanced when crossed to the 
deficiency line for both, RASSF10B221 and RASSF10C321. Affected flies had in general 
one or two (less often three) mechanoreceptors missing. Unlike the stout bristle defect 
the difference between males and females was not significant (Table 7.3).  
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Furthermore, the rescue experiment with the different ubi-GFP lines (Figure 4.3D 
and Table 7.3), showed a clear rescue with the expression of ubi-GFP-RASSF10 for 
both RASSF10B221 single and RASSF9128, RASSF10B221 double mutants, whereas 
expression of ubi-GFP-RASSF9 did not. The missing macrochaete defect supported the 
result of the stout bristle defect that N-terminal RASSFs are unlikely to be redundant in 
this context, as loss of RASSF8, or RASSF8 and RASSF9, did not worsen the missing 
macrochaete phenotype of RASSF10B221 (Figure 4.3E and Table 7.3). 
 The different macrochaetes on the notum are responsive to the expression of 
different prepatterning genes, such as Wingless, Pannier, Iroquois, which activate the 
expression of proneural genes in their expression zone (reviewed in (Simpson, 2007)). 
Interestingly, the positions of the missing macrochaete in RASSF10B221 and RASSF9128, 
RASSF10B221 mutants (Figure 4.3B, the Wg expression zone is highlighted in green), 
did not display a specific pattern, as macrochaete on all positions were affected. 
Unlike the two defects described above, the extra macrochaete phenotype (see Figure 
4.4B and Table 7.3) did not appear to be linked to RASSF10 function. The two 
RASSF10 alleles as well as the control flies, but not the RASSF9128, RASSF10B221 double 
mutants, all had extra macrochaetes (Figure 4.4A). However, when crossed to the 
deficiency line the RASSF9128, RASSF10B221 mutants showed extra macrochaetes to a 
similar degree as the single RASSF10 mutants and also to the flies heterozygous for the 
deficiency. This suggests that a mutation eliciting the extra macrochaete defect is 
present in the background of the deficiency line. In addition, expression of ubi-GFP-
RASSF10 did not rescue the defect of RASSF10B221 mutants (Figure 4.4C). Similar to 
the RASSF9128, RASSF10B221 double mutants, the other recombinants with RASSF10B221, 
the RASSF86, RASSF10B221 double mutants and the RASSF86, RASSF9128, RASSF10B221 
triple mutants did not display a strong defect (Figure 4.3D), suggesting that the 
background defect was lost when the alleles were recombined. Taken together, the extra 
macrochaete phenotype is most certainly unrelated to loss of RASSF10 function and 
could have derived from the genetic background of the RASSF10 deficiency line, when 
the stocks for the RASSF10 alleles were originally made (see 3.5.2). Moreover, the 
differences in the genetic background could be the reason why the missing bristle defect 
was stronger in RASSF9128, RASSF10B221 double mutants compared to RASSF10B221 
single mutants, rather than a potential redundancy between RASSF9 and RASSF10.  
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Figure 4.3 - RASSF10 mutants have a missing macrochaete defect. 
(A) Schematic outline of the notum of an adult fly. Grey circles indicate the position of 
macrochaetes and their shortened names are shown for the left side (identical for the right). a: 
anterior, p: posterior, NP: notopleural, PS: presutural, SA: supraalar, DC: dorsocentral, PA: 
postalar, SC: scutellar bristle. (B) Schematic of the affected macrochaetes (highlighted in 
purple), in RASSF10B221 and RASSF9128, RASSF10B221 double mutants (Wingless expression 
pattern is highlighted in pale green, adapted from (Simpson, 2007)). (C-E) Quantification of 
missing thoracic macrochaetes of 50 female flies (and males in (C)) for each of the indicated 
genotype. (Continued on next page) 
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Figure 4.3 (Continued from previous page) - For each fly the number of missing macrochaetes 
without socket was counted. (C) Missing macrochaete defect in RASSF10 mutants (Df: 
Df(3L)BSC575). (D) Expression of ubi-GFP-RASSF10 but not ubi-GFP-RASSF9 rescues the 
defect of RASSF10B221 and RASSF9128, RASSF10B221. (E) Missing macrochaete defect in 
RASSF86 single, RASSF9128 single, RASSF86, RASSF10B221 double and RASSF86, RASSF9128, 
RASSF10B221 triple mutants. Statistics can be found in Table 7.3 in the Appendix. 
 
 
Figure 4.4 - RASSF10 mutants and control flies have an extra macrochaete defect.  
(A, C, D) Quantification of extra thoracic macrochaetes of 50 female flies (and males in (A)) for 
each of the indicated genotype (Extra: presence of extra bristle, Normal: no defect). (A) Extra 
macrochaete defect in RASSF10 mutants (Df: Df(3L)BSC575). (B) Image of the notum of an 
adult RASSF10B221 fly. Extra macrochaetes are indicated with a white arrow. (C) Expression of 
ubi-GFP-RASSF10 or ubi-GFP-RASSF9 does not affect the extra bristle defect of RASSF10B221 
and RASSF9128, RASSF10B221. (D) Extra macrochaete defects in RASSF86 single, RASSF86, 
RASSF10B221 double and RASSF86, RASSF9128, RASSF10B221 triple mutants. Statistics can be 
found in Table 7.3 in the Appendix. 
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In conclusion, the quantification of both stout bristle defect and missing macrochaete 
defect revealed that, firstly, the RASSF10B221 mutant is most likely a null allele or at 
least a strong hypomorph, whereas RASSF10C321 is a hypomorphic allele. Secondly, 
both defects are caused by loss of function of RASSF10, as they could be rescued upon 
GFP-RASSF10 expression. Moreover, the other N-terminal RASSFs, RASSF8 and 
RASSF9 did not exhibit either of the two defects and the analysis of RASSF86, 
RASSF10B221 double mutants and the RASSF86, RASSF9128, RASSF10B221 triple mutants 
showed no worsening of the RASSF10 phenotype, and thus argue against a potential 
redundancy in this setting. Interestingly, the severity of the RASSF10B221 phenotype 
seemed to be supressed upon loss of RASSF8, which could be obviously due to genetic 
background changes, as seen for the wing roundness in 3.6. The RASSF9128, 
RASSF10B221 double mutants were slightly more affected than the RASSF10B221 single 
mutant, however, expression of GFP-RASSF9 did not rescue the defects of either of 
them. This suggests that RASSF10 is the major N-terminal RASSF in the SOP lineage, 
rather than redundancy being a major issue in these cells. Lastly, the stout bristle defect 
gave the more reliable results and represents therefore a good system to perform genetic 
interactions, as the background extra macrochaete defect might interfere with the 
analysis of the missing macrochaete defect.  
 
4.1.3 The phenotype of RASSF10 mutants suggests defects in ACD  
The phenotype of the RASSF10 mutants, though relatively weakly penetrant, resembles 
phenotypes seen for components involved in the asymmetric cell divisions of SOPs and 
hence, cell fate determination of the daughter cells. Defects in asymmetric cell divisions 
lead to daughter cells adopting the wrong cell fate and therefore defects in the adult 
external sensory bristle, such as multiple or missing neurons/sheath cells and/or 
bristles/sockets, depending on which or how many of the asymmetric divisions were 
affected. Knockdown of the known ACD proteins, Pins or Gao/i (Kopein and Katanaev, 
2009), or Baz (Figure 4.12A, A’), cause the appearance of duplicated stout bristles, as 
seen for RASSF10 loss of function. Similarly, mis-expression of Numb results in 
duplication of margin bristles, twinning and loss of macrochaetes (Frise et al., 1996, 
Yaich et al., 1998).  
 
Chapter 4 Results 
 
 164 
Interestingly, the bristle defect of RASSF10 is distinct from the bristle defect caused 
by loss or overexpression of planar cell polarity proteins. Mutants for Fz, Dsh, Stbm 
and Pk show a randomised orientation of the external sensory organs (reviewed in 
(Shulman et al., 1998)), but no defects of cell fate determination. This is because planar 
cell polarity is required to establish the initial polarity within the SOP cell and also 
orients cell division within the tissue axis, but is not required for the asymmetric 
localisation of cell fate determinants (reviewed in (Segalen and Bellaiche, 2009)). As 
loss of RASSF10 function does not cause random orientation of bristles, it seemed 
unlikely that RASSF10 is involved in establishing the initial polarity together with 
Fz/Dsh, but rather suggests that RASSF10 acts downstream of these.  
 
4.1.4 Loss of RASSF10 function does not affect canonical Wg/Fz 
signalling 
Canonical Wg/Fz signalling is required for the prepatterning of the wing margin and for 
the selection and specification of the SOPs. The Wg target gene Senseless is required 
for the specification of the SOP cells and regulates the expression of proneural proteins 
(Acar et al., 2006, Jafar-Nejad et al., 2003, Jafar-Nejad et al., 2006, Nolo et al., 2000). 
Hence, loss of Wg (Couso et al., 1994) or Senseless (Jafar-Nejad et al., 2006) function 
in larval stages results in wings without any margin bristles, as no sensory organs are 
formed. Subsequently gain of function of canonical Wg/Fz signalling causes the 
formation of ectopic, but normally composed, bristles on the wing (Jafar-Nejad et al., 
2006, Axelrod et al., 1996). As RASSF10 interacts with Dsh/Fz, key players in the Wg 
signal transduction, it was possible that RASSF10 functions in the canonical Wg/Fz 
signalling pathway. However, this seemed unlikely for the following reasons: firstly, the 
duplicated stout bristle defect of RASSF10 mutants is clearly distinct from canonical 
Wg/Fz signalling-related phenotypes, secondly, the missing macrochaete defect also 
affected bristles outside of the Wg expression zone (Figure 4.3) and lastly, strong 
ectopic expression of RASSF10 did not cause the appearance of ectopic bristles, but 
caused a mild PCP defect (3.4.7). Taken together, this supported the idea that RASSF10 
is involved in the process of ACD of SOPs cells and might be connected to Fz/Dsh in 
the context of PCP, rather than in canonical Wg/Fz signalling and/or selection of SOP 
cells.  
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To validate the phenotypic observations I examined the expression of Wg and its 
target genes Distal-less (Dll) and Senseless (Sens) in wing imaginal discs of 
RASSF10B221 mutants. I could not detect obvious differences in the expression pattern of 
Wg, Dll or Sens in RASSF10B221 mutants (Figure 4.5A’-C’) compared to wild type wing 
discs (Figure 4.5A-C). The stainings for Sens together with the stainings for Hindsight 
(Hnt) (Figure 4.5D, D’), a marker for specified, mature SOP cells whose expression is 
activated by Sens (Koelzer and Klein, 2003), revealed that SOPs are still specified in 
RASSF10 mutants. Taken together, these results showed, that loss of RASSF10 function 
had no obvious effect on the expression of Wg and its target genes Dll and Sens or on 
the specification and selection of SOPs.  
 
 
 
 
Figure 4.5 - Loss of RASSF10 does not affect canonical Wg/Fz signalling or the 
specification of SOP cells.  
Planar confocal sections of wild type RASSF10 control (A-D) or RASSF10B221 (A’-D’) wing 
imaginal discs either stained for Wingless (Wg, A-A’), Distal-less (Dll, B-B’), Senseless (Sens, 
C-C’) or Hindsight (D-D’, images are identical to those in Figure 4.6A’’, B’’). Loss of 
RASSF10 does not affect Wg expression (A-A’), or the expression of Wg target genes Dll (B-
B’) and Sens (C-C’). SOPs are specified normally in RASSF10 mutants as seen by the staining 
of the SOP marker Hnt (D-D’) and Sens (C-C’). Anterior is to the left and posterior to the right. 
Scale bar = 50 µm. 
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4.2 RASSF10 localisation 
4.2.1 Endogenous RASSF10 localises exclusively in SOP cells in 
imaginal discs 
In order to study the endogenous localisation of RASSF10, I generated an antibody that 
targets a C-terminal region of RASSF10 (aa 375-486) (see Material and Methods 2.8).  
In control RASSF10 wing discs RASSF10 was exclusively detected in SOP cells 
(identified by the presence of the SOP marker Hnt) (Figure 4.6A-A’’). In contrast, no 
signal was detected in RASSF10B221 mutant discs (Figure 4.6B-B’’) or in hsFLP-
induced mitotic clones of RASSF10B221 (Figure 4.6C-C’), thus confirming that the signal 
was specific for RASSF10. This supported the previous findings that RASSF10 mRNA 
was highly expressed in SOP cells of wing imaginal discs and therefore suggested 
RASSF10 was an SOP-specific gene (Reeves and Posakony, 2005). The SOPs present in 
the late L3 wing imaginal disc give rise to the macrochaete of the notum and also to 
some of the bristles of the wing margin (as illustrated in Figure 4.6F). The clear double 
row of SOPs in the L3 wing pouch are the precursors of the chemosensory bristles of 
the anterior wing margin (Huang et al., 1991). Most interestingly, in co-stainings with 
E-cadherin to outline the cell cortex, RASSF10 was found not only localised to the 
membrane, but also highly asymmetrically enriched at one side at the cell cortex (Figure 
4.6D-E’’). The SOP cells of the wing imaginal discs are selected and specified at 
different time points, with the SOPs, which give rise to the macrochaete of the notum 
appearing first and the SOPs of the wing margin appearing at late L3 (Huang et al., 
1991). Indeed, looking at different stages of wing imaginal discs the occurrence of 
RASSF10 expression correlated with the presence of the SOP-marker Hnt (Figure 4.7A-
C’), thus suggesting that RASSF10 expression is activated upon specification of the 
SOPs. 
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Figure 4.6 - Endogenous RASSF10 localises exclusively in SOP cells in late third instar 
wing imaginal discs. 
(A-E’’) Planar confocal sections of L3 wing imaginal discs. (A-B’’) Wing discs stained for 
RASSF10 and the SOP marker Hnt. RASSF10 is expressed exclusively in SOP cells (A-A’’) 
and cannot be detected in wing discs of RASSF10B221 mutants (B-B’’). (C-C’) hsFLP induced 
mitotic clones of RASSF10B221 stained for RASSF10. Wild type tissue for RASSF10 is GFP 
positive and RASSF10B221 mutant tissue is GFP negative (outlined in green). Wing disc stained 
for RASSF10 and E-cadherin (D-D’’) and a close up of the same disc showing the margin SOP 
region (E-E’’). Scale bar = 50 µm (A-B’’, D-D’’) or 10 µm (C-C’, E-E’). Anterior is to the left 
and posterior to the right. (F) Outline of a late L3 wing imaginal discs showing the position of 
the SOP cells (adapted from (Simpson, 2007). 
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Figure 4.7 - RASSF10 expression in wing imaginal discs of different larval stages and in 
various imaginal discs. 
Planar confocal sections of imaginal discs stained for RASSF10. SOP cells were marked either 
by staining for Hnt (A-D’) or by the neuralized-Gal4 driven expression of Tau-GFP (E-F’). 
RASSF10 protein expression correlates with the expression pattern of Hnt in early L3, late L3 
and prepupal wing discs (A-C’). Anterior is to the left and posterior to the right (A-C’). 
RASSF10 is also expressed in SOP cells of the eye-antennal disc (D, D’), leg disc (E-E’) and 
haltere disc (F, F’). Scale bar = 50 µm.  
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This is in accordance with previous findings that RASSF10 transcription in wing 
imaginal disks is dependent on the presence of the proneural Achaete-Scute complex 
(Reeves and Posakony, 2005). RASSF10 was also expressed in SOPs of the eye-
antennal disc, the leg disc and the haltere disc (Figure 4.7F-F’). Thus, the endogenous 
RASSF10 protein is specifically expressed in SOP cells in different imaginal discs, 
appears upon SOP cell specification, and is localised asymmetrically at the SOP cell 
cortex. 
 
4.2.2 RASSF10 co-localises with polarity determinants in SOPs 
Intrigued by the finding that RASSF10 localised asymmetrically in wing imaginal disc 
SOPs, I went on to test whether it would co-localise with its binding partners Baz, Fz 
and Dsh and also with PCP components Stbm and Fmi. Interestingly, Baz-GFP, Fz-GFP, 
Dsh, Stbm and Fmi were all asymmetrically distributed in the wing margin SOPs, while 
E-cadherin or Arm showed no difference between SOP and the surrounding epithelial 
cells (Figure 4.8 and Figure 4.9). Baz-GFP (endogenously tagged) was found 
asymmetrically enriched on the same side as RASSF10, where its localisation 
overlapped with RASSF10 (Figure 4.8A-B’’’). The same was true for the localisation of 
Fz-GFP (arm-fz-GFP line, Figure 4.8C-D’’’) and Dsh (Figure 4.9A-B’’’). On the 
contrary, Stbm did not localise with RASSF10, but was found highly asymmetrically 
enriched in the neighbouring cell adjacent to RASSF10 (Figure 4.9C-D’’’). Lastly, 
RASSF10 localised with Fmi at the cell cortex, though their localisation did not 
completely overlap (Figure 4.9E-F’’’).  
Thus, RASSF10 co-localises with Baz, Dsh and Fz and all are asymmetrically 
enriched in the wing margin SOPs of the wing disc. As mentioned above, the SOP cells 
of the wing margin will not enter mitosis until after puparium formation (Hartenstein 
and Posakony, 1989), thus suggesting that the initial polarity within the SOP cell might 
already be established hours before the actual divisions start. Moreover it supports the 
finding that Fz and Dsh initiate the asymmetric localisation of the Baz-Par6-aPKC 
complex prior to mitosis in SOPs of the pupal notum, independently of Aurora A kinase 
activity (Besson et al., 2015). Together, the study of the Schweisguth lab (Besson et al., 
2015) and our findings that RASSF10 can bind to Baz as well as Fz/Dsh, with which 
Chapter 4 Results 
 
 170 
they co-localise in wing disc SOP cells prior to entry into mitosis, led us to hypothesise 
that RASSF10 might be the link that facilitates the association of Fz/Dsh with Baz.  
 
 
 
Figure 4.8 - RASSF10 co-localises with Baz and Fz in wing imaginal disc SOPs. 
Planar confocal sections of wing discs from late third instar larvae or white prepupae stained for 
RASSF10 and E-cadherin. RASSF10 co-localises with Baz-GFP (A-B’’’) and Fz-GFP (C-D’’’) 
in wing disc SOP cells. Close up of a single margin SOP cell (B-B’’’, D-D’’’). Anterior is to the 
left and posterior to the right. Scale bar = 5 µm. 
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Figure 4.9 - Description see following page. 
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Figure 4.9 - RASSF10 co-localises with Dsh and Fmi, but not with Stbm in wing imaginal 
disc SOPs. 
Planar confocal sections of wing discs from late third instar larvae or white prepupae stained for 
RASSF10 and either, Dsh and Arm (A-B’’’) or Stbm and Arm (C-D’’’) or Fmi and E-cadherin 
(E-F’’’). Close up of a single margin SOP cell (B-B’’’, D-D’’’, F-F’’’). RASSF10 co-localises 
with Dsh (A-B’’’) and partly with Fmi (E-F’’’), but not with Stbm (C-D’’’) in wing disc SOP 
cells. Anterior is to the left and posterior to the right. Scale bar = 5 µm. 
 
 
4.3 Genetic interactions with ACD polarity components 
In order to substantiate the hypothesis that RASSF10 might function together with 
Fz/Dsh and Baz in the context of ACD of SOP cells, I looked at genetic interactions 
between the RASSF10B221 mutant and different ACD polarity components using the 
duplicated stout bristle defect as a readout. In addition, I tested RASSF9128 for the same 
genetic interactions.  
 
4.3.1 Dsh 
Firstly, I tested whether RASSF9 and RASSF10 genetically interacted with Dsh. I 
combined dsh1 with either RASSF10B221 or RASSF9128. The dsh1 allele has an amino 
acid substitution (K417M) in its DEP domain and is a PCP-specific allele that is not 
thought to affect Wg signalling (Axelrod et al., 1998). dsh1 mutant flies can be kept as a 
homozygous stock and show random orientation of sensory bristles as well as trichomes 
on the body and wing. The stout bristle defect was found rather rarely (3% of wings, 
0.03 duplicated stout bristles per wing) in dsh1 single and dsh1;; RASSF9128 double 
mutants and no defect was seen for dsh1 mutants heterozygous for RASSF9128 (Figure 
4.10A). In contrast, the stout bristle defect of dsh1;; RASSF10B221 double mutants (83% 
of wings, 2.21 defects per wing) was strongly increased compared to RASSF10B221 alone 
(60%) (P<0.0001) (Figure 4.10A and Table 7.3). Besides wings with 1 to 3 duplicated 
stout bristles (as seen for loss of function of RASSF10) some wings contained up to 6 
duplicated bristles. Moreover, 98% of the dsh1;; RASSF10B221 animals analysed had a 
strong missing macrochaete defect (over 4 thoracic macrochaetes), compared to 40% of 
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RASSF10 (P<0.0001) or 16% of dsh single mutants (P<0.0001) (Figure 4.10B and 
Table 7.3).  
 
 
 
 
Figure 4.10 - Flies double mutant for dsh1 and RASSF10 have a strong bristle defect. 
(A) Duplicated stout bristles of the anterior wing margin (n=100) were quantified as described 
in Figure 4.2. The average stout bristle defect for 100 wings is indicated above the chart. (B) 
Flies (n=50) were also analysed for missing thoracic macrochaetes as described in Figure 4.3. 
The RASSF10B221 stout bristle defect (A) and missing macrochaete defect (B) are strongly 
enhanced in combination with dsh1, whereas dsh1;; RASSF9128 double mutants show no 
difference compared to dsh1 alone. Statistics can be found in Table 7.3 in the Appendix. 
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Strikingly, besides the stout bristle and the macrochaete defect, dsh1;; RASSF10B221 
double mutants displayed other notable defects, while dsh1;; RASSF9128 double mutants 
behaved like single dsh1 mutants. dsh1;; RASSF10B221 double mutants, were very 
unhealthy and died within 2 or 3 days. The animals were almost immobile, unable to fly 
and displayed a held-up wing phenotype, indicating a potential flight muscle defect. 
Interestingly, muscle progenitors were shown to divide asymmetrically, with Numb 
being unequally distributed onto the daughter cells (Gunage et al., 2014, Carmena et al., 
1998). Thus we could speculate that RASSF10 and Dsh might also be involved in ACD 
of muscle progenitors.  
 
4.3.2 Frizzled 
Next, I investigated whether RASSF10 genetically interacts with frizzled. I tested the 
effect of fz mis-expression under control of nubbin-Gal4 upon loss of function of 
RASSF10 (RASSF9 and RASSF9, RASSF10). Mis-expression of Fz causes swirly 
trichomes and randomised orientation of the margin bristles and resembles the PCP 
loss-of-function phenotype, but does not induce ectopic Wingless signalling (Zhang and 
Carthew, 1998). Ectopic expression of Fz did not cause duplicated stout bristles (0.02 
duplicated bristles per wing) in RASSF10 control, RASSF9128 homo- or heterozygous 
flies (Figure 4.11). However, the number of affected wings strongly increased for 
RASSF10B221 (86%, 2.06 duplicated bristles per wing) upon expression of fz compared 
to RASSF10B221 combined with nubbin-Gal4 alone (39%, 0.51 duplicated bristles per 
wing) (P<0.0001) (Figure 4.11 and Table 7.3). The defect increased even more for the 
RASSF9128, RASSF10B221 double mutant (97%, 2.80 duplicated bristles per wing) 
(P<0.0001). However, RASSF9128, RASSF10B221 double mutants in the nubbin-Gal4 
background were already more affected (59%, 0.76 duplicated bristles per wing) than 
RASSF10B221. 
To check whether the stout bristle defect of RASSF10B221 could increase upon 
induction of ectopic Wg signalling I mis-expressed arm with nubbin-Gal4 in the 
different genetic backgrounds. Though gain of function of Arm caused the appearance 
of ectopic bristles on the wing, the quantification revealed that it did not induce 
duplicated stout bristles (Figure 4.11 and Table 7.3). Moreover, the stout bristle defect 
did not increase for RASSF10B221 or RASSF9128, RASSF10B221. This further supports the 
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previous observation that RASSF10 does not interfere with canonical Wg/Fz signalling 
(4.1.4). Interestingly, ectopic expression of Fz already caused a slight stout bristle 
defect in the RASSF10B221 heterozygous (10%) and the RASSF9128, RASSF10B221 (12%) 
heterozygous background, which was not seen for ectopic expression of Arm in these 
backgrounds (Figure 4.11).  
In conclusion, RASSF10 genetically interacts with dsh and fz, as loss of dsh function 
or mis-expression of fz worsens the stout bristle defect of RASSF10B221. On the contrary 
no genetic interactions were detected for RASSF9.  
 
 
 
 
 
Figure 4.11 - Ectopic expression of Frizzled but not Arm increases the stout bristle defect 
of RASSF10 mutants. 
Duplicated stout bristles of the anterior wing margin (n=100) were quantified as described in 
Figure 4.2. The average stout bristle defect for 100 wings is indicated above the chart. Fz and 
Arm were expressed under control of nubbin-Gal4. Mis-expression of Fz, but not Arm, under 
control of nubbin-Gal4 strongly increases the stout bristle defect of RASSF10 mutants. Statistics 
can be found in Table 7.3 in the Appendix. 
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4.3.3 Bazooka and Pins 
Having examined genetic interactions with dsh and fz, I tested the effect of knocking 
down Baz on the stout bristle defect in the different RASSF9/10 mutant backgrounds. 
baz dsRNAs were expressed under control of the nubbin-Gal4 driver. Knockdown of 
Baz alone caused a relatively strong stout bristle defect, with 83% of the wings affected 
(1.87 duplicated bristles per wing) (Figure 4.12A, A’, E). Strikingly, in combination 
with RASSF10B221 or RASSF9128, RASSF10B221 the expression of the RNAi against Baz 
caused a very strong margin bristle defect (P<0.0001) (Figure 4.12C-D’ and Table 7.3). 
Many bristles were completely missing and almost all of the remaining ones were 
duplicated. Most interestingly, the stout bristle defect of the Baz knockdown increased 
upon loss of RASSF9 with an average of 4.4 duplicated stout bristles per wing and 99% 
of the wings being affected (P<0.0001) (Figure 4.12B, B’, E and Table 7.3).  
All the genetic interactions described so far were with posterior ACD components. 
Pins (partner of Inscuteable), localises together with Disc-large (Dlg) and Gαi at the 
anterior cortex and is important to restrict Baz localisation to the posterior side 
(Bellaiche et al., 2001b, Schaefer et al., 2001). Pins expression was silenced by RNAi 
expression under control of nubbin-Gal4 causing a mild stout bristle defect (17%, 0.18 
duplicated stout bristles per wing). Strikingly, in combination with RASSF10B221, the 
stout bristle defect was present in all of the wings with an average of 6.5 duplicated 
bristles per wing (P<0.0001) (6.95 for RASSF9128, RASSF10B221, P<0.0001) (Figure 
4.12E and Table 7.3). Moreover, knockdown of Pins in RASSF9128 mutants also led to 
an increased defect (55% of the wings, 0.76 duplicated bristles per wing, P<0.0001). 
Thus, knockdown of Baz or Pins function, which are both required for the 
asymmetric localisation of the cell fate determinants, caused duplicated stout bristles on 
the anterior wing margin and the defect was strongly increased upon loss of RASSF10. 
The genetic interaction of RASSF10 with fz and dsh, as well as baz and pins strongly 
supported the involvement of RASSF10 in ACD of SOPs. Moreover, RASSF9 also 
genetically interacted with baz and pins, suggesting it may have some role in ACD, 
despite not causing an obvious defect on its own.  
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Figure 4.12 - Knockdown of baz or pins strongly increases the stout bristle defect of 
RASSF10 mutants. 
Images of adult wings (A-D) and close up of anterior margin of the same wings (A’-D’), 
expressing baz RNAi with nubbin-Gal4 in wild type, RASSF9128 single, RASSF10B22 single or 
RASSF9128, RASSF10B221 double mutants. (E) Duplicated stout bristles of the anterior wing 
margin (n=100) were quantified as described in Figure 4.2. The average stout bristle defect for 
100 wings is indicated above the chart. baz RNAi and pins RNAi were expressed in the 
different genetic backgrounds with nubbin-Gal4 (nubbin-Gal4 /+ controls are identical to the 
ones in Figure 4.11). (Continued on next page) 
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Figure 4.12 (Continued from previous page) - (E) Knockdown of Baz or Pins cause duplicated 
stout bristles on their own and strongly increase the defect in RASSF10B221 single or RASSF9128, 
RASSF10B221 double mutants. Loss of RASSF9 increases the defects caused by silencing of Baz 
or Pins function. Statistics can be found in Table 7.3 in the Appendix. 
 
 
4.4 Is the function of RASSF10 in SOP cell division linked to 
the ASPP-PP1 phosphatase complex? 
The data presented so far suggests that RASSF10 is most likely involved in establishing 
the asymmetric distribution of cell fate determinants in SOP cells together with Fz, Dsh 
and Baz. Considering the previous findings that RASSF10 can bind to ASPP and all 
PP1 catalytic subunits and thus might be part of a PP1 complex (see 3.2), I was 
interested in testing, whether RASSF10 could function in ACDs as part of a 
phosphatase complex. Although RASSF10 could bind to PP1 catalytic subunits 
independently of ASPP, it is possible that ASPP is required in vivo. I had found that 
strong simultaneous over-expression of RASSF10 and ASPP with tubulin-Gal4 was 
lethal, whereas co-expression of a PP1-binding mutant of ASPP (ASPPVFAA) was not. 
The synthetic lethality could obviously be due to gain-of-function artefacts, however it 
might also indicate, that RASSF10 and ASPP might function together in vivo.  
Firstly, I checked whether loss or RNAi-mediated depletion of ASPP caused a stout 
bristle defect similar to RASSF10B221. Neither the ASPPD mutant (a null allele of ASPP), 
nor the expression of RNAi using nubbin-Gal4 displayed any stout bristle defects 
(Figure 4.13A and Table 7.3). However, knockdown of ASPP caused a slight increase 
of the stout bristle defect of RASSF10B221 with 58% of the wings being affected (0.86 
duplicated bristles per wing) compared to RASSF10B221 on its own (39%, 0.51 
duplicated bristles per wing) (P=0.0375). This effect was also seen for the RASSF9128, 
RASSF10B221 double mutants (75%, 1.12 duplicated bristles per wing) compared to their 
nubbin-Gal4 control (59%, 0.76 duplicated bristles per wing) (P=0.0209), whereas 
RASSF9128 mutants displayed no defect with or without knockdown of ASPP. Similar to 
the genetic background effects described for RASSF10B221 and ubi-GFP; RASSF10B221 
in 4.1.1, the stout bristle defect differed significantly between RASSF10B221 and nubbin-
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Gal4/+; RASSF10B221 flies (P=0.0153) (Table 7.3). The P values obtained for the 
enhancement of the RASSF10B221 phenotype upon ASPP knockdown are higher than 
this background noise P value and thus the stout bristle defect differences might not be 
biologically relevant. 
In addition to the genetic interactions, I looked at the localisation of ASPP in SOP 
cells of the wing imaginal discs. ASPP localised as in the neighbouring epithelial cell at 
the adherens junctions with E-Cadherin in SOPs and showed neither asymmetric 
enrichment nor overlapping localisation with RASSF10 (Figure 4.13B). However, this 
result does not rule out a transient co-localisation between ASPP and RASSF10, for 
instance during SOP division, which would not be visible in stainings.  
In order to investigate whether ASPP and PP1 are, similarly to RASSF10, involved 
in asymmetric cell divisions, I checked whether partial loss of ASPP or different PP1 
catalytic subunits would cause stout bristle duplications in combination with nubbin-
Gal4 driven Fz mis-expression or Baz knockdown. The following alleles for three 
different catalytic subunits of PP1 were tested: flw1, a hypomorphic allele for PP1β9C, 
PP1α87BBg-3, a null allele for PP1α87B (homozygous lethal) and PP1α96A2, a null 
allele for PP1α96A. 
Firstly, neither knockdown of ASPP nor partial loss of the PP1 alleles caused a stout 
bristle defect in combination with Fz mis-expression (Figure 4.14). However, the 
severity of the stout bristle defect caused by Baz knockdown (80%, 1.45 duplicated 
bristles per wing) was significantly increased upon reduction of PP1β9C (89%, 2.18 
duplicated bristles per wing) (P=0.0012), PP1α87B (94%, 2.8 duplicated bristles per 
wing, P<0.0001) or ASPP (95%, 3.04 duplicated bristles per wing) (P<0.0001) dosage 
(Figure 4.14 and Table 7.3). On the contrary, the Baz knockdown phenotype was not 
affected in the PP1α96A2 heterozygous background (77%, 1.59 duplicated bristles per 
wing) (n.s.). 
These preliminary results allow us to make the following considerations. If the 
RASSF10 mutant phenotype was solely caused by loss of its function as part of a 
phosphatase complex in ACD, one might expect similar phenotypes for loss of ASPP or 
PP1 catalytic subunits. However, knockdown or loss of ASPP does not cause ACD 
bristle defects (Figure 4.13).  
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Figure 4.13 - Genetic interaction between RASSF9/10 and ASPP and localisation ASPP in 
wing imaginal disc SOPs. 
(A) Duplicated stout bristles of the anterior wing margin (n=100) were quantified as described 
in Figure 4.2. The average stout bristle defect for 100 wings is indicated above the chart. RNAi 
against ASPP was expressed with nubbin-Gal4 (nubbin-Gal4 /+ controls are identical to the 
ones in Figure 4.11). Knockdown of ASPP mildly increases the stout bristle defect of 
RASSF10B221 single or RASSF9128, RASSF10B221 double mutants. (B-C’’’) Planar confocal 
sections of wing discs in late third instar larvae stained for RASSF10, ASPP and E-Cadherin. 
Close up of a single margin SOP cell (C-C’’’). ASPP does not co-localise with RASSF10 in L3 
wing disc SOP cells. Anterior is to the left and posterior to the right. Scale bar = 5 µm. Statistics 
can be found in Table 7.3 in the Appendix. 
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Figure 4.14 - Genetic interactions between different PP1 catalytic subunits or ASPP with  
fz and baz. 
Duplicated stout bristles of the anterior wing margin (n=100) were quantified as described in 
Figure 4.2. The average stout bristle defect for 100 wings is indicated above the chart. UAS-Fz 
or UAS-Baz RNAi lines were recombined with nubbin-Gal4 and tester stocks were subsequently 
crossed to wild type flies (control), different PP1 mutant alleles (flw1, PP1α87BBg-3, PP1α96A2) 
or ASPP RNAi. Partial loss of PP1 alleles or ASPP does not cause duplicated stout bristles upon 
Fz mis-expression, whereas loss of one copy of flw1 or PP1α87BBg-3 as well as ASPP 
knockdown increase the stout bristle defect induced by baz knockdown. Statistics can be found 
in Table 7.3 in the Appendix. 
 
 
Furthermore, I did not observe RASSF10-like defects in homozygous flw1 or 
PP1α96A2 homozygous or PP1α87BBg-3 heterozygous flies. However, this could be due 
to redundancy between the different PP1 catalytic subunits and double or triple mutants 
would have to be combined and analysed to see whether ACD defects are visible. These 
experiments might prove difficult due to the multitude of PP1 substrates. 
The effect of the ASPP knockdown on both the RASSF10 loss-of-function phenotype 
and the Baz knockdown suggests that ASPP might be required for ACD, possibly 
independently of RASSF10. Similarly to the ASPP RNAi, the reduction of PP1β9C and 
PP1α87B gene dosage increased the stout bristle phenotype caused by knockdown of 
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Baz. These preliminary findings open up the possibility that RASSF10 might function 
as part of a phosphatase complex in ACD, though further work is required to test this 
directly. In pupal retinas, Baz is mis-localised in ASPP mutant clones and ASPP/PP1 
can dephosphorylate Baz in vitro (Yanxiang Zhou, unpublished result). Hence, it is 
possible that ASPP/PP1 could regulate Baz independently of RASSF10. Another point 
worth considering is that PP1α87B is required for mitosis (Axton et al., 1990, 
Rodrigues et al., 2015) and subsequently the worsening of the phenotype could be due 
to an independent effect on SOP cell division. Future experiments will be necessary to 
substantiate the RASSF10/PP1 hypothesis and this will be addressed in the discussion 
(see 6.2 and 6.3.2). 
 
4.5 Asymmetric cell division of SOPs in the pupal notum 
The asymmetric localisation of RASSF10 in SOP cells in the wing imaginal discs of 
late L3 larvae, the association with Fz, Dsh and Baz and the genetic interactions with 
the different ACD components all support the hypothesis that RASSF10 might be 
required to establish asymmetry within the SOP. However, as mentioned above, the 
SOP cells that give rise to the chemosensory bristles of the wing margin do not enter 
mitosis until after puparium formation (Hartenstein and Posakony, 1989, Huang et al., 
1991). At this point, the morphogenetic movements of wing eversion are ongoing, 
making this system inappropriate to perform high-resolution live imaging. In order to 
image asymmetric cell division, I decided to use the pupal notum, a well-established 
system to study ACD of SOPs (Schweisguth, 2015). At approximately 15-16 hours APF, 
the SOPs, which will give rise to the thoracic microchaetes start to divide along the 
anterior-posterior axis. Expression of fluorescently tagged proteins can be used to 
follow this process dynamically. 
 
4.5.1 Localisation of RASSF10 and RASSF9 in SOPs of the pupal notum  
In order to examine the localisation of RASSF10 in SOP cells of the pupal notum, I first 
tried to detect endogenous RASSF10 with the RASSF10 antibody in pupal nota at 15-
16 hours APF. Unfortunately, the initial stainings for RASSF10 did not detect any 
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signal, while the co-staining for E-cadherin worked and thus would have required 
optimisation of the staining protocol. However, it is highly likely that endogenous 
RASSF10 is expressed in SOPs of the pupal notum, as RASSF10 mRNA had been 
previously shown to be highly enriched in pupal notum SOPs (Buffin and Gho, 2010) 
and RASSF10B221 mutants exhibited split microchaete defects. 
 
Hence, instead of looking at the endogenous RASSF10 protein, I decided to use the 
GFP-tagged UAS lines for live imaging before and during asymmetric divisions. GFP-
RASSF10 (or GFP-RASSF9) was specifically expressed in SOPs with the neuralized-
Gal4 driver (Bellaiche et al., 2001a).  
The live imaging revealed that GFP-RASSF10 localised apically to the membrane 
and was asymmetrically enriched at the posterior cortex prior to mitosis (Figure 4.15A, 
A’), similar to Fz, Dsh and Baz (Bellaiche et al., 2001a, Segalen et al., 2010, Roegiers 
et al., 2001a), and consequently opposite to Stbm, Pk, the Dlg-Pins-Gαi complex and 
cell fate determinants. Interestingly, just before onset of mitosis GFP-RASSF10 lost its 
asymmetric localisation and localised uniformly around the membrane (apically and 
basolaterally) and was partitioned into both daughter cells (pIIa and pIIb). This 
observation was puzzling, as ACD polarity determinants generally keep their 
asymmetric localisation (either anterior or posterior) during mitosis (Bellaiche et al., 
2001b, Bellaiche et al., 2004, Segalen and Bellaiche, 2009). It is possible that 
overexpression of GFP-RASSF10 causes it to lose its asymmetric distribution prior to 
mitosis as overexpression might saturate the proteins, required for RASSF10 
asymmetric localisation (presumably Dsh/Fz).  
In contrast, GFP-RASSF9 showed no asymmetric localisation prior to mitosis and 
was also found in the cytoplasm (Figure 4.15B, B’). Upon the onset of mitosis, GFP-
RASSF9 lost its membrane localisation completely and was evenly segregated into both 
pII cells.  
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Figure 4.15 - Localisation of GFP-RASSF10 and GFP-RASSF9 in SOP cells of the pupal 
notum. 
(A-B’) Frames from a time-lapse movie of planar confocal sections showing a dividing SOP 
cell. Histone2B-RFP and GFP-RASSF9/10 were expressed under the control of neuralized-
Gal4. Pupal nota were live imaged at 15-17 hours APF. Images are oriented with the anterior to 
the top and the posterior to the bottom. Apical stack (A, B) and basolateral stack (A’, B’) are 
shown for each time point. Time is given in minutes relative to the onset of mitosis (00:00). 
Scale bar = 5 µm. (Continued on next page) 
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Figure 4.15 (Continued from previous page) - (A, A’) GFP-RASSF10 localises apically and is 
asymmetrically enriched at the posterior side of the SOP cell prior to mitosis and loses its 
asymmetric localisation just before onset of mitosis. RASSF10 is equally distributed onto the 
pIIa and pIIb cell. (B, B’) GFP-RASSF9 is found apically localised to the membrane, as well as 
in the cytoplasm prior to mitosis, and loses its membrane localisation completely at mitosis 
onset, then partitions equally into pIIa and pIIb. 
  
 
4.5.2 The role of RASSF10 in asymmetric cell division of sensory organ 
precursors 
Finally, I went on to test whether RASSF10B221 mutants would show defects in pI 
asymmetric cell divisions - as suggested by their phenotype, by the localisation of 
RASSF10 and by the genetic interactions. Pon-GFP (GFP-tagged Partner of Numb) was 
expressed under control of neuralized-Gal4 in SOP cells in either wild type, 
RASSF10B221 mutant or RASSF10B221 heterozygotes, and its segregation was followed 
during the first division of the pI cell in the pupal notum at 15-17 hours APF. In the 
wild type, Pon-GFP localises at the anterior cortex of pI cells just before entry into 
mitosis (see Figure 4.16A and (Roegiers et al., 2001b)). The pI cell divides along the 
anterior-posterior axis and Pon-GFP is segregated unequally into the pIIb cell. 
RASSF10B221 heterozygotes behaved like the wild type pupae (Figure 4.16C). Strikingly, 
the RASSF10B221 mutants showed a clear Pon-GFP mis-segregation phenotype in many 
of the divisions. Prior to mitosis the Pon-GFP crescent was often not orientated along 
the posterior-anterior axis Figure 4.16B) and moreover the division angle was not 
aligned to the Pon-GFP crescent, leading to mis-segregation of Pon-GFP into both 
daughter cells (Figure 4.16B, B’). The Pon-GFP crescent appeared broader and 
occasionally spread over almost the entire pI cell, also resulting in a Pon-GFP mis-
segregation (Figure 4.16B’’). Moreover, the division of the pI cell was in some cases 
not aligned to the anterior-posterior axis. Figure 4.17A-C illustrates the phenotypes 
observed in RASSF10B221 mutants compared to the wild type situation.  
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Figure 4.16 - Asymmetric divisions of pupal notum pI cells in RASSF10 mutants and 
controls. 
Frames from a time-lapse movie of planar confocal sections showing the localisation of Pon-
GFP during the asymmetric division of a single SOP cell in the pupal notum at 15-17 hours 
APF. Pon-GFP was expressed under the control of neuralized-Gal4 and the interval between 
each time point is 51.6 seconds. The images are oriented with anterior to the top and posterior to 
the bottom. Scale bar = 0.5 µm. (A) In wild type pupae, Pon-GFP localises asymmetrically to 
the anterior of the pI cell and is distributed into the pIIb cell. (B-B’’) Examples of SOP 
divisions in RASSF10B221 mutants all resulting in a mis-segregation of Pon-GFP into both 
daughter cells. (B) The Pon-GFP crescent is not oriented towards the anterior and the division 
angle is not aligned to the Pon-crescent. (B’) The Pon-GFP crescent shows a normal orientation, 
but the division angle is randomised. (B’’) No clear Pon-GFP crescent is formed. (C) Divisions 
in RASSF10B221 heterozygous pupae mostly behave like the wild type.   
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I then analysed the asymmetric divisions of the different genotypes quantifying the 
following defects: the polarity of the Pon-GFP crescent, the mis-segregation of Pon into 
the two pII daughter cells and the division angle relative to the anterior-posterior body 
axis (as illustrated in Figure 4.18A). 60 divisions for each genotype were quantified for 
the three defects and the detailed description of how the defects were analysed can be 
found in the materials and methods (2.6.3).  
The polarity of the Pon-GFP crescent was determined by calculating the polarisation 
coefficient using a Fourier transformation (in case of no polarisation, the polarisation 
coefficient will approach 0). In RASSF10B221 mutants the Pon-GFP crescent was 
significantly less polarised (mean±SD: 0.2356±0.07729) compared to wild type 
(0.4188±0.04821) (P<0.001) and interestingly, heterozygotes already displayed a slight 
defect compared to wild type (P<0.001) (Figure 4.17D).  
In order to see whether Pon-GFP was mis-segregated onto the two daughter pII cells, 
the ratio of the Pon-GFP signal intensity from the two pII cells was quantified (in case 
of an equal distribution, the ratio will equal one). The intensity ratios in RASSF10B221 
mutants (mean±SD: 0.7228±0.1523) were significantly increased compared to wild type 
(0.4898±0.05602). Pon-GFP was mis-segregated into the pIIa and pIIb cells in 
approximately 73% of SOP divisions in RASSF10B221 mutants and in 12% of the 
heterozygotes (mis-segregation being defined as intensity ratios higher than the 
maximal ratio of the wild type).  
Lastly, the analysis revealed that the angle of division relative to the anterior-
posterior body axis was more randomised in RASSF10B221 mutants compared to wild 
type and heterozygotes (Figure 4.18B). Division angles were determined as illustrated 
in Figure 4.18A. The randomisation can be seen by means of the standard deviation 
(SD) of the division angles, which was almost twice as high for RASSF10B221 mutants 
(SD=68.33) as for wild type (SD=35.44) or for heterozygotes (SD=36.29).  
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Figure 4.17 - Polarity of Pon crescent in pI cells and Pon distribution onto pII cells in 
RASSF10 mutants.  
(A, B, C) Schematic of the observed phenotypes in RASSF10 mutants compared to the wild type 
situation. (A) Most pI cells of RASSF10 mutants have a widened Pon-GFP crescent. In many 
cases the direction of division is not aligned to the Pon-GFP crescent in pI cells (B), resulting in 
partitioning of Pon-GFP into both daughter pII cells instead of solely pIIb (C). (D) 
Quantification of the polarity coefficient of the Pon crescent of pI cells (no polarity = 0). (E) 
Quantification of Pon-GFP mis-segregation. The distribution of Pon-GFP into the two daughter 
cells was measured by dividing the mean grey value intensities of the daughter cells. In case of 
mis-segregation ratios will be approaching 1. n=60 for each genotype from 3 pupae and error 
bars represent the mean ± standard deviation. (One-way ANOVA with Bonferroni’s correction: 
***P<0.001) 
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Figure 4.18 - The angle of SOP divisions relative to the anterior-posterior axis is 
randomised in RASSF10B221 mutants. 
(A) Illustration of how the division angle relative to the anterior-posterior axis was determined. 
A line through the centre of both pII daughter cells was drawn and the angle relative to the A-P 
axis was measured. (B) The angle of asymmetric SOP divisions relative to the anterior-posterior 
axis is randomised in RASSF10B221 mutants compared to in wild type control or in RASSF10B221 
heterozygous. n=60 for each genotype from 3 pupae and error bars represent the mean ± 
standard deviation. 
 
 
Loss of function of Fz (Bellaiche et al., 2001a, Bellaiche et al., 2004) or Dsh (Bellaiche 
et al., 2004, Gomes et al., 2009) both cause only a mild Pon-GFP mis-segregation 
phenotype, as the antagonism between Baz and Pins in not affected in these mutants and 
maintains the asymmetric localisation of cell fate determinants consistent with the 
spindle orientation. However, the division angle relative to the anterior-posterior axis is 
randomised, as Fz/Dsh are required to orient the spindle in the plane of the epithelium 
by direct interaction with Mud (Segalen et al., 2010). In contrast, in baz and pins 
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mutants, either a weak Pon/Numb-crescent is present or no crescent forms at all and 
Pon/Numb are uniformly spread in pI cells, as Baz and Pins are required for cell fate 
determinant asymmetric localisation (Roegiers et al., 2001a, Bellaiche et al., 2001b). 
However, in both mutants the division angle remains orientated along the anterior-
posterior axis (Bellaiche et al., 2001b). Thus, the RASSF10B221 mutant ACD phenotype 
has elements of both Fz/Dsh and Baz/Pins disruption. Firstly, loss of RASSF10 function 
causes a broadening of the Pon crescent and a strong Pon-GFP mis-segregation defect 
(73%) similarly to Baz and secondly the randomised division angles relative to the 
anterior-posterior body axis resembles Fz/Dsh loss of function. As no spindle marker 
was expressed in this experiment, I did not analyse spindle orientation relative to the 
Pon crescent, which should be addressed in the future.  
 
4.5.3 Is RASSF10 required for the asymmetric localisation of Bazooka in 
SOPs?  
So far, I have demonstrated that RASSF10 is required for correct SOP ACDs. But what 
is the molecular mechanism underlying RASSF10’s function in ACD? One possible 
role for RASSF10 could be to facilitate the association of the Baz-Par6-aPKC complex 
with Fz/Dsh, by bridging the interaction between Baz and Fz/Dsh. This idea is 
supported by the findings that RASSF10 can bind to Baz and Fz/Dsh in co-IP 
experiments (Figure 3.6, Figure 3.8 and Figure 3.11), and co-localises with them in 
wing disc SOPs (Figure 4.8 and Figure 4.9). It has been recently shown that the 
asymmetric localisation of the Baz-Par6-aPKC is dependent on Fz/Dsh prior to mitosis 
(Besson et al., 2015). However, upon entry into mitosis, Fz/Dsh are dispensable for the 
asymmetric localisation of the Baz-Par6-aPKC complex, as dsh of fz mutants, Pins 
facilitates the asymmetric localisation of Baz opposite from the Dlg-Pins-Gαi complex, 
albeit with a random orientation with regards to the anterior-posterior axis (Bellaiche et 
al., 2001b, Bellaiche et al., 2004).  
In order to test whether RASSF10 is required for the initial asymmetric localisation 
and hence polarisation of Baz in SOP cells of the pupal notum prior to mitosis, I looked 
at the localisation of Baz in RASSF10B221 mutants. In wild type nota, Baz is found 
asymmetrically enriched in SOP cells at 15 hours APF (Figure 4.19A-A’’). In contrast, 
in RASSF10B221 mutants, Baz was not enriched in SOP cells compared to the 
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surrounding epithelial cells and appeared less polarised (Figure 4.19B-B’’). This 
suggests that RASSF10 might indeed be required for initial asymmetric localisation of 
Baz. This very preliminary experiment should be followed up by quantifications of the 
polarisation of Baz, similarly to the Besson et al. study, using the Baz-GFP line for live 
imaging. Moreover, live imaging will reveal whether RASSF10 is needed for the 
asymmetric localisation of Baz during mitosis or if Baz still asymmetrically localises 
(due to Pins) during mitosis, similar to Fz/Dsh loss.  
 
 
 
Figure 4.19 - Loss of RASSF10 affects the asymmetric localisation of Bazooka. 
Planar confocal sections of pupal nota at 15 h APF stained for Baz, Hnt and Ecad. pI cells were 
identified by the presence of the SOP marker Hnt (and are labelled with asterisk). Baz is 
asymmetrically enriched in pI cells of RASSF10 control nota (A-A’’). The asymmetric 
localisation of Baz in pI cells is less pronounced in the RASSF10B221 mutant (B-B’). Scale bar = 
10 µm. 
 
4.6 Concluding remarks 
In this chapter I have added substance to the hypothesis that RASSF10 is required for 
correct ACD of SOPs of the peripheral nervous system in Drosophila. Firstly, 
RASSF10B221 mutants exhibit a bristle phenotype, which is linked to defects in ACD of 
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SOPs. The requirement for RASSF10 function in ACD was supported by the genetic 
interactions with ACD polarity determinants such as fz, dsh, baz and pins. Furthermore, 
I demonstrated that RASSF10 is specifically expressed in SOPs of the wing imaginal 
disc and is found asymmetrically enriched at the cell cortex together with its binding 
partners Fz, Dsh and Baz. Moreover, RASSF10 localises in SOP cells of the pupal 
notum at the posterior cortex prior to mitosis, as is the case for Fz, Dsh and the Baz-
Par6-aPKC complex. In order to confirm the mitotic behaviour of GFP-RASSF10 live 
imaging could be repeated in the RASSF10B221 mutant background, or a GFP-RASSF10 
(also for GFP-RASSF9) knockin at the endogenous locus could be generated with 
CRISPR/Cas9. In addition, the staining protocol for endogenous RASSF10 will need to 
be optimised.  
Ultimately, ACD of SOPs of the pupal notum display several defects in RASSF10B221 
mutants. Firstly, the asymmetric localisation of the cell fate determinant Pon is less 
pronounced in pI cells and Pon is mis-segregated onto both daughter cells, instead of 
solely pIIb. In addition, the division angle of the SOP cells relative to the anterior-
posterior body axis is markedly randomised. Taken together, these findings suggest that 
RASSF10 might function together with Dsh, Fz and Baz at the posterior cortex to 
establish the asymmetric distribution of cell fate determinants. 
However the exact mechanism of how RASSF10 functions at the posterior cortex 
remains unanswered. One possible hypothesis is that RASSF10 functions as the linker 
between Fz/Dsh and Baz. Fz/Dsh (together with the other PCP components) establish 
the initial polarity in SOPs and could localise the Baz-Par6-aPKC complex by recruiting 
RASSF10 at the posterior cortex prior to mitosis. This model is supported by the 
preliminary finding that the asymmetric localisation of Baz prior to mitosis was 
impaired in RASSF10B221 mutants (Figure 4.19). However, RASSF10 must also have 
additional functions, as loss of function of RASSF10 causes stronger and additional 
ACD phenotypes than mutants of PCP components, which cannot be explained by a 
simple linker role (Bellaiche et al., 2001a, Bellaiche et al., 2004, Gomes et al., 2009). I 
will address the potential roles of RASSF10 in more detail in the discussion (see 6.3) 
and will also propose future experiments to elucidate the function of RASSF10 in ACD.  
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Chapter 5 The function of the ubiquitin system around 
Spc25 at the kinetochore 
 
In this chapter of my thesis I will present the project I worked on in Helle Ulrich’s lab. 
My main focus lay on studying the function of the ubiquitin binding of Spc25 in the 
context of the kinetochore, and consequently revealing the interactors and underlying 
regulation, as well as to further characterise the ubiquitin-binding domain of Spc25. In 
this way, I hoped to build on Shengkai Zhao’s work ((Zhao, 2010), see 1.10.4) and to 
ascertain whether substance can be added to the theory it implies - namely that the 
ubiquitin binding of Spc25 might be prerequisite in the stable maintenance of the 
kinetochore complex.  
 
5.1 Genetic interactions of spc25 (L109A) with temperature-
sensitive mutants of kinetochore components 
The ubiquitin-binding defective spc25 (L109A) mutant has no obvious phenotype. 
Therefore, it is difficult to predict the function of the ubiquitin binding of Spc25. One 
hint regarding the function was the synthetic interaction of spc25 (L109A) with 
temperature-sensitive alleles of DSN1. The spc25 (L109A) mutation led to an increased 
temperature sensitivity of dsn1-7 and dsn1-8 (Zhao, 2010) (see 1.10.4). This could 
mean that the function of ubiquitin binding lies in maintaining the stability of the 
kinetochore. However, is the genetic interaction specific for DSN1? This would indicate 
that the Dsn1 protein might be the direct ubiquitylated interactor of Spc25. Or, does the 
Spc25 (L109A) mutation further destabilise already unstable kinetochore proteins in 
general? In order to investigate these two options I decided to systematically analyse the 
genetic interactions of the spc25 (L109A) mutant with temperature-sensitive mutants of 
other kinetochore proteins. I tested the effect of the spc25 (L109A) mutation on different 
temperature-sensitive alleles of inner, outer and central kinetochore components (ask1-
22, dad1-13, dam1-31, duo1-61, mtw1-11, ndc10-1, ndc80-1, nnf1-77, nsl1-5, nsl1-6, 
nuf2-61, spc24-1, spc105-4 and spc105-15 (Nekrasov et al., 2003)). In Figure 5.1A the 
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tested mutants are grouped according to the kinetochore complex they belong to and 
Figure 5.1B illustrates the position of the tested mutants within the kinetochore.  
Double mutants were created by mating of spc25 (L109A) with different 
temperature-sensitive mutants, followed by tetrad dissection. For the temperature 
sensitivity test cultures were spotted on YPD plates in serial dilutions and then grown at 
different temperatures. 
Firstly, I was able to confirm the previous result that the spc25 (L109A) dsn1-7 and 
spc25 (L109A) dsn1-8 double mutants were more sensitive to higher temperatures than 
the temperature-sensitive mutants alone and that the L109A mutation of spc25 on its 
own had no effect (Figure 5.2). By contrast, the spc25 (L109A) mutation had no 
influence on the temperature sensitivity of ndc10-1, mtw1-11, nnf1-77, nsl1-5, nsl1-6, 
dam1-31, duo1-61, dad1-13, ask1-22. However, I did find additional genetic 
interactions for spc25 (L109A) as it worsened the phenotypes of spc105-4, spc105-15, 
nuf2-61 and ndc80-1 (Figure 5.2). The strongest impact was observed for the 
temperature-sensitive alleles of SPC105. For both spc105-4 and spc105-15 the 
permissive temperature was reduced from 35 °C to 31 °C, which was an even stronger 
effect than was seen with Dsn1. 
When I was trying to cross spc24-1, a temperature-sensitive allele of SPC24, with 
the spc25 mutant, I discovered a synthetic lethality between those two mutants. I 
performed several tetrad dissections, but a double mutant was never obtained. The 
spc24-1 mutant has overall 8 amino acid substitutions, which are scattered from the C- 
to the N-terminus of Spc24 (Wigge and Kilmartin, 2001). In order to determine whether 
the synthetic lethality is specific for this mutant or whether other temperature-sensitive 
alleles carrying different mutations of SPC24 are also lethal in combination with spc25 
(L109A), I tested spc24-12 and spc24-13 (Le Masson et al., 2002). For both of them, 
initial crossings with spc25 (L109A) resulted only in single mutants. The spc24-12 
allele expresses a truncated version of Spc24 (amino acids 1-183) that lacks the N-
terminus and spc24-13 has just a single substitution (L38P) (Le Masson et al., 2002).  
From these preliminary results I could conclude that the synthetic lethality is clearly 
not specific for the spc24-1 allele.  
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Figure 5.1 - Temperature-sensitive mutants of kinetochore components tested for genetic 
interaction with spc25 (L109A). 
(A) Grouping of the temperature-sensitive (ts) mutants screened for genetic interaction with 
spc25 (L109A) according to their kinetochore complex. Spc25 is a member of the Ndc80 
complex. (B) Position of the relevant complexes (highlighted in colour) within the kinetochore 
(figure adapted from (Westermann et al., 2007)).  
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Figure 5.2 - spc25 (L109A) increases the temperature sensitivity of other kinetochore 
mutants.  
Double mutants were created by mating and tetrad dissection. 3.3 µL of each yeast culture 
(OD600 = 0.2) and three serial 10-fold dilutions were spotted on YPD plates and grown for three 
days at 25, 28, 30, 31, 33 and 35 °C. 
 
 
 
In summary, I was able to show that the genetic interactions of spc25 (L109A) with 
temperature-sensitive alleles of DSN1 are not specific for Dsn1 of the Mtw1 complex as 
the L109A mutant also affects the temperature sensitivity of other kinetochore protein 
mutants. Interestingly, all of the mutants were in close proximity to Spc25, namely 
Spc105 and the remaining members of the Ndc80 complex in which Spc25 resides. 
Additionally, there was no effect on temperature-sensitive alleles of NDC10, the 
remaining Mtw1 complex (Nsl1, Mtw1, Nnf1) and members of the Dam1 complex 
(Dam1, Duo1, Ask1, Dad1). 
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5.2 Are the genetic interactions of spc25 (L109A) due to the 
ubiquitin-binding deficiency?  
These results raised the question of whether the observed synthetic effects were caused 
by the defect of the ubiquitin-binding domain of Spc25 or whether the L109A mutation 
affects the temperature-sensitive mutants in an ubiquitin-independent manner?  
To answer this question I tested whether the fusion of different ubiquitin-binding 
domains to the C-terminus of Spc25 (L109A) or to Spc24 would rescue the phenotype 
of the spc105-15 spc25 (L109A) double mutant or the synthetic lethality of spc24-1 and 
spc25 (L109A). I chose the spc105-15 spc25 (L109A) double mutant as it held the 
strongest increase for the temperature sensitivity, so that a rescue would be more 
obvious. In addition, the synthetic lethality with spc24-1 was chosen, as the rescue 
would mean the survival of double mutants. If a different ubiquitin-binding domain and 
therefore the restoration of the ubiquitin-binding ability of Spc25 (L109A) rescued the 
double mutants, one could assume that the phenotype was linked to the defect in 
ubiquitin binding. I decided to use the following two UBDs for the fusion: the UIM-1 
(ubiquitin-interacting motif) domain of yeast Vps27 and the MIU (motif interacting 
with ubiquitin) domain of human Rabex-5. The UIM-1 (256-278) domain binds 
ubiquitin with a low to intermediate affinity (KD = 277 µM) (Swanson et al., 2003), 
while the MIU (48-74) domain has a comparatively higher affinity for ubiquitin (KD = 
28.7 µM) (Penengo et al., 2006). Both of them interact with ubiquitin via a single α-
helix. In order to fuse them to the C-terminus of Spc24 and Spc25 (see Figure 5.3A), I 
modified a 3xFLAG-HIS3MX6 tagging cassette (Funakoshi and Hochstrasser, 2009) to 
the following construct: a 6 amino acid linker, the UBD (UIM or MIU), then another 
linker (six glycine residues) and lastly the 3xFLAG-tag for the detection (Figure 5.3B). 
The yeast strains were transformed with the cassettes and positive transformants were 
selected on plates lacking histidine.  
Figure 5.4A-B shows that all the fusion proteins for Spc24 and Spc25 were 
expressed in the different strains. However, looking at the fusions to spc24-1 (Figure 
5.4A), it was noticeable that the protein behaved differently for all the constructs 
compared to the wild type Spc24, as the signal was weaker and ran higher on an SDS 
PAGE gel. This already indicated that the mutant protein is likely quite unstable.  
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Figure 5.3 - Fusion of ubiquitin-binding domains to the C-terminus of Spc24 or Spc25. 
(A) Model of the fusion of a UBD to the C-terminus of either Spc24 or Spc25 (structure of the 
Spc24/25 globular domains: PDB access code 2FV4). (B) Protein sequences of the two tagging 
cassettes for the fusions of the UBD. 
 
After confirming that all fusions were expressed I started the rescue experiments. 
Fusion of neither the UIM nor the MIU domain to Spc25 (L109A) rescued the synthetic 
lethality with spc24-1 as none of the crossings resulted in the formation of viable double 
mutants. I then examined the temperature sensitivity of single mutants harbouring the 
fusions. The wild type strains expressing the FLAG-tagged Spc25, the UIM or MIU 
domain fusions to Spc25 behaved as the original strain (Wt) as seen in Figure 5.5. Also 
the different fusions (FLAG, UIM or MIU) to spc25 (L109A) did not result in any 
difference in the temperature sensitivity compared to the original spc25 (L109A) strain. 
Therefore, I could be relatively sure that the fusion did not affect Spc25. Also, 
expression of FLAG-tagged Spc25 did not influence the temperature sensitivity of the 
spc24-1 mutant. However, the fusion between Spc25 and the UIM or the MIU domain 
reduced the permissive temperature of the mutant. Similarly, there was no sign of the 
fusions rescuing the increased temperature sensitivity of spc105-15 spc25 (L109A) 
double mutant and for the UIM domain the phenotype was even further debilitated 
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(Figure 5.5). Even for the spc105-15 mutant alone, fusion of the UIM and MIU domain 
to Spc25 made the strain even more sensitive, while the FLAG-tag had no effect. 
Next, I tested whether there is a rescue-effect by fusing the UBDs to the C-terminus 
of Spc24. At first, there was a surprising result, because I suddenly got double mutants 
when I crossed the spc25 (L109A) mutant with the spc24-1 fusions (FLAG, UIM and 
MIU), even for the FLAG-tagged spc24-1 control. From there the next step was to test 
whether the fusion of the UIM or MIU domain had an effect on the temperature 
sensitivity of the double mutants compared to the FLAG-tag alone.  
Checking the behaviour at higher temperatures for the spc24-1 mutant as well as all 
the different fusion constructs (Figure 5.6A) showed that all three increased the 
permissive temperature from 30 °C to 32 °C. The double mutants with the different 
fusion proteins reflected exactly the same pattern as that of the spc24-1 mutant fusions 
alone, just with a slightly increased sensitivity, as seen in Figure 5.6A. I concluded from 
these findings and the protein expression results (Figure 5.4A) that the protein of spc24-
1 seemed to be quite unstable, such that even the fusion of a FLAG-tag alone somehow 
had the ability to stabilise it. The rescue of the synthetic lethality of spc25 (L109A) and 
spc24-1 had therefore nothing to do with the potentially restored ubiquitin binding of 
Spc25 (L109A), but more so with the stabilisation of the spc24-1 protein itself.  
The last rescue I tested was the fusion of the UBDs to Spc24 and its impact on the 
spc105-15 spc25 (L109A) double mutant. For the spc105-15 control, all of the 
constructs acted as the original strain, although the UIM-fusion seemed to slightly 
worsen the phenotype in the temperature sensitivity screen (Figure 5.6A). This UIM 
fusion showed no rescue effect for the double mutant and actually caused the opposite - 
an increase of the temperature sensitivity. However, I found that the fusion of the MIU 
domain to Spc24 led to a very marginal rescue of spc105-15 spc25 (L109A) compared 
to the FLAG-tag control and the untagged double mutant at 31 °C, which was 
noticeable in more dense colonies for the MIU fusion.  
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Figure 5.4 - Expression of the different Spc24- and Spc25-UBD-fusion proteins in the 
different strain backgrounds.  
In order to fuse the FLAG-tag or the UBD constructs to the C-terminus of Spc24/Spc25 the 
different strains were transformed with the tagging cassettes. Tagging cassettes consisted of a 
FLAG-tag alone or an UBD-FLAG-tag. To test the expression of the created UBD-fusions 
proteins in the different strain backgrounds total protein extracts were analysed in western blots 
using anti-FLAG antibody. PGK was used as a loading control. (Continued on next page) 
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Figure 5.4 (Continued from previous page) - Cross-reacting, unspecific bands are labelled with 
an asterisk. (A) Expression of Spc24/spc24-1 fusion proteins. (B) Expression of Spc25/spc25 
(L109A) fusion proteins. (C) Expression of Spc24-MIU A58G-FLAG.  
 
 
Figure 5.5 - The fusion of the UIM or MIU ubiquitin-binding domain to Spc25 (L109A) 
does not rescue the phenotype of the double mutants.  
Strains expressing the Spc25-UBD fusions were created by PCR-based epitope tagging. For the 
temperature sensitivity test cultures were prepared and spotted as described in Figure 5.2.  
 
 
In order to prove that this little rescue is due to a restored ubiquitin binding and not 
to other interactions, I mutated the alanine 58 residue of the MIU domain to glycine, as 
this mutation was shown to cause loss of the interaction with ubiquitin (Penengo et al., 
2006). The strains with the fusion of the MIU (A58G) domain to Spc24 were created as 
previously described and Figure 5.4C confirms that all strains expressed the fusion and 
that protein levels were the same as for the wild type MIU (last lane). The temperature 
sensitivity screen in Figure 5.6B shows that the ubiquitin-binding deficient mutant of 
the MIU domain behaved exactly as the functional MIU domain. The tiny rescue by the 
fusion of the MIU domain to Spc24 of spc105-15 spc25 (L109A) could not therefore be 
associated with a re-establishment of ubiquitin binding.  
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Figure 5.6 - The fusion of the UIM or MIU domain to Spc24 does not rescue the phenotype 
of the double mutants.  
Strains expressing the Spc24-UBD fusions were created by PCR-based epitope tagging. For the 
temperature sensitivity test cultures were prepared and spotted as described in Figure 5.2.  
 
 
In conclusion, the spc25 (L109A) mutation did not only affect temperature-sensitive 
alleles of DSN1, but also those of SPC105, NUF2, NDC80 and SPC24. Unfortunately, I 
could not link the observed genetic interactions of spc25 (L109A) to the deficiency in 
ubiquitin binding, as none of the rescue attempts with the UBD fusions to Spc24/25 
were successful. However, this negative result is inconclusive and does not rule out the 
connection to the ubiquitin system.  
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5.3 Ubiquitylation of kinetochore proteins 
5.3.1 Dsn1, Nsl1 and Spc105 are ubiquitylated 
The genetic interaction studies have shown that the L109A mutation of Spc25 affected 
several kinetochore mutants located close to Spc25 in the kinetochore. However, I could 
not prove a connection to the ubiquitin-binding deficiency. Another approach to reveal 
the function of the ubiquitin binding of Spc25 was trying to find the ubiquitylated 
protein(s) that interact(s) with the UBD of Spc25. Using a TAP-tagged strain collection, 
it has previously been shown in the laboratory that several kinetochore proteins were 
ubiquitylated in vivo (Zhao, 2010). Most interestingly, Dsn1 of the Mtw1 complex was 
found to be monoubiquitylated and also Mtw1 and Nnf1 were ubiquitylated. Based 
partly on my previous findings with the temperature-sensitive mutants, I decided to 
focus on kinetochore proteins in close proximity to Spc25 (Joglekar et al., 2009). 
Therefore, I checked ubiquitylation for the members of the Mtw1 complex (Dsn1, Nsl1, 
Nnf1 and Mtw1) and Spc105.  
To analyse the in vivo ubiquitylation of kinetochore proteins I used TAP-tagged 
alleles of members of the Mtw1 complex. For the purpose of confirming the previous 
results I also tagged Dsn1 with a 6xHA- or with a 9xmyc-tag and I did the same for 
Spc105, as there was no TAP-tagged allele available. Strains harbouring tagged alleles 
were then transformed with an episomal expression vector for copper-inducible 
expression of His-tagged ubiquitin, and pull-downs of total ubiquitin conjugates were 
performed under denaturing conditions (Ulrich and Davies, 2009). Pull-down and input 
samples were analysed by western blot using tag-specific antibodies.  
Firstly, I reproduced the finding that TAP-tagged Dsn1 is ubiquitylated, as is 
indicated by a shift of the input band (I, +/− His-Ubi) to a higher molecular weight for 
the pull-down sample (P, + His-Ubi) in Figure 5.7A. The ubiquitylation was also 
present for HA- and myc-tagged Dsn1 (Figure 5.7B). Above the band representing the 
monoubiquitin signal were faint bands of a higher molecular weight visible for the 
TAP- and HA-tagged versions. I concluded from this that Dsn1 is mainly 
monoubiquitylated, but also polyubiquitylated. In all Dsn1 pull-down samples (P, + 
His-Ubi) as well as the negative control without expression of His-tagged ubiquitin (P, 
− His-Ubi), a band was detectable on the same height as unmodified Dsn1, indicating 
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that Dsn1 itself bound to the Ni-NTA beads. I discovered that TAP-tagged Nsl1 was 
also ubiquitylated (P, + His-Ubi), with a strong signal for monoubiquitin as well as the 
presence of an additional band at a higher molecular weight, which I interpreted as 
diubiquitylation (Figure 5.7A). However, I could not detect any ubiquitylation signals 
for TAP-tagged Mtw1 (P, + His-Ubi) and Nnf1 (P, + His-Ubi) (Figure 5.7A). The pull-
downs with HA- and myc-tagged Spc105 (Figure 5.7C) revealed the ubiquitylation of 
Spc105. As Spc105 has a high molecular weight it was not possible to distinguish 
between mono- and polyubiquitylation.  
In conclusion Dsn1 and Nsl1 of the Mtw1 complex and Spc105 of the Spc105 
complex were shown to be positive for ubiquitylation. 
To be sure that the ubiquitylation signals of Dsn1, Spc105 and Nsl1 were not due to 
degradation caused by the tag, I checked the stability of the tagged proteins in a 
cycloheximide assay. Cycloheximide inhibits the de novo protein synthesis and was 
therefore used to study the amount of tagged proteins over a period of time. For this 
purpose, cells expressing the tagged alleles were treated with 100 mg/mL 
cycloheximide. Samples were taken at several different time points and analysed by 
western blot.  
The results showed there was no difference detectable for HA-, myc- and TAP-
tagged Dsn1, as seen in Figure 5.8. The tagged proteins remained stable for 3 hours and 
only after 21 hours was a reduction of the protein amount detectable. HA- and myc-
tagged Spc105 behaved in the same pattern. Only TAP-tagged Nsl1 seemed to be less 
stable as in this instance the signal decreased gradually within 3 hours. 
It was apparent that the identity of the tag did not influence the stability of Dsn1 and 
Spc105. Therefore, I was fairly sure that their ubiquitylation was not caused by the 
presence of the tags. It was, however, possible that the ubiquitylation of Dsn1 and 
Spc105 was a signal for degradation via the 26S proteasome. Therefore, I tested the 
effect of inhibition of the proteasome using the inhibitor MG132 on the ubiquitylation 
of Dsn1 and Spc105. Under those conditions polyubiquitin conjugates, which are 
normally degraded by the proteasome, will accumulate. 
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Figure 5.7 - In vivo ubiquitylation of different kinetochore proteins.  
Yeast cells harbouring HA-, myc- or TAP-tagged alleles of the relevant genes were transformed 
with a vector expressing His-tagged ubiquitin (+His-Ubi) or an empty vector (−His-Ubi). His-
Ubi expression was induced by addition of copper and Ni-NTA pull-downs under denaturing 
condition were performed with lysates prepared under denaturing conditions. Pull-down (P) and 
input samples (I) were analysed by western blot using the appropriate antibodies according to 
the respective tags. (A) Ubiquitylation of components of the Mtw1 complex (TAP-tagged 
strains). (B) Ubiquitylation of HA- and myc-tagged Dsn1. (C) Ubiquitylation of HA- and myc-
tagged Spc105. 
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Figure 5.8 - Cycloheximide chase assays to test the stability of tagged Dsn1, Spc105 and 
Nsl1.  
The tagged strains were treated with 100 µg/mL cycloheximide, samples were taken at the 
indicated time points and the protein extracts were analysed by western blot. PGK was used as a 
loading control. 
 
 
If ubiquitylation of Dsn1/Spc105 was due to degradation, an increased ubiquitin 
signal would occur. To enable the uptake of the inhibitor in the yeast cells I deleted 
PDR5, thereby increasing the permeability for the drug. Strains harbouring the tagged 
allele of Dsn1 or Spc105 and the deletion of PDR5 were then transformed with the 
episomal vector for copper-inducible His-Ubi expression. Cultures were then treated 
with 50 µM MG132 for two hours before performing the Ni-NTA pull-downs under 
denaturing conditions. Figure 5.9 shows the result from the pull-down experiments with 
the proteasomal inhibitor MG132. The monoubiquitylation band of Dsn1-HA for cells 
treated with MG132 (+ MG132, + His-Ubi, Δpdr5) was comparable to those without (− 
MG132, + His-Ubi, Δpdr5), while the intensity of the higher bands, representing 
polyubiquitylated Dsn1, was increased. The ubiquitin signal of Spc105-HA showed no 
difference (−/+ MG132, + His-Ubi, Δpdr5). As a control for successful inhibition of the 
proteasome pull-down, input samples (whole protein extracts) were blotted with an anti-
Ubiquitin antibody and - as shown in Figure 5.9 - total ubiquitin conjugates increased 
when cells were treated with MG132 (−/+ MG132). For both Dsn1 and Spc105 pull-
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down experiments, a band was present at around 170 kDa (labelled with an asterisk), 
and its intensity strongly increased in the MG132 treated samples. This band ran close 
to the band representing ubiquitylated Spc105. However, it was also present in controls 
without His-Ubi expression (+ MG132, − His-Ubi, Δpdr5), confirming that it was 
indeed an unspecific cross-reacting band and not ubiquitylated Spc105.  
These results indicated that monoubiquitylation of Dsn1 and ubiquitylation of 
Spc105 was independent of proteasome activity, whereas the polyubiquitin signal on 
Dsn1 was likely to be targeted by the proteasome.  
 
 
 
Figure 5.9 - Test of in vivo ubiquitylation of tagged Dsn1 and Spc105 upon inhibition of 
the proteasome.  
PDR5 was deleted in HA-tagged Dsn1 and Spc105 strains in order to increase the cellular 
uptake of the proteasomal inhibitor MG132. Ni-NTA pull-downs were performed as described 
in Figure 5.7 with the difference that cells were treated with or without 50 µM MG132 (+ / − 
MG132) at an OD600 of 1 for 2 hours. Pull-down (P) and input samples (I) were analysed by 
western blot with the indicated antibodies. Upper panel: Ubiquitylation of HA-tagged Dsn1 and 
Spc105. Lower panel: Total ubiquitin-conjugates of input samples. Cross-reacting, unspecific 
bands are labelled with an asterisk.  
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In summary, these findings revealed that Dsn1, Nsl1 and Spc105 were ubiquitylated 
and could therefore all be potential interactors of the ubiquitin-binding domain of Spc25. 
Moreover, the experiments showed that monoubiquitylation of Dsn1 and Spc105 was 
independent of proteasome activity. Although Spc105 and Nsl1 were also possible 
candidates, I decided to begin by focussing on Dsn1 for my further studies. 
 
5.3.2 What is the ubiquitylated site within Dsn1? 
The next challenge was to prove that ubiquitylated Dsn1 actually binds to the UBD of 
Spc25. I therefore wanted to find an ubiquitylation deficient mutant of Dsn1. If this 
were true and Dsn1 was the ubiquitylated interactor, this mutant should be epistatic to 
the spc25 (L109A) mutant. However, Dsn1 contains a total of 46 lysine residues. Instead 
of mutating every single lysine in Dsn1, I ordered Dsn1 mutants synthesised from 
Addgene, in which the lysine residues were mutated in groups, as depicted in Figure 
5.10A. The Dsn1 constructs had a C-terminal HA-tag and were cloned in an integrative 
expression vector for integration in the yeast genome. Vectors contained the promoter 
region of Dsn1 to allow expression similar to a wild type level. As a control, wild type 
Dsn1 was also cloned in the integrative plasmid. Strains expressing HA-tagged mutants 
and wild type Dsn1 (besides the normal untagged Dsn1) were created by integration of 
the vector into the LEU2 locus of the yeast genome. To study the in vivo ubiquitylation 
of Dsn1, strains were transformed, as before, with an episomal expression vector for the 
copper-inducible expression of His-tagged ubiquitin, and pull-downs under denaturing 
conditions (Ulrich and Davies, 2009) were performed.  
Unfortunately, the result of the in vivo ubiquitylation of the Dsn1 lysine mutants was 
inconclusive, as all four mutants (a-d) were still ubiquitylated (as seen in Figure 5.10B). 
Mutant b and c seemed to be ubiquitylated even more strongly than the wild type. The 
input samples, however, showed that the expression of those two mutants was much 
stronger compared to the other samples. It is possible that there is no specific acceptor 
lysine residue in Dsn1 or that there is redundancy between the ubiquitylation sites. This 
would make it extremely difficult to create an ubiquitylation-deficient mutant of Dsn1. 
 
 
 
Chapter 5 Results 
 
 209 
 
 
 
 
 
Figure 5.10 - All four Dsn1 lysine group mutants are all positive for in vivo ubiquitylation. 
(A) Lysine residues (highlighted in pink) of Dsn1 were mutated in groups, as Dsn1 has 46 
lysine residues. Each of the Dsn1 lysine mutants (a-d) contained several mutations. (B) For 
expression of the four different lysine mutants and wild type Dsn1 (all HA-tagged) vectors were 
integrated into the LEU2 locus in the yeast genome and Ni-NTA pull-downs were done as 
described in Figure 5.7. Pull-down (P) and input samples (I) were analysed by western blot with 
the indicated antibodies. Upper panel: Ubiquitylation of Dsn1 lysine mutants and wild type. 
Middle panel: Expression of Dsn1 lysine mutants (a-d) and wild type of input samples. Lower 
panel: Total ubiquitin-conjugates of input samples. Cross-reacting, unspecific bands are labelled 
with an asterisk.  
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5.3.3 Dsn1 ubiquitylation factors 
As my strategy of creating an ubiquitylation-deficient lysine mutant of Dsn1 turned out 
to be extremely difficult, I decided to change my approach. Instead of creating an 
ubiquitylation deficient Dsn1 mutant, I hoped to be able to abolish ubiquitylation of 
Dsn1 by inactivating the responsible ubiquitin ligase E3 and/or ubiquitin-conjugating 
enzyme E2. A recent report from the Biggins group indicates that Ubr2 is the ubiquitin 
ligase responsible for ubiquitylation of Dsn1 (Akiyoshi et al., 2013b). Ubr2 has thus far 
been shown to work together with the ubiquitin-conjugating enzyme Rad6 on the 
ubiquitin-mediated degradation of the transcription factor Rpn4 (Ju et al., 2004, Wang 
et al., 2004) and the ribonucleotide reductase inhibitor Sml1 (Andreson et al., 2010). 
In order to confirm the observation of the Biggins group, I tested the effect of an 
UBR2 deletion on the in vivo ubiquitylation of Dsn1. Standard pull-down experiments 
for HA- and TAP-tagged Dsn1 (Figure 5.11) revealed that Ubr2 had no effect on the 
monoubiquitylation (P, + His-Ubi, Δubr2) compared to tagged Dsn1 in the wild type 
background (P, + His-Ubi). However, it seemed that the polyubiquitin signal was 
abolished in the Δubr2 background. This became even more obvious under conditions 
of proteasome inhibition (Figure 5.9). In the Δubr2 background and upon inhibition of 
the proteasome there was no polyubiquitin signal at all (+ MG132, + His-Ubi, Δubr2 
Δpdr5). Meanwhile, I observed a strong increase in polyubiquitylation for inhibition of 
the proteasome alone (+ MG132, + His-Ubi, Δpdr5). This experiment confirmed that 
the monoubiquitin signal was unaffected by Δubr2 and inhibition of the proteasome.  
As there was a chance that Ubr2 might be involved in ubiquitylating Spc105 and 
Nsl1, I also tested the deletion of UBR2 for these two. However Ubr2 did not seem to 
be the responsible ubiquitin ligase in their case (Figure 5.11). The bands representing 
ubiquitylation of TAP-tagged Nsl1 were still present (P, + His-Ubi, Δubr2) and, for 
HA-tagged Spc105, there was even an increase of the signal (P, + His-Ubi, Δubr2). This 
was supported by the notion that the UBR2 knockout had no effect on the ubiquitylation 
of Spc105-HA upon inhibition of the proteasome (Figure 5.9). 
In summary, these results elucidated that Ubr2 was responsible for 
polyubiquitylation of Dsn1, but was not the ubiquitin ligase involved in the 
monoubiquitylation.  
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Figure 5.11 - In vivo ubiquitylation of tagged Dsn1, Nsl1 and Spc105 in the Δubr2 
background.  
UBR2 was deleted in tagged Dsn1, Nsl1 and Spc105 strains. Ni-NTA pull-downs were 
performed as described in Figure 5.7. Pull-down (P) and input samples (I) were analysed by 
western blot using the appropriate antibodies according to the tags. Cross-reacting, unspecific 
bands are labelled with an asterisk.  
 
 
As there was also the possibility that polyubiquitylated Dsn1 interacts with the 
ubiquitin-binding domain of Spc25, I was interested in the effect of an UBR2 deletion 
on the synthetic temperature sensitivities involving the spc25 (L109A) mutation (see 
5.1). If Ubr2 was the responsible ubiquitin ligase and if Dsn1 was the ubiquitylated 
interactor of Spc25, Δubr2 and spc25 (L109A) should be epistatic with respect to their 
effect on other kinetochore mutants (epistatic effect being defined as spc25 (L109A) or 
Δubr2 single mutants showing similar synthetic interactions with the temperature-
sensitive mutants and the effect of Δubr2 spc25 (L109A) double mutants mirroring the 
effect of the single mutants). I therefore created double and triple mutants by 
transformations and crossings (Δubr2, temperature-sensitive mutant and spc25 (L109A)).  
I then tested the effect of the UBR2 deletion using a temperature sensitivity assay. 
However, an epistatic effect could not be observed for any of the temperature-sensitive 
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mutants, as seen in Figure 5.12. dsn1-7 Δubr2 and dsn1-7 Δubr2 spc25 showed higher 
temperature sensitivities, with the triple mutant being more sensitive, whereas in 
combination with the dsn1-8 mutant, deletion of UBR2 actually suppressed the synthetic 
phenotype to a certain degree and the phenotype of the triple mutants differed from both 
double mutants. The phenotypes of both alleles of the spc105 temperature-sensitive 
mutants were also attenuated by the ubr2 deletion (mild suppression) and triple mutant 
phenotypes differed from both double mutants. Although the mutants of the Ndc80 
complex (ndc80-1 and nuf2-61) exhibited increased temperature sensitivities in 
combination with Δubr2, similar to the effect of spc25 (L109A), the triple mutants 
displayed an even stronger phenotype. As earlier mentioned, the spc25 (L109A) spc24-1 
double mutant was not viable, and neither were the spc25 (L109A) spc24-1 Δubr2 triple 
mutants. The spc24-1 Δubr2 mutant was viable and displayed a higher temperature 
sensitivity than the spc24-1 mutant alone.  
Taken together, these results suggested that there must be at least two independent 
pathways of the ubiquitin system present at the kinetochore, one of them involving 
Ubr2 and the other involving the ubiquitin binding by Spc25. Ubr2 was responsible for 
polyubiquitylation of Dsn1, which seemed to be independent of the ubiquitin-binding 
deficiency of Spc25. Therefore, I strongly suspected that monoubiquitylated Dsn1 
might be interacting with the ubiquitin-binding domain of Spc25. 
As mentioned previously, both the ubiquitin ligase E3 and the ubiquitin-conjugating 
enzyme E2 would allow me to abolish monoubiquitylation of Dsn1 and therefore link it 
to the UBD of Spc25. This attempt to find the responsible E3 did not succeed, so I tried 
to find the E2 involved in the monoubiquitylation of Dsn1. In order to reveal the 
responsible E2, I looked at the in vivo ubiquitylation of HA-tagged Dsn1 in E2 deletion 
or temperature-sensitive strains. E2 candidates were Ubc1, Rad6 (Ubc2), Cdc34 (Ubc3), 
Ubc4, Ubc5, Ubc6, Ubc7, Ubc8, Ubc10, Ubc11 and Ubc13. I tagged Dsn1 with an HA-
tag in the different strain backgrounds. As before, episomal expression of His-tagged 
ubiquitin was induced by the addition of copper and pull-downs took place under 
denaturing conditions. For Cdc34, a temperature-sensitive mutant was used as the 
deletion mutant is inviable (Goebl et al., 1988), and cultures were grown at the 
permissive temperature until an OD of 1 was reached and then shifted for 3 hours to the 
non-permissive temperature. 
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With the exception of Rad6 none of the E2s influenced the in vivo ubiquitylation of 
Dsn1 (Figure 5.13A,B), as in all the pull-down samples (P, + His-Ubi, Dsn1-HA, ΔE2) 
at least two, compared to the input band, higher bands were detectable. In the Δrad6 
mutant, however, polyubiquitylation (but not monoubiquitylation) of Dsn1 was 
abolished, which is consistent with the cooperation between Rad6 and Ubr2 described 
earlier. After having looked at the genetic aspects of the project, I focused on the 
structural analysis of the ubiquitin binding of Spc25 in the following sections. 
 
 
 
 
Figure 5.12 - Genetic interactions of spc25 (L109A) and Δubr2 with temperature-sensitive 
mutants.  
UBR2 was deleted in the relevant single and double mutants and temperature sensitivity was 
tested. Therefore, 3.3 µL of each yeast culture (OD600 = 0.2) and three serial 10-fold dilutions 
were spotted on YPD plates and grown for three days at 25, 28, 30, 31, 33 and 35 °C. 
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Figure 5.13 - Effect of the deletion of different E2s on the in vivo ubiquitylation of tagged 
Dsn1.  
Dsn1 was HA-tagged in the different E2 mutants and the ubiquitylation was monitored in pull-
downs under denaturing conditions (as described in Figure 5.7). For the cdc34-1 temperature-
sensitive mutant the cultures for the pull-downs were grown at 25 °C until an OD600 of 1 was 
reached, and then they were shifted to the non-permissive temperature of 37 °C for 3 hours. 
Pull-down (P) and input samples (I) were analysed by western blot using anti-HA antibody. (A) 
Pull-downs for the different E2 deletion mutants. (B) Pull-down (upper panel) and input (lower 
panels) samples for the cdc34 temperature-sensitive mutant. Cross-reacting, unspecific bands 
are labelled with an asterisk.  
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5.4 Characterisation of the ubiquitin binding of Spc25 
5.4.1 Crystallisation trials of Spc25-Spc24 with ubiquitin 
The ubiquitin-binding domain of Spc25 is unknown and there is no sequence similarity 
to any of the so far identified UBDs. It has been shown that the linker region as well as 
the globular domain are needed and that the conserved L109 residue is critical for the 
ubiquitin binding (Zhao, 2010). Furthermore, in vitro experiments revealed that the 
Spc25 UBD binds ubiquitin via the hydrophobic I44 patch of the β-sheet. However, the 
exact sites of ubiquitin binding on Spc25 remained unknown. Though Spc24 was 
negative for interaction with ubiquitin in the yeast two-hybrid system, it is quite 
possible that Spc24 is also involved in the binding. When I started working on the 
project I was very keen to identify the residues on Spc25 (and also Spc24) involved in 
the interaction with ubiquitin. In order to do so, I decided to crystallise the Spc25-Spc24 
complex with ubiquitin to reveal their structure in collaboration with Martin Singleton.  
Considering that the structure of the C-terminal globular domains of the Spc25-
Spc24 complex has already been solved (Wei et al., 2006), I thought it would also be 
best to use a truncated version rather then the full-length complex. Additionally, I had to 
include the linker region of Spc25 (107-132), as it is also required for successful 
binding to ubiquitin (see 1.10.4). Hence, the truncated complex for the crystallisation 
trials with ubiquitin consisted of the globular domain of Spc24 (154-213) and the linker 
together with the globular domain of Spc25 (107-221) (Figure 5.14A) to which I will 
subsequently refer to as Spc24(G) and Spc25(L+G).  
For the crystallisation trials, large amounts of highly pure proteins were required. 
Therefore, I first had to establish and optimise the purification of the Spc25(L+G)-
Spc24(G) complex. Spc24(G) and Spc25(L+G) were co-expressed in BL21 Codon2+ 
cells to maintain the solubility of the proteins. The Spc24(G) construct had a N-terminal 
cleavable 6xhistidine-tag, which allowed Ni-NTA affinity purification. The His-tag of 
Spc24 was afterwards cleaved with TEV protease, followed by two Ni-NTA 
purification steps to remove the protease and the His6-peptide. The sample was then 
further purified, taking advantage of the fact that the complex just weakly bound to a 
strong anion exchange column. In the presence of 100 mM salt, Spc25(L+G)-Spc24(G) 
did not bind to the anion exchanger, but most of the other contaminating proteins did. In 
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the next step, Spc25(L+G)-Spc24(G) was under low-salt conditions loaded onto an 
anion exchange column, which allowed binding. Elution was achieved by a salt gradient. 
The purified complex was then run over a S75 16/60 gel filtration column. As seen in 
Figure 5.14B, Spc25(L+G) and Spc24(G) eluted as a heterodimeric complex with a 
molecular weight of about 20 kDa. Ubiquitin (from Sigma-Aldrich) was also loaded on 
the S75 16/60 gel filtration column and eluted, as expected, at around 8.5 kDa (Figure 
5.14C). The purified Spc25(L+G)-Spc24(G) complex and ubiquitin were then finally 
sent to Martin Singleton’s lab for crystallisation.  
Unfortunately, none of the crystallisation attempts, performed by Silva Zakian from 
Martin Singleton’s lab, led to the formation of ubiquitin-Spc24-Spc25 crystals and 
solely ubiquitin crystals were detectable. My concern now was that the interaction with 
ubiquitin was not strong enough for the formation of crystals. This was consistent with 
the fact that ubiquitin and the Spc25(L+G)-HisSpc24(G) complex (without cleavage of 
the His-tag) did not coelute when loaded onto a sizing column (ratio of 2:1), which 
would have been visible in a shift to a higher molecular weight in the elution profile. 
Instead, there were two separate peaks present, one for Spc25-Spc24, which was at the 
same position as the control of the complex alone and another for ubiquitin (Figure 
5.15A). The Coomassie stained gels showed that fractions of the first peak contained 
only the complex and no ubiquitin, while ubiquitin was detectable in the fractions of the 
second peak (Figure 5.15B).  
In summary, my approach to reveal the exact binding sites between the Spc25-Spc24 
complex and ubiquitin by crystallisation did not succeed, as no crystals were obtained. 
Also, the interaction of the Spc25(L+G)-Spc24(G) with monoubiquitin was too weak to 
be maintained in a sizing column. 
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Figure 5.14 - Purified Spc25(L+G)-Spc24(G)-complex and ubiquitin for the crystallisation. 
(A) Model of the truncated Spc25-Spc24 complex used for the crystallisation with ubiquitin. 
Ubiquitin (Ub, PDB access code: 1D3Z) interacts with the linker region of Spc25 (in grey). The 
binding sites of the globular domain of Spc25 and potentially Spc24 are unknown (PDB access 
code: 2FV4). (B) For the final purification step of the Spc25(L+G)-Spc24(G) complex a S75 
16/60 gel filtration column was used. (Continued on next page) 
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Figure 5.14 (Continued from previous page) - The peak fractions of the elution profile can be 
seen in the Coomassie stained gel and those containing Spc24 and Spc25 in a 1:1 ratio were sent 
off for the crystallisation. (C) Ubiquitin was also loaded onto the S75 16/60 gel filtration 
column and the ubiquitin containing fractions were used for the crystallisation trials.  
 
 
 
Figure 5.15 - Ubiquitin does not coelute with the Spc25(L+G)-Spc24(G) complex in a 
sizing column. 
The purified Spc25(L+G)-HisSpc24(G) complex was mixed in a 1:2 ratio with ubiquitin and 
loaded onto a S75 16/60 gel filtration column. (A) Elution profile of Spc25(L+G)-HisSpc24(G) 
and ubiquitin (red) or Spc25(L+G)-HisSpc24(G) alone as a control (blue). (B) Coomassie stained 
gel shows the corresponding fractions of the gel filtration.  
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5.4.2 The ubiquitin binding of the Spc25 (L109A) mutant is reduced but 
not abolished  
The unsuccessful crystallisation trial and the negative interaction in the sizing column 
already indicated that the binding between Spc25/Spc24 and ubiquitin was fairly weak. 
I therefore wanted to further characterise the interaction of Spc25 with ubiquitin. It has 
already been described that the dissociation constant for the HisSpc25(L+G)-HisSpc24(G) 
complex and ubiquitin was 14.2 µM (Zhao, 2010). The L109A mutant of Spc25 was 
unable to bind ubiquitin in the yeast two-hybrid system. However, cells harbouring that 
mutation displayed no obvious phenotype. I wanted to test how this mutation affected 
the affinity to ubiquitin using the BIACORE system (based on surface plasmon 
resonance) and compare it to the wild type affinity. 
To this end, I purified the HisSpc25(L+G)-HisSpc24(G) complex and the L109A 
mutant complex (Figure 5.16A). First, I wanted to confirm the described dissociation 
constant of 14.2 µM for the wild type complex. For the BIACORE analysis, 9000 RU of 
anti-GST antibody was immobilized on a CM5 sensor chip in order to capture 
equimolar amounts of GST (662 RU) in one cell and GST-tagged ubiquitin (GSTUb, 895 
RU) on the other cell. Increasing concentrations (double measurements) of purified 
HisSpc25(L+G)-HisSpc24(G) (1-40 µM) or the mutant HisSpc25 (L109A)(L+G)-
HisSpc24(G) complex (10-400 µM) were passed through both cells of the sensor chip 
and the SPR signal (RU) was measured over 300 seconds. The background signals of 
the GST cell were then subtracted from the GSTUb SPR signal. For the calculation of the 
dissociation constant KD, the SPR signals were derived from the equilibrium state of 
every concentration and plotted against the respective concentrations.  
The binding between ubiquitin and the truncated wild type complex revealed a 
dissociation constant of approximately 1 mM (Figure 5.16B), while the L109A mutant 
reduced the binding to a KD of approximately 6 mM (Figure 5.16C). However, these 
numbers were not considered reliable, as the Rmax values representing the theoretical 
binding capacity were far too high (1-2x103). I repeated the measurements, but the 
obtained values remained similar.  
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Figure 5.16 - The L109A mutation of Spc25 reduces but does not abolish the binding to 
ubiquitin.  
BIACORE surface plasmon resonance technology was used to measure the dissociation 
constants of wild type HisSpc25(L+G)-HisSpc24(G) complex versus the L109A mutant complex. 
(A) Coomassie stained gels showing purified HisSpc25(L+G)-HisSpc24(G) complex, purified 
HisSpc25(L109A)(L+G)-HisSpc24(G) complex and provided GST and GSTUb for the BIACORE 
analysis. (B) Interaction with ubiquitin for HisSpc25(L+G)-HisSpc24(G). (C) Interaction with 
ubiquitin for HisSpc25(L109A)(L+G)-HisSpc24(G). (Continued on next page)  
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Figure 5.16 (Continued from previous page) - (B+C) 9000 RU of anti-GST antibody were 
coupled to an activated CM5 sensor chip. Equimolar amounts of GST (662 RU) and GSTUb (895 
RU) were captured with the immobilized anti-GST. Increasing concentrations of wild type (1-
40 mM) and mutant (10-400 mM) Spc25-Spc24 complex where injected and the change of the 
response in RU was measured twice for every concentration over a period of 300 seconds (B+C 
left panel: sensorgrammes are shown for only one measurement per concentration). The 
dissociation constant KD was obtained by plotting the RU signal (equilibrium state) against the 
ligand concentration (B+C right panel). 
 
 
In conclusion, I was unable to reproduce the dissociation constant of 14.2 µM for the 
wild type complex (Zhao, 2010), instead the binding was approximately a hundred-fold 
weaker. However, I was able to show that the affinity of the L109A mutant Spc25-
Spc24 complex for ubiquitin was estimated to be at least 6-fold reduced compared to 
the wild type, indicating that this residue is indeed important for the binding, but also 
that ubiquitin binding is not completely abolished in this mutant.  
 
5.4.3 No evidence for ubiquitin binding by human Spc25 
One striking question was whether the ubiquitin system at the kinetochore is conserved 
in other organisms. Human Spc25 (hSpc25) and yeast Spc25 have very little sequence 
homology. However, it was shown that the globular domains of the human Spc25-
Spc24 complex and S. cerevisiae are structurally very similar (Ciferri et al., 2008). As 
the structures were related there was a chance that human Spc25 would also be able to 
interact with ubiquitin. I therefore tested the ubiquitin-binding ability of human Spc25 
in a yeast two-hybrid experiment. Yeast Spc25 was shown to bind to polyubiquitin 
(chain of four ubiquitin separated by a short linker) in the yeast two-hybrid system 
(Zhao, 2010). As yeast Spc25 requires Spc24 in vitro and for ectopic expression, I 
decided to co-express human Spc24 for the two-hybrid experiment. Consequently yeast 
cells were transformed with the respective plasmids and hSpc25 was expressed as a 
fusion to the Gal4 activation domain or as a fusion to the Gal4 binding domain and 
ubiquitin constructs were fused to the opposite Gal4 domain. 
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Unfortunately, none of the ubiquitin constructs used (monoubiquitin, a linear chain 
of four ubiquitin, a chain of four ubiquitin connected by a short linker) were positive for 
interaction with human Spc25 (with or without expressing human Spc24), while the 
yeast Spc25 positive control bound to ubiquitin (Figure 5.17A,B). From this first result, 
however, it cannot be ruled out that human Spc25 does interact with ubiquitin.  
 
 
 
Figure 5.17 - Human Spc25 does not interact with ubiquitin in the yeast two-hybrid 
system.  
Yeast two-hybrid analysis was performed to investigate the protein-protein interaction between 
ubiquitin and human Spc25 under co-expression of human Spc24. Five colonies of each 
transformation were picked, resuspended in 500 µL water and 3.3 µL cells were spotted on 
selective plates and grown for three days at 30 °C. Growth on –LWU plates represented the 
control for the individual transformations, growth on –HLWU showed week interactions and 
growth on –AHLWU stronger interactions (−LWU: lacking leucine, tryptophan, uracil; 
−HLWU: lacking histidine, leucine, tryptophan, uracil; –AHLWU: lacking adenine, histidine, 
leucine, tryptophan, uracil). Yeast Spc25 and Ub4L were used as a positive control as they were 
previously shown to interact (Zhao, 2010). Ub: monoubiquitin, Ub4L: linear chain of four 
ubiquitin separated by a short linker (VQIQ), Ub4: linear chain of four ubiquitin. 
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Chapter 6 Discussion 
 
This thesis investigates the function of RASSF9 and RASSF10 in Drosophila, by 
examining their interaction network, subcellular localisation, gain- and loss-of-function 
phenotypes and genetic interactions with binding partners. In the following subchapters 
I will discuss the main findings, focusing on the function of RASSF10, and what will be 
necessary to further substantiate them.      
In the last part of this chapter, I will discuss the separate project I worked on in Helle 
Ulrich’s lab, where I tried to elucidate the function of the ubiquitin binding of the 
kinetochore component Spc25.    
 
6.1 Summary of results 
Little is known about the function of the two N-terminal RASSFs, RASSF9 and 
RASSF10 in humans and even less in Drosophila (see 1.2.2 and 1.2.3). The starting 
point for my investigations was the interaction network of human N-terminal RASSFs 
placing RASSF9/10 closely interconnected to the ASPP/PP1 phosphatase complexes, 
PCP proteins and the polarity determinant Par3/Baz (Hauri et al., 2013). In summary 
(see Figure 6.1) I showed using co-IP experiments that the human interaction network 
of RASSF9 and RASSF10 (see Figure 1.3 and (Hauri et al., 2013)) is largely conserved 
in Drosophila, with the difference that RASSF9/10 seem to be specifically linked to the 
Fz/Dsh PCP group rather than to the Stbm/Pk group (see 3.4). I also showed that 
RASSF9/10 bind to other known RASSF8 interactors (see 3.3). While the initial 
characterisation of RASSF9 could not reveal its biological role (see 6.4), I found in vivo 
evidence that RASSF10 is indeed connected to Fz/Dsh and Baz. This work suggests that 
RASSF10 specifically functions, together with Fz/Dsh and Baz in asymmetric divisions 
of SOPs, most likely in establishing the initial asymmetry (see Chapter 4). However, 
many questions remain open and I will address these in the following sections. 
 
 
 
Chapter 6 Discussion 
 
 224 
 
 
Figure 6.1 - The interaction network of N-terminal RASSFs in Drosophila. 
The interaction network is based on co-IP experiments in S2 cells (dashed lines indicate 
previously described interactions). Drosophila RASSFs (orange) are found in an interaction 
network with ASPP (green) and PP1 catalytic subunits (blue). RASSF9 and RASSF10 bind to 
all catalytic subunits, similar to the known PP1 regulatory subunit ASPP, while RASSF8 
requires ASPP for PP1 interaction. RASSF8, RASSF9 and RASSF10 have several interactors 
(light purple) in common. RASSF9 and RASSF10 have also specific binding partners (darker 
purple).   
 
 
6.2 N-terminal RASSFs and their connection to PP1 
Drosophila RASSF9 and RASSF10 can both form complexes with ASPP/PP1 (Figure 
3.4) and moreover can bind PP1 catalytic subunits independently of ASPP (Figure 3.5), 
giving them, like human N-terminal RASSFs (Hauri et al., 2013) and Drosophila 
RASSF8 (Zhou, 2014), the potential to act as substrate specifying subunits of PP1 
complexes. While Drosophila RASSF8 requires ASPP, which binds to PP1 through its 
RVxF motif, for association with PP1 (Figure 3.4) (Zhou, 2014), it is not clear whether 
RASSF9/10 bind directly to PP1, through another regulatory subunit or through ASPP 
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(see 4.4 for discussion). This could be initially tested with in vitro pull-downs using 
bacterially expressed proteins. If the binding is direct, it will be crucial to identify the 
PP1-binding motif in order to generate PP1-binding deficient mutants. These mutants 
will ultimately allow us to test whether RASSF9/10 function in vivo as substrate 
specifying subunits (in the case of RASSF10 in ACD of SOPs), as they should 
phenocopy the null mutants. Obvious PP1-binding motifs (see 3.2.3) are not present in 
Drosophila RASSF9 and RASSF10. In depth sequence analysis of RASSF9/10 and 
their homologues in other species could reveal homology regions required for PP1 
interaction. Despite the fact that the in vivo relevance of RASSF9 or RASSF10 
phosphatase complexes remains to be elucidated, I will discuss how potential 
RASSF10/PP1 complexes might function in ACD of SOPs in 6.3.2. If in vivo evidence 
confirms that RASSF10 indeed functions with PP1, different biochemical approaches 
can be taken to further characterise the potential substrates, such as mass spectrometry 
on extracts from RASSF10 mutant versus wild type tissue and in vitro phosphatase 
assays in S2 cells. 
Interestingly, although classical and N-terminal RASSFs are two distinct groups, 
which have little in common besides the RA domain (Sherwood et al., 2010), they all 
appear to be part of phosphatase complexes. The only Drosophila homologue of 
classical RASSFs regulates the phosphorylation and thus activity of Hippo as part of a 
PP2A phosphatase complexes (Ribeiro et al., 2010) and one of its human homologues, 
RASSF3, can interact with PP2A complexes (Hauri et al., 2013).  
 
6.3 The function of RASSF10 in ACD of SOPs  
6.3.1 Summary 
The external sensory organs, which are part of the peripheral nervous system, derive 
from a series of asymmetric cell divisions (ACD) starting from a single SOP (see 1.7.1). 
In the first asymmetric division, the unequal distribution of cell fate determinants into 
the pIIa and pIIb daughter cells, which defines their fate, depends on the interplay 
between PCP proteins and polarity determinants (see 1.7.2). PCP proteins define the 
polarity along the tissue axis (anterior-posterior in case of the pupal notum), and 
promote the planar polarisation of the Baz-aPKC-Par6 complex to the posterior 
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(mediated by Fz/Dsh) and the Dlg-Pins-Gai complex to the anterior cell cortex 
(mediated by Stbm/Pk) upon mitotic entry in the case of the pupal notum (see Figure 
1.7). The opposing asymmetric localisation of the two polarity determinant complexes 
then positions cell fate determinants to the anterior cortex.  
A recent study provided evidence that the Baz-aPKC-Par6 complex already becomes 
polarised in a PCP-dependent manner during interphase and moreover that the 
formation of the Par complex at this stage is independent of Aurora A (Besson et al., 
2015). In this study, Besson et al, raise an important issue: PCP does not affect the 
localisation of Baz (or aPKC or Par6) in neighbouring epithelial cells and therefore 
specific factors must exist that allow the Baz-aPKC-Par6 complex to interpret the PCP 
signal in SOPs. Indeed, the mRNA expression profiles of SOPs and the adjacent 
epithelial cells differ vastly (Reeves and Posakony, 2005, Buffin and Gho, 2010) and 
both of these studies found RASSF10 mRNA to be highly expressed in SOPs. Moreover, 
RASSF10 mRNA expression was dependent on the expression of proneural genes 
(Reeves and Posakony, 2005). Consistent with this, I found endogenous RASSF10 
protein exclusively localised in wing imaginal disc SOPs (see 4.2.1).  
In this thesis I present data showing the requirement of RASSF10 for ACD of SOPs. 
Firstly, RASSF10 mutant flies exhibit bristle defects that resemble the defects of 
reduced Baz or Pins function (Figure 4.1) (Kopein and Katanaev, 2009). Secondly, 
RASSF10 strongly genetically interacted with PCP components and polarity 
determinants (see 4.3). Ultimately, loss of RASSF10 causes several defects in the actual 
ACD of SOPs (see 4.5.2): it affects the polarisation of the Pon crescent, causes Pon mis-
segregation into pIIa and pIIb daughter cells (Figure 4.17), similar to loss of baz or pins 
(Roegiers et al., 2001a, Bellaiche et al., 2001b) and the anterior-posterior division angle 
is not properly aligned along the tissue axis (Figure 4.18), similar to loss of fz or dsh 
(Bellaiche et al., 2001a, Bellaiche et al., 2004, Gomes et al., 2009). Together with the 
findings that (a) RASSF10 can bind to Fz/Dsh (Figure 3.8 and Figure 3.11) as well as 
Baz (Figure 3.6), (b) that it co-localises with them to one side of the cell cortex in wing 
imaginal disc SOPs (Figure 4.8 and Figure 4.9) and localises to the posterior cell cortex 
in pupal nota SOPs (Figure 4.15) and (c) that polarisation of Baz seems impaired in 
interphase SOPs upon loss of RASSF10 (Figure 4.19), my work strongly suggests that 
RASSF10 functions together with Fz/Dsh and Baz in SOP initial polarisation and ACD. 
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Furthermore, RASSF10 is most likely recruited to the membrane by Fz and Dsh, as 
ectopically expressed GFP-RASSF10 is planar polarised in epithelial cells (Figure 3.13) 
and membrane localisation is dependent on the presence of both Fz and Dsh (Figure 
3.14). In order to better understand the hierarchy of the Fz/Dsh-RASSF10-Baz network, 
it will be necessary to examine RASSF10 localisation in baz mutants. However, the 
molecular function of RASSF10 remains unexplored. In the following subchapter I will 
present different possible scenarios for how RASSF10 might act on Dsh, Fz or Baz. 
 
6.3.2 Possible mechanisms for the function of RASSF10 in ACD 
One possible mechanism is that RASSF10, as an SOP-specific factor, could promote the 
interaction between Fz/Dsh and Baz-aPKC-Par6, either by bridging a Fz-Baz or a Dsh-
Baz association. This could be initially tested in co-IP experiments and also in pupal 
nota stainings of RASSF10 mutants, as Baz localisation should in this situation be 
randomised relative to the Fz/Dsh localisation. In addition, ectopically expressed 
RASSF10 might lead to the planar polarisation of Baz in normal epithelial cells. 
However, as discussed in 4.6, RASSF10 must have additional functions, as the adult 
bristle phenotype as well as the Pon-segregation analysis differs from PCP mutants.  
One additional or alternative mechanism could be that RASSF10 is required to 
stabilise Fz and/or Dsh and/or Baz at the posterior cell cortex. The levels of Fz, Dsh and 
Baz are highly enriched in SOPs compared to the surrounding epithelial cells in wing 
imaginal discs (see 4.2.2) and in the pupal notum (e.g. (Bellaiche et al., 2004, Bellaiche 
et al., 2001b)). This hypothesis would be consistent with the observations that, upon co-
expression RASSF10, Fz and Dsh (Figure 3.15) all components appear stabilised in S2 
cell lysates. Furthermore, Baz levels seem less enriched at the posterior cell cortex in 
RASSF10 mutants compared to wild type tissue (Figure 4.19) and it will be important to 
test whether the same is true for Dsh and Fz. Lower levels of Fz/Dsh, could also explain 
the randomisation of the division angle relative to the anterior-posterior axis in 
RASSF10 mutant (Figure 4.18). Fz/Dsh position the spindle through direct binding 
between Dsh and Mud/NuMA (see 1.7.3) (Segalen et al., 2010). Reduced Fz/Dsh levels 
could therefore lead to less stable anchoring of the spindle at the apical posterior cell 
cortex. This can be tested through live imaging the spindle in RASSF10 mutants.  
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It is possible that RASSF10 could function as a regulatory subunit of PP1 to stabilise 
the components of the posterior cortex. RASSF10 could recruit PP1 to the posterior cell 
cortex to dephosphorylate and thus stabilise either Fz or Dsh or Baz (see below). All 
three are plausible substrates for potential RASSF10/PP1 complexes.  
Firstly, Fz can be inhibited by aPKC-dependent phosphorylation on two serine residues 
at the C-terminal cytoplasmic tail, leading to its destabilisation and removal from the 
membrane, at least in photoreceptors of the eye disc (Djiane et al., 2005). This study 
presented a model in which Baz binding to aPKC (in the planar polarised R3 and R4) 
would protect Fz from phosphorylation. In SOPs, Fz and the Baz-aPKC-Par6 complex 
co-localise and it is likely that residual aPKC activity could still lead to Fz 
phosphorylation. Dephosphorylation by RASSF10/PP1 complexes could therefore 
hypothetically stabilise Fz.  
Secondly, RASSF10/PP1 complexes could regulate Dsh levels by dephosphorylation. 
In pupal wings, Dsh (most likely a hyperphosphorylated form) is targeted by the Cullin-
3/Diablo/Kelch ubiquitin ligase complex (Strutt et al., 2013a). Interestingly, mammalian 
Dvl is targeted for ubiquitin-mediated degradation by the E3 ubiquitin ligase Itch 
(Drosophila Suppressor of deltex, Su(Dx)) and partial dephosphorylation by PP1 (in 
association with the kinase Hipk2) can prevent this degradation in vitro (Shimizu et al., 
2014). In order to test whether RASSF10/PP1 complexes prevent ubiquitin-mediated 
degradation of either Fz or Dsh, mutants of different E3 ligases could be combined with 
the RASSF10 mutant and the responsible E3 would be expected to rescue the RASSF10 
mutant bristle defect. As discussed in 6.2, it will be crucial to generate a PP1-binding 
deficient mutant of RASSF10 to prove that RASSF10 does indeed act as a substrate 
specifying subunit of PP1.   
Lastly, in the case of Baz, RASSF10/PP1 complexes could promote Baz association 
with aPKC/Par6. In several types of epithelial cells Baz localises at the adherens 
junctions and is separate from aPKC/Par6, which localises more apically (Walther and 
Pichaud, 2010, Morais-de-Sa et al., 2010, Harris and Peifer, 2005). The apical exclusion 
of Baz is based on two events: phosphorylation of Baz on Ser980 by aPKC, as well as 
competition between Crb and Baz for aPKC/Par6 binding (Morais-de-Sa et al., 2010, 
Walther and Pichaud, 2010). Assuming that this might also be true for epithelial cells 
and SOPs of the pupal notum, this would require a special regulatory mechanism, which 
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allows the formation of Baz-aPKC-Par6 complexes in SOPs at interphase (before 
Aurora A is active). PP1 can dephosphorylate the Ser980 residue of Baz/Par3 in vitro 
(Yanxiang Zhou, unpublished result) (Traweger et al., 2008). In neuroblasts and oocytes 
Ser980 phosphorylation does not affect the association of Baz with aPKC/Par6, as Crb 
is not present (Morais-de-Sa et al., 2010, Hong et al., 2001). Therefore the requirement 
of dephosphorylation of Ser980 to keep Baz associated to aPKC/Par6 would only occur 
if Crb was present in SOPs. However, there are no reports on Crb function in SOPs and 
this can first be addressed by testing Crb expression in SOPs. In addition, it will be 
important to look at the localisation of aPKC and Par6 in RASSF10 mutants to see 
whether they co-localise with Baz, or whether Baz is excluded from the aPKC crescent. 
Moreover, if this is the case, Ser980 phosphomimicking Baz mutants should phenocopy 
RASSF10 mutants. Alternatively, RASSF10/PP1 could stabilise Baz at the anterior cell 
cortex by dephosphorylating the Rho-kinase phosphorylation sites at the C-terminus of 
Baz, which were shown to disrupt Baz cortical localisation (Krahn et al., 2010b).  
A contrasting model is that RASSF10 could promote the stabilisation of Fz/Dsh and 
Baz independently of PP1 function. For example RASSF10 could promote polarised 
transport of Rab11 endosomes containing Fz, Dsh or Baz via its physical binding 
partner Sec15 (Figure 3.7) in SOPs, as seen for RASSF8 in L3/pupal wings. There are 
many other possible scenarios for how RASSF10 might function in ACD, and future 
research as proposed in this discussion will shed light into the mechanism(s) involved. 
It might also be informative to test RASSF10 in the subsequent divisions of the SOP 
lineage. While Baz is important for pIIa, pIIb and pIIIb divisions, PCP proteins do not 
appear to be involved (see 1.7.3) (Roegiers et al., 2001a, Roegiers et al., 2001b). pIIb 
and pIIIb asymmetric division are similar to neuroblast divisions as they involve 
Inscuteable (see 1.7.3). However, the mechanisms of pIIa divisions are unexplored and 
RASSF10 might function together with Baz in this process.      
 
6.3.3 Regulation of RASSF10 in SOPs  
RASSF10 transcription in SOPs is, as mentioned above, regulated by proneural genes 
(Reeves and Posakony, 2005). This study identified proneural protein binding sites 5 
kbp upstream of the RASSF10 locus, which are responsive to Achaete-Scute. In addition, 
several observations suggest that RASSF10 is regulated on a post-transcriptional level. 
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In fz or dsh mutants, RASSF10 levels are severely reduced (Figure 3.14) and RASSF10 
is stabilised by co-expression of Fz and Dsh (or Baz) in S2 cells (Figure 3.15). This 
indicates that RASSF10 may be prone to degradation if uncoupled from Fz/Dsh and 
would also explain why RASSF10 is planar polarised. In order to identify the relevant 
enzymes involved in regulating RASSF10 stability, one strategy might be to perform 
AP-MS experiments of ectopically expressed Drosophila RASSF10 from lysates of S2 
cells treated with proteasome inhibitors.  
 
6.3.4 Is the function of RASSF10 conserved in other species? 
Besides the similar interaction network of human RASSF9 and RASSF10 and 
Drosophila RASSF10 (see 6.1) there is no substantial evidence so far that the human 
homologues could function in a similar way (see 1.2.2). In fact, human RASSF9 and 
RASSF10 do not show membrane localisation in cell culture based stainings: RASSF10 
is cytoplasmic and re-localises to the spindle pole during mitosis (Hill et al., 2011). 
Ectopically expressed RASSF9 is also cytoplasmic and shows an enrichment in 
endosomes (Chen et al., 1998). However, the localisation could of course be dependent 
on the cell type. Interestingly, RASSF10 is primarily expressed in the brain in Xenopus 
tadpoles (Hill et al., 2011), suggesting that its expression is, like Drosophila RASSF10, 
tissue-specific and that it might be important for neurogenesis. RASSF9 is expressed in 
multiple tissues in mice and rats (Lee et al., 2011, Chen et al., 1998). However, as the 
functions of RASSF9 and RASSF10 in other species are not well understood, it is 
difficult to predict their conservation. In contrast, the function of RASSF8 in 
maintaining the integrity of cell junctions is conserved in Drosophila and humans (Lock 
et al., 2010, Langton et al., 2009, Zaessinger et al., 2015). While Drosophila and human 
RASSF8 show high sequence similarity (Langton et al., 2009), Drosophila RASSF10 
(and RASSF9) has very limited homology with human RASSF9/10 (see 3.1) and might 
therefore be functionally divergent. In the absence of a detailed phylogenetic analysis of 
the N-terminal RASSF genes through evolution, it is not possible to conclude whether 
Drosophila RASSF9 and RASSF10 are true homologues of human RASSF9/10. In this 
thesis, I have retained the nomenclature used by Sherwood et al (Sherwood et al., 2010), 
however, it may be necessary to change this nomenclature based on further analysis. It 
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will also be interesting to investigate the function of human or mouse RASSF9 and 10 
in order to relate their function to my findings on Drosophila RASSF10. 
 
6.4 What is the developmental function of RASSF9? 
Drosophila RASSF9 was so far an uncharacterised gene. My work showed that RASSF9 
can physically interact with the same proteins as RASSF8 and RASSF10 (Figure 6.1) 
and tagged transgenes localise apically at the cell cortex (Figure 3.13 and Figure 4.15). 
The localisation of ectopic expressed RASSF9 was not, in contrast to RASSF10, 
dependent on the presence of Fz or Dsh (Figure 3.14), indicating that other proteins 
recruit RASSF9 to the membrane. Potential candidates could be its physical interaction 
partners ASPP (Figure 3.3) or even Baz (Figure 3.6), as both localise at the junctions 
(Krahn et al., 2010b, Langton et al., 2007). This could be tested in ASPP or baz loss-of-
function experiments.  
However, unlike RASSF8 or RASSF10 mutants, RASSF9 mutants do not exhibit an 
obvious phenotype, making it difficult to address its biological function. The mild 
reduction in wing size (Figure 3.19) of RASSF9 mutants would suggest pro-growth 
functions. Interestingly, mice mutant for RASSF9 are also smaller compared to wild 
type (Lee et al., 2011). The findings that RASSF9 worsens the stout bristle phenotype of 
baz or pins knockdowns (Figure 4.12) and RASSF9, RASSF10 double mutants show 
stronger genetic interactions with ACD components compared to RASSF10 single 
mutants (see 4.3), could suggest that it might be involved in ACD of SOPs. However, it 
is unlikely that RASSF9 would function identically to RASSF10, as expression of 
RASSF9 cannot rescue the bristle defects of RASSF10 mutants (Figure 4.2 and Figure 
4.3) and it is also possible that the effects caused by RASSF9 loss are not specific for 
ACD of SOPs, as discussed for PP1s in 4.4. A crucial step in understanding the 
physiological function of RASSF9 will be to find when and where it is expressed. I 
generated an antibody against RASSF9. Hence, stainings across different 
developmental stages and tissues could be performed or alternatively an endogenous 
GFP-RASSF9 line could be generated using the CRISPR/Cas9 system. In addition, the 
RASSF9 mutants should be carefully analysed for defects through different 
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developmental stages. It will be interesting to see what the specific function of 
Drosophila RASSF9 might be. 
 
6.5 N-terminal RASSFs: similar interactions but specific 
functions 
Although N-terminal RASSFs share several binding partners and, as discussed in 3.6, 
we cannot rule out redundant functions, it seems that N-terminal RASSFs act 
specifically in different tissues and developmental stages, defined by differences of 
binding partners and expression patterns. RASSF8 is, together with ASPP, recruited to 
the membrane in photoreceptors of the developing retina by its binding partner MAGI 
and RASSF8 then in turn positions Baz at the adherens junctions (Zaessinger et al., 
2015). Yanxiang Zhou proposed in his thesis that ASPP/PP1 complexes could then 
stabilise Baz at the adherens junctions by dephosphorylation (unpublished results). In 
contrast, RASSF10 is specifically expressed in SOP cells and is recruited by its binding 
partners Fz/Dsh to one side of the cell cortex, and might then promote the planar 
polarisation of the Baz-aPKC-Par6 complex (perhaps by recruiting PP1, see 6.3.2). 
Ectopic expression of RASSF9/10 does not rescue the round wing phenotype of 
RASSF8 mutants (Figure 3.22) and RASSF9 expression does not rescue the bristle 
defect of RASSF10 mutants (Figure 4.2 and Figure 4.3), suggesting that the slight 
differences in binding partners are sufficient to separate their functions. This model is 
further supported by the observation that human RASSF8 localises at the tight junctions 
(Lock et al., 2010), while RASSF7 and RASSF10 seem to localise at the mitotic spindle 
(Hill et al., 2011, Recino et al., 2010). In this context, it would be interesting to test the 
functions the sole C. elegans N-terminal RASSF, K05B2.2, (Sherwood et al., 2010). 
 
6.6 Discussion of the Spc25 project 
6.6.1 The function of the ubiquitin binding of Spc25  
The kinetochore component Spc25 was identified as a novel ubiquitin-binding protein 
with an as yet unknown ubiquitin-binding domain, however the functional relevance of 
the ubiquitin binding remained elusive (Zhao, 2010). The ubiquitin-binding deficient 
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spc25 (L109A) mutant has no obvious phenotype, but Shengkai Zhao found a synthetic 
interaction between spc25 (L109A) and temperature-sensitive alleles of Dsn1 (dsn1-7 
and dsn1-8), suggesting that the function of Spc25's ubiquitin binding might lie in 
maintaining the stability of the kinetochore. In this work several approaches were taken 
to gain further insight into this theory.  
Firstly, I found additional genetic interactions of spc25 (L109A) with temperature-
sensitive mutants of other kinetochore components (Figure 5.2). Interestingly, all of the 
affected mutants were in close proximity to Spc25 and belonged to the KMN network, 
formed by the Mtw1 complex, the Spc105 complex and the Ndc80 complex 
(Cheeseman et al., 2006). spc25 (L109A) increased the temperature sensitivities of 
alleles (besides DSN1) of SPC105 as well as NDC80 and NUF2 of the Ndc80 complex. 
Strikingly, the combination of spc25 (L109A) with different temperature-sensitive 
alleles of SPC24 resulted in lethality. By contrast, no effect was seen for temperature-
sensitive mutants of the remaining Mtw1 complex (Nsl1, Mtw1, Nnf1), Ndc10 and 
members of the Dam1 complex (Dam1, Duo1, Ask1, Dad1). My findings support a 
model in which the ubiquitin system around Spc25 might act specifically within the 
KMN network and is important for the stability - at least of pre-destabilised - 
kinetochore complexes. 
However, the critical evidence that the genetic interactions of spc25 (L109A) are 
caused by its ubiquitin-binding deficiency and not due to the destabilisation of 
kinetochore components by the L109A mutation independently of ubiquitin, still needs 
to be provided. Attempts of fusing two different UBDs - UIM domain or MIU domain- 
to spc25 (L109A) (or SPC24) failed to rescue the phenotypes of spc105-15 spc25 
(L109A) and spc24-1 spc25 (L109A) double mutants (Figure 5.5 and Figure 5.6). As an 
alternative, catalytic domains of deubiquitylation enzymes could be fused to the 
temperature-sensitive alleles of DSN1, SPC105 or the members of the Ndc80 complex. 
If the phenotypes were due to the ubiquitin-binding deficiency, this should phenocopy 
the effects seen for spc25 (L109A).  
Furthermore, Dsn1, Nsl1 and Spc105 of the KMN network were shown to be 
ubiquitylated (Figure 5.7) and their stability was not affected by different tags (Figure 
5.8). Importantly, monoubiquitylation of Dsn1 and Spc105 was independent of 
proteasomal activity (Figure 5.9). All three are in immediate proximity to Spc25 
Chapter 6 Discussion 
 
 234 
(Joglekar et al., 2009) and associate with Spc24/Spc25 (Maskell et al., 2010, Hornung et 
al., 2010), which makes them attractive candidates for interacting with the UBD of 
Spc25.  
As a starting point I focused on analysing the ubiquitylation of Dsn1, trying to reveal 
the ubiquitylation site(s) and the responsible ubiquitylation factors. If Dsn1 (or other 
ubiquitylated potential targets) was the ubiquitylated interactor of Spc25, 
ubiquitylation-deficient mutants should behave epistatic to spc25 (L109A). However, 
the strategy of finding the region containing the relevant lysine residue(s) was 
inconclusive, as the four different lysine mutant groups of Dsn1 were all still 
ubiquitylated (Figure 5.10), suggesting that there might be a redundancy between 
ubiquitylation sites, or even that no specific lysine residue is required. It would be 
interesting to see how the ubiquitylation is affected in different lysine mutant group 
combinations. Furthermore, loss of none of the 11 E2 ubiquitin-conjugating enzymes in 
yeast affected the ubiquitylation of Dsn1, except in the case of Rad6. Rad6, together 
with the E3 ubiquitin ligase Ubr2, seems to be responsible for polyubiquitylation (and 
possibly subsequent degradation), but not monoubiquitylation of Dsn1 (Figure 5.11, 
Figure 5.13 and (Akiyoshi et al., 2013b)). This strongly suggests a redundancy between 
the E2s and thus, in order to reveal the responsible E2 enzymes for monoubiquitylation, 
different double mutant combinations could be tested.  
At this point, the ubiquitylated interactor(s) remains unknown. Spc105 and Nsl1 will 
have to be analysed using the same approach as for Dsn1, with regards to their 
regulation of ubiquitylation. Relevant, i.e. kinetochore-associated E3(s) could be 
identified using in vivo pull-down experiments combined with mass spectrometry 
approaches. Although Dsn1, Nsl1 and Spc105 are plausible candidates, it is possible 
that Spc25 binds to a different ubiquitylated target. Further candidates could be 
identified in mass spectrometry experiments, comparing in vivo pull-downs of wild type 
and Spc25 (L109A) mutant proteins (or with a stronger mutant) or screening the as yet 
untested kinetochore components for synthetic interactions with spc25 (L109A). 
Recently, a new centromere associated component Cnn1 (CENP-T) was identified, 
which can directly interact with the globular domains of Spc25/Spc24 and is, moreover, 
competing with Dsn1/Nsl1 for the same binding surface (Malvezzi et al., 2013). It 
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would be interesting to see whether Cnn1 is involved in the ubiquitin-binding activity of 
Spc25.     
Lastly, this work aimed to further characterise the unknown UBD of Spc25. The 
minimal region of Spc25 required for ubiquitin binding (linker and globular domain) 
does not show sequence similarity to any of the known ubiquitin-binding domains and 
interestingly, the L109 residue that is crucial for the ubiquitin binding lies in the flexible 
linker region (Zhao, 2010). Moreover, Spc24 might also contribute to the ubiquitin 
binding. Although the crystallisation trials of a truncated Spc25-Spc24 complex and 
ubiquitin in collaboration with Martin Singleton were unsuccessful, I found that the 
affinity for the binding of the Spc25 (L109A) mutant to ubiquitin was reduced 
compared to wild type Spc25 - but not abolished - using the BIACORE system (Figure 
5.16), which could be the reason for the not obvious phenotype. However, as the 
obtained KD values were not considered reliable and as the binding was 100 times 
weaker for wild type Spc25 than it was previously reported by Shengkai Zhao, these 
measurements should be repeated and complemented with alternative methods, e.g. ITC. 
Based on the finding that the Spc25 (L109A) mutant quite possibly has residual 
ubiquitin-binding abilities, it will be important to reveal other contact sites in order to 
obtain a stronger allele, which might give a stronger phenotype. This could be achieved 
by taking several different approaches. Firstly, crystallisation trials could be repeated by 
fusing ubiquitin to either Spc25 or Spc24. NMR titration studies could be an alternative 
approach to characterise the interaction between ubiquitin and Spc25 (Spc24), as the 
NMR structure for the globular domain of Spc25 is already available (Wei et al., 2006). 
Lastly, a negative two-hybrid screen between ubiquitin and different Spc25 mutants 
(created randomly by PCR) could reveal residues important for the interaction. Spc25 
mutants negative for the interaction with ubiquitin would then have to be tested for their 
ability to bind to Spc24 to dismiss the possibility that disassembly of the Spc25/Spc24 
complex causes the ubiquitin-binding deficiency.  
In conclusion, in this thesis several approaches were taken to further elucidate the 
function and mechanism of the ubiquitin binding of Spc25. However, as discussed 
above, the approaches taken in this thesis need to be continued in order to give 
satisfying answers. Together with the suggestions made above, other future experiments 
will be necessary to assess the role of the ubiquitin binding of Spc25. In his thesis, 
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Shengkai Zhao analysed defects in chromosome segregation performing a plasmid loss 
assay in spc25 (L109A) mutants and wild type cells and could not detect a difference 
(Zhao, 2010). However, there are more sensitive approaches to detect chromosome 
segregation defects. Chromosome loss assays with strains that harbour the 
minichromosome CFIII containing a suppressor of the ade2-101 locus indicate 
segregation defects upon loss of CFIII, based on a colour change from white to red 
(Spencer et al., 1990). Hanna Windecker, a post-doc in Helle Ulrich’s lab, found in the 
meantime that the spc25 (L109A) mutant indeed causes a mild defect in chromosome 
segregation using this approach (unpublished result). This strongly supports the 
relevance for the ubiquitin-binding ability of Spc25. One way to further characterise the 
chromosome segregation defect would be the live imaging of GFP-labelled 
chromosomes (Straight et al., 1996). Another approach to address whether the ubiquitin 
system based on the ubiquitin binding of Spc25 is important for the stability of the 
kinetochore could be to compare the composition of kinetochores in wild type versus 
spc25 (L109A) mutants. Native kinetochores can be purified from yeast cells with a 
minichromosome purification protocol combined with affinity purification of FLAG-
tagged Dsn1 (Akiyoshi et al., 2009, Akiyoshi et al., 2010). Mass-spectrometry of the 
purified kinetochore complexes would then reveal whether spc25 (L109A) mutants 
show differences in the composition compared to the wild type situation. These 
approaches are currently being pursued by Hanna Windecker in the Ulrich lab. 
 
6.6.2 The ubiquitin system(s) at the kinetochore 
The ubiquitin system was so far mainly reported to be important for regulating the 
kinetochore assembly by means of ubiquitin-mediated degradation (Akiyoshi et al., 
2013b, Davies and Kaplan, 2010, Honda et al., 2000, Kopski and Huffaker, 1997). In 
this study I provide evidence for the existence of a proteasome independent function for 
the ubiquitin system centred on the ubiquitin-binding activity of Spc25 and the KMN 
network (Spc105 complex, Mtw1 complex and Ndc80 complex).  
The E3 ubiquitin ligase Ubr2, together with its adaptor Mub1, were shown to 
regulate the levels of Dsn1 at the kinetochore and, moreover, were acting as a control 
system to remove malfunctioning Dsn1 (Akiyoshi et al., 2013b). As Dsn1 was one of 
our potential ubiquitylated interactors of Spc25, I assessed whether the Ubr2 ubiquitin-
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mediated degradation system and the Spc25 based ubiquitin system are connected and 
my results suggest that both systems act separately from each other.   
Firstly, loss of UBR2 function and the ubiquitin-binding deficient mutant of Spc25, 
spc25 (L109A), both further destabilise several temperature-sensitive mutants of the 
KMN network (dsn1-7, ndc80-1, nuf2-61, spc24-1) (Figure 5.12). However, their 
effects are not epistatic, indicating that they work independently.  
As mentioned above, Ubr2 (Mub1) was reported to ubiquitylate and target Dsn1 for 
degradation (Akiyoshi et al., 2013b). Indeed, I could confirm that polyubiquitylation of 
Dsn1 was dependent on the presence of Ubr2 (Figure 5.9 and Figure 5.11) and 
polyubiquitylation of Dsn1 seemed to target it to the proteasome (Figure 5.9). In 
addition, my results suggest that the ubiquitin-conjugating enzyme Rad6 is the 
responsible E2 for the polyubiquitylation of Dsn1, which is consistent with previous 
reports that Ubr2/Rad6 act together to target other substrates for degradation, such as 
Rpn4 (Ju et al., 2008, Wang et al., 2004) and Sml1 (Andreson et al., 2010). Interestingly, 
the study by Akiyoshi et al., suggests either that Rad6 is not the responsible E2, or that 
there might be a redundancy between the E2s targeting Dsn1, as deletion of RAD6 
failed to rescue the lethality of a mutant allele of DSN1, while deletion of UBR2 (and 
MUB1) did (Akiyoshi et al., 2013b).  
Importantly and in contrast, neither Ubr2 nor Rad6 affected the monoubiquitylation 
of Dsn1 and monoubiquitylated Dsn1 is not targeted by the proteasome (Figure 5.9 and 
Figure 5.11), thus further supporting the model of a proteasome independent function of 
the ubiquitin system. However, at this point one cannot completely rule out that 
Ubr2/Rad6 are not responsible for the monoubiquitylation of Dsn1, as they might act 
redundantly with other E2/E3s. 
The presence of the two different ubiquitin pathways is further strengthened by the 
finding that Δubr2 has an opposite effect on the phenotype of spc105 temperature-
sensitive alleles. While spc25 (L109A) worsens the phenotype, Δubr2 slightly rescues it 
(Figure 5.12). Together with the finding that deletion of UBR2 increased the levels of 
ubiquitylated Spc105 (Figure 5.11), this might suggest that Ubr2 could be involved in 
regulating Spc105 levels in a similar way to Dsn1. However, in the case of Spc105, 
further experiments would be necessary to validate this. 
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In conclusion, one could speculate that while Ubr2 guarantees the integrity of the 
kinetochore by regulating the levels of Dsn1 (and maybe other kinetochore proteins) 
and preventing assembly of malfunctioning kinetochore complexes, as suggested by the 
Biggin’s group (Akiyoshi et al., 2013b), the ubiquitin system around Spc25 would act to 
stabilise already formed kinetochore complexes. As discussed in 6.6.1, further 
experiments will be necessary to validate the latter hypothesis. However, regardless of 
whether or not Dsn1, or Spc105 or Nsl1 are the ubiquitylated interactors of Spc25, the 
fact that the monoubiquitylation of Dsn1, Nsl1 and Spc105 are independent of the E3 
ubiquitin ligase Ubr2 (Figure 5.11) and that the monoubiquitylation of Dsn1 and 
Spc105 are independent of proteasome activity (Figure 5.9), strongly implies 
proteasome-independent functions for the ubiquitin system at the kinetochore.     
One striking question remains unclear: is the ubiquitin system around Spc25 
conserved in other species? Human Spc25 (with or without human Spc24) did not 
interact with ubiquitin in the yeast two-hybrid experiment (Figure 5.17). However, the 
interaction could be too weak to be detected with the two-hybrid system. As an 
alternative, in vitro and in vivo pull-downs of human Spc25/24 with ubiquitin could be 
performed to assess the ubiquitin-binding ability. Interestingly, at least the ubiquitin-
mediated degradation of kinetochore components as a system to regulate the assembly 
of kinetochore components seems to be conserved in mammalian systems (Davies and 
Kaplan, 2010, Honda et al., 2000).  
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Chapter 7 Appendix 
 
7.1 Yeast strains 
Table 7.1 - List of yeast strains used in this thesis 
yHU Name Genotype Source 
2 DF5 alpha his3-Δ200, leu2-3,2-112, lys2-801, trp1-1(am), 
ura3-52 
(Finley et al., 
1987) 
3 DF5 a his3-Δ200, leu2-3,2-112, lys2-801, trp1-1(am), 
ura3-52 
(Finley et al., 
1987) 
4 Δubc6,7 DF5 ubc6::HIS3, ubc7::HIS3 (Mayer et al., 
1998) 
48 rad6 a DF5 rad6::HIS3 (Ulrich and 
Jentsch, 2000) 
69 cdc34-1 DF5 cdc34-1 (Goebl et al., 
1988) 
195 PJ69-4A trp1-901, leu2-3,112, ura3-52, his3-200, gal4Δ, 
gal80Δ, LYS2::GAL1-HIS3, GAL2-ADE2, 
met2::GAL7-lacZ 
(James et al., 
1996) 
198 ubc8 DF5 ubc8::URA3 (Davies et al., 
2010) 
338 ubr2 DF5 ylr024c::HIS3MX6 Helle Ulrich 
346 ubc13 DF5 ubc13::HIS3 (Ulrich and 
Jentsch, 2000) 
457 W303 K699 ade2-1, ura3-1, his3-11,15, trp1-1, leu2-3,112, 
can1-100  
(Thomas and 
Rothstein, 1989) 
458 W303 K700 ade2-1, ura3-1, his3-11,15, trp1-1, leu2-3,112, 
can1-100  
(Thomas and 
Rothstein, 1989) 
581 ubc1 DF5 ubc1::HIS3 (Seufert et al., 
1990) 
582 ubc4 DF5 ubc4::HIS3 (Seufert et al., 
1990) 
583 ubc5 DF5 ubc5::LEU2 (Seufert et al., 
1990) 
585 ubc10 DF5 ubc10::LEU2 (Davies et al., 
2010) 
586 ubc11 DF5 ubc11::HIS3 (Davies et al., 
2010) 
790 BY4741 leu2Δ0, met15Δ0, ura3Δ0, his3Δ0 (Brachmann et 
al., 1998) 
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 DSN1-TAP BY4741 DSN1-TAP::HIS3 OPEN 
BIOSYSTEMS 
 NNF1-TAP BY4741 NNF1-TAP::HIS3 OPEN 
BIOSYSTEMS 
 NSL1-TAP BY4741 NSL1-TAP::HIS3 OPEN 
BIOSYSTEMS 
 MTW1-TAP BY4741 MTW1-TAP::HIS3 OPEN 
BIOSYSTEMS 
 ubr2  BY4742 ubr2::KanMX EUROSCARF 
2260 pdr5Δ DF5 pdr5::KanMX (Zhao, 2010) 
2376 dsn1-7  ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1 
(Nekrasov et al., 
2003) 
2377 dsn1-8  ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1 
(Nekrasov et al., 
2003) 
2493 spc25 L109A ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1 spc25(L109A) 
(Zhao, 2010) 
2494 dsn1-8 spc25 
L109A 
ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1 dsn1-8 spc25(L109A) 
(Zhao, 2010) 
2606 YPH985 S288C ura3-52, lys2-801, ade2-101, trp1-Δ63, his3-
Δ200, leu2-Δ1 
ura3-52, lys2-801, ade2-101, trp1-Δ63, his3-
Δ200, leu2-Δ1 
CFIII (CEN3.L.YPH983) HIS3 SUP11 
(Connelly and 
Hieter, 1996) 
2619 ndc10-1 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, ndc10-1 
(Nekrasov et al., 
2003) 
2620 mtw1-11 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, mtw1-11 
(Nekrasov et al., 
2003) 
2621 nnf1-77 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, nnf1-77 
(Nekrasov et al., 
2003) 
2622 nsl1-6 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, nsl1-6 
(Nekrasov et al., 
2003) 
2623 nsl1-5 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, nsl1-5 
(Nekrasov et al., 
2003) 
2624 spc105-4 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, spc105-4 
(Nekrasov et al., 
2003) 
2625 spc105-15 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, spc105-15 
(Nekrasov et al., 
2003) 
2626 dam1-31 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, dam1-31 
(Nekrasov et al., 
2003) 
2627 duo1-61 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, duo1-61 
(Nekrasov et al., 
2003) 
2628 dad1-13 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, dad1-13 
(Nekrasov et al., 
2003) 
2629 ask1-22 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, ask1-22 
(Nekrasov et al., 
2003) 
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2630 spc24-1 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, spc24-1 
(Nekrasov et al., 
2003) 
2632 ndc80-1 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, ndc80-1 
(Nekrasov et al., 
2003) 
2633 nuf2-61 ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15 
ura3 ssd1, nuf2-61 
(Nekrasov et al., 
2003) 
2639 DSN1-6HA DF5 DSN1-6HA::klTRP1 This study 
2640 DSN1-9myc DF5 DSN1-9myc::klTRP1 This study 
2642 ndc10-1 spc25 
L109A 
W303 ndc10-1, spc25 L109A This study 
2644 mtw1-11 spc25 
L109A 
W303 mtw1-11, spc25 L109A This study 
2648 nnf1-77 spc25 
L109A 
W303 nnf1-77, spc25 L109A This study 
2650 nsl1-6 spc25 
L109A 
W303 nsl1-6, spc25 L109A This study 
2661 nsl1-5 spc25 
L109A 
W303 nsl1-5, spc25 L109A This study 
2663 spc105-4 spc25 
L109A 
W303 spc105-4, spc25 L109A This study 
2665 spc105-15 spc25 
L109A 
W303 spc105-15, spc25 L109A This study 
2667 dam1-31 spc25 
L109A 
W303 dam1-31, spc25 L109A This study 
2705 spc24-12  spc24-12 ura3-52 lys2-801 ade2-101 trp1-Δ63 
his3-Δ200 leu2-Δ1 (S288C) 
(Le Masson et 
al., 2002) 
2706 spc24-13  spc24-13 ura3-52 lys2-801 ade2-101 trp1-Δ63 
his3-Δ200 leu2-Δ1 (S288C) 
(Le Masson et 
al., 2002) 
2762 SPC105-9myc DF5 SPC105-9myc::klTRP1 This study 
2767 YPH985 spc25 
L109A 
ura3-52, lys2-801, ade2-101, trp1-Δ63, his3-
Δ200, leu2-Δ1, spc25(L109A) 
CFIII (CEN3.L.YPH983) HIS3 SUP11  
This study 
2781 DSN1-TAP 
Δubr2 
leu2Δ0, met15Δ0 or lys2Δ0, ura3Δ0, his3Δ0, 
DSN1-TAP::HIS3, ubr2::KanMX 
This study 
2782 DSN1-6HA 
Δubr2 
DF5 DSN1-6HA::klTRP1, ubr2::HIS3MX6 This study 
2783 DSN1-6HA DF5 DSN1-6HA::klTRP1 This study 
2784 NSL1-TAP 
Δubr2 
leu2Δ0, met15Δ0 or lys2Δ0, ura3Δ0, his3Δ0, 
NSL1-TAP::HIS3, ubr2::KanMX 
This study 
2773 duo1-61 spc25 
L109A 
W303 duo1-61, spc25 L109A This study 
2774 dad1-13 spc25 
L109A 
W303 dad1-13, spc25 L109A This study 
2776 ask1-22 spc25 
L109A 
W303 ask1-22, spc25 L109A This study 
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2778 ndc80-1 spc25 
L109A 
W303 ndc80-1, spc25 L109A This study 
2780 nuf2-61 spc25 
L109A 
W303 nuf2-61, spc25 L109A This study 
2797 SPC105-6HA 
Δubr2 
DF5 SPC105-6HA::klTRP1, ubr2::HIS3MX6 This study 
2796 DSN1-6HA 
Δpdr5 
DF5 DSN1-6HA::klTRP1, pdr5::KanMX This study 
2849 SPC105-HA 
Δpdr5 
DF5 SPC105-6HA::klTRP1, pdr5::KanMX This study 
2850 SPC105-HA 
Δpdr5 Δubr2 
DF5 SPC105-6HA::klTRP1, pdr5::KanMX, 
ubr2::HIS3MX6 
This study 
2851 DSN1-HA 
Δpdr5 Δubr2 
DF5 DSN1-6HA::klTRP1, pdr5::KanMX, 
ubr2::HIS3MX6 
This study 
2852  Δubr2 W303 ubr2::HIS3MX6 This study 
2853 spc25 L109A 
Δubr2 
W303 spc25(L109A) ubr2::HIS3MX6 This study 
2854 dsn1-7 Δubr2 W303 dsn1-7 ubr2::HIS3MX6 This study 
2856 dsn1-8 Δubr2 W303 dsn1-8 ubr2::HIS3MX6 This study 
2855 dsn1-7 spc25 
L109A Δubr2 
W303 dsn1-7 spc25(L109A) ubr2::HIS3MX6 This study 
2857 dsn1-8 spc25 
L109A Δubr2 
W303 dsn1-8 spc25(L109A) ubr2::HIS3MX6 This study 
2858 spc105-4 Δubr2 W303 spc105-4 ubr2::HIS3MX6 This study 
2860 spc105-15 
Δubr2 
W303 spc105-15 ubr2::HIS3MX6 This study 
2859 spc105-4 spc25 
L109A Δubr2 
W303 spc105-4 spc25(L109A) 
ubr2::HIS3MX6 
This study 
2861 spc105-15 spc25 
L109A Δubr2 
W303 spc105-15 spc25(L109A) 
ubr2::HIS3MX6 
This study 
2862 ndc80-1 Δubr2 W303 ndc80-1 ubr2::HIS3MX6 This study 
2863 ndc80-1 spc25 
L109A Δubr2 
W303 ndc80-1 spc25(L109A) ubr2::HIS3MX6 This study 
2864 nuf2-61 Δubr2 W303 nuf2-61 ubr2::HIS3MX6 This study 
2865 nuf2-61 spc25 
L109A Δubr2 
W303 nuf2-61 spc25(L109A) ubr2::HIS3MX6 This study 
2866 spc24-1 Δubr2 W303 spc24-1 ubr2::HIS3MX6 This study 
2995 SPC24-3FLAG W303 SPC24-3FLAG::HIS3MX6 This study 
2996 SPC24-UIM-
3FLAG 
W303 SPC24-UIM-3FLAG::HIS3MX6 This study 
2997 SPC24-MIU-
3FLAG 
W303 SPC24-MIU-3FLAG::HIS3MX6 This study 
2998 SPC25-3FLAG W303 SPC25-3FLAG::HIS3MX6 This study 
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2999 SPC25-UIM-
3FLAG 
W303 SPC25-UIM-3FLAG::HIS3MX6 This study 
3000 SPC25-MIU-
3FLAG 
W303 SPC25-MIU-3FLAG::HIS3MX6 This study 
3001 spc25 L109A 
SPC24-3FLAG 
W303 spc25 (L109A), SPC24-
3FLAG::HIS3MX6 
This study 
3002 spc25 L109A 
SPC24-UIM-
3FLAG 
W303 spc25 (L109A), SPC24-UIM-
3FLAG::HIS3MX6 
This study 
3003 spc25 L109A 
SPC24-MIU-
3FLAG 
W303 spc25 (L109A), SPC24-MIU-
3FLAG::HIS3MX6 
This study 
3004 spc25 L109A-
3FLAG 
W303 spc25 (L109A), SPC25-
3FLAG::HIS3MX6 
This study 
3005 spc25 L109A -
UIM-3FLAG 
W303 spc25 (L109A), SPC25-UIM-
3FLAG::HIS3MX6 
This study 
3006 spc25 L109A -
MIU-3FLAG 
W303 spc25 (L109A), SPC25-MIU-
3FLAG::HIS3MX6 
This study 
3007 spc105-15 
SPC24-3FLAG 
W303 spc105-15, SPC24-3FLAG::HIS3MX6 This study 
3008 spc105-15 
SPC24-UIM-
3FLAG 
W303 spc105-15, SPC24-UIM-
3FLAG::HIS3MX6 
This study 
3009 spc105-15 
SPC24-MIU-
3FLAG 
W303 spc105-15, SPC24-MIU-
3FLAG::HIS3MX6 
This study 
3010 spc105-15 
SPC25-3FLAG 
W303 spc105-15, SPC25-3FLAG::HIS3MX6 This study 
3011 spc105-15 
SPC25-UIM-
3FLAG 
W303 spc105-15, SPC25-UIM-
3FLAG::HIS3MX6 
This study 
3012 spc105-15 
SPC25-MIU-
3FLAG 
W303 spc105-15, SPC25-MIU-
3FLAG::HIS3MX6 
This study 
3013 spc105-15 spc25 
L109A SPC24-
3FLAG 
W303 spc105-15, spc25 L109A, SPC24-
3FLAG::HIS3MX6 
This study 
3014 spc105-15 spc25 
L109A SPC24-
UIM-3FLAG 
W303 spc105-15, spc25 L109A, SPC24-UIM-
3FLAG::HIS3MX6 
This study 
3015 spc105-15 spc25 
L109A SPC24-
MIU-3FLAG 
W303 spc105-15, spc25 L109A, SPC24-MIU-
3FLAG::HIS3MX6 
This study 
3016 spc105-15 spc25 
L109A-3FLAG 
W303 spc105-15, spc25 L109A, SPC25-
3FLAG::HIS3MX6 
This study 
3017 spc105-15 spc25 
L109A -UIM-
3FLAG 
W303 spc105-15, spc25 L109A, SPC25-UIM-
3FLAG::HIS3MX6 
This study 
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3018 spc105-15 spc25 
L109A -MIU-
3FLAG 
W303 spc105-15, spc25 L109A, SPC25-MIU-
3FLAG::HIS3MX6 
This study 
3019 spc24-1 3FLAG W303 spc24-1, SPC24-3FLAG::HIS3MX6 This study 
3020 spc24-1 UIM-
3FLAG 
W303 spc24-1, SPC24-UIM-
3FLAG::HIS3MX6 
This study 
3021 spc24-1 MIU-
3FLAG 
W303 spc24-1, SPC24-MIU-
3FLAG::HIS3MX6 
This study 
3022 spc24-1 SPC25-
3FLAG 
W303 spc24-1, SPC25-3FLAG::HIS3MX6 This study 
3023 spc24-1 SPC25-
UIM-3FLAG 
W303 spc24-1, SPC25-UIM-
3FLAG::HIS3MX6 
This study 
3024 spc24-1 SPC25-
MIU-3FLAG 
W303 spc24-1, SPC25-MIU-
3FLAG::HIS3MX6 
This study 
3065 DSN1_a  DF5 Leu2::Yip128-HADSN1_a[LEU2] This study 
3066 DSN1_b DF5 Leu2::Yip128-HADSN1_b[LEU2] This study 
3067 DSN1_c DF5 Leu2::Yip128-HADSN1_c[LEU2] This study 
3068 DSN1_d DF5 Leu2::Yip128-HADSN1_d[LEU2] This study 
3069 DSN1_wt DF5 Leu2::Yip128-HADSN1_wt[LEU2] This study 
3075 SPC24-MIU 
(A58G)-3FLAG 
W303 SPC24-MIU (A58G)-3FLAG::HIS3MX6 This study 
3076 SPC25 L109A 
SPC24-MIU 
(A58G)-3FLAG 
W303 spc25(L109A), SPC24-MIU (A58G)-
3FLAG::HIS3MX6 
This study 
3077 spc105-15 
SPC24-MIU 
(A58G)-3FLAG 
W303 spc105-15, SPC24-MIU (A58G)-
3FLAG::HIS3MX6 
This study 
3078 spc105-15 spc25 
L109A SPC24-
MIU (A58G)-
3FLAG 
W303 spc105-15, spc25 L109A, SPC24-MIU 
(A58G)-3FLAG::HIS3MX6 
This study 
3079 Δubc1 DSN1-
6HA 
DF5 ubc1::HIS3, DSN1-6HA::kanMX4 This study 
3080 Δrad6 a DSN1-
6HA 
DF5 rad6::HIS3, DSN1-6HA::kanMX4 This study 
3081 cdc34-1 DSN1-
6HA 
DF5 cdc34-1, DSN1-6HA::kanMX4 This study 
3082 Δubc4 DSN1-
6HA 
DF5 ubc4::HIS3 DSN1-6HA::kanMX4 This study 
3083 Δubc5 DSN1-
6HA 
DF5 ubc5::LEU2 DSN1-6HA::kanMX4 This study 
3084 Δubc6,7 DSN1-
6HA 
DF5 ubc6::HIS3, ubc7::HIS3, DSN1-
6HA::kanMX4 
This study 
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3085 Δubc8 DSN1-
6HA 
DF5 ubc8::URA3, DSN1-6HA::kanMX4 This study 
3086 Δubc10 DSN1-
6HA 
DF5 ubc10::LEU2, DSN1-6HA::kanMX4 This study 
3087 Δubc11 DSN1-
6HA 
DF5 ubc11::HIS3, DSN1-6HA::kanMX4 This study 
3088 Δubc13 DSN1-
6HA 
DF5 ubc13::HIS3, DSN1-6HA::kanMX4 This study 
3089 DSN1-6HA 
(KAN) 
DF5 DSN1-6HA::kanMX4 This study 
3098 spc25 L109A 
spc24-1 MIU-
3FLAG 
W303 spc25 L109A, spc24-1, SPC24-MIU-
3FLAG::HIS3MX6 
This study 
 
 
7.2 E. coli strains 
Table 7.2 - List of E. coli strains used for this thesis. 
Name Use  Genotype Source  
One Shot 
Top10 
Production of 
plasmids, 
cloning 
F- mcrA Δ( mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ lacX74 recA1 araD139 
Δ( araleu)7697 galU galK rpsL (StrR) 
endA1 nupG 
Life 
Technologies  
One Shot 
ccdB Survival 
2 T1R 
Production of 
plasmids with 
the ccdB gene 
F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araΔ139 
Δ(ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG fhuA::IS2 
Life 
Technologies 
BL21(DE3)p
LysS 
Protein 
expression 
F- ompT hsdSB(rB- mB-) dcm gal λ(DE3) 
pLysS Cmr 
Promega 
BL21 codon2+ Protein 
expression  
F- ompT hsdS(rB- mB-) dcm+ TetR 
gal (DE3) endA Hte 
Dale Wigley 
 
 
7.3 Statistics for the mechanoreceptor defect quantifications 
The bristle defects of different genotypes were analysed for significant differences 
using a Fisher’s exact test (Freeman-Halton extension) and P values are listed in Table 
7.3. For genotypes that had 7 different defect groups (Figure 4.10, Figure 4.11, Figure 
4.12 and Figure 4.14) group 5 bristle defects and group 6 (or over) bristle defects were 
treated as one group to allow the calculation of P values. 
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Table 7.3 - Test of significance for mechanoreceptor defects between genotypes using 
Fisher’s exact test.  
Genotype A Genotype B P value  
Figure 4.2   
F10B221 F10B221/Df >0.9999 n.s. 
F10C321 F10C321/Df 0.0381 * 
F9128, F10B221 F9128, F10B221 /Df 0.0670 n.s. 
ctrl F10 F10C321 0.0052 ** 
F10B221 F9128, F10B221 0.9198 n.s. 
F10B221 F10C321 <0.0001 *** 
F10B221/Df F9128, F10B221 /Df 0.0828 n.s. 
F10B221/Df F10C321/Df <0.0001 *** 
F10B221 males F10B221 0.0001 *** 
F10C321 males F10C321 0.8056 n.s. 
F9128, F10B221 males F9128, F10B221 0.0011 ** 
F10B221 ubi-GFP; F10B221 0.0031 ** 
F10B221 ubi-GFP-F9; F10B221 0.1000 n.s. 
ubi-GFP; F10B221 ubi-GFP-F9; F10B221 0.0047 ** 
ubi-GFP; F10B221 ubi-GFP; F9128, F10B221 0.1350 n.s. 
F9128, F10B221 ubi-GFP; F9128, F10B221 0.2757 n.s. 
F9128, F10B221 ubi-GFP-F9; F9128, F10B221 0.1559 n.s. 
ubi-GFP; F9128, F10B221 ubi-GFP-F9; F9128, F10B221 0.0834 n.s. 
ubi-GFP-F9; F10B221 ubi-GFP-F9; F9128, F10B221 0.0011 ** 
F10B221 F86, F10B221 0.0045 ** 
F10B221 F86, F9128, F10B221 0.7425 n.s. 
F9128, F10B221 F86, F9128, F10B221 0.4105 n.s. 
Figure 4.3  
F10B221 F10B221/Df 0.0186 * 
F10C321 F10C321/Df 0.1885 n.s. 
F9128, F10B221 F9128, F10B221 /Df 0.0231 * 
F10B221 F9128, F10B221 0.0246 * 
F10B221 F10C321 0.0028 ** 
F10B221/Df F9128, F10B221 /Df 0.6585 n.s. 
F10B221/Df F10C321/Df 0.0001 ** 
F10B221 males F10B221 0.2886 n.s. 
F10C321 males F10C321 0.2687 n.s. 
F9128, F10B221 males F9128, F10B221 0.3936 n.s. 
F10B221 ubi-GFP; F10B221 0.0870 n.s. 
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ubi-GFP; F10B221 ubi-GFP-F9; F10B221 0.0307 * 
F10B221 ubi-GFP-F9; F10B221 0.5523 n.s. 
ubi-GFP; F10B221 ubi-GFP; F9128, F10B221 0.0354 * 
F9128, F10B221 ubi-GFP; F9128, F10B221 0.0648 n.s. 
ubi-GFP; F9128, F10B221 ubi-GFP-F9; F9128, F10B221 0.0092 ** 
F9128, F10B221 ubi-GFP-F9; F9128, F10B221 0.0251 * 
ubi-GFP-F9; F10B221 ubi-GFP-F9; F9128, F10B221 0.0569 n.s. 
F10B221 F86, F10B221 0.4626 n.s. 
F10B221 F86, F9128, F10B221 0.1428 n.s. 
F9128, F10B221 F86, F9128, F10B221 <0.0001 *** 
Figure 4.4   
F10B221 F10B221/Df 0.0076 ** 
F10C321 F10C321/Df 0.0272 * 
F9128, F10B221 F9128, F10B221 /Df <0.0001 *** 
F10B221 F9128, F10B221 <0.0001 *** 
F10B221 F10C321 <0.0001 *** 
F10B221/Df F9128, F10B221 /Df 0.0881 n.s. 
F10B221/Df F10C321/Df 0.1328 n.s. 
F10B221 males F10B221 <0.0001 *** 
F10C321 males F10C321 0.0091 ** 
F9128, F10B221 males F9128, F10B221 >0.9999 n.s. 
F10B221 ubi-GFP; F10B221 <0.0001 n.s. 
ubi-GFP; F10B221 ubi-GFP-F10; F10B221 0.8330 n.s. 
ubi-GFP; F10B221 ubi-GFP-F9; F10B221 0.3678 n.s. 
ubi-GFP; F10B221 ubi-GFP; F9128, F10B221 0.0050 ** 
F9128, F10B221 ubi-GFP; F9128, F10B221 >0.9999 n.s. 
ubi-GFP; F9128, F10B221 ubi-GFP-F9; F9128, F10B221 0.6777 n.s. 
ubi-GFP; F9128, F10B221 ubi-GFP-F10; F9128, F10B221 0.6777 n.s. 
F86 F86, F10B221 0.1531 n.s. 
F86 F86, F9128, F10B221 0.0095 ** 
F10B221 F86, F10B221 <0.0001 *** 
F10B221 F86, F9128, F10B221 <0.0001 *** 
F9128, F10B221 F86, F9128, F10B221 >0.9999 n.s. 
Figure 4.10A  
F10B221 dsh1;; F10B221 <0.0001 *** 
Figure 4.10B  
F10B221 dsh1;; F10B221 <0.0001 *** 
dsh1 dsh1;; F10B221 <0.0001 *** 
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dsh1 dsh1;; F10B221/+ 0.5955 n.s. 
dsh1 dsh1;; F9128 0.7596 n.s. 
dsh1 dsh1;; F9128/+ >0.9999 n.s. 
Figure 4.11  
nubG4/+; F10B221 nubG4/UAS-fz; F10B221 <0.0001 *** 
nubG4/+; F9128, F10B221 nubG4/UAS-fz; F9128, F10B221 <0.0001 *** 
nubG4/UAS-fz; F10B221 nubG4/UAS-fz; F9128, F10B221 0.0018 ** 
nubG4/UAS-fz; F10B221/+ nubG4/UAS-fz; F9128, F10B221/+ 0.8217 n.s. 
nubG4/+; F10B221 nubG4/+; F9128, F10B221 0.2084 n.s. 
nubG4/+; F10B221 nubG4/UAS-arm; F10B221 0.6931 n.s. 
nubG4/+; F9128, F10B221 nubG4/UAS-arm; F9128, F10B221 0.7516 n.s. 
nubG4/UAS-arm; F10B221 nubG4/UAS-arm; F9128, F10B221 0.8772 n.s. 
Figure 4.12  
nubG4/baz RNAi nubG4/baz RNAi; F9128 <0.0001 *** 
nubG4/baz RNAi nubG4/baz RNAi; F10B221 <0.0001 *** 
nubG4/+; F10B221 nubG4/baz RNAi; F10B221 <0.0001 *** 
nubG4/baz RNAi nubG4/baz RNAi; F9128, F10B221 <0.0001 *** 
nubG4/+; F9128, F10B221 nubG4/baz RNAi; F9128, F10B221 <0.0001 *** 
nubG4/pins RNAi nubG4/pins RNAi; F9128 <0.0001 *** 
nubG4/pins RNAi nubG4/pins RNAi; F10B221 <0.0001 *** 
nubG4/+; F10B221 nubG4/pins RNAi; F10B221 <0.0001 *** 
nubG4/pins RNAi nubG4/pins RNAi; F9128, F10B221 <0.0001 *** 
nubG4/+; F9128, F10B221 nubG4/pins RNAi; F9128, F10B221 <0.0001 *** 
nubG4/pins RNAi; F10B221 nubG4/pins RNAi; F9128, F10B221 >0.9999 n.s. 
Figure 4.13  
nubG4/+; F10B221 nubG4/ASPP RNAi; F10B221 0.0375 * 
nubG4/+; F9128, F10B221 nubG4/ASPP RNAi; F9128, F10B221 0.0209 * 
nubG4/ASPP RNAi; F10B221 nubG4/ASPP RNAi; F9128, F10B221 0.1438 n.s. 
Figure 4.14  
nubG4, baz RNAi/+  flw1/+; nubG4, baz RNAi/+ 0.0012 ** 
nubG4, baz RNAi/+ nubG4, baz RNAi/+; PP1α87B87Bg-3/+ <0.0001 *** 
nubG4, baz RNAi/+ nubG4, baz RNAi/+; PP1α96A2/+ 0.0851 n.s. 
nubG4, baz RNAi/+ nubG4, baz RNAi/ASPP RNAi <0.0001 *** 
Background noise (Figure 4.2 and 4.11)  
F10B221 nubG4/+; F10B221 0.0153 * 
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